
<!-- saved from url=(0081)https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm -->
<html><head><meta http-equiv="Content-Type" content="text/html; charset=windows-1252"></head><body bgcolor="WHITE"><document>
<type>S-1
<sequence>1
<filename>d460243ds1.htm
<description>S-1
<text>

<title>S-1</title>

 
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>As filed with the Securities and Exchange Commission on October&nbsp;2, 2018. </b></font></p>
<p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="1"><b>Registration No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b></font></p>
<p style="line-height:3px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</p> <p style="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</p>
<p style="margin-top:2px;margin-bottom:0px" align="center"><font style="font-family:arial" size="4"><b>UNITED STATES </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="4"><b>SECURITIES
AND EXCHANGE COMMISSION </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2"><b>Washington, D.C. 20549 </b></font></p>
<p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p><center> <p style="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</p></center>
<p style="margin-top:3px;margin-bottom:0px" align="center"><font style="font-family:arial" size="4"><b>FORM <font style="white-space:nowrap">S-1</font> </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="4"><b>REGISTRATION STATEMENT </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2"><b><i>UNDER </i></b></font></p>
<p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2"><b><i>THE SECURITIES ACT OF 1933 </i></b></font></p> <p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p><center>
<p style="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</p></center> <p style="margin-top:3px;margin-bottom:0px" align="center"><font style="font-family:arial" size="5"><b>TWIST BIOSCIENCE
CORPORATION </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>(Exact name of Registrant as specified in its charter) </b></font></p>
<p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p><center> <p style="line-height:4px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</p></center>
<p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="34%"></td>
<td valign="bottom"></td>
<td width="32%"></td>
<td valign="bottom" width="1%"></td>
<td width="32%"></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top" align="center"><font style="font-family:arial" size="1"><b>Delaware</b></font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="1"><b>2836</b></font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="1"><b><font style="white-space:nowrap">46-2058888</font></b></font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top" align="center"><font style="font-family:arial" size="1"><b>(State or other jurisdiction of</b></font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="1"><b>(Primary Standard Industrial</b></font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="1"><b>(I.R.S. Employer</b></font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top" align="center"><font style="font-family:arial" size="1"><b>incorporation or organization)</b></font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="1"><b>Classification Code Number)</b></font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="1"><b>Identification Number)</b></font></td></tr>
</tbody></table> <p style="margin-top:3px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>455 Mission Bay Boulevard South, Suite 545 </b></font></p>
<p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>San Francisco, CA 94158 </b></font></p>
<p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>(800) <font style="white-space:nowrap">719-0671</font> </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices) </b></font></p>
<p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p><center> <p style="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</p></center>
<p style="margin-top:3px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Emily M. Leproust </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>President
and Chief Executive Officer </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Twist Bioscience Corporation </b></font></p>
<p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>455 Mission Bay Boulevard South, Suite 545 </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>San Francisco, CA 94158 </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>(800) <font style="white-space:nowrap">719-0671</font>
</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>(Name, address including zip code, and telephone number including area code, of agent for service) </b></font></p>
<p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p><center> <p style="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</p></center>
<p style="margin-top:3px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b><i>COPIES TO: </i></b></font></p> <p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="34%"></td>
<td valign="bottom"></td>
<td width="32%"></td>
<td valign="bottom" width="1%"></td>
<td width="32%"></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top" align="center"> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>John V. Bautista, Esq.</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Peter M. Lamb, Esq.</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Christopher J. Austin, Esq.</b></font></p>
<p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Orrick, Herrington&nbsp;&amp; Sutcliffe LLP</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>1000 Marsh Road</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Menlo Park, CA 94025</b></font></p>
<p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="1"><b>(650) <font style="white-space:nowrap">614-7400</font></b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Mark Daniels, Esq.</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>General Counsel</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Twist Bioscience Corporation</b></font></p>
<p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>455 Mission Bay Boulevard</b></font></p>
<p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Suite 545</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>San Francisco, CA
94158</b></font></p> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="1"><b>(844) 362-8978</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Brian J. Cuneo, Esq.</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>B. Shayne Kennedy, Esq.</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Latham&nbsp;&amp; Watkins LLP</b></font></p>
<p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>140 Scott Drive</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Menlo Park,
CA 94025</b></font></p> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="1"><b>(650) <font style="white-space:nowrap">328-4600</font></b></font></p></td></tr>
</tbody></table> <p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p><center> <p style="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</p></center>
<p style="margin-top:3px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Approximate date of commencement of proposed sale to the public: </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1">As soon as practicable after this Registration Statement becomes effective. </font></p> <p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p><center>
<p style="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</p></center> <p style="margin-top:3px;margin-bottom:0px"><font style="font-family:arial" size="1">If any of the securities being registered
on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.&nbsp;&nbsp; <font style="font-family:Times New Roman" size="1">&#9744;</font> </font></p>
<p style="margin-top:3px;margin-bottom:0px"><font style="font-family:arial" size="1">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp; <font style="font-family:Times New Roman" size="1">&#9744;</font></font></p>
<p style="margin-top:3px;margin-bottom:0px"><font style="font-family:arial" size="1">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp; <font style="font-family:Times New Roman" size="1">&#9744;</font> </font></p> <p style="margin-top:3px;margin-bottom:0px"><font style="font-family:arial" size="1">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective
registration statement for the same offering.&nbsp;&nbsp; <font style="font-family:Times New Roman" size="1">&#9744;</font> </font></p> <p style="margin-top:3px;margin-bottom:0px"><font style="font-family:arial" size="1">Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a <font style="white-space:nowrap">non-accelerated</font> filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated
filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule <font style="white-space:nowrap">12b-2</font> of the Securities Exchange Act of 1934 (check one): </font></p>
<p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="14%"></td>
<td valign="bottom" width="1%"></td>
<td width="65%"></td>
<td valign="bottom" width="1%"></td>
<td width="17%"></td>
<td valign="bottom" width="1%"></td>
<td width="1%"></td></tr>


<tr style="page-break-inside:avoid">
<td valign="bottom"><font style="font-family:arial" size="1">Large&nbsp;accelerated&nbsp;filer</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1"><font style="font-family:Times New Roman" size="1">&#9744;</font></font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">Accelerated&nbsp;filer</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1"><font style="font-family:Times New Roman" size="1">&#9744;</font></font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom"><font style="font-family:arial" size="1">Non-accelerated&nbsp;filer</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1"><font style="font-family:Times New Roman" size="1">&#9746;</font></font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">Smaller&nbsp;reporting&nbsp;company</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1"><font style="font-family:Times New Roman" size="1">&#9744;</font></font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">Emerging&nbsp;growth&nbsp;company</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1"><font style="font-family:Times New Roman" size="1">&#9746;</font></font></td></tr>
</tbody></table> <p style="margin-top:3px;margin-bottom:0px"><font style="font-family:arial" size="1">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp; <font style="font-family:Times New Roman" size="1">&#9746;</font> </font></p>
<p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p><center> <p style="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</p></center>
<p style="margin-top:3px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>CALCULATION OF REGISTRATION FEE </b></font></p> <p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="72%"></td>
<td valign="bottom" width="1%"></td>
<td width="13%"></td>
<td valign="bottom" width="1%"></td>
<td width="13%"></td></tr>


<tr style="font-size:1px">
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" align="center" style="BORDER-TOP:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Title of each class&nbsp;of</b></font></p>
<p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="1"><b>securities to be registered</b></font></p></td>
<td valign="bottom" style=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" nowrap="" align="center" style="BORDER-TOP:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>Proposed</b></font></p>
<p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>maximum</b></font></p>
<p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="1"><b>aggregate</b></font></p> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="1"><b>offering price
per<br>share (1)(2)</b></font></p></td>
<td valign="bottom" style=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" nowrap="" align="center" style="BORDER-TOP:1px solid #000000"><font style="font-family:arial" size="1"><b>Amount of<br>registration fee</b></font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top" style="BORDER-TOP:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Common Stock, par value $0.00001 per share</font></p></td>
<td valign="bottom" style=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" nowrap="" align="center" style="BORDER-TOP:1px solid #000000"><font style="font-family:arial" size="1">$86,250,000</font></td>
<td valign="bottom" style=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" nowrap="" align="center" style="BORDER-TOP:1px solid #000000"><font style="font-family:arial" size="1">$10,453.50</font></td></tr>
<tr style="font-size:1px">
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td></tr>
<tr style="font-size:1px">
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td></tr>
</tbody></table>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Includes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of Common Stock issuable upon exercise of the Underwriters’ option to purchase
additional shares, solely to cover overallotments. See “Underwriting.” </font></td></tr></tbody></table> <p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(2)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. </font></td></tr></tbody></table>
<p style="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</p><center> <p style="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</p></center> <p style="margin-top:3px;margin-bottom:0px"><font style="font-family:arial" size="1"><b>The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that
this Registration Statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange
Commission, acting pursuant to said Section&nbsp;8(a), may determine. </b></font></p> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<p style="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</p> <p style="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</p>
</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2" color="#cc062a"><b>The information in this preliminary prospectus is not complete and may be changed. We may not
sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in
any jurisdiction where the offer or sale is not permitted. </b></font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2" color="#cc062a"><b>Subject to completion, dated October&nbsp;2, 2018 </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b>PRELIMINARY PROSPECTUS </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares </i></b></font></p>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p> <p style="margin-top:0px;margin-bottom:0px">


<img src="./S-1_files/g460243g62v45.jpg" alt="LOGO">
 </p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><i>Common stock </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">This
is the initial public offering of shares of common stock of Twist Bioscience Corporation. Prior to this offering, there has been no public market for our common stock. The initial public offering price is expected to be between
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are applying to list our common stock on the Nasdaq Global Market under the symbol “TWST.” </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are an
“emerging growth company,” as defined under the federal securities laws and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings. </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="74%"></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Per&nbsp;Share</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="10"></td>
<td height="10" colspan="4"></td>
<td height="10" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Initial public offering price</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="top" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="top" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="10"></td>
<td height="10" colspan="4"></td>
<td height="10" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Underwriting discounts and commissions</font><font style="font-family:arial" size="1"><sup style="vertical-align:baseline; position:relative; bottom:.8ex">(1)</sup></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="top" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="top" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="10"></td>
<td height="10" colspan="4"></td>
<td height="10" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Proceeds, before expenses, to Twist Bioscience Corporation</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="top" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="top" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">See “Underwriting” for additional disclosure regarding underwriting discounts and commissions and estimated offering expenses. </font></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have granted the underwriters a <font style="white-space:nowrap">30-day</font> option to purchase up
to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of common stock from us at the initial public offering price less the underwriting discounts and commissions, solely to cover
overallotments. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b></b><b><i>Investing in our common stock involves a high degree of risk. See the section entitled “<a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_2">Risk factors
</a>” beginning on page 18 to read about factors you should consider before buying shares of our common stock.</i></b><b> </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b>Neither the
Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.
</b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p><center> <p style="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</p></center>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The underwriters expect to deliver the shares of common stock to purchasers on or
about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018. </font></p>
<p style="margin-top:12px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2"><i>Joint book running managers </i></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="45%"></td>
<td valign="bottom" width="2%"></td>
<td width="42%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="5"><b>J.P. Morgan</b></font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="5"><b>&nbsp;</b></font></td>
<td valign="top" align="right"><font style="font-family:arial" size="5"><b>Cowen</b></font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="5"><b>&nbsp;</b></font></td></tr></tbody></table>
<p style="margin-top:12px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2"><i><font style="white-space:nowrap">Co-managers</font> </i></font></p> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="46%"></td>
<td valign="bottom" width="2%"></td>
<td width="43%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>

<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="5"><b>Allen&nbsp;&amp; Company LLC</b></font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="5"><b>&nbsp;</b></font></td>
<td valign="top" align="right"><font style="font-family:arial" size="5"><b>Baird</b></font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="5"><b>&nbsp;</b></font></td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018
</b></font></p>
</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc"></a>Table of contents </b></font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="94%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right"><font style="font-family:arial" size="1"><b>Page</b></font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_1">Prospectus summary</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">1</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_24">Summary consolidated financial information </a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">15</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_2">Risk factors</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">18</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_3">Special note regarding forward-looking statements</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">55</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_4">Industry and market data</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">57</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_5">Use of proceeds</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">58</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_6">Dividend policy</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">60</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_7">Capitalization</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">61</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_8">Dilution</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">63</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_9">Selected consolidated financial data</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">66</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_10">Management’s discussion and analysis of financial condition and results of operations</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">69</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_11">Business</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">92</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_12">Management</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">124</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_13">Executive compensation</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">136</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_14">Certain relationships and related party transactions</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">151</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_15">Principal stockholders</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">156</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_16">Description of capital stock</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">159</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_17">Shares eligible for future sale</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">164</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_18">Material U.S. federal income tax considerations for <font style="white-space:nowrap">non-U.S.</font>
holders</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">166</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_19">Underwriting</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">170</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_20">Legal matters</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">181</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_21">Experts</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">181</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc460243_22">Where you can find more information</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">181</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Twist Bioscience Corporation Index to consolidated financial statements</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2"><font style="white-space:nowrap">F-1</font></font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b>NEITHER WE NOR THE UNDERWRITERS HAVE AUTHORIZED ANYONE TO PROVIDE ANY INFORMATION OR TO MAKE ANY REPRESENTATIONS OTHER THAN THOSE
CONTAINED IN THIS PROSPECTUS OR IN ANY FREE WRITING PROSPECTUSES WE HAVE PREPARED. NEITHER WE NOR THE UNDERWRITERS TAKE RESPONSIBILITY FOR, AND CAN PROVIDE NO ASSURANCE AS TO THE RELIABILITY OF, ANY OTHER INFORMATION THAT OTHERS MAY GIVE YOU. THIS
PROSPECTUS IS AN OFFER TO SELL ONLY THE SHARES OFFERED HEREBY, BUT ONLY UNDER CIRCUMSTANCES AND IN JURISDICTIONS WHERE IT IS LAWFUL TO DO SO. THE INFORMATION CONTAINED IN THIS PROSPECTUS IS CURRENT ONLY AS OF ITS DATE. </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For investors outside of the United States: We have not, and the underwriters have not, done anything that would permit this offering or possession or distribution
of this prospectus in any jurisdiction where action for that purpose is required, other than the United States. Persons outside of the United States who come into possession of this prospectus must inform themselves about, and observe any
restrictions relating to, the offering of the shares of common stock and the distribution of this prospectus outside of the United States. </font></p> <p style="margin-top:8px;margin-bottom:0px;padding-bottom:0px; "><font style="font-family:arial" size="2">“Twist Bioscience,” and “Sequencespace” are registered trademarks in the U.S. and, in some cases, in certain other countries and our logo is an unregistered trademark of Twist Bioscience
Corporation. All other brand names or trademarks appearing in this prospectus are the property of their respective holders. Solely for convenience, the trademarks and trade names in this prospectus are referred to without the <font style="font-family:arial" size="1"><sup style="vertical-align:baseline; position:relative; bottom:.8ex">®</sup></font> and
<font style="font-family:arial" size="1"><sup style="vertical-align:baseline; position:relative; bottom:.8ex">™</sup></font> symbols, but such references should not be construed as any indicator that their respective owners will not assert, to
the fullest extent under applicable law, their rights thereto. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">i </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_1"></a>Prospectus summary </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>This summary highlights information contained in greater detail elsewhere in this prospectus. Before making an investment in our common stock, you should carefully read this entire prospectus, including our
consolidated financial statements and the related notes thereto and the information in the sections entitled “Risk factors,” “Management’s discussion and analysis of financial condition and results of operations” and
“Business.” The last day of our fiscal year is September 30. </i></font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Overview </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of our platform is a proprietary
technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. We have combined this technology with proprietary software, scalable commercial infrastructure and an e-commerce platform to create an
integrated technology platform that enables us to achieve high levels of quality, precision, automation, and manufacturing throughput at a significantly lower cost than our competitors. We are leveraging our unique technology to manufacture a broad
range of synthetic DNA-based products, including synthetic genes, tools for next generation sample preparation, and antibody libraries for drug discovery and development. Additionally, we believe our platform will enable new value-add opportunities,
such as discovery partnerships for biologic drugs, and will enable new applications for synthetic DNA, such as digital data storage, which will drive growth in the market for our products. We sell our synthetic DNA and synthetic DNA-based products
to a customer base of over 600 customers across a broad range of industries. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">DNA is the fundamental building block of biology. The ability to design DNA
and engineer biology, a field known as synthetic biology, is growing rapidly, and we believe this field represents one of the most exciting areas of growth and technological innovation in the 21st&nbsp;century. The ability to modify DNA to serve
different purposes is leading to a broad range of applications for synthetic DNA and synthetic DNA-based products across multiple industries, including: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">healthcare for the discovery and production of new therapeutics and molecular diagnostics; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">industrial chemicals for cost-effective and sustainable production of new and existing specialty chemicals and materials, such as spider silk, nylon, rubber,
fragrances, food flavors and food additives; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">agriculture for more effective and sustainable crop production; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">academic research for a broad range of applications; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">technology for potential use as an alternative long-term data storage medium. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The synthetic biology market is growing rapidly and is being fueled by increased access to affordable and innovative tools that enable new applications. We believe this is analogous to the trends seen in the next
generation sequencing, or NGS, market, where declining costs of sequencing drove adoption, new applications and market expansion. Similarly, tools that combine advanced production technology with modern digital technology and software capabilities,
such as our DNA synthesis platform, are driving growth and market creation for synthetic DNA and synthetic DNA-based products. In calendar year 2017, the market for synthetic biology products was approximately $4.4&nbsp;billion and is expected to
grow to $13.9&nbsp;billion by calendar year 2022. We believe this period of accelerated growth in the synthetic biology industry is in its early stages. </font></p>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">1 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The applications of our DNA synthesis platform are broad. Our mission is to be the leading provider of synthetic
genes, which are comprised of strands of synthetic DNA, and to leverage the versatility of our platform to expand our portfolio to include other synthetic DNA-based products and address additional market opportunities, including next generation
sequencing sample preparation, biological drug discovery and development and digital data storage. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In April 2016, we launched the first applications of
our platform, synthetic genes and high diversity collections of oligonucleotides, or oligo pools, to disrupt the gene synthesis market and make legacy DNA synthesis methods obsolete. We believe that the traditional DNA synthesis methods used by our
competitors are inherently limited in scalability and are not optimized to satisfy the rapidly growing demand for high-quality, <font style="white-space:nowrap">low-cost</font> synthetic DNA. Our silicon-based chip technology is able to increase DNA
production by a factor of 9,600 on a footprint similar to that of traditional DNA synthesis methods. Also, it significantly lowers the volume of required reagents, specifically the most expensive reagent by a factor of 1,000,000, and improves the
precision of the synthesis process relative to legacy methods. This enables us to produce high-quality synthetic DNA on a much larger scale and at lower cost than competitors. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have rapidly become a leading synthetic DNA provider. Between September 30, 2015 and June 30, 2018, the Company sold its products to more than 600 customers. In fiscal 2017, we served 286 customers including
$0.3 million in sales to seven of the top 20 pharmaceutical companies by revenue, $4.3 million in sales to Ginkgo Bioworks, Inc., or Ginkgo Bioworks (which we believe is the largest global purchaser of synthetic DNA), $0.3 million in sales to three
of the largest agricultural biotechnology companies, $2.7 million in sales to over 100 academic research institutions worldwide, and $7.3 million in sales to innovative customers using synthetic DNA for new and emerging applications, such as
Microsoft Corporation and the University of Washington for use of DNA as a digital data storage medium. We are also an original equipment manufacturer, or OEM, of synthetic DNA to four synthetic DNA manufacturers that also compete with us, which we
believe is a strong demonstration of the superiority of our platform. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the nine months ended June 30, 2018, we served 539 customers as follows: 50% to
industrial chemicals, 47% to academic research, 2% to agriculture and 1% to healthcare sectors. Sales to industrial chemicals, academic research, agriculture and healthcare sectors accounted for 73%, 25%, 2% and 0.1% of the total $17.0 million
revenues for the nine months ended June 30, 2018. Sales to Ginkgo Bioworks amounted to $5.5 million, or 32% and sales to customers other than Ginkgo Bioworks was $11.5 million, or 68%, for the nine months ended June&nbsp;30, 2018; an increase in
revenue of 89% and 162%, respectively, as compared to the nine months ended June 30, 2017. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have also leveraged the versatility of our platform to
expand our product portfolio into other markets in which we believe we have a competitive advantage. In February 2018, we launched an innovative and comprehensive sample preparation kit for next generation sequencing at the Advances in Genome
Biology and Technology conference. Our kit leverages our platform to precisely synthesize oligo pools and uniformly amplify the desired target DNA segments, considerably improving the accuracy of the downstream sequencing analysis. We have also
commercialized a custom DNA library solution which enables more effective biologic drug discovery and development for our customers. We believe we can further leverage our platform to develop other proprietary tools, such as our G-protein coupled
receptor, or GPCR, library and antibody optimization solution, to provide an end-to-end solution in biologics drug discovery and early development, from target to investigational new drug, or IND, application, adding value as a partner to
biotechnology and pharmaceutical companies. We also aim to explore development of DNA as a digital data storage medium via internal research and industry partnerships. </font></p>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">2 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Our currently marketed products target the synthetic DNA market, a
<font style="white-space:nowrap">sub-segment</font> of the synthetic biology market, and NGS sample preparation, a large adjacent market opportunity. We estimate that the combined market opportunity was $1.8&nbsp;billion in calendar year 2016. We
believe that current estimates understate our market potential because they reflect the costly, time-consuming, and cumbersome nature of legacy DNA synthesis technologies. We believe our solution has the potential to materially expand our initial
market by providing end users access to high-quality and lower cost tools, encouraging adoption and facilitating new applications for our products. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We
have built a scalable commercial platform that enables us to reach a diverse customer base that we estimate consists of over 100,000 synthetic DNA users today. In order to address this diverse customer base, we have employed a multi-channel strategy
comprised of a direct sales force targeting synthetic DNA customers, a direct sales force focusing on the NGS market and an <font style="white-space:nowrap">e-commerce</font> platform. We launched our proprietary, innovative, and <font style="white-space:nowrap"><font style="white-space:nowrap">easy-to-use</font></font> <font style="white-space:nowrap">e-commerce</font> platform in October 2017 to existing customers and expanded access to the general public in January 2018. Our
platform allows customers to design, validate, and place <font style="white-space:nowrap">on-demand</font> orders of customized DNA online. This is a critical part of our strategy to address our large and diverse customer base, as well as drive
commercial productivity, enhance the customer experience, and promote loyalty. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Since our formation in 2013, we have grown rapidly and achieved several
key milestones that we believe position us for continued growth and success: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">In 2015, we demonstrated the benefits and validated the commercial utility of our proprietary silicon-based platform for DNA synthesis through a proof-of-concept
program called the Alpha Access program, which provided initial access to our platform to select customers. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">In 2016, we (i) secured a long-term contract with Ginkgo Bioworks to provide up to 100 million base pairs of DNA, which we believe was the largest agreement for
synthetic DNA at that time, (ii) launched our early commercial access program in April called the Beta Access program to select customers and expanded our existing relationship with Ginkgo Bioworks, (iii) acquired Genome Compiler Corporation to add
software design capabilities for our <font style="white-space:nowrap">e-commerce</font> ordering system, (iv) laid the groundwork to pursue an opportunity in biologics drug discovery though a relationship with Distributed Bio, Inc., or Distributed
Bio, and (v) supplied DNA to Microsoft Corporation for its work with the University of Washington to develop DNA as a data storage medium. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">In 2017, we continued to increase penetration with existing customers and expand our customer base, by (i)&nbsp;serving 286 customers (up from 97 customers in
2016), (ii) extending the scope of our relationship with Microsoft Corporation and the University of Washington, (iii)&nbsp;entering into an agreement to supply thousands of genes for public benefit through the BioBricks Foundation,
(iv)&nbsp;successfully achieving industry-leading volumes of synthetic DNA shipped every month, (v)&nbsp;becoming an OEM supplier of synthetic DNA to four synthetic DNA manufacturers that also compete with us, (vi) launching our e-commerce platform
to existing customers in October 2017, and (vii) shipping over 38,000 genes in the fourth quarter of fiscal 2017 compared to approximately 7,600 for the fourth quarter of fiscal 2016, which represents 400% year-over-year growth.
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">In 2018, we continued to experience revenue growth greater than the estimated rate of growth of the synthetic biology market, expanded into new market
opportunities for next-generation sequencing and antibody biologics discovery, and enhanced our global distribution capabilities by (i) launching our e-commerce platform to the general public, (ii) launching our NGS target enrichment solutions at a
major </font></p></td></tr></tbody></table>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">3 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%"><font size="1">&nbsp;</font></td>
<td valign="top"> <p><font style="font-family:arial" size="2">
medical conference, (iii) completing a private financing with funds reserved for building Chinese operations, (iv) signing international distributors in Asia Pacific, (v) expanding our management
team to support our entry into the biologics drug discovery and early development, (vi) signing a new agreement with Ginkgo Bioworks to deliver up to approximately 1.3 billion base pairs over a period of four years and (vii) shipping 19,794 genes in
the third quarter of fiscal 2018 compared to 8,297 for the third quarter of fiscal 2017, which represents 139% year-over-year growth, and compared to shipping 2,650&nbsp;genes in the third quarter of fiscal 2016. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We generated revenue of $2.3&nbsp;million in fiscal 2016 and $10.8&nbsp;million in fiscal 2017, representing 375% year-over-year growth, while incurring net losses
of $44.1&nbsp;million in fiscal 2016 and $59.3&nbsp;million in fiscal 2017. In addition, we generated revenue of $7.3 million and $17.0 million in the nine months ended June 30, 2017 and 2018, representing 133% period-over-period growth, while
incurring net losses of $42.3 million and $51.4 million in the nine months ended June 30, 2017 and 2018. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our headquarters and manufacturing facilities
are located in San Francisco, California. As of June 30, 2018, we had 221 full-time employees worldwide, including three locations in the San Francisco Bay Area and an international location in Tel Aviv, Israel. We also utilize a team of
14&nbsp;dedicated commercial consultants across the European Union and the United Kingdom and five dedicated commercial consultants across Asia. We also recently received private funding to establish production facilities and commercial operations
in Asia. We plan to begin operations in Asia in 2019. As of August 31, 2018, we have raised a total of $291.5&nbsp;million in gross proceeds from the sale of equity securities. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>The synthetic biology industry </u></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We operate in the field of synthetic biology, which is undergoing an era
of rapid innovation and transformation. Synthetic biology is the engineering of biology to build new biological systems or <font style="white-space:nowrap">re-design</font> existing biological systems. The ability to design DNA and engineer biology
is creating advances and benefits for a broad and growing range of applications for synthetic DNA and synthetic DNA-based products across multiple industries, including: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">healthcare for the discovery and production of new therapeutics and molecular diagnostics; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">industrial chemicals for cost-effective and sustainable production of new and existing specialty chemicals and materials, such as spider silk, nylon, rubber,
fragrances food flavors and food additives; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">agriculture for more effective and sustainable crop production; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">academic research for a broad range of applications; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">technology for potential use as an alternative long-term data storage medium. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">According to BCC Research, the overall market for synthetic biology products was approximately $4.4&nbsp;billion in calendar year 2017 and is expected to grow to over $13.9&nbsp;billion by calendar year 2022. This
industry momentum creates a significant opportunity for us to grow within our existing markets as well as expand our product offering. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Synthetic DNA is
the fundamental building block of synthetic biology. Users of synthetic biology can design synthetic DNA to regulate the production of these proteins and molecules to achieve a specific functional purpose. While synthetic DNA has been produced for
more than 40&nbsp;years, the complexities of biology and the production constraints inherent in legacy processes have historically limited the applications and market opportunities for DNA synthesis. </font></p>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">4 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Limitations of existing solutions </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Traditional methods of DNA synthesis consist of a <font style="white-space:nowrap">two-step</font> process that initially involves the synthesis of oligonucleotides, also referred to as oligos, which are short
strands of DNA. These oligos are then combined to create longer strands of DNA. Currently, there are two primary methodologies used by others to create synthetic DNA, the 96-well plate method and the microarray method, each having production
limitations that we believe make these technologies <font style="white-space:nowrap">sub-optimal</font> to satisfy the rapidly growing demand for synthetic DNA. In addition, because the synthesis of oligos can introduce errors in the sequence order,
all DNA synthesis methods require a process called cloning to produce many identical copies of a strand of DNA, such as a clonal gene. Today, all of our competitors use one of these two primary methods of DNA synthesis and require cloning for clonal
genes. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i><font style="white-space:nowrap">96-well</font> plate method of DNA synthesis </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Introduced as early as the 1950s, a <font style="white-space:nowrap">96-well</font> plate is a flat plastic plate, roughly the size of two smartphones, with eight
rows of 12 wells that are used as small test tubes. Instead of creating one sequence of DNA at a time in a single test tube, the <font style="white-space:nowrap">96-well</font> plate allows researchers to create 96 oligos in parallel, one in each
well. While this process successfully achieves DNA synthesis, it requires high volumes of phosphoramidites, an expensive raw material, as well as other ancillary reagents. It also produces excessive amounts of the final product, significantly more
than is required for most subsequent processes, resulting in material that is discarded and an unnecessary expense. Additionally, this process is not scalable to produce high volumes, as approximately 100 oligos are needed to assemble one gene and
therefore only one gene can be made from each <font style="white-space:nowrap">96-well</font> plate. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Microarray method of DNA synthesis
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Unlike a <font style="white-space:nowrap">96-well</font> plate, a microarray is a flat surface made of plastic or glass on which DNA is
synthesized directly in an array of discrete locations. Microarrays allow large numbers of oligos to be synthesized in parallel, increasing DNA production by up to four orders of magnitude when compared to the
<font style="white-space:nowrap">96-well</font> plate. However, while this method can make 100 genes in parallel, it remains difficult to scale, requires many steps, and results in significant waste of materials. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Cloning </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Cloning is a tedious process to filter out
errors and produce many identical copies of a strand of DNA, such as a gene. While the cloning process results in a precise sequence, it is incredibly slow and labor intensive and generally takes around 10 business days to complete. As a result, it
is time consuming, expensive, and, in many cases, not an efficient use of researchers’ time. In general, more accurate DNA synthesis technology results in fewer errors in the sequence order and reduces the time and costs required or allocated
to the cloning process. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Our platform </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We
developed the Twist Bioscience DNA synthesis platform to address the limitations of throughput, scalability, and cost inherent in legacy DNA synthesis methods. Our platform stems from extensive analyses of, and improvements to, the existing gene
synthesis and assembly workflows. Our core technologies combine expertise in silicon, software, fluidics, chemistry, and motion and vision control to miniaturize thousands of parallel chemical reactions on silicon and write thousands of strands of
DNA in parallel. With a footprint that is similar to the size of a <font style="white-space:nowrap">96-well</font> plate that produces one gene, we are able to produce 9,600&nbsp;genes in parallel. Based on current production needs, we have
intentionally designed our latest chip to make 6,144 genes in parallel, but we have the current capability to increase this to 9,600 genes, as needed. We have combined our </font></p>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">5 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
DNA synthesis technology with propriety software and a scalable commercial infrastructure to create our vertically integrated DNA synthesis platform capable of delivering very large volumes of
high-quality synthetic DNA at low cost. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p> <p style="margin-top:0px;margin-bottom:0px" align="center">


<img src="./S-1_files/g460243g39z57.jpg" alt="LOGO">
 </p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe that buyers of DNA are looking for a product and purchasing experience that delivers on a number of key factors and
that our platform is uniquely designed to meet these customer needs and overcome the limitations of legacy DNA synthesis methods in order to support the growing demand for synthetic DNA: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="18%"></td>
<td valign="bottom" width="2%"></td>
<td width="39%"></td>
<td valign="bottom" width="2%"></td>
<td width="39%"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Customer desires</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Twist Bioscience advantages</b></font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2"><i>Quality and accuracy</i></font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Quality and accuracy is a basic requirement for all customers. Deviations from customer specifications can render
customers’ downstream uses less productive or ineffective.</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Synthetic DNA providers are able to supply perfect clonal DNA to the customer. However, existing DNA synthesis
technologies require significant cloning and error filtration to produce perfect clonal DNA. We are able to consistently produce high-quality oligos with what we believe is an industry-leading error rate of 1/1000 base pairs. This enables us to
reduce the cloning and error filtration necessary to achieve perfect clonal DNA.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><i>Cost</i></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Cost is a critical consideration for both large and small-scale customers. Large-scale commercial DNA purchasers that
outsource their DNA supply are becoming increasingly price sensitive due to their growing demand for DNA.</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Because we miniaturize the chemical reaction on a silicon chip, require lower volumes of reagents, and automate the
production process, we are able to dramatically lower the production cost per base pair of DNA and offer our</font></p></td></tr></tbody></table>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">6 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="18%"></td>
<td valign="bottom" width="2%"></td>
<td width="39%"></td>
<td valign="bottom" width="2%"></td>
<td width="39%"></td></tr>

<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Customer desires</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Twist Bioscience advantages</b></font></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:0.00em"><font style="font-family:arial" size="2">On the other hand, smaller-scale users, particularly academic users, typically have made their own DNA because of limited budgets relative to the prices charged
by legacy DNA suppliers.</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:0.00em"><font style="font-family:arial" size="2">synthetic DNA at a lower price than competitors. As of September 2018, the publicly available pricing of our competitors for clonal DNA ranged from
$0.15—$2.00 per base pair (assuming an order size of 150&nbsp;base pairs). Our standard pricing for comparable DNA is $0.09 per base pair for genes between 300 and 1,800 base pairs in length. One of the best demonstrations of our cost advantage
is that we supply synthetic DNA to four other competing synthetic DNA providers.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2"><i>Throughput/scale</i></font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;As the applications for synthetic biology have expanded, customers are increasingly seeking to purchase large
quantities of DNA in relatively short periods of time, which often cannot be supplied by a single synthetic DNA provider due to production capacity constraints. Ordering from multiple suppliers to fulfill large orders can be costly and
administratively cumbersome for customers.</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Our silicon chip technology is able to increase DNA production by a factor of 9,600 on a footprint similar to
traditional DNA synthesis methods. We currently have the capability to manufacture 20 million oligonucleotides per month that can be combined into high-precision oligo pools of various sizes. These oligonucleotides can be used to create multiple
products including genes. We currently have the capacity to produce more than 45,000 genes per month, which we believe is the highest in the industry. We have agreed to supply up to approximately 1.3 billion base pairs to Ginkgo Bioworks over a
period of four years, which we believe is the largest volume supply commitment in the industry to date.</font></p></td></tr>
<tr style="font-size:1px">
<td colspan="5" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2"><i>Turnaround time</i></font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;The time between placement of the order and delivery is a key consideration for customers. For example, pharmaceutical
companies are focused on shortening internal R&amp;D timelines and ready availability of high-quality, synthetic DNA to meet their internal timelines.</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Because our platform enables the large-scale production of DNA, our turnaround time is largely independent of order
size. We have enhanced our manufacturing capabilities and expect to reduce turnaround time on large commercial quantities of genes (i.e., orders of over 15,000 genes per month) to 10 business days.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2"><i>Product offering/ complexity</i></font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Customers require a broad range of products including different gene lengths, complicated sequences and a wide range of
additional configurations to fulfill a diverse set of applications and uses.</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Because we synthesize each oligonucleotide individually, we can customize orders to almost any customer’s
specifications. We currently offer genes of up to 3,200 base pairs in length, which we believe satisfies a substantial portion of the market for</font></p></td></tr></tbody></table>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">7 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="18%"></td>
<td valign="bottom" width="2%"></td>
<td width="39%"></td>
<td valign="bottom" width="2%"></td>
<td width="39%"></td></tr>

<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Customer desires</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Twist Bioscience advantages</b></font></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:0.00em"><font style="font-family:arial" size="2">synthetic DNA today. We expect to offer genes of up to 10,000 base pairs in the</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em"><font style="font-family:arial" size="2">future. Unlike traditional DNA synthesis technologies, we can also manufacture a broad range of additional products on our same DNA synthesis platform,
including antibody libraries and oligo pools, among others.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><i>Reliability</i></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Customers value the reliability of a supplier to deliver on promises of quality and turnaround time to allow them to
plan their downstream workflow and hit internal deadlines.</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Due to our throughput capability and proprietary integrated production and ordering process we have been able to
consistently meet the specifications and turnaround time that we promise customers.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2"><i><font style="white-space:nowrap">E-commerce</font> capability</i></font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Customers, particularly smaller-scale customers, value an intuitive, seamless
<font style="white-space:nowrap">e-commerce</font> experience that tracks orders from placement to delivery to simplify and automate the purchasing process. Some customers also value an application protocol interface, or an API, for electronic
integration into their own procurement systems.</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;While some synthetic DNA providers have an <font style="white-space:nowrap">e-commerce</font> platform for ordering
DNA, we believe we offer the most comprehensive <font style="white-space:nowrap">e-commerce</font> platform consisting of customized quotes, automated feedback on the feasibility of the sequence and the ability to track orders from placement to
delivery. An API is also a core component of our <font style="white-space:nowrap">e-commerce</font> system.</font></p></td></tr>
<tr style="font-size:1px">
<td colspan="5" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td></tr>
</tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Our target markets </u></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our currently marketed product offering addresses a market opportunity that was approximately $1.8&nbsp;billion in calendar year 2016. We believe our solution has
the potential to materially expand our initial market by providing end-users with access to high-quality and lower cost tools, encouraging adoption and facilitating new applications for our products, such as pharmaceutical biologics drug discovery
and digital data storage in DNA. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Synthetic DNA market </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe that our current market opportunity for synthetic DNA was approximately $1.3&nbsp;billion in calendar year 2016. The market consists of those who buy DNA, or DNA Buyers, and those who make their own DNA,
or DNA Makers. Driven by access to more affordable and high-quality synthetic DNA, we believe that there is a strong trend of DNA Makers converting to DNA Buyers. According to BCC Research, the size of the DNA Buyer market in 2016 was approximately
$300&nbsp;million and is growing at a rate of approximately 20% annually as existing DNA Buyers develop new uses for synthetic DNA and existing DNA Makers convert to DNA Buyers. We estimate our market opportunity in the DNA Maker market to be
approximately $950&nbsp;million. Our market estimate is based on the market sizes for products used in manual DNA synthesis, including the cloning and restriction digestion enzyme market in 2016, according to a report on Molecular Biology by Markets
and Markets. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>NGS sample preparation market </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our NGS sample preparation kits address the demand for better sample preparation products that improve the sequencing workflow, increase sequencing accuracy and
lower sequencing costs. We offer kits consisting of </font></p>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">8 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
double-stranded DNA probes and a comprehensive target enrichment kit that are used for exome sequencing and custom targeted sequencing. Kalorama Information, a division of marketresearch.com,
estimates the market for sample preparation for next generation sequencing was approximately $500&nbsp;million in calendar year 2016 and growing at approximately 20% annually. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Pharmaceutical biologics drug discovery </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe we are uniquely positioned to capture a larger
portion of the drug discovery value chain given that our synthetic DNA products are already used by our pharmaceutical partners throughout the drug development process. As part of our effort in this market, we recently launched our custom DNA
library solution which facilitates biologic drug discovery and development. We are already in agreement with a top three pharmaceutical company by revenue to supply our custom DNA libraries instead of them producing their own. In addition to our
custom DNA libraries, we are also developing other proprietary tools, such as a wholly-owned GPCR library and an antibody optimization solution, that we believe will enable us to provide an end-to-end solution in biologics drug discovery and early
development, from target to investigational new drug, or IND, application, and adding value as a partner to biotechnology and pharmaceutical companies. These partnerships may include upfront, milestone and royalty payments. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Digital data storage in DNA </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Due to the explosion of
data across many industries, finding efficient means of storage has become more important. Through the Semiconductor Research Corporation, many leading semiconductor companies, including Microsoft Corporation, IBM Corporation, Micron Technology,
Inc., Autodesk Inc., Mentor Graphics Corporation and GlobalFoundries Inc., are exploring DNA as a data storage medium. We have strategic relationships with Microsoft Corporation and the University of Washington through which we have demonstrated the
feasibility of storing data on DNA and the unique benefits of longevity, density, and universality of this format. We believe that in three to five years, new DNA technologies and cost efficiencies could surpass mature information technology
hardware solutions to allow data storage in DNA to become cost competitive with traditional storage media and enable us to target several large markets within data storage. The market for digital data storage is more than $35 billion and we believe
DNA can address several segments within this market. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our growth strategy </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our objective is to be the leading provider of synthetic DNA worldwide and to leverage the versatility of our platform to build a leadership position in other synthetic DNA-based product markets in which we have a
competitive advantage. We intend to accomplish this objective by executing on the following: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Maintain and expand our position as the provider of choice for high-quality, affordable synthetic genes and DNA to customers across multiple industries;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Become a leading supplier of NGS sample preparation products; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Conduct antibody therapeutic discovery and optimization for our current customers and future partners; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Continue to explore development of DNA as a digital data storage medium via internal research and government and industry partnerships; and
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Expand our global presence. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Beyond these
opportunities, we are working with industry partners to create new markets for our products by leveraging the versatility of our platform. </font></p>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">9 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Risks related to our business</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Investing in our common stock involves substantial risk. You should carefully consider all of the information in this prospectus prior to investing in our common stock. There are several risks related to our
business that are described under “Risk factors” elsewhere in this prospectus. Among these important risks are the following: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">We are an early stage company with limited operating history, which may make it difficult to evaluate our current business and predict our future
performance;</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">We have incurred net losses in every period to date, and we expect to continue to incur significant losses as we develop our business and may never achieve
profitability; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Our consolidated financial statements contain a going concern qualification and we will require additional financing to achieve our goals;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">If we are unable to attract new customers and retain and grow sales from our existing customers, our business will be materially and adversely affected;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Rapidly changing technology and extensive competition in synthetic biology could make the products we are developing obsolete or
<font style="white-space:nowrap">non-competitive</font> unless we continue to develop new and improved products and pursue new market opportunities; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">We and our chief executive officer are currently involved in litigation with Agilent Technologies, Inc., or Agilent, in which Agilent has alleged a claim of
trade secret misappropriation against Twist Bioscience and trade secret misappropriation and other related claims against our chief executive officer, and an adverse result could harm our business and results of operations;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Our revenue, results of operations, cash flows and reputation in the marketplace may suffer upon the loss of a significant customer;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">The continued success of our business relies heavily on our disruptive technologies and products and our position in the market as a leading provider of
synthetic DNA using a silicon chip; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">If we are unable to obtain, maintain and enforce intellectual property protection, others may be able to make, use, or sell products and technologies
substantially the same as ours, which could adversely affect our ability to compete in the market. </font></p></td></tr></tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Corporate information
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We were incorporated in Delaware on February&nbsp;4, 2013. Our principal executive offices are located at 455&nbsp;Mission Bay Boulevard South,
Suite 545, San Francisco, CA 94158. Our telephone number at that location is (800) <font style="white-space:nowrap">719-0671.</font> References in the prospectus to “we,” “our,” “us,” “Twist Bioscience” and
the “Company” refer to Twist Bioscience Corporation and, where appropriate, its wholly-owned subsidiaries unless the context requires otherwise. Our corporate website address is www.twistbioscience.com. The information contained on our
website is not incorporated by reference into this prospectus, and you should not consider any information contained on, or that can be accessed through, our website to be part of this prospectus. We have included our website address only as an
inactive textual reference and do not intend it to be an active link to our website. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Implications of being an emerging growth company
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We qualify as an “emerging growth company,” as defined in Section&nbsp;2(a) of the Securities Act of 1933, as amended, or the Securities
Act, as modified by the Jumpstart Our Business Startups Act of 2012, or the JOBS </font></p>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">10 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth
companies” including, but not limited to: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">an exemption from complying with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes Oxley Act of 2002, as amended, or Section&nbsp;404;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">a requirement to have only two years of audited financial statements and only two years of related selected financial data and management’s discussion and
analysis of financial condition and results of operations disclosure; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">an exemption from the requirement to seek <font style="white-space:nowrap">non-binding</font> advisory votes on executive compensation.
</font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have not made a decision regarding whether to take advantage of these exemptions. If we do take advantage of any of these
exemptions, we do not know if some investors will find our common stock less attractive as a result. The result may be a less active trading market for our common stock and our stock price may be more volatile. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, Section&nbsp;107 of the JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in
Section&nbsp;7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise
apply to private companies. We have irrevocably opted out of the extended transition period for complying with new or revised accounting standards pursuant to Section&nbsp;107(b) of the JOBS Act. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We could remain an “emerging growth company” for up to five years, or until the earliest of (a)&nbsp;the last day of the first fiscal year in which our
annual gross revenues exceed $1.07&nbsp;billion, (b)&nbsp;the date that we become a “large accelerated filer” as defined in Rule <font style="white-space:nowrap">12b-2</font> under the Securities Exchange Act of 1934, as amended, or the
Exchange Act, which would occur if the market value of our common stock that is held by <font style="white-space:nowrap">non-affiliates</font> exceeds $700&nbsp;million as of the last business day of our most recently completed second fiscal quarter
and (c)&nbsp;the date on which we have issued more than $1&nbsp;billion in <font style="white-space:nowrap">non-convertible</font> debt during the preceding three-year period. </font></p>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">11 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b>The offering </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following information assumes that the underwriters do not exercise their option to purchase additional shares in the offering. See “Underwriting.” </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr valign="TOP">
<td width="27%"> <p style="margin-bottom:1px"><font style="font-family:arial" size="2"><b>Common stock offered by us </b></font></p></td>
<td><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares </font></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr valign="TOP">
<td width="27%"> <p style="margin-bottom:1px"><font style="font-family:arial" size="2"><b>Common stock to be outstanding after the offering</b></font></p></td>
<td><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr valign="TOP">
<td width="27%"> <p style="margin-bottom:1px"><font style="font-family:arial" size="2"><b>Option to purchase additional shares of common stock </b></font></p></td>
<td><font style="font-family:arial" size="2">The underwriters have an option to purchase a maximum of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of common stock from us, solely to
cover overallotments. The underwriters can exercise this option at any time within 30 days from the date of this prospectus. </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr valign="TOP">
<td width="27%"> <p style="margin-bottom:1px"><font style="font-family:arial" size="2"><b>Use of proceeds </b></font></p></td>
<td><font style="font-family:arial" size="2">We intend to use the net proceeds from this offering primarily to improve and update our platform and core technologies, expand our sales and marketing capabilities in the U.S. and in other geographies,
including China, develop and expand into the biologics drug discovery and DNA data storage markets, and for working capital and general corporate purposes. While we have no current agreements, commitments or understandings for any specific strategic
acquisitions or in-licenses at this time, we may use a portion of the net proceeds for these purposes. See “Use of proceeds” for more information. </font></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr valign="TOP">
<td width="27%"> <p style="margin-bottom:1px"><font style="font-family:arial" size="2"><b>Listing </b></font></p></td>
<td><font style="font-family:arial" size="2">We are applying to list our common stock on the Nasdaq Global Market under the symbol “TWST.” </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr valign="TOP">
<td width="27%"> <p style="margin-bottom:1px"><font style="font-family:arial" size="2"><b>Material U.S. federal income tax considerations for <font style="white-space:nowrap">non-U.S.</font> holders </b></font></p></td>
<td><font style="font-family:arial" size="2">For a discussion of the material U.S. federal income tax considerations that may be relevant to prospective investors who are <font style="white-space:nowrap">non-U.S.</font> holders, please see
“Material U.S. federal income tax considerations for <font style="white-space:nowrap">non-U.S.</font> holders.” </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr valign="TOP">
<td width="27%"> <p style="margin-bottom:1px"><font style="font-family:arial" size="2"><b>Risk factors </b></font></p></td>
<td><font style="font-family:arial" size="2">Investing in our common stock involves a high degree of risk. You should carefully read and consider the information set forth under “Risk factors” and all other information in this prospectus
before investing in our common stock. </font></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We refer to our Series A redeemable convertible preferred stock, Series B redeemable convertible
preferred stock, Series C redeemable convertible preferred stock and Series D redeemable convertible preferred stock as our “convertible preferred stock” in this prospectus, as well as for financial reporting-term purposes and in the
financial tables included in this prospectus, as more fully explained in Note 13 to our audited annual consolidated financial statements. In this prospectus (as well as, for financial reporting-term purposes and in the financial tables included in
this prospectus as more fully described in Note 12 to our audited annual consolidated financial statements), we refer to our outstanding warrants as either warrants to purchase shares of redeemable convertible preferred stock or warrants to purchase
shares of common stock. </font></p>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">12 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Except as otherwise indicated, all information in this prospectus is based upon 213,961,940 shares of our common
stock (including 1,452,917 unvested shares of restricted common stock subject to our repurchase right) outstanding as of June&nbsp;30, 2018, and excludes: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">5,592,578 shares of our common stock issuable upon conversion of 5,592,578 shares of Series D convertible preferred stock issued after June 30, 2018;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">24,000,608 shares of our common stock issuable upon exercise of stock options outstanding as of June&nbsp;30, 2018, having a weighted-average exercise price of
$0.81 per share; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock issuable upon exercise of stock options granted after
June&nbsp;30, 2018, having a weighted-average exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock reserved for future grant or issuance under our 2018 Equity
Incentive Plan, or the 2018 Plan (which includes 9,347,391&nbsp;shares of our common stock as of June&nbsp;30, 2018 reserved for future grant under our 2013 Stock Plan, or the 2013 Plan, that will be added to the shares reserved for future issuance
under our 2018 Plan upon effectiveness of that plan if the shares are not issued or subject to outstanding grants under the 2013 Plan at that time), which will become effective in connection with this offering and contains provisions that
automatically increase its share reserve each year, as more fully described in “Executive compensation—Equity incentive plans;” </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock reserved for future grant or issuance under our 2018 Employee
Stock Purchase Plan, or the 2018 ESPP, which will become effective in connection with this offering and contains provisions that automatically increase its share reserve each year, as more fully described in “Executive Compensation—Equity
incentive plans;” </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">634,921 shares of our common stock issuable upon the exercise of outstanding warrants to purchase our common stock outstanding as of June 30, 2018, having an
exercise price of $0.63 per share, and an additional 634,920 shares of our common stock issuable upon the exercise of outstanding warrants to purchase our common stock, having an exercise price of $0.63 per share that would be exercisable upon the
drawing down of additional loans under our amended and restated loan and security agreement with Silicon Valley Bank, or SVB, dated September&nbsp;6, 2017, or credit facility; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">364,742 shares of our common stock issuable upon the exercise of outstanding warrants to purchase Series&nbsp;A convertible preferred stock outstanding as of
June 30, 2018, having an exercise price of $0.329 per share; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">160,606 shares of our common stock issuable upon the exercise of outstanding warrants to purchase Series&nbsp;B convertible preferred stock outstanding as of
June 30, 2018, having an exercise price of $0.792 per share; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">186,679 shares of our common stock, issuable upon the exercise of outstanding warrants to purchase Series&nbsp;C convertible preferred stock outstanding as of
June&nbsp;30, 2018, having an exercise price of $1.4999 per share; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">74,567 shares of our common stock issuable upon the exercise of outstanding warrants to purchase Series D convertible preferred stock outstanding as of June 30,
2018, having an exercise price of $2.1457 per share. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Except as otherwise indicated, all information in this prospectus reflects and
assumes: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the conversion immediately prior to the completion of this offering of all of our outstanding shares of convertible preferred stock into an aggregate of
182,045,056 shares of common stock; </font></p></td></tr></tbody></table>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">13 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the automatic conversion of warrants to purchase an aggregate of 786,594 shares of convertible preferred stock into warrants to purchase an aggregate of 786,594
shares of common stock immediately prior to the closing of this offering; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">no exercise or termination of outstanding stock options or warrants after June 30, 2018; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the filing and effectiveness of our amended and restated certificate of incorporation and the adoption of our amended and restated bylaws immediately prior to
the closing of this offering; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">no exercise by the underwriters of their overallotment option to purchase additional shares of common stock from us. </font></p></td></tr></tbody></table>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">14 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_24"></a>Summary consolidated financial information </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table summarizes our historical consolidated financial data and should be read together with our consolidated financial statements, the notes to our
consolidated financial statements and the sections titled “Selected consolidated financial data” and “Management’s discussion and analysis of financial condition and results of operations” contained elsewhere in this
prospectus. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We derived the summary consolidated statements of operations data and consolidated balance sheet data for the fiscal years ended
September&nbsp;30, 2016 and 2017 from our audited consolidated financial statements included elsewhere in this prospectus. We have derived the unaudited condensed consolidated statements of operations data for the nine months ended June 30, 2017 and
2018, and the unaudited condensed consolidated balance sheet data as of June 30, 2018, from our unaudited condensed consolidated financial statements included elsewhere in this prospectus. We have prepared the unaudited financial information on a
basis consistent with our audited consolidated financial statements and have included, in our opinion, all adjustments, consisting only of normal recurring adjustments, that we consider necessary for a fair statement of the financial information set
forth in those statements. The summary financial data included in this section are not intended to replace the financial statements and related notes included elsewhere in this prospectus. Our historical results are not necessarily indicative of our
future performance, and our interim results are not necessarily indicative of the results to be expected for the full fiscal year. </font></p>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">15 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="44%"></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years&nbsp;ended&nbsp;September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months ended June 30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except share and per share data)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Consolidated statements of operations data:</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,767</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Operating expenses:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cost of revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,421</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,191</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,096</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,230</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">19,169</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,318</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,282</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Selling, general and administrative</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,274</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,060</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,651</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">30,497</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total operating expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">45,925</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">69,249</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">49,160</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">67,875</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss from operations</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(43,656</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(58,482</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(41,859</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(50,855</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">241</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">412</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">225</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">590</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest expense</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(746</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(905</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(927</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other income (expense), net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">73</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(55</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">151</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(76</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss before income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,030</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,140</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,268</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Provision for income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(280</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(161</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(166</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,434</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other comprehensive loss</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Change in unrealized gain (loss) on investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(9</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(25</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Foreign currency translation adjustment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">33</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">35</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Comprehensive loss</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,079</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,286</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,320</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,399</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss per share attributable to common stockholders—basic and diluted(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2.38</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2.47</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1.80</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1.91</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Weighted average shares used in computing net loss per share attributable to common stockholders—basic and diluted(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,511,202</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,982,605</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,556,612</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,921,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Pro forma net loss per share—basic and diluted(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(0.39</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2"> (0.28</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Pro forma weighted-average shares used in computing pro forma net loss per share—basic and diluted(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">152,397,059</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">185,949,305</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">See Note 16 of the notes to our audited annual consolidated financial statements and Note 12 of the notes to our unaudited interim condensed consolidated financial statements
included elsewhere in this prospectus for a description of the method used to compute basic and diluted net loss per share attributable to common stockholders and pro forma basic and diluted net loss per share. </font></td></tr></tbody></table>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">16 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<div style="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="67%"></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="10" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>As of June&nbsp;30, 2018</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(In thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Actual</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Pro<br>forma(2)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Pro&nbsp;forma&nbsp;as<br>adjusted(3)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Consolidated balance sheet data:</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash, cash equivalents, and short-term investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">92,499</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">92,499</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Working capital</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">85,688</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">85,688</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">122,665</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">122,665</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,919</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,209</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Convertible preferred stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">278,505</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Additional <font style="white-space:nowrap">paid-in</font> capital</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,226</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">287,441</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accumulated deficit</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(191,053</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(191,053</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total stockholders’ equity (deficit)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(182,759</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">96,456</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td colspan="12" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(2)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The pro forma column reflects, effective immediately prior to the closing of this offering, the conversion of all outstanding shares of our convertible preferred stock into an
aggregate of 182,045,056 shares of common stock. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(3)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The pro forma as adjusted column gives effect to the pro forma adjustments set forth in footnote 2 above and further reflects the sale by us
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock in this offering at an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share,
which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Each $1.00 increase or
decrease in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, would increase or
decrease, as applicable, our pro forma as adjusted cash, cash equivalents and short-term investments, working capital, total assets and total stockholders’ equity by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million,
assuming that the number of shares of our common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by
us. Each increase or decrease of 1.0&nbsp;million shares in the number of shares offered by us would increase or decrease the amount of our cash, cash equivalents and short-term investments, working capital, total assets and total stockholders’
equity by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range
set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </font></td></tr></tbody></table>
</div></div>

 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">17 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_2"></a>Risk factors </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Investing in our common stock involves a high degree of risk. You should consider carefully the risks and uncertainties described below, together with all of the other information in this prospectus, including our
consolidated financial statements and related notes, before deciding whether to purchase shares of our common stock. If any of the following risks is realized, our business, financial condition, results of operations and prospects could be
materially and adversely affected. In that event, the price of our common stock could decline, and you could lose part or all of your investment. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Risks related to our business </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We are an early stage
company with limited operating history, which may make it difficult to evaluate our current business and predict our future performance. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are
an early stage company and have a limited operating history. We were incorporated in February 2013 and began commercial operations in April 2016. Prior to engaging in commercial operations, we focused on research and development of DNA synthesis.
Our revenue for the fiscal years ended September&nbsp;30, 2016 and 2017 was $2.3&nbsp;million and $10.8&nbsp;million, respectively. Our revenue for the nine months ended June 30, 2017 and 2018, was $7.3 million and $17.0 million, respectively. We
may never achieve commercial success and we have limited historical financial data upon which we may base our projected revenue. We also have limited historical financial data upon which we may base our planned operating expense or upon which you
may evaluate our business and our prospects. Based on our limited experience in developing and marketing new products, we may not be able to effectively: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">drive adoption of our products; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">attract and retain customers for our products; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">anticipate and adapt to changes in our the existing and emerging markets in which we operate; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">focus our research and development efforts in areas that generate returns on these efforts; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">maintain and develop strategic relationships with suppliers to acquire necessary materials and equipment for the production of our products on appropriate
timelines, or at all; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">implement an effective marketing strategy to promote awareness of our products with potential customers; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">scale our manufacturing activities to meet potential demand at a reasonable costs; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">avoid infringement of third-party intellectual property; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">obtain licenses on commercially reasonable terms to third-party intellectual property, as needed; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">obtain valid and enforceable patents that give us a competitive advantage; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">protect our proprietary technology; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">provide appropriate levels of customer training and support for our products; and </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">attract, retain and motivate qualified personnel. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, a high percentage of our expenses have been and will continue to be fixed. Accordingly, if we do not generate revenue as and when anticipated, our losses may be greater than expected and our operating
results will suffer. You should consider the risks and difficulties frequently encountered by companies like ours in new and rapidly evolving markets when making a decision to invest in our common stock. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">18 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We have incurred net losses in every period to date, and we expect to continue to incur significant losses
as we develop our business and may never achieve profitability. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have incurred net losses in each year since inception and have generated
limited revenue from product sales to date. We expect to incur increasing costs as we grow our business. We cannot be certain if or when we will produce sufficient revenue from our operations to support our costs. Even if profitability is achieved,
we may not be able to sustain profitability. We incurred net losses of $44.1&nbsp;million and $59.3&nbsp;million for the years ended September&nbsp;30, 2016 and 2017, respectively, and a net loss of $51.4 million for the nine months ended June 30,
2018. As of June 30, 2018, we had an accumulated deficit of $191.1&nbsp;million. We expect to incur substantial losses and negative cash flow for the foreseeable future. In addition, as a public company, we will incur significant legal, accounting,
and other expenses that we did not incur as a private company. These increased expenses will make it harder for us to achieve and sustain future profitability. We may incur significant losses in the future for a number of reasons, many of which are
beyond our control, including the other risks described in this prospectus, the market acceptance of our products, future product development and our market penetration and margins. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our consolidated financial statements contain a going concern qualification. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our annual audited
consolidated financial statements contain a going concern qualification. We have incurred net losses and used significant cash in operating activities since inception and have an accumulated deficit of $191.1&nbsp;million and working capital of
$85.7&nbsp;million as of June 30, 2018. These factors raise substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern is dependent on our ability to raise adequate capital to fund operating losses
until we are able to engage in profitable business operations. To the extent financing is not available, we may not be able to develop, or may be delayed in developing, our products and meeting our obligations. There can be no assurance that we will
be able to obtain additional debt or equity capital required in order to continue our operations on terms acceptable to us or at all. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We will
require additional financing to achieve our goals, and a failure to obtain this necessary capital when needed on acceptable terms, or at all, could force us to delay, limit, reduce or terminate our product manufacturing and development and other
operations. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Since our inception, substantially all of our resources have been dedicated to the development of our DNA synthesis platform. Net
cash used in operating activities was $38.6&nbsp;million and $51.3&nbsp;million for the years ended September&nbsp;30, 2016 and 2017, respectively, and $49.5&nbsp;million for the nine&nbsp;months ended June&nbsp;30, 2018. As of September&nbsp;30,
2017, we had working capital of $58.4&nbsp;million and capital resources consisting of cash, cash equivalents and short-term investments of $62.2&nbsp;million. As of the nine months ended June 30, 2018, we had working capital of $85.7 million and
capital resources consisting of cash, cash equivalents and short-term investments of $92.5 million. We believe that we will continue to expend substantial resources for the foreseeable future as we expand into additional markets we may choose to
pursue. These expenditures are expected to include costs associated with research and development, manufacturing and supply as well as marketing and selling existing and new products. In addition, other unanticipated costs may arise. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">After giving effect to the anticipated net proceeds from this offering, we expect that our existing cash, cash equivalents and short-term investments will be
sufficient to fund our planned operating expenses, capital expenditure requirements and debt service payments through at least the next 12 months. However, our operating plan may change as a result of factors currently unknown to us, and we may need
to seek additional funds sooner than planned, through public or private equity or debt financings or other sources, such as strategic collaborations. Such financing may result in dilution to stockholders, imposition of debt covenants and repayment
obligations, or other restrictions that may adversely affect our business. In addition, we may seek </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">19 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
additional capital due to favorable market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our future capital requirements depend on many factors, including: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the number and characteristics of any additional products or manufacturing processes we develop or acquire to serve new or existing markets;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the scope, progress, results and costs of researching and developing future products or improvements to existing products or manufacturing processes;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the cost of manufacturing our DNA synthesis equipment and tools and any future products we successfully commercialize; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of such agreements;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">any lawsuits related to our products or commenced against us, including the costs associated with our current litigation with Agilent;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the expenses needed to attract and retain skilled personnel; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the costs associated with being a public company; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims, including litigation costs and the outcome of such
litigation; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the timing, receipt and amount of sales of, or royalties on, any future approved products, if any. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Additional funds may not be available when we need them, on terms that are acceptable to us, or at all. If adequate funds are not available to us on a timely basis,
we may be required to: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">delay, limit, reduce or terminate our manufacturing, research and development activities; or </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">delay, limit, reduce or terminate our establishment of sales and marketing capabilities or other activities that may be necessary to generate revenue and achieve
profitability. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>If we are unable to maintain adequate revenue growth or do not successfully manage such growth, our business and
growth prospects will be harmed. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have experienced significant revenue growth in a short period of time. We may not achieve similar growth
rates in future periods. Investors should not rely on our operating results for any prior periods as an indication of our future operating performance. To effectively manage our anticipated future growth, we must continue to maintain and enhance our
manufacturing, sales, financial and customer support administration systems, processes and controls. Failure to effectively manage our anticipated growth could lead us to over-invest or under-invest in development, operational, and administrative
infrastructure; result in weaknesses in our infrastructure, systems, or controls; give rise to operational mistakes, losses, loss of customers, productivity or business opportunities; and result in loss of employees and reduced productivity of
remaining employees. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our continued growth could require significant capital expenditures and might divert financial resources from other projects such
as the development of new products and services. As additional products are commercialized, we may need to incorporate new equipment, implement new technology systems, or hire new personnel with different qualifications. Failure to manage this
growth or transition could result in turnaround time delays, higher manufacturing costs, declining product quality, deteriorating customer service, and slower responses to competitive challenges. A failure in any one of these areas could make it
difficult for us to meet market expectations for our products, and could damage our reputation and the prospects for our business. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">20 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">If our management is unable to effectively manage our anticipated growth, our expenses may increase more than
expected, our revenue could decline or grow more slowly than expected and we may be unable to implement our business strategy. The quality of our products may suffer, which could negatively affect our reputation and harm our ability to retain and
attract customers. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>The estimates of market opportunity and forecasts of market growth included in this prospectus may prove to be inaccurate, and
even if the market in which we compete achieves the forecasted growth, our business could fail to grow at similar rates, if at all. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Market
opportunity estimates and growth forecasts are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. For example, several of the reports rely on discussions with industry thought leaders,
employ projections of future applications of synthetic biology and next generation sequencing technology in major <font style="white-space:nowrap">end-user</font> market segments and by technology type, and incorporate data from secondary sources
such as company websites as well as industry, trade and government publications.&nbsp;The estimates and forecasts in this prospectus relating to the size and expected growth of our market may prove to be inaccurate. Even if the market in which we
compete meets the size estimates and growth forecasted in this prospectus, our business could fail to grow at the rate we anticipate, if at all. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our quarterly and annual operating results and cash flows have fluctuated in the past and might continue to fluctuate, causing the value of our common stock
to decline substantially. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Numerous factors, many of which are outside our control, may cause or contribute to significant fluctuations in our
quarterly and annual operating results. These fluctuations may make financial planning and forecasting difficult. In addition, these fluctuations may result in unanticipated decreases in our available cash, which could negatively affect our business
and prospects. In addition, one or more of such factors may cause our revenue or operating expenses in one period to be disproportionately higher or lower relative to the others. As a result, comparing our operating results on a <font style="white-space:nowrap"><font style="white-space:nowrap">period-to-period</font></font> basis might not be meaningful. You should not rely on our past results as indicative of our future performance. Moreover, our stock price might be based on
expectations of future performance that are unrealistic or that we might not meet and, if our revenue or operating results fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our operating results have varied in the past. As a result, our operating results could be unpredictable, particularly on a quarterly basis. In addition
to other risk factors listed in this section, some of the important factors that may cause fluctuations in our quarterly and annual operating results are further described in “Risk factors—Risks relating to owning our stock and this
offering.” </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, a significant portion of our operating expense is relatively fixed in nature, and planned expenditures are based in part on
expectations regarding future revenue. Accordingly, unexpected revenue shortfalls might decrease our gross margins and could cause significant changes in our operating results from quarter to quarter. If this occurs, the trading price of our common
stock could fall substantially. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>If we are unable to attract new customers and retain and grow sales from our existing customers, our business will
be materially and adversely affected. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In order to grow our business, we must continue to attract new customers and retain and grow sales from
our existing customers on a cost-effective basis. To do this, we aim to attract new and existing buyers of synthetic DNA, convert makers of synthetic DNA into buyers of synthetic DNA, and achieve widespread market acceptance by delivering both our
current product offerings and new products and technologies at <font style="white-space:nowrap">low-cost,</font> with high-quality, reliable turn-around times and throughput, superior <font style="white-space:nowrap">e-commerce</font> services and
effective technical support. For additional information on our growth strategy, see the section of this prospectus </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">21 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
captioned “Business—Business strategy.” We cannot guarantee that our efforts to provide these key requirements will be consistently acceptable to, and meet the performance
expectations of, our customers and potential customers. If we are unable to successfully attract and retain customers, our business, financial position and results of operations would be negatively impacted. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Internet security poses a risk to our <font style="white-space:nowrap">e-commerce</font> sales. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We currently generate a small portion of our revenue through sales on our <font style="white-space:nowrap">e-commerce</font> platform. However, as part of our
growth strategy, we intend to increase the level of customer traffic and volume of customer purchases through our <font style="white-space:nowrap">e-commerce</font> platform which we formally launched to the general public in January 2018. We manage
our website and <font style="white-space:nowrap">e-commerce</font> platform internally and as a result any compromise of our security or misappropriation of proprietary information could have a material adverse effect on our business, financial
condition and results of operations. We rely on encryption and authentication technology licensed from third parties to provide the security and authentication necessary to effect secure Internet transmission of confidential information, such as
credit and other proprietary information. Advances in computer capabilities, new discoveries in the field of cryptography or other events or developments may result in a compromise or breach of the technology used by us to protect customer
transaction data. Anyone who is able to circumvent our security measures could misappropriate proprietary information or cause material interruptions in our operations. We may be required to expend significant capital and other resources to protect
against security breaches or to minimize problems caused by security breaches. To the extent that our activities or the activities of others involve the storage and transmission of proprietary information, security breaches could damage our
reputation and expose us to a risk of loss and/or litigation. Our security measures may not prevent security breaches. Our failure to prevent these security breaches may result in consumer distrust and may adversely affect our business, results of
operations and financial condition. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our actual operating results may differ significantly from our guidance. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">From time to time, we plan to release guidance in our quarterly earnings conference calls, quarterly earnings releases, or otherwise, regarding our future
performance that represents our management’s estimates as of the date of release. This guidance, which will include forward-looking statements, will be based on projections prepared by our management. These projections will not be prepared with
a view toward compliance with published guidelines of the American Institute of Certified Public Accountants, or AICPA, and neither our registered public accountants nor any other independent expert or outside party compiles or examines the
projections. Accordingly, no such person will express any opinion or any other form of assurance with respect to the projections. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Projections are based
upon a number of assumptions and estimates that, while presented with numerical specificity, are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control and are based
upon specific assumptions with respect to future business decisions, some of which will change. We intend to state possible outcomes as high and low ranges which are intended to provide a sensitivity analysis as variables are changed but are not
intended to imply that actual results could not fall outside of the suggested ranges. The principal reason that we release guidance is to provide a basis for our management to discuss our business outlook with analysts and investors. We do not
accept any responsibility for any projections or reports published by any such third parties. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Guidance is necessarily speculative in nature, and it can
be expected that some or all of the assumptions underlying the guidance furnished by us will not materialize or will vary significantly from actual results. Accordingly, our guidance is only an estimate of what management believes is realizable as
of the date of release. Actual results may vary from our guidance and the variations may be material. In light of the foregoing, investors are urged not to rely upon our guidance in making an investment decision regarding our common stock.
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">22 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Any failure to successfully implement our operating strategy or the occurrence of any of the events or
circumstances set forth in this “Risk factors” section in this prospectus could result in the actual operating results being different from our guidance, and the differences may be adverse and material. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Rapidly changing technology and extensive competition in synthetic biology could make the products we are developing and producing obsolete or <font style="white-space:nowrap">non-competitive</font> unless we continue to develop and manufacture new and improved products and pursue new market opportunities. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The synthetic biology industry is characterized by rapid and significant technological changes, frequent new product introductions and enhancements and evolving industry demands and standards. Our future success
will depend on our ability to continually improve the products we are developing and producing, to develop and introduce new products that address the evolving needs of our customers on a timely and cost-effective basis and to pursue new market
opportunities that develop as a result of technological and scientific advances. These new market opportunities may be outside the scope of our proven expertise or in areas which have unproven market demand, and the utility and value of new products
and services developed by us may not be accepted in the markets served by the new products. Our inability to gain market acceptance of existing products in new markets or market acceptance of new products could harm our future operating results. Our
future success also depends on our ability to manufacture these new and improved products to meet customer demand in a timely and cost-effective manner, including our ability to resolve manufacturing issues that may arise as we commence production
of any new products we develop. Unanticipated difficulties or delays in replacing existing products with new products we introduce or in manufacturing improved or new products in sufficient quantities to meet customer demand could diminish future
demand for our products and harm our future operating results. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, there is extensive competition in the synthetic biology industry, and our
future success will depend on our ability to maintain a competitive position with respect to technological advances. Technological development by others may result in our technologies, as well as products developed using our technologies, becoming
obsolete. Our ability to compete successfully will depend on our ability to develop proprietary technologies and products that are technologically superior to and/or are less expensive than our competitors’ technologies and products. Our
competitors may be able to develop competing and/or superior technologies and processes, and compete more aggressively and sustain that competition over a longer period of time. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>The continued success of our business relies heavily on our disruptive technologies and products and our position in the market as a leading provider or synthetic DNA using a silicon chip. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our future profitability will depend on our ability to successfully execute and maintain a sustainable business model and generate continuous streams of revenue.
Our business model is premised on the fact that we are the only DNA synthesis provider to synthesize DNA on a silicon chip and the competitive advantages this creates. Our DNA synthesis methods, among other things, reduce the amount of raw materials
required, speed up the synthesis process and deliver large volumes of high-quality synthetic DNA at low unit cost. However, if other competitors develop and commercialize a manufacturing process using a silicon chip or other similar technologies
providing for the development of competitive synthetic DNA products at scale, this could be disruptive to our business model and could adversely affect our business prospects, financial condition and results of operations. If we are unable to
convert sufficient number of current manufacturers of synthetic DNA to buyers of our synthetic DNA, surpass our competitors regarding certain industry-related data points, and effectively implement our
<font style="white-space:nowrap">e-commerce</font> platform which facilitates efficient order entry and fulfillment for our customers, our business, prospects, financial condition and results of operation will be adversely affected. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">23 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>If we are unable to expand into adjacent addressable markets, our business may be materially and adversely
affected. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our future revenue growth and market potential may depend on our ability to leverage our DNA synthesis platform together with our
custom libraries and other proprietary tools, such as our anti-GPCR library and antibody optimization solution, in adjacent businesses such as pharmaceutical biologics drug discovery and digital data storage in DNA. However, we may not be able to
validate that our antibody libraries will accelerate the lead identification and lead optimization steps of antibody discovery or will allow us to discover more effective antibody drugs. In addition, our technology may not develop in a way that
allows data storage in DNA to become cost competitive with traditional data storage media or in a way that otherwise enables us to address the markets opportunities that we believe exist. If we are unable to expand into adjacent addressable markets,
our business, financial position and results of operations could be negatively impacted. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>A significant portion of our sales depends on
customers’ capital spending budgets that may be subject to significant and unexpected variation, including seasonality. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our customers’
spending on research and development impacts our sales and profitability. Our customers and potential customers include healthcare, agriculture, industrial chemicals and academic research sectors, and their capital spending budgets can have a
significant effect on the demand for our products. Their research and development budgets are based on a wide variety of factors, including factors beyond our control, such as: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the allocation of available resources to make purchases; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">funding from government sources; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">changes in government programs that provide funding to research institutions and companies; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the spending priorities among various types of research equipment; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">policies regarding capital expenditures during recessionary periods; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">macroeconomic conditions and the political climate; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">changes in the regulatory environment; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">differences in budgetary cycles; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">market acceptance of relatively new technologies, such as ours. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Any decrease in capital spending or change in spending priorities of our customers and potential customers could significantly reduce the demand for our products. As we expand into new geographic markets, our
revenue may be impacted by seasonal trends in the different regions, the&nbsp;seasonality&nbsp;of customer capital budgets in those regions and the mix of domestic versus international sales. Moreover, we have no control over the timing and amount
of purchases by these customers and potential customers, and as a result, revenue from these sources may vary significantly due to factors that can be difficult to forecast. Any delay or reduction in purchases by customers and potential customers or
our inability to forecast fluctuations in demand could harm our future operating results. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We generally do not have long-term contracts with our
customers requiring them to purchase any specified quantities from us. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We generally do not have long-term contracts with our customers requiring
them to purchase any specified quantities from us and without such contracts our customers are not obligated to order or reorder our products. As a result, we cannot accurately predict our customers’ decisions to reduce or cease purchasing our
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">24 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
products. Additionally, even where we enter into contracts with our customers, there is no guarantee that such agreements will be negotiated on terms that are commercially favorable to us in the
long-term. Therefore, if many of our customers were to substantially reduce their transaction volume or cease ordering products from us, this could materially and adversely affect our financial performance. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We have limited experience in sales and marketing of our products and, as a result, may be unable to successfully increase our market share and expand our
customer base. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have limited experience in sales and marketing of our products. Our ability to achieve profitability depends on our being able
to increase our market share and expand our customer base. Although members of our sales and marketing teams have considerable industry experience and have engaged in marketing activities for our products, in the future we must expand our sales,
marketing, distribution and customer support capabilities with the appropriate technical expertise to effectively market our products. To perform sales, marketing, distribution and customer support successfully, we will face a number of risks,
including: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">we may not be able to attract, retain and manage the sales, marketing and service force necessary to publicize and gain broader market acceptance for our
technology; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the time and cost of establishing a specialized sales, marketing and service force for a particular product or service, which may be difficult to justify in
light of the revenue generated; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our sales, marketing and service force may be unable to initiate and execute successful commercialization activities with respect to new products or markets we
may seek to enter. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">If our sales and marketing efforts, or those of any third-party sales and distribution partners, are not
successful, our new technologies and products may not gain market acceptance, which could materially impact our business operations. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We have
limited experience in manufacturing our DNA synthesis equipment and tools. If we are unable to expand our DNA synthesis manufacturing capacity, this would result in lost revenue and harm our business. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In order to expand our manufacturing capacity of new and existing products, we need to either build additional internal manufacturing capacity, contract with one or
more partners, or both. Our technology and the production process for our DNA synthesis equipment and tools are complex, involving specialized parts, and we may encounter unexpected difficulties in manufacturing our DNA synthesis equipment and
tools. There is no assurance that we will be able to continue to build manufacturing capacity internally or find one or more suitable partners, or both, to meet the volume and quality requirements necessary to be successful in our existing and
potential markets. Manufacturing and product quality issues may arise as we increase the scale of our production. If our DNA synthesis equipment and tools do not consistently produce DNA products that meet our customers’ performance
expectations, our reputation may be harmed, and we may be unable to generate sufficient revenue to become profitable. Any delay or inability in establishing or expanding our manufacturing capacity could diminish our ability to develop or sell our
products, which could result in lost revenue and materially harm our business, financial condition and results of operations. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We are substantially
dependent on the success of our synthetic DNA products. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">To date, we have invested nearly all of our efforts and financial resources in the
research and development of our synthetic DNA products. The DNA synthesis business is very capital intensive, particularly for early stage companies that do not have significant <font style="white-space:nowrap">off-setting</font> revenues.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our financial results are dependent on strengthening our core business while diversifying into other developing sectors such as pharmaceutical biologics
drug discovery and data storage. Substantially all of our revenue generated to date is from our synthetic DNA products. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">25 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Our near-term prospects, including our ability to finance our Company and enter into strategic collaborations,
will depend heavily on the successful development and commercialization of our synthetic DNA products. These initiatives will be substantially dependent on our ability to generate revenue from our synthetic DNA products and obtain other funding
necessary to support these initiatives. Our inability to continue these initiatives and initiate new research and development efforts could result in a failure to develop new products, improve upon existing products such that sectors like
pharmaceutical biologics drug discovery and data storage may never be fully developed, and expand our addressable market which could have a material and adverse impact on our sales, business, financial position and results of operations. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We and our chief executive officer are currently involved in litigation with Agilent Technologies, Inc., in which Agilent has alleged a claim of trade secret
misappropriation against Twist Bioscience and trade secret misappropriation and other related claims against our chief executive officer, and an adverse result could harm our business and results of operations. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We and our chief executive officer are currently involved in litigation with Agilent in which Agilent has alleged a claim of trade secret misappropriation against
our Company and trade secret misappropriation and other related claims against our chief executive officer. This litigation with Agilent could result in significant expense. Agilent has considerable resources available to it; we, on the other hand,
are an early-stage commercial company with comparatively few resources available to us to engage in costly and protracted litigation. Intellectual property infringement claims asserted against us could be costly to defend and could limit our ability
to use some technologies in the future. They will be time consuming, will divert our chief executive officer’s, management’s and scientific personnel’s attention and may result in liability for substantial damages. For example, we
have incurred and anticipate that we will continue to incur significant expense and substantial time in defending against our current intellectual property infringement dispute with Agilent. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">An adverse judgment in the Agilent proceeding could require us to pay damages, attorneys’ fees, costs and expenses, or result in injunctive relief, any of which could materially adversely affect our business,
financial condition, results of operations and prospects. For more information on our current legal and regulatory proceedings, see the section of this prospectus captioned “Business&nbsp;—&nbsp;Legal proceedings.” And for other risks
related to our intellectual property, see the section of this prospectus captioned “Risks related to our intellectual property.” We may also in the future be involved with other litigation. We expect that the number of such claims may
increase as our scale and the level of competition in our industry segments grows. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We depend on one single-source supplier for a critical
component for our DNA synthesis process. The loss of this supplier or its failure to supply us with the necessary component on a timely basis, could cause delays in the future capacity of our DNA synthesis process and adversely affect our business.
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We depend on one single-source supplier for a critical component for our DNA synthesis process. We do not currently have the infrastructure or
capability internally to manufacture this component. Although we have a substantial reserve of supplies and although alternative suppliers exist for this critical component of our synthesis process, our existing DNA synthesis manufacturing process
has been designed based on the functions, limitations, features and specifications of the components that we currently utilize. We have a supply agreement in place with this component supplier. However, there can be no assurance that our supply of
this component will not be limited, interrupted, or of satisfactory quality or continue to be available at acceptable prices. Additionally, we do not have any control over the process or timing of the acquisition or manufacture of materials by our
manufacturer, and cannot ensure that it will deliver to us the component we order on time, or at all. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The loss of this component provided by this
supplier could require us to change the design of our manufacturing process based on the functions, limitations, features and specifications of the replacement components. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">26 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, the lead time needed to establish a relationship with a new supplier can be lengthy, and we may
experience delays in meeting demand in the event we must switch to a new supplier. The time and effort to qualify a new supplier could result in additional costs, diversion of resources or reduced manufacturing yields, any of which would negatively
impact our operating results. Further, we may be unable to enter into agreements with a new supplier on commercially reasonable terms, which could have a material adverse impact on our business. Our dependence on this single-source supplier exposes
us to certain risks, including the following: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our supplier may cease or reduce production or deliveries, raise prices or renegotiate terms; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">we may be unable to locate a suitable replacement on acceptable terms or on a timely basis, if at all; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">if there is a disruption to our single-source supplier’s operations, and if we are unable to enter into arrangements with alternative suppliers, we will
have no other means of completing our synthesis process until they restore the affected facilities or we or they procure alternative manufacturing facilities or sources of supply; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">delays caused by supply issues may harm our reputation, frustrate our customers and cause them to turn to our competitors for future projects; and
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our ability to progress our DNA synthesis products could be materially and adversely impacted if the single-source supplier upon which we rely were to experience
a significant business challenge, disruption or failure due to issues such as financial difficulties or bankruptcy, issues relating to other customers such as regulatory or quality compliance issues, or other financial, legal, regulatory or
reputational issues. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Moreover, to meet anticipated market demand, our single-source supplier may need to increase manufacturing
capacity, which could involve significant challenges. This may require us and our supplier to invest substantial additional funds and hire and retain the technical personnel who have the necessary experience. Neither we nor our supplier may
successfully complete any required increase to existing manufacturing capacity in a timely manner, or at all. For additional information on our single-source and other suppliers, see the section of this prospectus captioned “Business —
Suppliers.” </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We must continue to secure and maintain sufficient and stable supplies of raw materials. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Although historically we have not experienced price increases due to unexpected raw material shortages and other unanticipated events, there is no assurance that
our supply of raw materials will not be significantly adversely affected in the future, adversely affecting our business, prospects, financial condition and results of operation. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, as we grow, our existing suppliers may not be able to meet our increasing demand, and we may need to find additional suppliers. There is no assurance that we will always be able to secure suppliers who
provide raw materials at the specification, quantity and quality levels that we demand (or at all) or be able to negotiate acceptable fees and terms of services with any such suppliers. Identifying a suitable supplier is an involved process that
requires us to become satisfied with their quality control, responsiveness and service, financial stability and labor and other ethical practices. Even if we are able to expand existing sources, we may encounter delays in production and added costs
as a result of the time it takes to train suppliers in our methods, products and quality control standards. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We typically do not enter into agreements
with our suppliers but secure our raw materials on a purchase order basis. Our suppliers may reduce or cease their supply of raw materials and outsourced services and products to us at any time in the future. If the supply of raw materials and the
outsourced services and products is interrupted, our production processes may be delayed. If any such event occurs, our operation and financial position may be adversely affected. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">27 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">A deterioration of our relationship with any of our suppliers, or problems experienced by these suppliers, could
lead to shortages in our production capacity for some or all of our products. In such case, we may not be able to fulfill the demand of existing customers or supply new customers. A raw material shortage or an increase in the cost of the raw
materials we use could result in decreased revenue or could impair our ability to maintain or expand our business. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For the years ended
September&nbsp;30, 2016 and 2017, our cost of raw materials accounted for approximately 27%, and 30%, respectively, of our total cost of revenues. And, for the nine months ended June 30, 2017 and 2018, our cost of raw materials accounted for
approximately 29% and 30%, respectively, of our total cost of revenues. In the event of significant price increases for raw materials, we may have to pass the increased raw materials costs to our customers. However, we cannot assure you that we will
be able to raise the prices of our products sufficiently to cover increased costs resulting from increases in the cost of our raw materials or overcome the interruption of a sufficient supply of qualified raw materials for our products. As a result,
a price increase for our raw materials may negatively impact our business, financial position and results of operations. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We may encounter
difficulties in managing our growth, and these difficulties could impair our profitability. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Currently, we are working simultaneously on multiple
projects targeting several market sectors, including activities in the healthcare, agriculture, industrial chemicals and academic sectors. These diversified operations place significant demands on our limited resources and require us to
substantially expand the capabilities of our technical, administrative and operational resources. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">If we are unable to manage this growth effectively,
our business and operating results could suffer. Our ability to manage our operations and costs, including research and development, costs of components, manufacturing, sales and marketing, requires us to continue to enhance our operational,
financial and management controls, reporting systems and procedures and to attract and retain sufficient numbers of talented employees. Failure to attract and retain sufficient numbers of talented employees will further strain our human resources
and could impede our growth. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our revenue, results of operations, cash flows and reputation in the marketplace may suffer upon the loss of a
significant customer. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have derived, and believe we may continue to derive, a significant portion of our revenues from one large customer or a
limited number of large customers. Our largest customer Ginkgo Bioworks accounted for 30% and 40% of our revenue for the years ended September&nbsp;30, 2016 and 2017. Ginkgo Bioworks also accounted for 40% and 32% of our revenue for the nine months
ended June 30, 2017 and 2018, respectively. Our customers may buy less of our products depending on their own technological developments, <font style="white-space:nowrap">end-user</font> demand for our products and internal budget cycles. In
addition, existing customers may choose to produce some or all of their synthetic DNA requirements internally by using or developing manufacturing capabilities organically or by using capabilities from acquisitions of assets or entities from third
parties with such capabilities. For example, in January 2017, Ginkgo Bioworks announced the acquisition of Gen9, Inc., which was a DNA synthesis manufacturer. If Ginkgo Bioworks reduces the amount of products it purchases from us and increases the
amount of synthetic DNA products it manufactures internally using the capabilities acquired in the Gen9 acquisition or otherwise, it could have a material adverse impact on our revenue, results of operations, cash flows and reputation in the
marketplace. The loss of Ginkgo Bioworks as a customer, or the loss of any other significant customer or a significant reduction in the amount of product ordered by Ginkgo Bioworks or any other significant customer would adversely affect our
revenue, results of operations, cash flows and reputation in the marketplace. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">28 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our credit facility contains restrictions that limit our flexibility in operating our business.
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In September 2017, we entered into an amended and restated loan and security agreement with SVB. Our credit facility contains various covenants
that limit our ability to engage in specified types of transactions. These covenants limit our ability to, among other things: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">sell, transfer, lease or otherwise dispose of our assets; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">create, incur or assume additional indebtedness; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">engage in certain changes in business, management, control, or business location; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">encumber or permit liens on certain of our assets; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">make restricted payments, including paying dividends on, repurchasing or making distributions with respect to our common stock; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">make specified investments (including loans and advances); </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">consolidate, merge, sell or otherwise dispose of all or substantially all of our assets or acquire other entities; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">make or permit any payment on any subordinated debt; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">enter into certain transactions with our affiliates. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our incurrence of this debt, and any future increases in our aggregate level of debt, may adversely affect our operating results and financial condition by, among other things: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">increasing our vulnerability to downturns in our business, to competitive pressures and to adverse economic and industry conditions;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">requiring the dedication of an increased portion of our expected cash flows from operations to service our indebtedness, thereby reducing the amount of expected
cash flows available for other purposes, including capital expenditures, acquisitions and dividends; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">limiting our flexibility in planning for, or reacting to, changes in our business and our industry. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">A breach of any of these covenants could result in a default under our credit facility. Upon the occurrence of an event of default under our credit facility, SVB
could elect to declare all amounts outstanding under our credit facility to be immediately due and payable and terminate all commitments to extend further credit. If we were unable to repay those amounts, the lenders under our credit facility could
proceed against the collateral granted to them to secure such indebtedness. We have pledged substantially all of our assets, other than our intellectual property, as collateral under our credit facility. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We depend on the continuing efforts of our senior management team and other key personnel. If we lose members of our senior management team or other key
personnel or are unable to successfully retain, recruit and train qualified researchers, engineering and other personnel, our ability to develop our products could be harmed, and we may be unable to achieve our goals. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our future success depends upon the continuing services of members of our senior management team and scientific and engineering personnel. We are highly dependent
on Emily Leproust, our President and Chief Executive Officer, who is employed “at will,” meaning we or she may terminate the employment relationship at any time. In particular, our researchers and engineers are critical to our future
technological and product innovations, and we will need to hire additional qualified personnel. We may not be able to attract and retain qualified personnel on acceptable terms, or at all. In addition, to the extent we hire personnel from
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">29 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
competitors, we may be subject to allegations that they have been improperly solicited or that they have divulged proprietary or other confidential information, or that their former employers own
their research output. Our industry, particularly in the San Francisco Bay Area, is characterized by high demand and intense competition for talent, and the turnover rate can be high. We compete for qualified management and scientific personnel with
other life science companies, academic institutions and research institutions, particularly those focusing on genomics. Many of these employees could leave our company with little or no prior notice and would be free to work for a competitor. If one
or more of our senior executives or other key personnel were unable or unwilling to continue in their present positions, we may not be able to replace them easily or at all, and other senior management may be required to divert attention from other
aspects of the business. In addition, we do not have “key person” life insurance policies covering members of our management team or other key personnel except Emily Leproust. The loss of any of these individuals or our inability to
attract or retain qualified personnel, including researchers, engineers and others, could prevent us from pursuing collaborations and adversely affect our product development and introductions, business growth prospects, results of operations and
financial condition. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We may engage in strategic transactions, including acquisitions that could disrupt our business, cause dilution to our
stockholders, reduce our financial resources, or prove not to be successful. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the future, we may enter into transactions to acquire other
businesses, products or technologies and our ability to do so successfully cannot be ensured. In April 2016, we acquired Genome Compiler Corporation, which became a wholly owned subsidiary. This acquisition allowed us to add software design
capabilities for our <font style="white-space:nowrap">e-commerce</font> ordering system. However, to date, we have not successfully concluded other acquisitions, and we are pursuing opportunities in the life sciences industry that complement and
expand our synthetic DNA product, products and markets both locally and internationally. If we identify suitable opportunities, we may not be able to make such acquisitions on favorable terms or at all. Any acquisitions we make may not strengthen
our competitive position, and these transactions may be viewed negatively by customers or investors. We may decide to incur debt in connection with an acquisition or issue our common stock or other equity securities to the stockholders of the
acquired company, which would reduce the percentage ownership of our existing stockholders. We could incur losses resulting from undiscovered liabilities of the acquired business that are not covered by any indemnification we may obtain from the
seller. In addition, we may not be able to successfully integrate the acquired personnel, technologies and operations into our existing business in an effective, timely and <font style="white-space:nowrap">non-disruptive</font> manner. Acquisitions
may also divert management attention from <font style="white-space:nowrap"><font style="white-space:nowrap">day-to-day</font></font> responsibilities, increase our expenses and reduce our cash available for operations and other uses. In addition, we
cannot guarantee that we will be able to fully recover the costs of such acquisitions or that we will be successful in leveraging any such strategic transactions into increased business, revenue or profitability. We also cannot predict the number,
timing or size of any future acquisitions or the effect that any such transactions might have on our operating results. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">From time to time, we may
consider other strategic transactions, including collaborations. The competition for collaborators is intense, and the negotiation process is time-consuming and complex. Any new collaboration may be on terms that are not optimal for us, and we may
not be able to maintain any new collaboration. Any such collaboration may require us to incur <font style="white-space:nowrap">non-recurring</font> or other charges, increase our near- and long-term expenditures and pose significant integration or
implementation challenges or disrupt our management or business. These transactions would entail numerous operational and financial risks, including exposure to unknown liabilities, disruption of our business and diversion of our management’s
time and attention to manage a collaboration, incurrence of substantial debt or dilutive issuances of equity securities to pay transaction consideration or costs, higher than expected collaboration, acquisition or integration costs, write-downs of
assets or goodwill or impairment charges, increased amortization expenses, difficulty and cost in facilitating the collaboration or combining the operations and personnel of any acquired business, impairment
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">30 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
of relationships with key suppliers, manufacturers or customers of any acquired business due to changes in management and ownership and the inability to retain key employees of any acquired
business. Accordingly, although there can be no assurance that we will undertake or successfully complete any collaborations, any transactions that we do complete may be subject to the foregoing or other risks and have a material and adverse effect
on our business, financial condition, results of operations and prospects. Conversely, any failure to enter any collaboration or other strategic transaction that would be beneficial to us could delay the development and potential commercialization
of our products and technologies. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>As we expand our development and commercialization activities outside of the United States, we will be subject
to an increased risk of inadvertently conducting activities in a manner that violates the U.S. Foreign Corrupt Practices Act and similar laws. If that occurs, we may be subject to civil or criminal penalties which could have a material adverse
effect on our business, financial condition, results of operations and growth prospects. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are subject to the U.S. Foreign Corrupt Practices
Act, or the FCPA, which prohibits corporations and individuals from paying, offering to pay, or authorizing the payment of anything of value to any foreign government official, government staff member, political party, or political candidate in an
attempt to obtain or retain business or to otherwise influence a person working in an official capacity. We are also subject to the UK Anti-Bribery Act, which prohibits both domestic and international bribery, as well as bribery across both public
and private sectors. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the course of establishing and expanding our commercial operations and complying with
<font style="white-space:nowrap">non-U.S.</font> regulatory requirements, we will need to establish and expand business relationships with various third parties and we will interact more frequently with foreign officials, including regulatory
authorities. Expanded programs to maintain compliance with such laws will be costly and may not be effective. Any interactions with any such parties or individuals where compensation is provided that are found to be in violation of such laws could
result in substantial fines and penalties and could materially harm our business. Furthermore, any finding of a violation under one country’s laws may increase the likelihood that we will be prosecuted and be found to have violated another
country’s laws. If our business practices outside the United States are found to be in violation of the FCPA, UK Anti-Bribery Act or other similar laws, we may be subject to significant civil and criminal penalties which could have a material
adverse effect on our financial condition and results of operations. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We could engage in exporting or related activity that contravenes
international trade restraints, or regulatory authorities could promulgate more far reaching international trade restraints, which could give rise to one or more of substantial legal liability, impediments to our business and reputational damage.
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our international business activities must comport with U.S. export controls and other international trade restraints, including the U.S.
Department of Commerce’s Export Administration Regulations and economic sanctions regulations administered by the U.S. Treasury Department’s Office of Foreign Assets Controls. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have established an international trade compliance program that encompasses best practices for preventing, detecting and addressing noncompliance with international trade restraints. Furthermore, to date our
exports have not been licensable under export controls; however, we could fail to observe the compliance program requirements in a manner that leaves us in noncompliance with export controls or other international trade restraints. In addition,
authorities could promulgate international trade restraints that impinge on our ability to prosecute our business as planned. One or more of resulting legal penalties, restraints on our business or reputational damage could have material adverse
effects on our business and financial condition. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Adverse conditions in the global economy and disruption of financial markets may significantly
harm our revenue, profitability and results of operations. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The global economy has a significant impact on our business and volatility and
disruption of financial markets could limit our customers’ ability to obtain adequate financing or credit to purchase and pay for our products in </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">31 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
a timely manner or to maintain operations, which could result in a decrease in sales volume that could harm our results of operations. General concerns about the fundamental soundness of domestic
and international economies may also cause our customers to reduce their purchases. Changes in banking, monetary and fiscal policies to address liquidity and increase credit availability may not be effective. Significant government investment and
allocation of resources to assist the economic recovery of sectors which do not include our customers may reduce the resources available for government grants and related funding for life sciences research and development. Continuation or further
deterioration of these financial and macroeconomic conditions could significantly harm our sales, profitability and results of operations. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We
operate in a highly competitive industry and if we are not able to compete effectively, our business and operating results will likely be harmed. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We face competition from a broad range of providers of core synthetic biology products such as GenScript Biotech Corporation, GENEWIZ, Integrated DNA Technologies,
Inc., DNA 2.0 Inc. d/b/a/ ATUM, GeneArt (owned by Thermo Fisher Scientific Inc.), Eurofins Genomics LLC, <font style="white-space:nowrap">Sigma-Aldrich</font> Corporation (an indirect wholly owned subsidiary of Merck &amp; Company), Promega
Corporation, OriGene Technologies, Inc., Blue Heron Biotech, LLC and others. Additionally, we compete with both large and emerging providers in the life sciences tools and diagnostics industries focused on sample preparation for next generation
sequencing such as Thermo Fisher Scientific Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Agilent, and Roche NimbleGen, Inc. In the antibody discovery market, we compete with clinical research organizations, such as LakePharma (mouse
hybridoma, llama immune libraries, XOMA phage display library) and Aldevron, LLC (genetic mouse immunization coupled with hybridoma), and antibody discovery biotechnology companies, such as Iontas (human phage display libraries, human phage display
library focused on ion channels), Adimab (human synthetic yeast display libraries), and Distributed Bio (human synthetic phage display library, lead optimization libraries). In the field of DNA digital data storage, we compete with Catalog
Technologies, Inc., ETH Zurich, Helixworks, Iridia, Inc., North Shore Bio and Roswell. We may not be successful in maintaining our competitive position for a number of reasons. Some of our current competitors, as well as many of our potential
competitors, have significant name recognition, substantial intellectual property portfolios, longer operating histories, greater resources to invest in new technologies, substantial experience in new product development and manufacturing
capabilities and more established distribution channels to deliver products to customers than we do. These competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards or
customer requirements. Our competitors may develop disruptive technologies or products that are comparable or superior to our technologies and products. In light of these advantages, even though we believe our technology is superior to the products
offerings of our competitors, current or potential customers might accept competitive products in lieu of purchasing our products. Increased competition is likely to result in continued pricing pressures, which could harm our sales, profitability or
market share. Our failure to continue competing effectively or wining additional business with our existing customers could materially and adversely affect our business, financial condition or results of operations. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We may be subject to significant pricing pressures. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Over time, increasing customer demand for lower prices could force us to discount our products and result in lower margins. The impact may be further exacerbated if
we are unable to successfully control production costs. Alternatively, if due to rising market prices, our suppliers increase prices or reduce discounts on their supplies, we may be unable to pass on any cost increase to our customers, thereby
resulting in reduced margins and profits. Furthermore, changes in our product mix may negatively affect our gross margins. Overall, these pricing pressures may adversely affect our business, financial position and results of operations. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">32 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Ethical, legal and social concerns surrounding the use of genetic information could reduce demand for our
technology. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our products may be used to create DNA sequences of humans, agricultural crops and other living organisms. Our products could be
used in a variety of applications, which may have underlying ethical, legal and social concerns. Governmental authorities could, for safety, social or other purposes, impose limits on or implement regulation of the use of gene synthesis. Such
concerns or governmental restrictions could limit the use of our DNA synthesis products, which could have a material adverse effect on our business, financial condition and results of operations. In addition, public perception about the safety and
environmental hazards of, and ethical concerns over, genetically engineered products and processes could influence public acceptance of our technologies, products and processes. These concerns could result in increased expenses, regulatory scrutiny,
delays or other impediments to our programs. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We use biological and hazardous materials that require considerable expertise and expense for
handling, storage and disposal and may result in claims against us. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We work with materials, including chemicals, biological agents, and
compounds and DNA samples that could be hazardous to human health and safety or the environment. Our operations also produce hazardous and biological waste products. Federal, state and local laws and regulations govern the use, generation,
manufacture, storage, handling and disposal of these materials and wastes. Compliance with applicable environmental laws and regulations is expensive, and current or future environmental laws and regulations may restrict our operations. If we do not
comply with applicable regulations, we may be subject to fines and penalties. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, we cannot eliminate the risk of accidental injury or
contamination from these materials or wastes, which could cause an interruption of our commercialization efforts, research and development programs and business operations, as well as environmental damage resulting in costly <font style="white-space:nowrap">clean-up</font> and liabilities under applicable laws and regulations. Furthermore, environmental laws and regulations are complex, change frequently and have tended to become more stringent. We cannot predict the impact
of such changes and cannot be certain of our future compliance. While our property insurance policy provides limited coverage in the event of contamination from hazardous and biological products and the resulting cleanup costs, we do not currently
have any additional insurance coverage for legal liability for claims arising from the handling, storage or disposal of hazardous materials. Accordingly, in the event of contamination or injury, we could be liable for damages or penalized with fines
in an amount exceeding our resources and our operations could be suspended or otherwise adversely affected. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We could develop DNA sequences or
engage in other activity that contravenes biosecurity requirements, or regulatory authorities could promulgate more far reaching biosecurity requirements that our standard business practices cannot accommodate, which could give rise to substantial
legal liability, impediments to our business and reputational damage. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Federal Select Agent Program, or the FSAP, involves rules administered
by the Centers for Disease Control and Prevention and Toxins and the Animal and Plant Health Inspection Service that regulate possession, use and transfer of biological select agents and toxins that have the potential to pose a severe threat to
public, animal or plant health or to animal or plant products. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have established a biosecurity program under which we follow biosafety and biosecurity
best practices and avoid DNA synthesis activities that implicate FSAP rules; however, we could err in our observance of compliance program requirements in a manner that leaves us in noncompliance with FSAP or other biosecurity rules. In addition,
authorities could promulgate new biosecurity requirements that restrictions our operations. One or </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">33 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
more resulting legal penalties, restraints on our business or reputational damage could have material adverse effects on our business and financial condition. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Third parties may use our products in ways that could damage our reputation. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">After our customers have received our products, we do not have any control over their use and our customers may use them in ways that are harmful to our reputation as a supplier of synthetic DNA products. In
addition, while we have established a biosecurity program designed to comply with biosafety and biosecurity requirements and perform export control screening in an effort to ensure that third parties do not obtain our products for malevolent
purposes, we cannot guarantee that these preventative measures will eliminate or reduce the risk of the domestic and global opportunities for the misuse of our products. Accordingly, in the event of such misuse, our reputation, future revenue and
operating results may suffer. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Any damage to our reputation or brand may materially and adversely affect our business, financial condition and
results of operations. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe that developing and maintaining our brand is important to our success and that our financial success is
influenced by the perception of our brand by our customers. Furthermore, the importance of our brand recognition may become even greater to the extent that competitors offer more products similar to ours. Many factors, some of which are beyond our
control, are important to maintaining our reputation and brand. These factors include our ability to comply with ethical, social, product, labor and environmental standards. Any actual or perceived failure in compliance with such standards could
damage our reputation and brand. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Because we are subject to existing and potential additional governmental regulation, the markets for our products
may be narrowed. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are subject, both directly and indirectly, to the adverse impact of existing and potential future government regulation of
our operations and markets. For example, export of our products is subject to strict regulatory control in a number of jurisdictions. The failure to satisfy export control criteria or obtain necessary clearances could delay or prevent shipment of
products, which could adversely affect our revenues and profitability. Moreover, the life sciences industry, which is currently the primary market for our technology, has historically been heavily regulated. There are, for example, laws in several
jurisdictions restricting research in genetic engineering, which can operate to narrow our markets. Given the evolving nature of this industry, legislative bodies or regulatory authorities may adopt additional regulation that adversely affects our
market opportunities. Our business is also directly affected by a wide variety of government regulations applicable to business enterprises generally and to companies operating in the life science industry in particular. Failure to comply with these
regulations or obtain or maintain necessary permits and licenses could result in a variety of fines or other censures or an interruption in our business operations which may have a negative impact on our ability to generate revenues and could
increase the cost of operating our business. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our products could in the future be subject to additional regulation by the U.S. Food and Drug
Administration or other domestic and international regulatory agencies, which could increase our costs and delay our commercialization efforts, thereby materially and adversely affecting our business and results of operations. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The U.S. Food and Drug Administration, or FDA, regulates medical devices, including in vitro diagnostics, or IVDs. IVDs include reagents, instruments, and systems
intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. IVDs are intended for use in the collection, preparation, and
examination of specimens taken from the human body. A research use only, or RUO, IVD product is an IVD product that is in the laboratory research phase of development and is being shipped or delivered for an investigation that is not subject to
FDA’s investigational device exemption requirements. As such, an RUO IVD is not intended for use in clinical </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">34 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
investigations or in clinical practice. Such RUO products do not require premarket clearance or approval from the FDA, provided that they be labeled “For Research Use Only. Not for use in
diagnostic procedures” pursuant to FDA regulations. Our IVD products are not intended for clinical or diagnostic use, and we market and label them as RUO. Accordingly, we have not sought clearance or approval from the FDA to market our
products. However, the FDA may disagree with our assessment that our products are properly marketed as RUO, and may determine that our products are subject to <font style="white-space:nowrap">pre-market</font> clearance, approval, or other
regulatory requirements. If the FDA determines that our products are subject to such requirements, we could be subject to enforcement action, including administrative and judicial sanctions, and additional regulatory controls and submissions for our
tests, all of which could be burdensome. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Further, in the future, certain of our products or related applications could be subject to additional FDA
regulation. Even where a product is not subject to FDA clearance or approval requirements, the FDA may impose restrictions as to the types of customers to which we can market and sell our products. Such regulation and restrictions may materially and
adversely affect our business, financial condition and results of operations. Other regulatory regimes that do not currently present material challenges but that could in the future present material challenges include export controls and
biosecurity. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Similarly, even though our products and services are not currently covered and reimbursed by third-party payors, including government
healthcare programs such as Medicare and Medicaid, to the extent our products or related applications become eligible for coverage and reimbursement by such payors, we could be subject to healthcare fraud and abuse laws of both the federal
government and the states in which we conduct our business. Because of the breadth of these laws and the narrowness of available statutory and regulatory exceptions, it is possible that some of our business activities could be subject to challenge
under one or more of such laws. If we or our operations are found to be in violation of any of the laws described above or any other governmental regulations that apply to us, we may be subject to penalties, including civil and criminal penalties,
damages, fines, imprisonment, and the curtailment or restructuring of our operations, any of which could materially adversely affect our ability to operate our business and our financial results. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Many countries have laws and regulations that could affect our products. The number and scope of these requirements are increasing. Unlike many of our competitors,
this is an area where we do not have expertise. We may not be able to obtain regulatory approvals in such countries or may incur significant costs in obtaining or maintaining foreign regulatory approvals. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Certain of our potential customers may require that we become certified under the Clinical Laboratory Improvement Amendments of 1988. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Although we are not currently subject to the Clinical Laboratory Improvement Amendment of 1988, or CLIA, we may in the future be required by certain customers to
obtain a CLIA certification. CLIA, which extends federal oversight over clinical laboratories by requiring that they be certified by the federal government or by a federally approved accreditation agency, is designed to ensure the quality and
reliability of clinical laboratories by mandating specific standards in the areas of personnel qualifications, administration and participation in proficiency testing, patient test management, quality control, quality assurance and inspections. If
our customers require a CLIA certification, we will have to continually expend time, money and effort to ensure that we meet the applicable quality and safety requirements, which may divert the attention of management and disrupt our core business
operations. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>If we experience a significant disruption in, or breach in security of, our information technology systems, or if we fail to implement
new systems and software successfully, our business could be adversely affected. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We rely on several centralized information technology systems
throughout our company to provide products, keep financial records, process orders, manage inventory, process shipments to customers and operate other </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">35 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
critical functions. Our information technology systems may be susceptible to damage, disruptions or shutdowns due to power outages, hardware failures, computer viruses, attacks by computer
hackers, telecommunication failures, user errors, catastrophes or other unforeseen events. Our information technology systems also may experience interruptions, delays or cessations of service or produce errors in connection with system integration,
software upgrades or system migration work that takes place from time to time. If we were to experience a prolonged system disruption in the information technology systems that involve our interactions with customers or suppliers, including
negatively impacting our order fulfilment and order entry on our <font style="white-space:nowrap">e-commerce</font> platform, it could result in the loss of sales and customers and significant incremental costs, which could adversely affect our
business. In addition, security breaches of our information technology systems could result in the misappropriation or unauthorized disclosure of confidential information belonging to us or to our employees, partners, customers or suppliers, which
could result in our suffering significant financial or reputational damage. Further, such a breach may require notification to governmental agencies, the media or individuals pursuant to various federal and state privacy and security laws. We would
also be exposed to a risk of litigation and potential liability, which could materially adversely affect our business, results of operations and financial condition. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our facilities in California are located near known earthquake faults, and the occurrence of an earthquake or other catastrophic disaster could cause damage to our facilities and equipment, which could
require us to cease or curtail operations. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our facilities in the San Francisco Bay Area are located near known earthquake fault zones and are
vulnerable to damage from earthquakes. We are also vulnerable to damage from other types of disasters, including fire, floods, power loss, communications failures and similar events. If any disaster were to occur, our ability to operate our business
at our facilities would be seriously, or potentially completely, impaired. In addition, the nature of our activities could cause significant delays in our research programs and commercial activities and make it difficult for us to recover from a
disaster. The insurance we maintain may not be adequate to cover our losses resulting from disasters or other business interruptions. Accordingly, an earthquake or other disaster could materially and adversely harm our ability to conduct business.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Delivery of our products could be delayed or disrupted by factors beyond our control, and we could lose customers as a result. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We rely on third-party carriers for the timely delivery of our products. As a result, we are subject to carrier disruptions and increased costs that are beyond our
control, including employee strikes, inclement weather and increased fuel costs. Any failure to deliver products to our customers in a timely and accurate manner may damage our reputation and brand and could cause us to lose customers. If our
relationship with any of these third-party carriers is terminated or impaired or if any of these third parties is unable to deliver our products, the delivery and acceptance of our products by our customers may be delayed which could harm our
business and financial results. The failure to deliver our products in a timely manner may harm our relationship with our customers, increase our costs and otherwise disrupt our operations. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Doing business internationally creates operational and financial risks for our business. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">During our
fiscal years ended September&nbsp;30, 2016 and 2017, approximately 22% and 23%, respectively, of our revenue was generated from customers located outside of the United States. During the nine month period ended June 30, 2018, approximately 29% of
our revenue was generated from customers located outside of the United States. In connection with our growth strategy, we intend to further expand in international markets. Conducting and launching operations on an international scale requires close
coordination of activities across multiple jurisdictions and time zones and consumes significant management resources. If we fail to coordinate and manage these activities effectively, our business, financial condition or results of operations could
be </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">36 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
adversely affected. International sales entail a variety of risks, including longer payment cycles and difficulties in collecting accounts receivable outside of the United States, currency
exchange fluctuations, challenges in staffing and managing foreign operations, tariffs and other trade barriers, unexpected changes in legislative or regulatory requirements of foreign countries into which we sell our products, difficulties in
obtaining export licenses or in overcoming other trade barriers, laws and business practices favoring local companies, political and economic instability, difficulties protecting or procuring intellectual property rights, and restrictions resulting
in delivery delays and significant taxes or other burdens of complying with a variety of foreign laws. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Changes in the value of the relevant currencies
may affect the cost of certain items required in our operations. Changes in currency exchange rates may also affect the relative prices at which we are able to sell products in the same market. Our revenue from international customers may be
negatively impacted as increases in the U.S. dollar relative to our international customers’ local currency could make our products more expensive, impacting our ability to compete. Our costs of materials from international suppliers may
increase if in order to continue doing business with us they raise their prices as the value of the U.S. dollar decreases relative to their local currency. Foreign policies and actions regarding currency valuation could result in actions by the
United States and other countries to offset the effects of such fluctuations. The recent global financial downturn has led to a high level of volatility in foreign currency exchange rates and that level of volatility may continue, which could
adversely affect our business, financial condition or results of operations. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our ability to use our net operating loss carryforwards to offset
future taxable income may be subject to certain limitations. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In general, under Section&nbsp;382 of the Internal Revenue Code of 1986, as
amended, or the Code, a corporation that undergoes an “ownership change” is subject to limitations on its ability to use its <font style="white-space:nowrap">pre-change</font> net operating loss carryforwards, or NOLs, to offset future
taxable income. If the Internal Revenue Service challenges our analysis that our existing NOLs will not expire before utilization due to previous ownership changes, our ability to use our NOLs could be limited by Section&nbsp;382 of the Code. Future
changes in our stock ownership, some of which are outside of our control, could result in an ownership change under Section&nbsp;382 of the Code. Furthermore, our ability to use NOLs of companies that we may acquire in the future may be subject to
limitations. For these reasons, we may not be able to use a material portion of the NOLs reflected on our balance sheet, even if we attain profitability. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>The enactment of legislation implementing changes in taxation of international business activities, the adoption of other corporate tax reform policies, or
changes in tax legislation or policies could impact our future financial position and results of operations. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Corporate tax reform, base-erosion
efforts and tax transparency continue to be high priorities in many tax jurisdictions where we intend to have business operations. As a result, policies regarding corporate income and other taxes in numerous jurisdictions are under heightened
scrutiny and tax reform legislation is being proposed or enacted in a number of jurisdictions. For example, the Tax Cuts and Jobs Act of 2017, or the Tax Act, signed into law on December&nbsp;22, 2017, adopting broad U.S. corporate income tax reform
will, among other things, reduce the U.S. corporate income tax rate, but will impose base-erosion prevention measures on <font style="white-space:nowrap">non-U.S.</font> earnings of U.S. entities as well as a
<font style="white-space:nowrap">one-time</font> mandatory deemed repatriation tax on accumulated <font style="white-space:nowrap">non-U.S.</font> earnings of U.S. entities. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, many countries are beginning to implement legislation and other guidance to align their international tax rules with the Organisation for Economic
<font style="white-space:nowrap">Co-operation’s</font> Base Erosion and Profit Shifting recommendations and action plan that aim to standardize and modernize global corporate tax policy, including changes to cross-border tax, transfer-pricing
documentation rules, and nexus-based tax incentive practices. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">37 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Such legislative initiatives may materially and adversely affect our plans to expand internationally and may
negatively impact our financial condition and results of operations generally. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our inability to collect on our accounts receivable by a
significant number of customers may have an adverse effect on our business, financial condition and results of operations. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Sales to our
customers are generally made on open credit terms. Management maintains an allowance for potential credit losses. The average days sales outstanding of our trade receivables as of September 30, 2016 and 2017 were 57 and 78 days outstanding,
respectively. The average days sales outstanding of our trade receivables as of June 30, 2018 was 60 days. If our customers’ cash flow, working capital, financial conditions or results of operations deteriorate, they may be unable or even
unwilling to pay trade receivables owed to us promptly or at all. As a result, we could be exposed to a certain level of credit risk. If a major customer experiences, or a significant number of customers experience, financial difficulties, the
effect on us could be material and have an adverse effect on our business, financial condition and results of operations. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Risks related to being a
public company </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely
basis could be impaired, which would adversely affect our business. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Ensuring that we have adequate internal financial and accounting controls
and procedures in place to produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be <font style="white-space:nowrap">re-evaluated</font> frequently. The rapid growth of our operations and the
planned initial public offering has created a need for additional resources within the accounting and finance functions due to the increasing need to produce timely financial information and to ensure the level of segregation of duties customary for
a U.S. public company. We have hired additional resources in the accounting and finance function and continue to reassess the sufficiency of finance personnel in response to these increasing demands and expectations. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our management is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the
reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our management does not expect that our internal control over financial reporting
will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Because of the inherent
limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within our company will have been
detected. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Commencing with our fiscal year ending September&nbsp;30, 2019, we must perform system and process evaluation and testing of our internal
control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting in our Form <font style="white-space:nowrap">10-K</font> filing for that year, as required by Section&nbsp;404 of
the Sarbanes Oxley Act. We expect to expend significant resources in developing the necessary documentation and testing procedures required by Section&nbsp;404. We cannot be certain that the actions we will be taking to improve our internal controls
over financial reporting will be sufficient, or that we will be able to implement our planned processes and procedures in a timely manner. In addition, if we are unable to produce accurate financial statements on a timely basis, investors could lose
confidence in the reliability of our financial statements, which could cause the market price of our common stock to decline and make it more difficult for us to finance our operations and growth. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">38 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We are an emerging growth company and we cannot be certain if the reduced disclosure requirements
applicable to emerging growth companies will make our common stock less attractive to investors. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are an “emerging growth company”
as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of
this exemption from new or revised accounting standards and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not “emerging growth companies.” </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For as long as we continue to be an emerging growth company, we also intend to take advantage of certain other exemptions from various reporting requirements that
are applicable to other public companies including, but not limited to, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding
advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions. If some
investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We will remain an emerging growth company until the earliest of (i)&nbsp;the last day of the fiscal year in which we have total annual gross revenue of $1.07&nbsp;billion or more; (ii)&nbsp;the last day of our
fiscal year following the fifth anniversary of the date of the closing of this offering; (iii)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in nonconvertible debt during the previous three years; or (iv)&nbsp;the date on which
we are deemed to be a large accelerated filer under the rules of the SEC. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>The requirements of being a public company may strain our resources,
divert management’s attention and affect our ability to attract and retain qualified board members. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As a public company, we will be subject
to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, the listing requirements of the stock exchange on which our common stock is traded and
other applicable securities rules and regulations. The SEC and other regulators have continued to adopt new rules and regulations and make additional changes to existing regulations that require our compliance. Stockholder activism, the current
political environment, and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact, in ways we cannot
currently anticipate, the manner in which we operate our business. Compliance with these rules and regulations may cause us to incur additional accounting, legal and other expenses that we did not incur as a private company. We also anticipate that
we will incur costs associated with corporate governance requirements, including requirements under securities laws, as well as rules and regulations implemented by the SEC and the Nasdaq Global Market, particularly after we are no longer an
“emerging growth company.” We expect these rules and regulations to increase our legal and financial compliance costs and to make some activities more time-consuming and costly. Furthermore, these rules and regulations could make it more
difficult or more costly for us to obtain certain types of insurance, including director and officer liability insurance, and we may be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or
similar coverage. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers. We are currently evaluating and
monitoring developments with respect to these rules and regulations, and we cannot predict or estimate the amount of additional costs we may incur or the timing of such costs. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">39 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Risks related to our intellectual property </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our ability to protect our intellectual property and proprietary technology through patents and other means is uncertain. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our commercial success depends in part on our ability to protect our intellectual property and proprietary technologies. We rely on patent protection, where appropriate and available, as well as a combination of
copyright, trade secret and trademark laws, and nondisclosure, confidentiality and other contractual restrictions to protect our proprietary technology. However, these legal means afford only limited protection and may not adequately protect our
rights or permit us to gain or keep any competitive advantage. As of June&nbsp;30, 2018, we own nine issued U.S. patents and two issued international patents in China. There are 81 pending patent applications, including 39 in the United States, 31
international applications and 11 applications filed under the Patent Cooperation Treaty. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Several patent applications covering our technologies have
been filed recently. We cannot offer any assurances about which, if any, patents will issue, the breadth of any such patent, or whether any issued patents will be found invalid and unenforceable or will be threatened by third parties. Any successful
opposition to these patents or any other patents owned by or, if applicable in the future, licensed to us could deprive us of rights necessary for the practice of our technologies or the successful commercialization of products that we may develop.
Since patent applications in the U.S. and most other countries are confidential for a period of time after filing, we cannot be certain that we were the first to file any patent application related to our technologies or products. Furthermore, an
interference proceeding can be provoked by a third party or instituted by the U.S. Patent and Trademark Office, or the USPTO, to determine who was the first to invent any of the subject matter covered by the patent claims of our applications.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Patent law can be highly uncertain and involve complex legal and factual questions for which important principles remain unresolved. In the United
States and in many international jurisdictions, policy regarding the breadth of claims allowed in patents can be inconsistent. The U.S. Supreme Court and the Court of Appeals for the Federal Circuit have made, and will likely continue to make,
changes in how the patent laws of the United States are interpreted. Similarly, international courts have made, and will continue to make, changes in how the patent laws in their respective jurisdictions are interpreted. We cannot predict future
changes in the interpretation of patent laws or changes to patent laws that might be enacted into law by U.S. and international legislative bodies. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Moreover, the United States Leahy-Smith American Invents Act, enacted in September 2011, brought significant changes to the U.S. patent system, including a change
from a “first to invent” system to a “first to file” system. Under a “first to file” system, assuming the other requirements for patentability are met, the first inventor to file a patent application generally will be
entitled to the patent on an invention regardless of whether another inventor had made the invention earlier. Other changes affect the way the patent applications are prosecuted, redefine prior art, and may affect patent litigation. The USPTO
developed new regulations and procedures to govern administration of the Leahy-Smith Act, and many of the substantive changes to patent law associated with the Leahy-Smith Act became effective on March&nbsp;16, 2013. The Leahy-Smith Act and its
implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, which could have a material adverse effect on our business and financial
condition. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">40 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>If we are unable to obtain, maintain and enforce intellectual property protection, others may be able to
make, use, or sell products and technologies substantially the same as ours, which could adversely affect our ability to compete in the market. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We may not pursue or maintain patent protection for our products in every country or territory in which we sell our products and technologies. In addition, our
pending U.S. and foreign patent applications may not issue as patents or may not issue in a form that will be sufficient to protect our proprietary technology and gain or keep our competitive advantage. Any patents we have obtained or do obtain may
be subject to <font style="white-space:nowrap">re-examination,</font> reissue, opposition or other administrative proceeding, or may be challenged in litigation, and such challenges could result in a determination that the patent is invalid or
unenforceable. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Patents have a limited lifespan. Patent terms may be shortened or lengthened by, for example, terminal disclaimers, patent term
adjustments, supplemental protection certificates, and patent term extensions. Although extensions may be available, the life of a patent, and the protection it affords, is limited. Patent term extensions and supplemental protection certificates,
and the like, may be impacted by the regulatory process and may not significantly lengthen patent term. <font style="white-space:nowrap">Non-payment</font> or delay in payment of patent fees or annuities, delay in patent filings or delay in
extension filing, whether intentional or unintentional, may also result in the loss of patent rights important to our business. In such an event, competitors might be able to enter the market earlier than would otherwise have been the case. In
addition, certain countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to other parties. Furthermore, many countries limit the enforceability of patents against other parties, including government
agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of any patents. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We cannot be certain that the steps we have taken will prevent unauthorized use or unauthorized reverse engineering of our technology. In addition, competitors may be able to design alternative methods or devices
that avoid infringement of our patents. To the extent our intellectual property, including licensed intellectual property, offers inadequate protection, or is found to be invalid or unenforceable, we are exposed to a greater risk of direct
competition. If our intellectual property does not provide adequate protection against our competitors’ products, our competitive position could be adversely affected, as could our business. Both the patent application process and the process
of managing patent disputes can be time consuming and expensive. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Monitoring unauthorized use of our intellectual property is difficult and costly. From
time to time, we review our competitors’ products, and may in the future seek to enforce our patents or other rights against potential infringement. However, the steps we have taken to protect our proprietary rights may not be adequate to
prevent misappropriation of our intellectual property. We may not be able to detect unauthorized use of, or take appropriate steps to enforce, our intellectual property rights. We cannot guarantee that any of our patent searches or analyses,
including but not limited to the identification of relevant patents, the scope of patent claims or the expiration of relevant patents, are complete or thorough, nor can we be certain that we have identified each and every third party patent and
pending application in the United States and abroad that is relevant to or necessary for the commercialization of our products in any jurisdiction. For example, U.S.&nbsp;applications filed before November&nbsp;29, 2000 and certain
U.S.&nbsp;applications filed after that date that will not be filed outside the United States&nbsp;remain confidential until patents issue. Patent applications in the United States&nbsp;and elsewhere are published approximately 18&nbsp;months after
the earliest filing for which priority is claimed. Therefore, patent applications covering our product candidates or technologies could have been filed by others without our knowledge. Additionally, pending patent applications that have been
published can, subject to certain limitations, be later amended in a manner that could cover our platform technologies, our products or the use of our products or technologies. The scope of a patent claim is determined by an interpretation of the
law, the written disclosure in a patent and the patent’s prosecution history. Our interpretation of the relevance or the scope of a patent or a pending application may be incorrect, which may
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">41 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
negatively impact our ability to market our products. We may incorrectly determine that our products are not covered by a third party patent or may incorrectly predict whether a third
party’s pending application will issue with claims of relevant scope. Our determination of the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect, which may negatively impact our ability to
develop and market our product candidates. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Any inability to meaningfully protect our intellectual property could result in competitors offering products
or technologies that incorporate our products or technologies, which could reduce demand for our products or technologies. A court or other judicial body may decide that the patent we seek to enforce is invalid or unenforceable, or may refuse to
stop the other party from using the technology at issue on the grounds that the patent in question does not cover the technology in question. An adverse result in any litigation could put one or more of our patents at risk of being invalidated or
interpreted narrowly. Some of our competitors may be able to devote significantly more resources to intellectual property litigation, and may have significantly broader patent portfolios to assert against us if we assert our rights against them.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We cannot predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. For example: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">we might not have been the first to make the inventions covered by each of our pending patent applications; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">we might not have been the first to file patent applications for these inventions; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">others may independently develop similar or alternative products and technologies or duplicate any of our products and technologies;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">it is possible that none of our pending patent applications will result in issued patents, and even if they issue as patents, they may not provide a basis for
commercially viable products, or may not provide us with any competitive advantages, or may be challenged and invalidated by third parties; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">we may not develop additional proprietary products and technologies that are patentable; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the patents of others may have an adverse effect on our business; and </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">we apply for patents covering our products and technologies and uses thereof, as we deem appropriate. However, we may fail to apply for patents on important
products and technologies in a timely fashion or at all. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We may not be able to protect our intellectual property rights
throughout the world. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Filing, prosecuting and defending patents on our technologies and products in all countries throughout the world would be
prohibitively expensive. In addition, the laws of some <font style="white-space:nowrap">non-U.S.</font> countries do not protect intellectual property rights to the same extent as the laws of the United States, and many companies have encountered
significant problems in protecting and defending such rights in foreign jurisdictions. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing
products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own technologies and products and further,
may export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete with our products, and our patents or other intellectual property
rights may not be effective or sufficient enough to prevent them from competing. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The legal systems of certain countries, particularly certain developing
countries, do not favor the enforcement of patents and other intellectual property protection, particularly those relating to biotechnology, which could </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">42 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
make it difficult for us to stop the infringement of our patents. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and
attention from other aspects of our business, could put our own patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may not
prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a
significant commercial advantage from the intellectual property that we develop. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>If we are unable to protect the confidentiality of our
proprietary information and <font style="white-space:nowrap">know-how,</font> the value of our technology and products could be adversely affected. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition to pursuing patents on our technology, we take steps to protect our intellectual property and proprietary technology by entering into confidentiality agreements and intellectual property assignment
agreements with our employees, consultants, corporate partners and, when needed, our advisors. Such agreements may not be enforceable or may not provide meaningful protection for our trade secrets or other proprietary information in the event of
unauthorized use or disclosure or other breaches of the agreements, and we may not be able to prevent such unauthorized disclosure. Monitoring unauthorized disclosure is difficult, and we do not know whether the steps we have taken to prevent such
disclosure are, or will be, adequate. If we were to enforce a claim that a third party had illegally obtained and was using our trade secrets, it would be expensive and time consuming, and the outcome would be unpredictable. In addition, courts
outside the United States may be less willing to protect trade secrets. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Trade secrets and <font style="white-space:nowrap">know-how</font> can be
difficult to protect as trade secrets, and <font style="white-space:nowrap">know-how</font> will over time be disseminated within the industry through independent development, the publication of journal articles, and the movement of personnel
skilled in the art from company to company. In addition, because we may rely on third parties in the development of our products, we may, at times, share trade secrets with them. We seek to protect our proprietary technology in part by entering into
confidentiality agreements and, if applicable, material transfer agreements, consulting agreements or other similar agreements with third parties prior to beginning research or disclosing proprietary information. These agreements typically limit the
rights of the third parties to use or disclose our confidential information, including our trade secrets. Despite the contractual provisions employed when working with third parties, the need to share trade secrets and other confidential information
increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. If we are unable to prevent material disclosure of
the intellectual property related to our technologies to third parties, we will not be able to establish or maintain a competitive advantage in our market, which could materially adversely affect our business, results of operations and financial
condition. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Despite our efforts to protect our trade secrets, our competitors may discover our trade secrets, either lawfully or through breach of our
agreements with third parties, independent development or publication of information by any of our third-party collaborators. Competitors could willfully infringe our intellectual property rights, design around our protected technology or develop
their own competitive technologies that fall outside of our intellectual property rights. In addition, if any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent such
competitor from using that technology or information to compete with us, which could harm our competitive position. Given that our proprietary position is based, in part, on our <font style="white-space:nowrap">know-how</font> and trade secrets, a
competitor’s discovery of our trade secrets or other unauthorized use or disclosure would impair our competitive position and may have an adverse effect on our business and results of operations. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">43 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">We may also be subject to claims that former employees, collaborators or other third parties have an ownership
interest in our patents or other intellectual property. Other than the currently pending litigation filed by Agilent, described under the captions “Business – Legal proceedings” and “Risk factors – We and our chief executive
officer are currently involved in litigation with Agilent in which Agilent has alleged a claim of trade secret misappropriation against Twist Bioscience and trade secret misappropriation and other related claims against our chief executive officer,
and an adverse result could harm our business and results of operations,” no legal claims against us are currently pending. Some of our employees were previously employed at universities or biotechnology or biopharmaceutical companies,
including our competitors or potential competitors. We may be subject to claims that these employees or we have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers. Litigation may be
necessary to defend against these and other claims challenging inventorship or ownership. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights. A loss of key research
personnel or their work product could hamper our ability to commercialize, or prevent us from commercializing, our products and technologies. Such an outcome could have a material adverse effect on our business. Even if we are successful in
defending against such claims, litigation could result in substantial costs and distraction to management and other employees. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We may be involved
in lawsuits to protect or enforce our patents and proprietary rights, to determine the scope, coverage and validity of others’ proprietary rights, or to defend against third party claims of intellectual property infringement that could require
us to spend significant time and money and could prevent us from selling our products or impact our stock price. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Litigation may be necessary for
us to enforce our patent and proprietary rights and/or to determine the scope, coverage and validity of others’ proprietary rights. Litigation on these matters has been prevalent in our industry and we expect that this will continue. As the
biotechnology and synthetic biology industries expand and more patents are issued, the risk increases that there may be patents issued to third parties that relate to our technologies and products of which we are not aware or that we may need to
challenge to continue our operations as currently contemplated. In addition, our competitors and others may have patents or may in the future obtain patents and claim that the use of our products or processes infringes these patents. As we move into
new markets and applications for our products and processes, incumbent participants in such markets may assert their patents and other proprietary rights against us as a means of slowing our entry into such markets or as a means to extract
substantial license and royalty payments from us. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">To determine the priority of inventions, we may have to initiate and participate in interference
proceedings declared by the USPTO that could result in substantial legal fees and could substantially affect the scope of our patent protection. Also, our intellectual property may be subject to significant administrative and litigation proceedings
such as invalidity, unenforceability, <font style="white-space:nowrap">re-examination</font> and opposition proceedings against our patents. Whether merited or not, we may additionally face allegations that we have infringed the trademarks,
copyrights, patents and other intellectual property rights of third parties, including patents held by our competitors or by <font style="white-space:nowrap">non-practicing</font> entities. If we fail to identify and correctly interpret relevant
patents, we may be subject to infringement claims. We may also face allegations that our employees have misappropriated the intellectual property rights of their former employers or other third parties. The outcome of any litigation or other
proceeding is inherently uncertain and the results might not be favorable to us. For more information on our current legal and regulatory proceedings, see the section of this prospectus captioned “Business — Legal proceedings.”
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity
challenge could be an alleged failure to meet any of several statutory requirements, for example, lack of novelty, obviousness or <font style="white-space:nowrap">non-enablement.</font> Grounds for an unenforceability assertion could be an
allegation that someone connected with prosecution of the patent withheld relevant </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">44 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
information from the USPTO, or made a misleading statement during prosecution. The outcome following legal assertions of invalidity and unenforceability during patent litigation is unpredictable.
If a defendant were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on certain aspects of our platform technology. Such a loss of patent protection could have
a material and adverse effect on our business, financial condition, results of operations and prospects. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Patent infringement suits can be expensive,
lengthy and disruptive to business operations. We could incur substantial costs and divert the attention of our management and technical personnel in prosecuting or defending against any claims, and may harm our reputation. Some of our competitors
may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. There can be no assurance that we will prevail in any suit initiated against us by third parties,
successfully settle or otherwise resolve patent infringement claims. If we are unable to successfully settle claims on terms acceptable to us, we may be required to engage in or continue costly, unpredictable and time-consuming litigation and may be
prevented from or experience substantial delays in marketing our technologies and products. Furthermore, parties making claims against us may be able to obtain injunctive or other relief, which could block our ability to develop, commercialize and
sell products, and could result in the award of substantial damages against us, including treble damages and attorneys’ fees and costs in the event that we are found to be a willful infringer of third party patents. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the event of a successful claim of infringement against us, we may be required to obtain one or more licenses from third parties, which we may not be able to
obtain at a reasonable cost, if at all. We could therefore incur substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our gross margins. In addition, we could encounter delays in
product introductions while we attempt to develop alternative methods or products to avoid infringing third-party patents or proprietary rights. Defense of any lawsuit or failure to obtain any required licenses on favorable terms could prevent us
from commercializing our products, and the risk of a prohibition on the sale of any of our products could adversely affect our ability to grow and gain market acceptance for our products. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure
during this type of litigation. In addition, during the course of this kind of litigation, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors
perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development
activities or any future sales, marketing or distribution activities. Finally, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to
continue our operations. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, our agreements with some of our suppliers, distributors, customers and other entities with whom we do business may
require us to defend or indemnify these parties to the extent they become involved in infringement claims against us, including the claims described above. We could also voluntarily agree to defend or indemnify third parties in instances where we
are not obligated to do so if we determine it would be important to our business relationships. If we are required or agree to defend or indemnify any of these third parties in connection with any infringement claims, we could incur significant
costs and expenses that could adversely affect our business, operating results, or financial condition. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">45 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We may not be successful in obtaining or maintaining necessary rights to our products and technologies
through acquisitions and <font style="white-space:nowrap">in-licenses,</font> and our intellectual property agreements with third parties may involve unfavorable terms or be subject to disagreements over contract interpretation. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We may find that our programs require the use of proprietary rights held by third parties, and the growth of our business may depend in part on our ability to
acquire, <font style="white-space:nowrap">in-license</font> or use these proprietary rights. We may be unable to acquire or <font style="white-space:nowrap">in-license</font> compositions, methods of use, processes or other third party intellectual
property rights from third parties that we identify as necessary for our products and technologies. The licensing and acquisition of third-party intellectual property rights is a competitive area, and other companies may also be pursuing strategies
to license or acquire third-party intellectual property rights that we may consider attractive. These companies may have a competitive advantage over us due to their size, financial resources and greater commercialization capabilities. In addition,
companies that perceive us to be a competitor may be unwilling to assign or license rights to us. Moreover, collaboration arrangements are complex and time-consuming to negotiate, document, implement and maintain. We may not be successful in our
efforts to establish and implement collaborations or other alternative arrangements should we so choose to enter into such arrangements. We also may be unable to license or acquire third-party intellectual property rights on terms that that would be
favorable to us or would allow us to make an appropriate return on our investment. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We engage in discussions regarding other possible commercial and
cross-licensing agreements with third parties from time to time. There can be no assurance that these discussions will lead to the execution of commercial license or cross-license agreements or that such agreements will be on terms that are
favorable to us. Even if we are able to obtain a license to intellectual property of interest, we may not be able to secure exclusive rights, in which case others could use the same rights and compete with us. In addition, if we enter into
cross-licensing agreements, there is no assurance that we will be able to effectively compete against others who are licensed under our patents. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In
addition, provisions in our licensing and other intellectual property agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could affect the scope of our rights to the
relevant intellectual property or technology, or affect financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations and prospects.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We have not yet registered some of our trademarks in all of our potential markets, and failure to secure those registrations could adversely
affect our business. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Some of our trademark applications may not be allowed for registration, and our registered trademarks may not be maintained
or enforced. In addition, in the U.S. Patent and Trademark Office and in comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks.
Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not survive such proceedings. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, third
parties may file first for our trademarks in certain countries. If they succeed in registering such trademarks, and if we are not successful in challenging such third party rights, we may not be able to use these trademarks to market our products
and technologies in those countries. Over the long-term, if we are unable to establish name recognition based on our trademarks, then our marketing abilities may be materially adversely impacted. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We depend on certain technologies that are licensed to us. We do not control these technologies and any loss of our rights to them could prevent us from
selling our products. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We rely on, or may in the future rely on, licenses in order to be able to use various proprietary technologies that are
material to our business. We do not or will not own the patents that underlie these licenses. Our rights to </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">46 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
use the technology we license are subject to the negotiation of, continuation of and compliance with the terms of those licenses. In some cases, we do not or will not control the prosecution,
maintenance, or filing of the patents to which we hold licenses, or the enforcement of these patents against third parties. Some of our patents and patent applications were either acquired from another company who acquired those patents and patent
applications from yet another company, or are licensed from a third party. For example, Twist Bioscience acquired Genome Compiler Corporation in 2016, and Genome Compiler had a <font style="white-space:nowrap">non-exclusive</font> license to U.S.
Patent No.&nbsp;7,805,252 owned by DNA 2.0. Thus, these patents and patent applications are not written by us or our attorneys, and we did not have control over the drafting and prosecution. The former patent owners and our licensors might not have
given the same attention to the drafting and prosecution of these patents and applications as we would have if we had been the owners of the patents and applications and had control over the drafting and prosecution. We cannot be certain that
drafting and/or prosecution of the licensed patents and patent applications by the licensors have been or will be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents and other intellectual
property rights. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our rights to use the technology we license is subject to the validity of the owner’s intellectual property rights. Enforcement of
our licensed patents or defense or any claims asserting the invalidity of these patents is often subject to the control or cooperation of our licensors. Legal action could be initiated against the owners of the intellectual property that we license.
Even if we are not a party to these legal actions, an adverse outcome could harm our business because it might prevent these other companies or institutions from continuing to license intellectual property that we may need to operate our business.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our licenses contain or will contain provisions that allow the licensor to terminate the license upon specific conditions. Our rights under the licenses
are subject to or will be subject to our continued compliance with the terms of the license, including the payment of royalties due under the license. Termination of these licenses could prevent us from marketing some or all of our products. Because
of the complexity of our products and the patents we have licensed, determining the scope of the license and related royalty obligation can be difficult and can lead to disputes between us and the licensor. An unfavorable resolution of such a
dispute could lead to an increase in the royalties payable pursuant to the license. If a licensor believed we were not paying the royalties due under the license or were otherwise not in compliance with the terms of the license, the licensor might
attempt to revoke the license. If such an attempt were successful, we might be barred from producing and selling some or all of our products. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Risks
related to doing business in China </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>The People’s Republic of China, or the PRC, government has the ability to exercise significant
influence and control over our proposed wholly owned foreign entity in China. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The PRC plays a significant role in regulating industrial
development by imposing business regulations. It also exercises significant control over the country’s economic growth through the allocation of resources, controlling payment of foreign currency-denominated obligations, setting monetary policy
and providing preferential treatment to particular industries or companies. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Additional factors that we may experience in connection with setting up
operations in China that may adversely affect our business and results of operations include: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our inability to enforce or obtain a remedy under our agreements; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">PRC restrictions on foreign investment that could impair our ability to conduct our business or acquire or contract with other entities in the future;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">restrictions on currency exchange that may limit our ability to use cash flow most effectively or to repatriate our investments; </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">47 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">fluctuations in currency values; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">increased challenges of defending our intellectual property; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">cultural, language and managerial differences that may reduce our overall performance; and </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">political instability in China. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We may
not be able to enforce our rights in China. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">China’s legal and judicial system may negatively impact foreign investors. The legal system in
China is evolving rapidly, and enforcement of laws is inconsistent. It may be impossible to obtain swift and equitable enforcement of laws or enforcement of the judgment of one court by a court of another jurisdiction. China’s legal system is
based on civil law or written statutes and a decision by one judge does not set a legal precedent that must be followed by judges in other cases. In addition, the interpretation of Chinese laws may vary to reflect domestic political changes.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">There are substantial uncertainties regarding the interpretation and application to our business of PRC laws and regulations, since many of the rules
and regulations that companies face in China are not made public. The effectiveness of newly enacted laws, regulations or amendments may be delayed, resulting in detrimental reliance by foreign investors. We cannot predict what effect the
interpretation of existing or new PRC laws or regulations may have on the proposed business of our wholly foreign owned entity. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>China is a
developing nation governed by a one-party communist government and susceptible to political, economic, and social upheaval that could disrupt the economy. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">China is a developing country governed by a one-party government. China is also a country with an extremely large population, wide income gaps between rich and poor and between urban and rural residents, minority
ethnic and religious populations, and growing access to information about the different social, economic, and political systems found in other countries. China has also experienced extremely rapid economic growth over the last decade, and its legal
and regulatory systems have had to change rapidly to accommodate this growth. If China experiences political or economic upheaval, labor disruptions or other organized protests, nationalization of private businesses, civil strife, strikes, acts of
war and insurrections, this may disrupt China’s economy and could materially and adversely affect the financial performance of our proposed wholly foreign owned entity. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>If relations between China and the U.S. deteriorate, our business in China may be materially and adversely affected. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The relationship between China and the U.S. is subject to periodic tension. Relations may also be compromised if the U.S. becomes a more active advocate of Taiwan or pressures the PRC government regarding its
monetary, economic or social policies. Changes in political conditions in China and changes in the state of China-U.S. relations are difficult to predict and could adversely affect the operations or financial condition of our proposed wholly owned
foreign owned entity. In addition, because of our involvement in the Chinese market, any deterioration in political or trade relations might cause a public perception in the U.S. or elsewhere that might cause our products to become less attractive.
A proposed enhancement of U.S. export controls is expected to apply to U.S. technology exports to China and Chinese companies, in addition to more stringent review of foreign investment in U.S. technology companies by the committee on foreign
investment in the United States. We cannot predict what effect any changes in China-U.S. relations may have on our ability to access capital or effectively do business in China, including through the proposed business of our proposed wholly foreign
owned entity. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Governmental control of currency conversion may limit our ability to utilize our revenues effectively and affect the value of your
investment. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The PRC government imposes controls on the convertibility of the Chinese currency, Renminbi, into foreign currencies and, in certain
cases, the remittance of currency out of China. Under existing PRC foreign exchange </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">48 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
regulations, payments of current account items, including profit distributions, interest payments and trade and service-related foreign exchange transactions, can be made in foreign currencies
without prior approval of State Administration of Foreign Exchange, or SAFE, by complying with certain procedural requirements. However, in practice sometimes payment of current account items may be subject to delay and other restrictions.
Furthermore, approval from or registration with appropriate government authorities is required where Renminbi is to be converted into foreign currency and remitted out of China to pay capital expenses such as the repayment of loans denominated in
foreign currencies. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In light of the flood of capital outflows of China in 2016 due to the weakening Renminbi, the PRC government has imposed more
restrictive foreign exchange policies and stepped up scrutiny of major outbound capital movement including overseas direct investment. More restrictions and substantial vetting process are put in place by SAFE to regulate cross-border transactions
falling under the capital account. The PRC government may at its discretion further restrict access in the future to foreign currencies for current account transactions. Therefore, if we receive revenues in Renminbi by our proposed wholly foreign
owned entity or otherwise, due to China’s foreign exchange control, such revenues may not be converted to foreign currency and remitted out of China in a timely manner. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Risks relating to owning our common stock and this offering </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our share price may be volatile, and you
maybe unable to sell your shares at or above the offering price. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The market price of our common stock is likely to be volatile and could be
subject to wide fluctuations in response to many risk factors listed in this section, and others beyond our control, including: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">actual or anticipated fluctuations in our financial condition and operating results, including fluctuations in our quarterly and annual results;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">announcements of technological innovations by us or our competitors; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">overall conditions in our industry and the markets in which we operate; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">addition or loss of significant customers, or other developments with respect to significant customers; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">changes in laws or regulations applicable to our products; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">actual or anticipated changes in our growth rate relative to our competitors; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">additions or departures of key personnel; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">competition from existing products or new products that may emerge; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">issuance of new or updated research or reports by securities analysts; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">fluctuations in the valuation of companies perceived by investors to be comparable to us; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">disputes or other developments related to proprietary rights, including patents, litigation matters including the Agilent litigation, and our ability to obtain
intellectual property protection for our technologies; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">announcement or expectation of additional financing efforts; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">sales of our common stock by us or our stockholders; </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">49 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">share price and volume fluctuations attributable to inconsistent trading volume levels of our shares; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the expiration of contractual <font style="white-space:nowrap">lock-up</font> agreements with our executive officers, directors and stockholders; and
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">general economic and market conditions. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Furthermore, the stock markets have experienced price and volume fluctuations that have affected and continue to affect the market prices of equity securities of
many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. These broad market and industry fluctuations, as well as general economic, political and market conditions such as
recessions, interest rate changes or international currency fluctuations, may negatively impact the market price of our common stock. If the market price of our common stock after this offering does not exceed the initial public offering price, you
may not realize any return on your investment in us and may lose some or all of your investment. In the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We
may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert our management’s attention from other business concerns, which could seriously harm our business.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>No public market for our common stock currently exists, and an active trading market may not develop or be sustained following this offering.
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Prior to this offering, there has been no public market for our common stock. Although we will apply to have our common stock listed on the
Nasdaq Global Market, an active trading market may not develop following the closing of this offering or, if developed, may not be sustained. The lack of an active market may impair your ability to sell your shares at the time you wish to sell them
or at a price that you consider reasonable. The lack of an active market may also reduce the fair market value of your shares. An inactive market may also impair our ability to raise capital to continue to fund operations by selling shares and may
impair our ability to acquire other companies or technologies by using our shares as consideration. The initial public offering price was determined by negotiations between us and the underwriters and may not be indicative of the future prices of
our common stock. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>If securities or industry analysts do not publish research or reports about our business or publish negative reports about our
business, our share price and trading volume could decline. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The trading market for our common stock will depend on the research and reports that
securities or industry analysts publish about us or our business. Currently, we do not have any analyst coverage and we may not obtain analyst coverage in the future. In the event we obtain analyst coverage, we will not have any control over such
analysts. If one or more of the analysts who cover us downgrade our shares or change their opinion of our shares, our share price would likely decline. If one or more of these analysts cease coverage of our company or fail to regularly publish
reports on us, we could lose visibility in the financial markets, which could cause our share price or trading volume to decline. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Future sales and
issuances of our common stock or rights to purchase common stock, including pursuant to our equity incentive plans, could result in additional dilution of the percentage ownership of our stockholders and could cause the stock price of our common
stock to decline. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We may issue additional securities following the completion of this offering. In the future, we may sell common stock,
convertible securities or other equity securities in one or more transactions at prices and in a manner we determine from time to time. We also expect to issue common stock to employees and directors pursuant to our equity incentive plans. If we
sell common stock, convertible securities or other equity securities in subsequent transactions, or common stock is issued pursuant to equity incentive plans, investors may be materially diluted.
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">50 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
New investors in such subsequent transactions could gain rights, preferences and privileges senior to those of holders of our common stock. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Future sales of our common stock in the public market could cause our share price to fall. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Sales of a substantial number of shares of our common stock in the public market after this offering, or the perception that these sales might occur, could depress the market price of our common stock and could
impair our ability to raise capital through the sale of additional equity securities. Based on the number of shares of common stock outstanding as of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
upon the closing of this offering, we will have &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock outstanding, assuming no exercise of our outstanding options. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">All of the common stock sold in this offering will be freely tradable without restrictions or further registration under the Securities Act of 1933, as amended, or
the Securities Act, except for any shares held by our affiliates as defined in Rule 144 under the Securities Act. The remaining &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock outstanding after this
offering, based on shares outstanding as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, will be restricted as a result of securities laws, <font style="white-space:nowrap">lock-up</font> agreements or other contractual
restrictions that restrict transfers for at least 180 days after the date of this prospectus, subject to certain extensions. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The underwriters may, in
their sole discretion, release all or some portion of the shares subject to <font style="white-space:nowrap">lock-up</font> agreements with the underwriters prior to expiration of the <font style="white-space:nowrap">lock-up</font> period. See also
the section of this prospectus captioned “Shares eligible for future sale.” For more information regarding the <font style="white-space:nowrap">lock-up</font> agreements with the underwriters see the section of this prospectus captioned
“Underwriting.” </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The holders of 203,420,957 shares of common stock, or 95.1% based on shares outstanding on an
<font style="white-space:nowrap">as-converted</font> basis as of June 30, 2018, will be entitled to rights with respect to registration of such shares under the Securities Act pursuant to a registration rights agreement between such holders and us.
See “Certain relationships and related party transactions—Registration rights agreement” below. If such holders, by exercising their registration rights, sell a large number of shares, they could adversely affect the market price for
our common stock. If we file a registration statement for the purpose of selling additional shares to raise capital and are required to include shares held by these holders pursuant to the exercise of their registration rights, our ability to raise
capital may be impaired. We intend to file a registration statement on Form <font style="white-space:nowrap">S-8</font> under the Securities Act to register &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common
stock for issuance under the 2018 Plan, the 2013 Plan and the 2018 ESPP. Both the 2018 Plan and the 2018 ESPP provide for automatic increases in the shares reserved for issuance under the plans which could result in additional dilution to our
stockholders. Once we register the shares under these plans, they can be freely sold in the public market upon issuance and vesting, subject to a <font style="white-space:nowrap">180-day</font> <font style="white-space:nowrap">lock-up</font> period
and other restrictions provided under the terms of the applicable plan and/or the option agreements entered into with option holders. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our
management team may invest or spend the proceeds of this offering in ways with which you may not agree or in ways which may not yield a return. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our management will have broad discretion in the application of the net proceeds, and you will not have the opportunity, as part of your investment decision, to
assess whether the proceeds are being used appropriately. Accordingly, investors will need to rely on our judgment with respect to the use of these proceeds. We currently intend to use the proceeds from this offering primarily to improve and update
our platform and core technologies, expand our sales and marketing capabilities in the U.S. and in other geographies, including China, develop and expand into the biologics drug discovery and DNA data storage markets, and for working capital and
general corporate purposes. While we have no current agreements, commitments or understandings for any specific strategic acquisitions or in-licenses at this time, we may use a portion of the net proceeds for these purposes. For more information
see, “Use of proceeds.” The failure by our management to apply these funds effectively could adversely affect our ability to continue maintaining and expanding our business. Until the net
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">51 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
proceeds are used, they may be placed in investments that do not produce significant income or that may lose value. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>We have never paid dividends on our capital stock and we do not intend to pay dividends for the foreseeable future. Consequently, any gains from an investment in our common stock will likely depend on whether
the price of our common stock increases. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have never declared or paid any dividends on our common stock and do not intend to pay any dividends
in the foreseeable future. We anticipate that we will retain all of our future earnings for use in the operation of our business and for general corporate purposes. Any determination to pay dividends in the future will be at the discretion of our
board of directors. Accordingly, investors must rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investments. Furthermore, we are party to a credit agreement
with Silicon Valley Bank which contains negative covenants that limit our ability to pay dividends. For more information, see the section of this prospectus captioned “Management’s discussion and analysis of financial condition and results
of operation – Liquidity and capital resources.” For more information regarding the negative covenants in our loan and security agreement with Silicon Valley Bank, see “Risk factors—Our credit facility contains restrictions that
limit our flexibility in operating our business.” </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our charter documents and Delaware law could prevent a takeover that stockholders consider
favorable and could also reduce the market price of our stock. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our amended and restated certificate of incorporation and our amended and
restated bylaws will contain provisions that could delay or prevent a change in control of our company. These provisions could also make it more difficult for stockholders to elect directors and take other corporate actions. These provisions
include: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">providing for a classified board of directors with staggered, three year terms; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">authorizing our board of directors to issue preferred stock with voting or other rights or preferences that could discourage a takeover attempt or delay changes
in control; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">prohibiting cumulative voting in the election of directors; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">providing that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">prohibiting the adoption, amendment or repeal of our amended and restated bylaws or the repeal of the provisions of our amended and restated certificate of
incorporation regarding the election and removal of directors without the required approval of at least 66.67% of the shares entitled to vote at an election of directors; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">prohibiting stockholder action by written consent; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">limiting the persons who may call special meetings of stockholders; and </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">requiring advance notification of stockholder nominations and proposals. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors,
which is responsible for appointing the members of our management. In addition, the provisions of Section&nbsp;203 of the Delaware General Corporate Law, or the DGCL, govern us. These provisions may prohibit large stockholders, in particular those
owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time without the consent of our board of directors. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">52 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">These and other provisions in our amended and restated certificate of incorporation and our amended and restated
bylaws and under Delaware law could discourage potential takeover attempts, reduce the price investors might be willing to pay in the future for shares of our common stock and result in the market price of our common stock being lower than it would
be without these provisions. For more information, see the section of this prospectus captioned “Description of capital stock—Anti-takeover effects of Delaware law and our amended and restated certificate of incorporation and amended and
restated bylaws.” </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Insiders have substantial control over us and will be able to influence corporate matters. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June 30, 2018, our directors and executive officers and their affiliates will beneficially own, in the aggregate, approximately 35.1% of our outstanding
capital stock upon the completion of this offering. As a result, these stockholders will be able to exercise significant influence over all matters requiring stockholder approval, including the election of directors and approval of significant
corporate transactions, such as a merger or other sale of our company or its assets. This concentration of ownership could limit stockholders’ ability to influence corporate matters and may have the effect of delaying or preventing a third
party from acquiring control over us. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Claims for indemnification by our directors and officers may reduce our available funds to satisfy
successful third-party claims against us and may reduce the amount of money available to us. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our amended and restated certificate of
incorporation and amended and restated bylaws provide that we will indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, as permitted by Section&nbsp;145 of the DGCL, our amended and restated bylaws and our indemnification agreements that we have entered into with our directors and officers provide that: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">We will indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our request, to the fullest extent
permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the registrant and,
with respect to any criminal proceeding, had no reasonable cause to believe such person’s conduct was unlawful; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">We may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">We are required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that such directors or officers
shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">We will not be obligated pursuant to our amended and restated bylaws to indemnify a person with respect to proceedings initiated by that person against us or our
other indemnitees, except with respect to proceedings authorized by our board of directors or brought to enforce a right to indemnification; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">The rights conferred in our amended and restated bylaws are not exclusive, and we are authorized to enter into indemnification agreements with our directors,
officers, employees and agents and to obtain insurance to indemnify such persons; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">We may not retroactively amend our amended and restated bylaw provisions to reduce our indemnification obligations to directors, officers, employees and agents.
</font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">53 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Our amended and restated certificate of incorporation to be in effect upon completion of this offering will
provide that the Court of Chancery of the State of Delaware and the federal district courts of the United States will be the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’
ability to obtain a favorable judicial forum for disputes with us or our directors, officers or other employees. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our amended and restated
certificate of incorporation to be in effect upon completion of this offering provides that the Court of Chancery of the State of Delaware is the sole and exclusive forum for any derivative action or proceeding brought on our behalf, any action
asserting a breach of fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders, any action asserting a claim against us arising pursuant to any provisions of the DGCL, our amended and restated certificate of
incorporation or our amended and restated bylaws to be in effect upon completion of this offering, any action or proceeding asserting a claim as to which the Delaware General Corporation Law confers jurisdiction upon the Court of Chancery of the
State of Delaware or any action asserting a claim against us that is governed by the internal affairs doctrine, subject in each case to the Court of Chancery having personal jurisdiction over the parties named as defendants therein. The choice of
forum provision may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors,
officers and other employees. If a court were to find the choice of forum provision contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with
resolving such action in other jurisdictions. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our amended and restated certificate of incorporation to be in effect upon completion of this offering
further provides that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Because the public offering price of our common stock will be substantially higher than the net tangible book value per share of our outstanding common stock following this offering, new investors will
experience immediate and substantial dilution. </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The public offering price of our common stock is substantially higher than the net tangible book
value per share of our common stock immediately following this offering based on the total value of our tangible assets less our total liabilities. Therefore, if you purchase shares of our common stock in this offering, you will experience immediate
dilution of approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, the difference between the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the
estimated offering price range set forth on the cover page of this prospectus, and the net tangible book value per share of our common stock as of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, after
giving effect to the issuance of shares of our common stock in this offering. Furthermore, if the underwriters exercise their overallotment option, or outstanding options and warrants are exercised, you could experience further dilution. For a
further description of the dilution that you will experience immediately after the offering, see the section of this prospectus captioned “Dilution.” </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">54 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_3"></a>Special note regarding forward-looking statements </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">This prospectus includes forward-looking statements within the meaning of the federal securities laws. We have based these forward-looking statements largely on our
current expectations and projections about future events and financial trends affecting the operating results and financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results, and
will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s
good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.
Important factors that could cause such differences include, but are not limited to, statements about: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our ability to increase our revenue and our revenue growth rate; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">estimates of our expenses, future revenues, capital requirements and our needs for additional financing; our estimates of the size of our market opportunities;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our expectations regarding our ability to increase DNA production, reduce turnaround times and drive cost reductions for our customers;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our ability to effectively manage our growth; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our ability to successfully enter new markets and manage our international expansion; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our ability to protect our intellectual property, including our proprietary DNA synthesis platform; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">costs associated with defending intellectual property infringement and other claims; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the effects of increased competition in our business; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our ability to keep pace with changes in technology and our competitors; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our ability to successfully identify, evaluate and manage any future acquisitions of businesses, solutions or technologies; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the success of our marketing efforts; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">significant disruption in, or breach in security of our information technology systems and resultant interruptions in service and any related impact on our
reputation; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the attraction and retention of qualified employees and key personnel; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the effects of natural or <font style="white-space:nowrap">man-made</font> catastrophic events; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the effectiveness of our internal controls; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">changes in government regulation affecting our business; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the impact of adverse economic conditions; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our use of the net proceeds from this offering; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">other risk factors included under “Risk factors” in this prospectus. </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">55 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, in this prospectus, the words “believe,” “may,” “will,”
“estimate,” “continue,” “anticipate,” “intend,” “expect,” “predict,” “potential” and similar expressions, as they relate to our company, our business and our management, are
intended to identify forward-looking statements. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this prospectus may not occur and actual results could differ materially from those anticipated or
implied in the forward-looking statements. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Forward-looking statements speak only as of the date of this prospectus. You should not put undue reliance on
any forward-looking statements. We assume no obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by
applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">You should read this prospectus and the documents that we reference in this prospectus and have filed with the Securities and Exchange Commission as exhibits to the
registration statement of which this prospectus is a part with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">56 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_4"></a>Industry and market data </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">This prospectus contains estimates, projections and other information concerning our industry, our business, and the markets for our products, including data
regarding our current manufacturing capacity, product features and benefits, product quality, turnaround time, reliability and cost, as well as data regarding market research, estimates and forecasts prepared by our management. Information that is
based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances that are assumed in this information.
Unless otherwise expressly stated, we obtained this industry, business, market and other data from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general
publications, government data and similar sources. In some cases, we do not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or more sources of this type of data in any paragraph, you should assume
that other data of this type appearing in the same paragraph is derived from the same sources, unless otherwise expressly stated or the context otherwise requires. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">57 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_5"></a>Use of proceeds </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We estimate that the net proceeds from our issuance and sale of shares of our common stock in this offering will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming an initial public
offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and
commissions and estimated offering expenses that the net proceeds from this offering will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">A $1.00 increase or decrease in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the
cover page of this prospectus, would increase or decrease our net proceeds from this offering by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming that the number of shares offered by us, as set forth on the cover page
of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. An increase or decrease of 1,000,000 shares in the number of shares offered by us, as set forth
on the cover page of this prospectus, would increase or decrease our net proceeds from this offering by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming no change in the assumed initial public offering price per share
and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. We do not expect that a change in the offering price or the number of shares by these amounts would have a material effect on our
intended uses of the net proceeds from this offering, although it may impact the amount of time prior to which we may need to seek additional capital. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June 30, 2018, we had cash, cash equivalents and short-term investments of $92.5&nbsp;million. We currently estimate that we will use the net proceeds from
this offering, together with our existing cash, cash equivalents and short-term investments as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million to improve and update our
platform and core technologies by investing in equipment, expanding our research and development capabilities and establishing new and scalable operation facilities; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million to expand our sales and
marketing capabilities in the U.S., Europe and Asia; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million to develop our manufacturing
operations in China; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million to develop and expand into
the biologics drug discovery and DNA data storage markets; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Any proceeds not applied to the foregoing will be used for working capital and general corporate purposes. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe opportunities may exist from time to time to expand our current business through strategic acquisitions or
<font style="white-space:nowrap">in-licenses</font> of complementary companies or technologies. While we have no current agreements, commitments or understandings for any specific strategic acquisitions or
<font style="white-space:nowrap">in-licenses</font> at this time, we may use a portion of the net proceeds for these purposes. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">This expected use of the
net proceeds from this offering and our existing cash, cash equivalents and short-term investments represents our intentions based upon our current plans and business conditions, which could change in the future as our plans and business conditions
evolve. As of the date of this prospectus, we cannot predict with certainty all of the particular uses for the proceeds to be received upon the completion of this offering or the actual amounts that we will spend on the uses set forth above. As a
result, our management will retain broad discretion over the allocation of the net proceeds from this offering. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">58 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">After giving effect to the anticipated net proceeds from this offering, we expect that our existing cash, cash
equivalents and short-term investments will be sufficient to fund our planned operating expenses, capital expenditure requirements and debt service payments through at least the next 12 months. We have based this estimate on assumptions that may
prove to be wrong, and we could use our available capital resources sooner than we currently expect. For additional information regarding our potential capital requirements, see “We will require additional financing to achieve our goals, and a
failure to obtain this necessary capital when needed on acceptable terms, or at all, could force us to delay, limit, reduce or terminate our product manufacturing and development and other operations” under the heading “Risk factors.”
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Pending our use of the net proceeds from this offering, we intend to invest the net proceeds in a variety of capital preservation investments, including
short-term, investment-grade, interest-bearing instruments and U.S. government securities. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">59 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_6"></a>Dividend policy </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have never declared or paid cash dividends on our capital stock. We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying
any cash dividends in the foreseeable future. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Any decision to declare and pay dividends in the future will be made at the discretion of our board of
directors and will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restrictions including compliance with covenants under our credit facilities and other factors that our board of
directors may deem relevant. In addition, under the terms of our current credit facilities, we are prohibited from paying cash dividends without the prior consent of Silicon Valley Bank. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">60 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_7"></a>Capitalization </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table sets forth our cash, cash equivalents and short-term investments and capitalization as of June 30, 2018 on: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">An actual basis; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">A pro forma basis, to give effect to (i)&nbsp;the conversion of the outstanding shares of our convertible preferred stock as of June 30, 2018 into 213,961,940
shares of our common stock immediately prior to the closing of this offering, (ii)&nbsp;the automatic conversion of warrants to purchase 786,594 shares of our convertible preferred stock into warrants to purchase 786,594 shares of common stock
immediately prior to the closing of this offering; and (iii)&nbsp;the effectiveness of our amended and restated certificate of incorporation, as if such conversions, and effectiveness had occurred immediately prior to the closing of this offering;
and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">A pro forma as adjusted basis, giving effect to (i)&nbsp;the pro forma adjustments set forth above and (ii)&nbsp;the sale and issuance of shares of our common
stock by us in this offering, based upon the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this
prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">You should
read this table together with the section of this prospectus entitled “Management’s discussion and analysis of financial condition and results of operations” and our consolidated financial statements and related notes included
elsewhere in this prospectus. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="67%"></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="10" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>As of June 30, 2018</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(In&nbsp;thousands,&nbsp;except&nbsp;share&nbsp;and per share data)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Actual</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Pro&nbsp;forma</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Pro&nbsp;forma&nbsp;as<br>adjusted(1)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash, cash equivalents and short-term investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">92,499</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">92,499</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:3px double #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:3px double #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:3px double #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:3px double #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:3px double #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:3px double #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Long-term debt</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,535</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,535</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Convertible preferred stock warrant liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">710</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="top" align="right"><font style="font-family:arial" size="2">—&nbsp;&nbsp;</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Convertible preferred stock, $0.00001 par value: 150,231,568 shares authorized, 189,110,349 shares issued and outstanding, actual; no
shares authorized, no shares issued and outstanding, pro forma and pro forma as adjusted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">278,505</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Stockholders’ equity (deficit):</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Common stock, $0.00001 par value: 275,000,000 shares authorized, 31,916,884 shares issued and outstanding, actual; 275,000,000 shares
authorized, 213,961,940 shares issued and outstanding, pro forma; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding, pro forma as adjusted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Additional <font style="white-space:nowrap">paid-in</font> capital</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,226</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">287,439</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accumulated other comprehensive income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">68</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">68</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accumulated deficit</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(191,053</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(191,053</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total stockholders’ equity (deficit)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(182,759</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">96,456</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total capitalization</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">105,991</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">105,991</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="12" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="1">Each $1.00 increase or decrease in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint
of the estimated offering price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, our cash, cash equivalents and short-term investments, working capital, total assets and total stockholders’ equity
and total capitalization by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming that </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">61 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p><font style="font-family:arial" size="1">
the number of shares of our common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions
and estimated offering expenses payable by us. Each increase or decrease of 1.0&nbsp;million shares in the number of shares offered by us would increase or decrease the amount of our cash, cash equivalents, and short-term investments working
capital, total assets and total stockholders’ equity by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is
the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The total number of shares of our common stock reflected in the discussion and table above is based upon 213,961,940&nbsp;shares of our common stock outstanding on
a pro forma basis as of June 30, 2018, and excludes: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">5,592,578 shares of our common stock issuable upon conversion of 5,592,578 shares of Series D convertible preferred stock issued after June 30, 2018;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">1,452,917 unvested shares of restricted common stock subject to our repurchase right; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">24,000,608&nbsp;shares of our common stock issuable upon the exercise of options to purchase shares of our common stock outstanding as of June 30, 2018, with a
weighted-average exercise price of $0.81 per share; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock issuable upon the exercise of options
to purchase shares of our common stock granted after June&nbsp;30, 2018, with a weighted-average exercise price of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">634,921 shares of our common stock issuable upon the exercise of outstanding warrants to purchase our common stock outstanding as of June&nbsp;30, 2018, having
an exercise price of $0.63 per share and an additional 634,920 shares of our common stock issuable upon the exercise of outstanding warrants to purchase our common, having an exercise price of $0.63 per share that would be exercisable upon the
drawing down of additional loans under our credit facility; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">364,742 shares of our common stock issuable upon the exercise of outstanding warrants to purchase Series&nbsp;A convertible preferred stock outstanding as of
June 30, 2018, having an exercise price of $0.329 per share; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">160,606 shares of our common stock issuable upon the exercise of outstanding warrants to purchase Series&nbsp;B convertible preferred stock outstanding as of
June 30, 2018, having an exercise price of $0.792 per share; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">186,679 shares of our common stock, issuable upon the exercise of outstanding warrants to purchase Series&nbsp;C convertible preferred stock outstanding as of
June&nbsp;30, 2018, having an exercise price of $1.4999 per share; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">74,567 shares of our common stock issuable upon the exercise of outstanding warrants to purchase Series D convertible preferred stock outstanding as of June 30,
2018, having an exercise price of $2.1457 per share; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock reserved for future grants under our stock-based compensation
plans, consisting of: </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">9,347,391 shares of common stock reserved for future grants under the 2013 Plan as of June 30, 2018, which shares will be added to the shares to be reserved
under the 2018 Plan, which will become effective upon completion of this offering and contains provisions that automatically increase its share reserve each year, as more fully described in “Executive compensation—Equity incentive
plans”; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock reserved for future grants under the 2018 Plan, which will become
effective upon completion of this offering; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock reserved for future issuance under the 2018 ESPP, which will
become effective upon completion of this offering. </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">62 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_8"></a>Dilution </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">If you invest in our common stock, your interest will be diluted to the extent of the difference between the public offering price per share of our common stock and the pro forma as adjusted net tangible book value
per share of our common stock after this offering. Our historical net tangible book value as of June 30, 2018 was $(187.1)&nbsp;million, or $(5.86) per share of common stock. Our net tangible book value per share represents total tangible assets
less total liabilities and convertible preferred stock, divided by the number of shares of common stock outstanding as of June 30, 2018. Our pro forma net tangible book value at June 30, 2018, before giving effect to this offering, was
$92.1&nbsp;million, or $0.43 per share of our common stock. Our pro forma net tangible book value before the issuance of shares in this offering gives effect to the conversion of our outstanding convertible preferred stock into our common stock
immediately prior to the completion of this offering and the related reclassification of the convertible preferred stock warrant liability into additional <font style="white-space:nowrap">paid-in</font> capital immediately prior to the closing of
this offering. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">After giving effect to our sale of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
of our common stock in this offering at an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this
prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible book value as of June 30, 2018 would have been
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. This represents an immediate increase in net tangible book value of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share to our
existing stockholders and an immediate dilution of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share to new investors purchasing shares of common stock in this offering. The following table illustrates this dilution on a per share basis:
</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="85%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top" style="BORDER-TOP:2px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Assumed initial public offering price per share</font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom" style="BORDER-TOP:2px solid #000000"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" style="BORDER-TOP:2px solid #000000" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom" style="BORDER-TOP:2px solid #000000"></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Historical net tangible book value per share as of June 30, 2018</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(5.86)</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Pro forma increase in net tangible book value per share attributable to automatic conversion of convertible preferred stock</font></p></td>

<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6.29</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Pro forma net tangible book value per share as of June 30, 2018 before giving effect to this offering</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.43</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Increase in net tangible book value per share attributable to new investors purchasing shares in this offering</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Pro forma as adjusted net tangible book value per share after giving effect to this offering</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Dilution in pro forma net tangible book value per share to new investors in this offering</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Each $1.00 increase or decrease in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, our pro forma as adjusted net tangible book value by approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, and would increase or decrease, as applicable, dilution per share to new investors in this offering by
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and
estimated offering expenses payable by us. An increase or decrease of 1,000,000 shares in the number of shares offered by us would increase or decrease, as applicable, our pro forma as adjusted net tangible book value by approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, and would increase or decrease, as applicable, dilution per share to new investors in this offering by
approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, assuming an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth
on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. The pro forma as adjusted information discussed
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">63 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
above is illustrative only and will be adjusted based on the actual public offering price and other terms of this offering determined at pricing. If the underwriters exercise their overallotment
option to purchase additional shares in full, the pro forma as adjusted net tangible book value per share would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, and the dilution per share to new investors in this offering would be
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table summarizes the pro forma on an as adjusted basis as described above, as
of June 30, 2018, the differences between the existing stockholders and new investors with respect to the number of shares of common stock purchased from us, the total consideration paid to us and the average price per share paid or to be paid to us
at an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, before deducting estimated
underwriting discounts and commissions and estimated offering expenses payable by us: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="54%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares&nbsp;purchased</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Total consideration</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" rowspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Weighted</b></font><br><font style="font-family:arial" size="2"><b>Average&nbsp;price<br>per&nbsp;share</b></font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Number</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Percent</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Percent</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Existing stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">New investors</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100.0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100.0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td colspan="20" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Each $1.00 increase or decrease in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, the total consideration paid to us by new investors and total consideration paid to us by
all stockholders by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting estimated underwriting discounts
and commissions and estimated offering expenses payable by us. An increase or decrease of 1,000,000 shares in the number of shares offered by us would increase or decrease the total consideration paid to us by new investors and total consideration
paid to us by all stockholders by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering
price range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">If all of the outstanding options and warrants noted below were exercised, (1) the number of shares of our common stock held by existing stockholders would be increased to
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares, or &nbsp;&nbsp;&nbsp;&nbsp;% of the total number of shares of our common stock outstanding after this offering, and the percentage of shares of common stock held by new
investors participating in the offering would be decreased to &nbsp;&nbsp;&nbsp;&nbsp;% of the total number of shares of our common stock outstanding after this offering, (2) the consideration paid by existing stockholders would be increased to
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or &nbsp;&nbsp;&nbsp;&nbsp;% of the total consideration paid by stockholders after this offering, and the percentage of consideration paid by new investors participating in the offering would
be decreased to &nbsp;&nbsp;&nbsp;&nbsp;% of the total consideration paid by stockholders after this offering, and (3) the average price per share paid by existing stockholders would decrease to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per
share. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Assuming the exercise of all of our outstanding options and warrants as of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, the amounts set forth </font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">in the table immediately above would change as follows:
</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="54%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares purchased</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Total consideration</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" rowspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Weighted</b></font><br><font style="font-family:arial" size="2"><b>Average&nbsp;price</b></font><br><font style="font-family:arial" size="2"><b>per&nbsp;share</b></font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Number</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Percent</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Percent</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Existing stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">New investors</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100.0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100.0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td colspan="20" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">64 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The total number of shares of our common stock reflected in the discussion and table above is based upon
213,961,940 shares of our common stock outstanding on a pro forma basis as of June 30, 2018 and excludes: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">5,592,578 shares of our common stock issuable upon conversion of 5,592,578 shares of Series D convertible preferred stock issued after June 30, 2018;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">1,452,917 unvested shares of restricted common stock subject to our repurchase rights; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">24,000,608 shares of our common stock issuable upon exercise of stock options outstanding as of June 30, 2018, having a weighted-average exercise price of $0.81
per share; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock issuable upon exercise of stock options granted after June 30,
2018, having a weighted-average exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">634,921 shares of our common stock issuable upon the exercise of outstanding warrants to purchase our common stock outstanding as of June 30, 2018, having an
exercise price of $0.63 per share and an additional 634,920 shares of our common stock issuable upon the exercise of outstanding warrants to purchase our common, having an exercise price of $0.63 per share that would be exercisable upon the drawing
down of additional loans under our credit facility </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">364,742 shares of our common stock issuable upon the exercise of outstanding warrants to purchase our Series A convertible preferred stock outstanding as of June
30, 2018, having an exercise price of $0.329 per share; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">160,606 shares of our common stock issuable upon the exercise of outstanding warrants to purchase Series&nbsp;B convertible preferred stock outstanding as of
June 30, 2018, having an exercise price of $0.792 per share; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">186,679 shares of our common stock issuable upon the exercise of outstanding warrants to purchase Series C convertible preferred stock outstanding as of June 30,
2018, having an exercise price of $1.4999 per share; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">74,567 shares of our common stock, issuable upon the exercise of outstanding warrants to purchase Series D convertible preferred stock outstanding as of June 30,
2018, having an exercise price of $2.1457 per share. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock reserved for future grants under our
stock-based compensation plans, consisting of: </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">9,347,391 shares of common stock reserved for future grants under the 2013 Plan as of June 30, 2018, which shares will be added to the shares to be reserved
under the 2018 Plan, which will become effective upon completion of this offering and contains provisions that automatically increase its share reserve each year, as more fully described in “Executive compensation – Equity incentive
plans”; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock reserved for future grants under the 2018 Plan, which will become
effective upon completion of this offering; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock reserved for future issuance under the 2018 ESPP, which will
become effective upon completion of this offering. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">To the extent that any outstanding options or warrants are exercised, new options
are issued under our stock-based compensation plans or we issue additional shares of common stock in the future, there will be further dilution to investors participating in this offering. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">65 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_9"></a>Selected consolidated financial data </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">You should read the selected consolidated financial data set forth below in conjunction with our consolidated financial statements, the notes to our consolidated
financial statements and “Management’s discussion and analysis of financial condition and results of operations” contained elsewhere in this prospectus. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We derived the selected consolidated statements of operations data and consolidated balance sheet data for the fiscal years ended September&nbsp;30, 2016 and 2017 from our audited consolidated financial statements
included elsewhere in this prospectus. We have derived the unaudited condensed consolidated statements of operations data for the nine months ended June 30, 2017 and 2018, and the unaudited condensed consolidated balance sheet data as of June 30,
2018, from our unaudited condensed consolidated financial statements included elsewhere in this prospectus. We have prepared the unaudited financial information on a basis consistent with our audited consolidated financial statements and have
included, in our opinion, all adjustments, consisting only of normal recurring adjustments, that we consider necessary for a fair statement of the financial information set forth in those statements. The summary financial data included in this
section are not intended to replace the financial statements and related notes included elsewhere in this prospectus. Our historical results are not necessarily indicative of our future performance, and our interim results are not necessarily
indicative of the results to be expected for the full fiscal year. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">66 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="46%"></td>
<td valign="bottom" width="8%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="8%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="8%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="8%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine&nbsp;months&nbsp;ended June 30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except share and per share data)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="8"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Consolidated statements of operations data:</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td colspan="5" valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,767</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Operating expenses:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cost of revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,421</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,191</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,096</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,230</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">19,169</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,318</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,282</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Selling, general and administrative</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,274</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,060</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,651</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">30,497</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total operating expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">45,925</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">69,249</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">49,160</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">67,875</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss from operations</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(43,656</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(58,482</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(41,859</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(50,855</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">241</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">412</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">225</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">590</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest expense</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(746</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(905</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(927</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other income (expense), net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">73</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(55</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">151</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(76</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss before income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,030</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,140</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,268</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Provision for income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(280</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(161</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(166</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,434</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other comprehensive loss:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Change in unrealized gain (loss) on investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(9</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(25</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Foreign currency translation adjustment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">33</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">35</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Comprehensive loss</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,079</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,286</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,320</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,399</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss per share attributable to common stockholders—basic and<br>diluted(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2.38</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2.47</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1.80</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1.91</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Weighted average shares used in computing net loss per share attributable to common stockholders—basic and diluted(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,511,202</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,982,605</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,556,612</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,921,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Pro forma net loss per share—basic and diluted(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(0.39</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(0.28</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Pro forma weighted-average shares used in computing pro forma net loss per share—basic and diluted(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">152,397,059</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">185,949,305</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">See Note 16 of the notes to our audited annual consolidated financial statements and Note 12 of the notes to our unaudited interim condensed consolidated financial statements
included elsewhere in this prospectus for a description of the method used to compute basic and diluted net loss per share attributable to common stockholders and pro forma basic and diluted net loss per share. </font></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">67 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="64%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>As&nbsp;of&nbsp;September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>As&nbsp;of&nbsp;June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="8"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Consolidated balance sheet data:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td colspan="5" valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash, cash equivalents, and short-term investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">55,920</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">62,204</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">92,499</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Working capital</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">50,361</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">58,392</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">85,688</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">76,463</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">85,657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">122,665</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">19,037</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">19,382</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,919</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Convertible preferred stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">134,037</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">199,633</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">278,505</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Additional <font style="white-space:nowrap">paid-in</font> capital</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,689</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,228</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,226</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accumulated deficit</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(80,309</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(139,619</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(191,053</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total stockholders’ deficit</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(76,611</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(133,358</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(182,759</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="12" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">68 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_10"></a>Management’s discussion and analysis of financial condition and&nbsp;results
of operations </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our
consolidated financial statements and the related notes to those statements included elsewhere in this prospectus. In addition to historical financial information, the following discussion and analysis contains forward-looking statements that
involve risks, uncertainties and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those discussed under “Risk
factors” and elsewhere in this prospectus. The last day of our fiscal year is September&nbsp;30, and we refer to our fiscal year ended September&nbsp;30, 2016 as fiscal 2016 or 2016 and our fiscal year ended September&nbsp;30, 2017 as fiscal
2017 or 2017. </i></font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Overview </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are a leading and
rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic
DNA by “writing” DNA on a silicon chip. We have combined this technology with proprietary software, scalable commercial infrastructure and an e-commerce platform to create an integrated technology platform that enables us to achieve high
levels of quality, precision, automation, and manufacturing throughput at a significantly lower cost than our competitors. We are leveraging our unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic
genes, tools for next generation sample preparation, and antibody libraries for drug discovery and development. Additionally, we believe our platform will enable new value-add opportunities, such as discovery partnerships for biologic drugs, and
will enable new applications for synthetic DNA, such as digital data storage. We sell our synthetic DNA and synthetic DNA-based products to a customer base of over 600 customers across a broad range of industries. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We launched the first application of our platform, synthetic genes and oligo pools, in April 2016 to disrupt the gene synthesis market and make legacy DNA synthesis
methods obsolete. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">From inception to June&nbsp;30, 2018, we have sold our products to more than 600 customers. In fiscal 2017, we served 286 customers
including $0.3&nbsp;million in sales to seven of the top 20 pharmaceutical companies by revenue, $4.3&nbsp;million in sales to Ginkgo Bioworks, Inc., or Ginkgo Bioworks (which we believe is the largest global purchaser of synthetic DNA), $0.3
million in sales to three of the largest agricultural biotechnology companies, $2.7 million in sales to over 100 academic research institutions worldwide, and $7.3 million in sales to innovative customers using synthetic DNA for new and emerging
applications, such as Microsoft Corporation and the University of Washington for use of DNA as a digital data storage medium. We are also an original equipment manufacturer, or OEM, of synthetic DNA to four synthetic DNA manufacturers that also
compete with us, which we believe is a strong demonstration of the superiority of our platform. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the nine months ended June 30, 2018, we served 539
customers as follows: 50% to the industrial chemicals sector, 47% to the academic research sector, 2% to the agriculture sector and 1% to the healthcare sector. Sales to the industrial chemicals sector, the academic research sector, the agricultural
sector and the healthcare sector accounted for 73%, 25%, 2% and 0.1% of the total $17.0 million revenues for the nine months ended June 30, 2018. Sales to Ginkgo Bioworks amounted to $5.5 million, or 32% and sales to customers other than Ginkgo
Bioworks was $11.5 million, or 68%, for the nine months ended June&nbsp;30, 2018; an increase in revenue of 89% and 162%, respectively, as compared to the nine months ended June 30, 2017. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have also leveraged the versatility of our platform to expand our product portfolio into other markets in which we believe we have a competitive advantage. In February 2018, we launched an innovative and
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">69 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
comprehensive preparation kit for next generation sequencing at the Advances in Genome Biology and Technology conference. Our kit leverages our platform to precisely synthesize oligo pools and
uniformly amplify the desired target DNA segments, considerably improving the accuracy of the downstream sequencing analysis. We have also commercialized a custom DNA library solution which enables more effective biologic drug discovery and
development for our customers. We believe we can further leverage our platform to develop other proprietary tools, such as our anti-GPCR library and antibody optimization solution, to provide an end-to-end solution in biologics drug discovery and
early development, from target to Investigational New Drug (IND) application, adding value as a partner to biotech and pharmaceutical companies. We also aim to explore development of DNA as a digital data storage medium via internal research and
industry partnerships. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have built a scalable commercial platform that enables us to reach a diverse customer base that we believe includes over
100,000 synthetic DNA users today. In order to address this diverse customer base, we have employed a multi-channel strategy comprised of a direct sales force targeting synthetic DNA customers, a direct sales force focusing on the NGS market and an
e-commerce platform. We launched our proprietary, innovative, and <font style="white-space:nowrap"><font style="white-space:nowrap">easy-to-use</font></font> <font style="white-space:nowrap">e-commerce</font> platform in October 2017 to existing
customers and expanded access to the general public in January 2018. Our platform allows customers to design, validate, and place <font style="white-space:nowrap">on-demand</font> orders of customized DNA online. This is a critical part of our
strategy to address our large and diverse customer base, as well as drive commercial productivity, enhance the customer experience, and promote loyalty. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We generated revenues of $7.3 million in the nine months ended June 30, 2017, and $17.0 million in the nine months ended June 30, 2018, while incurring net losses
of $42.3 million and $51.4 million in the nine months ended June 30, 2017 and 2018, respectively. We generated revenues of $2.3&nbsp;million in fiscal 2016, and $10.8&nbsp;million in fiscal 2017, while incurring net losses of $44.1&nbsp;million in
fiscal 2016, and $59.3&nbsp;million in fiscal 2017. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Since our inception, we have incurred significant operating losses. Our ability to generate product
revenue sufficient to achieve profitability will depend heavily on the success of our existing products and development and commercialization of additional products in the synthetic biology industry. Our net loss was $42.3&nbsp;million and
$51.4&nbsp;million for the nine months ended June 30, 2017 and 2018, respectively. As of June 30, 2018, we had an accumulated deficit of $191.1&nbsp;million. We expect to continue to incur significant expenses for at least the next several years.
Furthermore, upon the closing of this offering, we expect to continue to incur additional costs associated with operating as a public company including accounting, investor relations, legal and other expenses that we did not incur as a private
company. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy. Until such time
as we can generate significant revenue from product sales, we expect to finance our operations from revenue from our commercial operations, the sale of equity, debt financings or other capital sources, including collaborations with other companies
or other strategic transactions. We may be unable to grow our revenue, raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements
as, and when, needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more of our product opportunities or delay our pursuit of potential
<font style="white-space:nowrap">in-licenses</font> or acquisitions. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June 30, 2018, we had $92.5&nbsp;million in cash, cash equivalents and
short-term investments. In fiscal year 2017, we received net cash proceeds of $65.6&nbsp;million from the sale of shares of Series&nbsp;D convertible preferred stock, and as of August 31, 2018, we received additional net cash proceeds of $90.8
million from the sale of additional shares of Series&nbsp;D convertible preferred stock. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">After giving effect to the anticipated net proceeds from this
offering, we expect that our existing cash, cash equivalents and short-term investments will be sufficient to fund our planned operating expenses, capital </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">70 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
expenditure requirements and debt service payments through at least the next 12 months. We have based these estimates on assumptions that may prove to be wrong, and we could exhaust our available
capital resources sooner than we expect. See “Liquidity and capital resources.” </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the future, we expect we will need to raise additional
capital to finance our operations which cannot be assured, on acceptable terms, or at all. If sufficient funds on acceptable terms are not available when needed, we will be required to significantly reduce our operating expenses. As a result, we
have concluded that this circumstance raises substantial doubt about our ability to continue as a going concern. See Note 1 to our consolidated financial statements appearing in this prospectus for additional information. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Similarly, in its report on our financial statements for fiscal 2017, our independent registered public accounting firm included an explanatory paragraph stating
that our recurring losses from operations since inception and required additional funding to finance our operations raise substantial doubt about our ability to continue as a going concern. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Key factors affecting our performance </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe that our financial performance has been and in the
foreseeable future will continue to be primarily driven by the following factors: </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Adoption of our products and solutions by existing and new
customers.</i></b>&nbsp;&nbsp;&nbsp;&nbsp;A key factor to our future success is and will be our ability to increase orders from and sell new solutions to existing customers, and to acquire new customers. To do so, we must offer these customers
synthetic DNA-based products with a superior combination of quality, cost, throughput, turnaround time, and scalability, and develop affordable tools for existing and prospective customers that expand the applications of our products and drive
higher volume purchases. We must also convince potential customers who currently synthesize their own DNA that our products and solutions are superior and offer greater value to their organizations. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Expansion into new geographic markets.</i></b>&nbsp;&nbsp;&nbsp;&nbsp;Our revenue is currently generated from customers primarily in the United States. As we
begin to expand our global sales efforts, we must be successful in selling and marketing our products and solutions in geographies where we have limited experience. We are in the process of establishing a wholly owned foreign entity in China which
will enable us to expand our manufacturing capacity in China and grow our sales organization in China. We are also expanding our Asia Pacific and European sales and marketing organizations, which will include hiring new personnel and recruiting
distributors to serve local markets. Our revenue may be affected by seasonal trends in some geographies during the calendar year as we expand into new geographic markets. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Expansion into adjacent addressable markets.</i></b>&nbsp;&nbsp;&nbsp;&nbsp;Our revenue growth and market potential depends on our ability to meet customer needs in adjacent markets, such as in pharmaceutical
biologics discovery and development and data storage. By combining our affordable and high-quality synthetic DNA with our proprietary, innovative, and <font style="white-space:nowrap"><font style="white-space:nowrap">easy-to-use</font></font> <font style="white-space:nowrap">e-commerce</font> platform that allows customers to design, validate, and place <font style="white-space:nowrap">on-demand</font> orders of customized DNA online, we believe we will continue to convert those who make DNA,
or DNA Makers, into those who buy their own DNA, or DNA Buyers. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Leverage our manufacturing capacity and commercial
infrastructure.</i></b>&nbsp;&nbsp;&nbsp;&nbsp;We have invested, and will continue to invest, significantly in our manufacturing capabilities and commercial infrastructure. With our current operating model and infrastructure, we can increase our
manufacturing production and commercialize additional products. By doing so, we expect to grow revenue and spread our costs over a larger volume of products, which we believe will further reduce our manufacturing costs on a per-unit basis and
improve our operating margins. We are planning to consolidate our manufacturing operations in the United States into a </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">71 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
new facility in South San Francisco, and expand into new geographies including China. Our ability to achieve and enhance profitability is dependent upon growing our revenue and further increasing
our manufacturing efficiency, successful knowledge transfer, and recruiting and retaining personnel, among other factors. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Key business metrics
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We regularly review the following key business metrics to evaluate our business, measure our performance, identify trends affecting our business,
formulate financial projections and make strategic decisions. We believe that the following metrics are representative of our current business; however, we anticipate these will change or may be substituted for additional or different metrics as our
business grows. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Value of orders received </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe that the value of orders we receive is a leading indicator of our ability to generate revenue. We define an order as a contract with a customer or
purchase order from a customer, which outlines the promised goods at an agreed upon price. We regularly assess trends relating to the value of orders we receive, including with respect to our customer concentration. For example, we have experienced
quarterly growth in the value of orders received from customers other than Ginkgo Bioworks, which has increased by approximately 15.5 times from the quarter ended June&nbsp;30, 2016 to the quarter ended June&nbsp;30, 2018. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Since commercially launching our product in April 2016, orders from customers have rapidly increased over the last nine quarters. Commencing with our Beta Access
program, we believe we have successfully achieved industry-leading volumes of synthetic DNA orders. In 2018, we launched our e-commerce platform to enable customers to conveniently order our products online. These steps have contributed to
outstanding order growth over the last nine quarters, which is illustrated in the table below. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p> <p style="font-size:0px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<p style="margin-top:0px;margin-bottom:0px" align="center">


<img src="./S-1_files/g460243g57h71.jpg" alt="LOGO">
 </p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="31%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="34" align="center" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Three months ended</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except<br>percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>June&nbsp;30,<br>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>September&nbsp;30,<br>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>December&nbsp;31,<br>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>March&nbsp;31,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>June&nbsp;30,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>September&nbsp;30,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>December&nbsp;31,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>March&nbsp;31,<br>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>June&nbsp;30,<br>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Customers other than Ginkgo Bioworks</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">494</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">$737</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,153</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,707</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,682</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,686</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,893</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,704</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,167</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Percentage change from prior quarter</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">49%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">56%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">135%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">37%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">33%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">37%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">22%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="36" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">72 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Orders may never convert into actual revenue and the timing of delivery of our orders and recognition of revenue,
if any, may vary based on the nature of the order, and there can be no assurance that orders will result in recognized revenue. The following table lists the value of orders received, including Ginkgo and non-Ginkgo orders, during the periods
indicated: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="29%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="34" align="center" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Three months&nbsp;ended&nbsp;</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>(in&nbsp;thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="1"><b>June&nbsp;30,</b></font></p>
<p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="1"><b>2016</b></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>September&nbsp;30,<br>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>December&nbsp;31,<br>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>March&nbsp;31,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="1"><b>June&nbsp;30,</b></font></p>
<p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="1"><b>2017</b></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>September&nbsp;30,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>December&nbsp;31,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>March&nbsp;31,<br>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="1"><b>June&nbsp;30,</b></font></p>
<p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="1"><b>2018</b></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Order value</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">753</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,307</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,732</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,207</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,432</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,186</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,393</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,517</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,673</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="36" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Number of customers </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe that the number of customers who have purchased from us since inception is representative of our ability to drive adoption of our products and convert
DNA Makers to DNA Buyers. We define customers as separate legal entities or persons who have purchased and directly paid for our products. This means that if a parent company is a customer of ours, it is counted as one customer, and if its
subsidiary also purchases our products from us, and the subsidiary makes a payment directly to us, we count the subsidiary as a separate customer. We apply this methodology of counting customers because it is not possible for our e-commerce platform
and other data tracking software to distinguish accurately between affiliated purchasers. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Percentage of revenue from new vs. repeat customers
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe that the percentage of revenue that we generate from both new and repeat customers is a leading indicator of our ability to drive
adoption of our products amongst existing customers while also generating a robust pipeline of new customers. We define a new customer as a customer who, as a separate legal entity or person, has not previously purchased any products or services
from us. We define a repeat customer as any customer who, as a separate legal entity or person, has previously purchased any products or services from us. Because our first commercial shipment was in April 2016, 100% of our revenue for fiscal 2016
was from new customers, therefore we had no revenue from repeat customers in fiscal 2016. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The table below represents sales to individual customers. We
shipped products to 97 customers in fiscal 2016 and 286 customers in fiscal 2017. In the nine months ended June 30, 2017, we shipped product to 208 customers and in the nine months ended June 30, 2018, we shipped product to 539 customers. Between
September 30, 2015 and June 30, 2018, we sold products to more than 600 customers. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="55%"></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td valign="bottom" width="8%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years&nbsp;ended&nbsp;September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine&nbsp;months&nbsp;ended&nbsp;June,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Percentage of revenue from repeat customers</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">63%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">74%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">91%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Percentage of revenue from new customers</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">37%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Financial overview </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The
following table summarizes certain selected historical financial results: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="58%"></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years&nbsp;ended&nbsp;September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine&nbsp;months&nbsp;ended&nbsp;June,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,767</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss from operations</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(43,656</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(58,482</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(41,859</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(50,855</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,434</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">73 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b></b><b><i>Revenues</i></b><b> </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We generate revenue from sales of synthetic genes, oligo pools, next generation sequencing tools and DNA libraries. We recognize revenue upon delivery to our customers and bill them directly for the shipments. Our
ability to increase our revenues will depend on our ability to further penetrate the domestic and international markets, generate sales through our direct sales force, and over time from our <font style="white-space:nowrap">e-commerce</font>
platform. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b></b><b><i>Revenues by geography</i></b><b> </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have one reportable segment from the sale of synthetic DNA products. The following table shows our revenues by geography, based on our customers’ shipping addresses. North America consists of Canada and
Mexico; EMEA consists of Europe, Middle East, and Africa; and APAC consists of Japan, China, South Korea, Singapore, Malaysia and Australia. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="42%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine&nbsp;months&nbsp;ended&nbsp;June&nbsp;30, </b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="2"><b>%</b></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="2"><b>%</b></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">United States</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,769</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">78%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,252</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">77%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,723</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">78%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,011</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">71%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">EMEA</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">459</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">20%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,059</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">19%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,342</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,116</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">APAC</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">41</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">259</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">105</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">740</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">North America</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">197</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">131</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">153</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,767</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b></b><b><i>Revenues by products</i></b><b> </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The table below sets forth revenues by products: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="42%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended September 30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months ended June 30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Synthetic genes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,087</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">48%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,122</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">75%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,379</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">74%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">11,903</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">70%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Oligo pools</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">862</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">38%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,056</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">19%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,512</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">21%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,146</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">13%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">DNA libraries</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">320</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">517</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">410</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,208</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">NGS tools</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">72</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,763</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="29" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,767</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="32" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b></b><b><i>Revenues by industry</i></b><b> </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Revenues by industry were as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="40%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months ended June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except<br>percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>% </b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>% </b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>% </b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Industrial chemicals</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">960</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">42%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,702</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">62%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,237</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">72%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,350</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">73%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Academic research</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">830</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">37%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,709</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">25%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,019</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,223</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">25%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Healthcare</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">461</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">20%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,226</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">25</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Agriculture</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">130</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">41</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">422</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="29" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,767</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">100%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="32" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">74 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b></b><b><i>Revenues and accounts receivable concentration</i></b><b> </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Customer revenues equal to or greater than 10% of total revenues was as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="56%"></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years&nbsp;ended&nbsp;September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Customer A</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">30%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">40%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Customer B</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">11%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">16%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="12" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">*</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Less than 10 percent </font></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">One customer accounted for greater than 10% of
net accounts receivable as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="56%"></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years&nbsp;ended&nbsp;September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Customer A</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">41%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">35%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">40%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b></b><b><i>Cost of revenues</i></b><b> </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Cost of revenues reflect the aggregate cost incurred in the production and delivery of our products and consists of: production materials, personnel costs (salaries, benefits, bonuses and stock-based compensation),
cost of expensed equipment and consumables, laboratory supplies, depreciation of capitalized equipment, production overhead costs and allocations of IT and facility costs. We expect that our cost of revenues will increase as we increase our revenues
with new product developments. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Other operating expenses </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our operating expenses are classified in the following categories: Research and development, and selling, general and administrative. For each category, the largest component is personnel costs, which includes
salaries, employee benefit costs, bonuses, and stock-based compensation expenses. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Research and development </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Research and development expenses consist primarily of costs incurred for the development of our products, which include personnel costs, laboratory supplies,
consulting costs and allocated overhead, including IT and facility costs. We expense our research and development expenses in the period in which they are incurred. We expect to increase our research and development expenses as we continue to
develop new products. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Selling, general and administrative </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Selling expenses consist of personnel cost, customer service expenses, direct marketing expenses, educational and promotional expense, market research and analysis. General and administrative expenses include
executive, finance and accounting, legal and human resources. These expenses consist of personnel costs, audit and legal expenses, consulting costs and allocated IT and facility costs. We expense all selling, general and administrative expenses as
incurred. We expect our selling and marketing cost will continue to increase in absolute dollars, primarily driven by our efforts to expand our commercial capability, with an increased presence both within and outside the United States, and to
expand our brand awareness and customer base through targeted marketing initiatives. We expect general and administrative expenses will increase as well as we scale our operations. In addition, we expect to incur additional accounting, legal and
other expenses that we did not incur as a private company. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">75 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Interest expense </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Interest expense is attributable to borrowing under our senior secured term loan and our equipment financing facility. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Interest income </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Interest income consists primarily of
interest earned on our cash, cash equivalents, and short-term investments. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Other income (expense), net </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Other income (expense), net consists of realized gains and losses on sales of short-term investments and stock warrant expense. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Results of operations </b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="60%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine Months ended<br>June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,767</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Operating expenses:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cost of revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,421</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,191</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,096</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,230</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">19,169</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,318</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,282</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Selling, general and administrative</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,274</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,060</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,651</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">30,497</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total operating expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">45,925</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">69,249</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">49,160</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">67,875</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss from operations</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(43,656</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(58,482</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(41,859</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(50,855</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">241</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">412</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">225</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">590</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest expense</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(746</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(905</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(927</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other income (expense), net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">73</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(55</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">151</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(76</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Provision for income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(280</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(161</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(166</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,434</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Comparison of Nine Months Ended June 30, 2017 and 2018 </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Revenues </i></b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="71%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months ended<br>June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Change</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,719</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">133%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the nine months ended June 30, 2017, we generated revenue of $7.3&nbsp;million from shipments of our synthetic DNA products,
primarily oligonucleotides, clonal and non-clonal synthetic genes, and DNA libraries. Revenues from customers in the United States was 78%, and outside the United States was 22%. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Revenues increased $9.7 million or 133% to $17.0 million in the nine months ended June 30, 2018, driven by revenues from synthetic genes of $11.9 million and NGS tools of $1.8 million. The primary increase in
synthetic genes revenue was attributed to volume increases of genes shipped to customers period-over-period, driven by increased investment in our sales force infrastructure and the launching of the e-commerce platform in fiscal 2018. In the nine
months ended June 30, 2018, we shipped 176,292 genes versus 87,439 genes in the nine months ended June 30, 2017, an increase of 102%. Gene pricing to our customers was relatively constant </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">76 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
period-over-period. The primary reasons for NGS tools revenue growth period-over-period was attributed to the full commercial launching of the product in February 2018, increased investment in
our sales force infrastructure and the volume of units shipped in fiscal 2018. We do not believe the pricing had a meaningful impact on the revenue changes for NGS tools period-over-period. Revenues from customers other than Ginkgo Bioworks
increased $7.1&nbsp;million or 162% from $4.4 million to $11.5 million and revenue from Ginkgo Bioworks increased $2.6&nbsp;million, an increase of 89% from $2.9 million to $5.5 million versus the prior nine months ended June 30, 2017. Revenue from
repeat customers increased $10.0 million or 186% from $5.4 million to $15.4&nbsp;million in the nine months ended June 30, 2017 and 2018, respectively. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Cost of revenues </i></b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="71%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months ended<br>June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Change</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cost of revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,191</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,096</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,905</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">34%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Cost of revenues increased by $5.9&nbsp;million, or 34%, from $17.2&nbsp;million in the nine months ended June 30, 2017 to
$23.1&nbsp;million in the nine months ended June 30, 2018, due to the increase in revenues. Cost of revenues was $17.2&nbsp;million in the nine months ended June 30, 2017, driven by additional ramp up of production capacity. Cost of revenues was
primarily related to payroll expenses of $5.9&nbsp;million, consumption of reagents and production materials of $5.5&nbsp;million, information technology and facilities costs of $2.8&nbsp;million, depreciation expense of $1.4 million, consulting and
outside services of $0.7&nbsp;million, and other production related costs of $0.9 million. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the nine months ended June 30, 2018, total cost of
revenues increased to $23.1&nbsp;million, primarily from $8.5&nbsp;million of payroll expenses driven by an increase in headcount, consumption of reagents and production materials of $7.3&nbsp;million, information technology and facilities costs of
$3.6&nbsp;million, consulting and outside services of $1.3&nbsp;million, $1.7&nbsp;million of depreciation expense related to additional equipment for increased production capacity, and other production related costs of $0.7 million. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Research and development expenses </i></b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="74%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months ended<br>June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Change</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,318</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,282</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(36</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For the nine months ended June 30, 2017 and June 30, 2018, research and development expenses remained relatively flat and the total
expense amounted to $14.3 million for both periods. An increase in payroll expenses, IT and facilities cost and stock compensation expenses were offset by lower material and laboratory supplies costs. Research and development cost was
$14.3&nbsp;million in the nine months ended June 30, 2017, primarily related to payroll expenses of $6.5&nbsp;million, production and laboratory supplies of $2.6&nbsp;million, information technology and facilities costs of $2.2&nbsp;million, and
other research expenses of $3.0&nbsp;million. Research and development cost was $14.3&nbsp;million in the nine months ended June 30, 2018, primarily related to payroll expenses of $6.9&nbsp;million, production and laboratory supplies of
$1.7&nbsp;million, information technology and facilities costs of $2.3&nbsp;million, and other research expenses of $3.4 million. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Selling, general
and administrative expenses </i></b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="70%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months ended<br>June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Change</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Selling, general and administrative</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,651</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">30,497</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,846</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">73%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">77 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Selling, general and administrative expenses increased by $12.8&nbsp;million, or 73%, from $17.7&nbsp;million in
the nine months ended June 30, 2017 to $30.5&nbsp;million in the nine months ended June 30, 2018, primarily due to increases in payroll expenses related to increased headcount, advertising and marketing expenses, professional and legal expenses,
stock compensation expenses and information technology related charges. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Selling, general and administrative expenses was $17.7 million as of June 30,
2017 primarily due to headcount costs of $6.6 million, professional and legal fees of $7.9 million, advertising and marketing expenses of $0.7 million, online services expenses of $0.9 million, stock compensation expense of $0.7 million and other
selling and administrative expenses of $1.0 million. Selling, general and administrative expenses was $30.5 million as of June 30, 2018 primarily due to headcount related costs of $11.3 million, professional and legal fees of $12.7 million,
advertising and marketing expenses of $1.9&nbsp;million, online services expenses of $1.2 million, stock compensation expense of $1.1 million and other selling and administrative expenses of $2.3 million. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Interest, and other income (expense), net </i></b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="73%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months<br>ended June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Change</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">225</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">590</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">365</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">162%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest expense</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(927</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(270</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(41)%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other income (expense)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">151</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(76</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(227</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(150)%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total interest, and other income (expense), net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(281</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(413</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(132</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(47)%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Interest income was $0.2&nbsp;million in the nine months ended June 30, 2017, and $0.6&nbsp;million in the nine months ended June
30, 2018, resulting from our short-term investments. Other income and expenses were primarily due to the disposal of property and equipment. Interest expense was $0.7&nbsp;million in the nine months ended June 30, 2017, and $0.9&nbsp;million in the
nine months ended June 30, 2018, related to our outstanding debt. Stock warrant expense was $0.2&nbsp;million in the nine months ended June 30, 2017, and $0.1&nbsp;million in the nine months ended June 30, 2018. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Provision for income taxes </i></b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="78%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months<br>ended June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Change</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Provision for income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(161</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(166</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(5</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(3)%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We recorded a provision for income taxes of $0.2 million in the nine months ended June 30, 2017 and $0.2&nbsp;million in the nine
months ended June 30, 2018. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Comparison of Years Ended September 30, 2016 and 2017 </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Revenues </i></b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="71%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Change</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,767</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,498</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">375%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:48px;margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">78 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">We commenced selling our products in April 2016. In 2016, we generated revenue of $2.3&nbsp;million from
shipments of our synthetic DNA products, primarily oligonucleotides, clonal and non-clonal synthetic genes, and DNA libraries. Revenue from customers in the United States was 78% and 22% outside the United States. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Revenue increased to $10.8&nbsp;million in 2017, as we continued to ramp up production capacity and sales of our synthetic DNA products, primarily oligonucleotides,
clonal and <font style="white-space:nowrap">non-clonal</font> synthetic genes, DNA libraries and oligo pools. In 2017, revenues from customers in the United States accounted for 77% and 23% from customers outside the United States. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Since launching our products in April 2016, we have seen increased adoption by the market and our customer base has grown. In reviewing year-over-year results, our
first commercial shipment was in April 2016 as compared to a full year of product shipments to customers in 2017. Revenue from synthetic genes, oligo pools, NGS tools and DNA libraries increased $8.5 million from $2.3 million in 2016 to $10.8
million in 2017, primarily driven by increases in the volume of orders and new customers. Additionally, revenue for 2017 included approximately $4.0 million from new customers, because our customer base increased from 97 customers in 2016 to 286
customers in 2017. In addition, the increase in 2017 revenue was also due to an increase from sales to Ginkgo Bioworks of $3.6 million in revenue from $0.7 million in 2016 to $4.3 million in 2017. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Cost of revenues </i></b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="70%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Change</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cost of revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,421</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,599</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">155%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Cost of revenues increased by $14.6&nbsp;million or 155% from $9.4&nbsp;million in 2016 to $24.0&nbsp;million in 2017 due to the
increase in revenues. Cost of revenues was $9.4&nbsp;million in 2016, driven by our initial ramp up of production capacity. Cost of revenues was primarily related to payroll expenses of $3.5&nbsp;million, consumption of reagents and production
materials of $3.2&nbsp;million, information technology and facilities costs of $1.8&nbsp;million, consulting and outside services of $0.5&nbsp;million, and maintenance costs of $0.3&nbsp;million. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In 2017, total cost of revenues increased to $24.0&nbsp;million, primarily from $8.2&nbsp;million of payroll expenses due to an increase in headcount, consumption
of reagents and production material of $7.4&nbsp;million, information technology and facilities costs of $3.8&nbsp;million, consulting and outside services of $1.1&nbsp;million, $1.9&nbsp;million of depreciation expense related to additional
equipment for increased production capacity, maintenance costs of $0.7&nbsp;million, and stock-based compensation expenses of $0.2&nbsp;million. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Research and development expenses </i></b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="74%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years&nbsp;ended</b></font><br><font style="font-family:arial" size="2"><b>September&nbsp;
30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Change</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,230</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">19,169</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">939</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Research and development expenses increased by $0.9&nbsp;million or 5% from $18.2&nbsp;million in 2016 to $19.2&nbsp;million in
2017. This was primarily due to increased development activities for new product offerings, materials costs, and information technology and facilities costs. In 2017, information technology and facilities costs increased by $0.9 million compared to
2016 primarily due to the signing of lease agreements for additional facilities located in San Francisco and South San Francisco. Additional research and development expenses of $3.4 million were also incurred in 2017 in connection with the
acquisition of Genome Compiler Corporation in the prior fiscal year. In 2016, we received $2.4 million Defense Advanced Research Projects Agency, or DARPA, payments, whereas in 2017 there were no DARPA payments to offset expenses. In 2017,
laboratory materials used in research and </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">79 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
development increased $0.5 million from $2.7&nbsp;million to $3.2&nbsp;million and allocations from facilities and information technology increased $0.9 million. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Selling, general and administrative expenses </i></b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="71%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years&nbsp;ended</b></font><br><font style="font-family:arial" size="2"><b>September&nbsp;
30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Change</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Selling, general and administrative</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,274</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,060</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,786</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">43%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Selling, general and administrative expenses increased by $7.8&nbsp;million, or 43%, from $18.3&nbsp;million in 2016 to
$26.1&nbsp;million in 2017 primarily due to increases in payroll related to increased headcount, commercialization of products, professional and legal expenses, information technology and facilities. Salaries and related costs increased by $1.9
million in 2017, as a result of increases in sales headcount. In addition, professional and legal expenses increased by $5.2 million due to commercial expansion of our products. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Interest, and other income (expense), net </i></b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="73%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years&nbsp;ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Change</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">241</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">412</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">171</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">71%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest expense</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(746</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(905</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(159</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(21)%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other income (expense)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">73</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(55</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(128</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(175)%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total interest, and other income (expense), net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(432</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(548</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(116</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(27)%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Interest income was $0.2&nbsp;million in 2016, and $0.4&nbsp;million in 2017, resulting from our short-term investments. Other
income and expenses were primarily due to the disposal of property and equipment. Interest expense was $0.7&nbsp;million in 2016 and $0.9&nbsp;million in 2017 related to our outstanding debt. Stock warrant expense was $(0.1)&nbsp;million in 2016 and
$0.3&nbsp;million in 2017. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Provision for income taxes </i></b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="72%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Change</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except percentages)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Provision for income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(280</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(280</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(100)%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We recorded an immaterial provision for income taxes in 2016 and $0.3&nbsp;million in 2017. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Quarterly Results of Operations </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table shows
unaudited quarterly consolidated statement of operations data for each of the last seven quarters. In the opinion of management, the information for each of these quarters has been prepared on the same basis as our audited financial statements and
include all adjustments, consisting of normal recurring adjustments and accruals, necessary for the fair statement of financial information in accordance with generally accepted accounting principles. This information should be read in conjunction
with the audited consolidated financial statements and related notes included elsewhere in this prospectus. Historical results are not necessarily indicative of results that may be achieved in future periods, and operating results for quarterly
periods are not necessarily indicative of operating results for a full year. You should read this unaudited consolidated statement of operations data in conjunction with our consolidated financial statements and the related notes included elsewhere
in this prospectus. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">80 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="30%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="26" align="center" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Three months ended</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>December&nbsp;31,<br>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>March&nbsp;31,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>June&nbsp;30,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>December&nbsp;31,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>March&nbsp;31,<br>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>June&nbsp;30,<br>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,692</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,433</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,176</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,466</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,313</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,166</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,541</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Operating expenses:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cost of revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,987</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,984</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,220</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,829</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,498</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,095</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,503</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,332</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,709</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,277</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,851</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,303</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,711</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,268</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Selling, general and administrative</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,740</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,992</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,919</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,409</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,263</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,978</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">11,256</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="25" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total operating expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">15,059</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">16,685</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,416</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">20,089</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">21,064</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">22,784</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,027</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="25" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss from operations</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(13,367</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(14,252</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(14,240</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(16,623</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(16,751</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(16,618</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(17,486</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">59</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">50</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">116</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">187</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">158</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">148</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">284</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest expense</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(192</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(199</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(266</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(248</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(273</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(317</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(337</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other income (expense), net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(3</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">11</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">143</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(206</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(19</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(43</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(14</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="25" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss before income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(13,503</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(14,390</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(14,247</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(16,890</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(16,885</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(16,830</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(17,553</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Provision for income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(33</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(58</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(70</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(119</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(52</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(43</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(71</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="25" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(13,536</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(14,448</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(14,317</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(17,009</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(16,937</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(16,873</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(17,624</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="28" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For the three months ended December 31, 2017, we shipped 44,784 genes via 964 shipments, a 18% growth in the number of genes shipped
compared to the three months ended September 30, 2017. For the three months ended March 31, 2018, we shipped 71,246 genes via 1,251 shipments, a 59% growth in the number of genes shipped over the prior quarter. For the three months ended June 30,
2018, we shipped 60,252 genes via 1,694 shipments, a decrease of 15% in the number of genes shipped compared to the three months ended March 31, 2018. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Shipments and number of genes shipped in the three months ended September 30, 2017, December 31, 2017, March 31, 2018, and June 30, 2018 were as follows:
</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="60%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="center" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Three months ended</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except shipments)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>December&nbsp;31,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>March&nbsp;31,<br>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>June&nbsp;30,<br>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Number of genes shipped</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">38,023</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">44,784</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">71,246</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">60,252</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Number of shipments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">751</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">964</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,251</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,694</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Liquidity and capital resources </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Sources of liquidity </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">To date, we have financed our operations principally through private placements of
our convertible preferred stock, borrowings from credit facilities and revenue from our commercial operations. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">81 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Since our inception on February&nbsp;4, 2013 and through June&nbsp;30, 2018, we have received an aggregate of
$278.5&nbsp;million in gross proceeds from the issuance of equity securities and an aggregate of $13.8&nbsp;million from debt. As of June&nbsp;30, 2018, we had a balance of $90.9&nbsp;million of cash and cash equivalents and $1.6&nbsp;million of
short-term investments. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Preferred stock financings </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June 30, 2018, we had raised $278.5&nbsp;million in gross proceeds from the sale of our equity securities, including the sale of 59,743,942 shares of our Series D convertible preferred stock from January 2016
through September 2017 at a purchase price of $2.146 per share for gross proceeds of $128.2 million. On March 19, 2018 and May 29, 2018, we issued 23,302,418 and 9,320,967 shares of Series D convertible preferred stock for an aggregate purchase
price of approximately $50.0 million and $20.0 million, respectively. On July 2, 2018 and July 3, 2018, we issued 5,126,530 and 466,048 shares of Series D convertible preferred stock for an aggregate purchase price of $11.0 million and $1.0 million,
respectively. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Debt financings </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have
entered into various credit facilities to obtain debt financing from time to time beginning in October 2013. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In December 2015, we entered into a Second
Amended and Restated Loan and Security Agreement, or the Third Loan, for amounts aggregating up to $15.0&nbsp;million in a series of three advances. The Third A&amp;R Loan contains an acceleration clause under which the loan can become due and
payable to SVB in certain events of default, including in the event of a material adverse change in our business. The term of the loan was 41 months with an interest rate equal to the greater of (i)&nbsp;the prime rate or (ii)&nbsp;3.25%, and there
was a final payment fee of 6% of the amount loaned. In addition, we obtained a revolving facility from SVB of $5.0&nbsp;million for which the principal amount outstanding under the revolving line would accrue interest at a floating per annum rate
equal to one percentage point (1.00%) above the Prime Rate, which interest shall be payable monthly. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The first advance, totaling $7.0&nbsp;million, was
drawn in December 2015 and comprised $3.3&nbsp;million to refinance our prior loan with SVB and a new advance of $3.7&nbsp;million. The debt provides interest only payments through December&nbsp;31, 2016 at which time monthly principal payments
become due. In connection with this advance, we issued warrants to purchase a total of 186,679 shares of Series&nbsp;C convertible preferred stock at an exercise price of $1.4999 per share. We accounted for this transaction as a debt modification
and did not incur any gains or losses relating to the modification. The second advance, totaling $4.0&nbsp;million, was drawn in March 2016. In connection with this advance, we issued warrants to purchase a total of 74,567 shares of Series D
convertible preferred stock at an exercise price of $2.1457 per share. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In September 2017, we entered into a Fourth Amended and Restated Loan and
Security Agreement, or the Fourth Loan, with SVB, for amounts aggregating up to $20.0&nbsp;million in a series of three advances. The first advance provides a principal amount of $10.0 million, the second advance provides a principal amount of
$5.0&nbsp;million and the third advance provides a principal amount of $5.0&nbsp;million during their respective draw down periods; however, the draw periods for the second and third tranches under this agreement have expired. In connection with the
first advance, we issued warrants to purchase 634,921&nbsp;shares of common stock at an exercise price of $0.63 per share. If we draw down the second and third advances, the warrants would become exercisable for an additional 634,920&nbsp;shares of
common stock at an exercise price of $0.63 per share. The Fourth Loan contains a subjective acceleration clause under which the Fourth Loan could become due and payable to SVB in the event of a material adverse change in our business. The term of
the loan was 51&nbsp;months with an interest rate of prime plus 3.00% and a final payment fee of $0.7&nbsp;million. We had the ability to draw </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">82 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
down the additional second and third advances of the loan and security agreement, subject to achieving various revenue milestones, through January 31, 2018 and June 30, 2018, respectively. In
addition, we obtained a revolving facility from SVB in September 2017 as part of the Fourth Loan and the facility allows us to borrow up to $10.0 million. The principal amount outstanding under the revolving line accrues interest at a floating per
annum rate equal to one percentage point (1.00%) above the prime rate, which interest shall be payable monthly. The amounts available under the revolving line are limited by an advance rate which is a percentage of our account receivables balance.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our credit facilities contain customary representations and warranties and customary affirmative and negative covenants applicable to us and our
subsidiaries, including, among other things, restrictions on changes in business, management, ownership or business locations, indebtedness, encumbrances, investments, mergers or acquisitions, dispositions, maintenance of collateral accounts,
prepayment of other indebtedness, distributions and transactions with affiliates. The credit facilities contain customary events of default subject in certain cases to grace periods and notice requirements, including (a)&nbsp;failure to pay
principal, interest and other obligations when due, (b)&nbsp;material misrepresentations, (c)&nbsp;breach of covenants, conditions or agreements in the credit facilities, (d)&nbsp;default under material indebtedness, (e)&nbsp;certain bankruptcy
events, (f)&nbsp;a material adverse change; (g)&nbsp;attachment, levy or restraint on business, (h)&nbsp;default with respect to subordinated debt, (i)&nbsp;cross default under our credit facilities, and (j)&nbsp;government approvals being revoked.
As of June 30, 2018, as part of the Fourth Loan, all rights, title and interest to our personal property with the exception of our intellectual property, have been pledged as collateral, including cash and cash equivalents, short-term investments,
accounts receivable, contractual rights to payment, license agreements, general intangibles, inventory and equipment. We were in compliance with all covenants under the loan and security agreement as of September&nbsp;30, 2017 and June&nbsp;30,
2018. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Future maturities of the loan as of June 30, 2018 are as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="73%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Principal</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Interest</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom"><font style="font-family:arial" size="2"><b>Years ending September&nbsp;30,</b></font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td colspan="2" valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td colspan="2" valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td colspan="2" valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2018</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">204</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">204</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2019</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,500</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">743</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,243</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2020</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,333</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">485</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,818</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2021</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,333</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">214</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,547</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2022</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">834</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">11</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">845</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">11,657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Less: Interest</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1,657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total amount of loan principal</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Less unamortized debt discount</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(629</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Add accretion of final payment fee</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">164</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,535</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="12" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Capital resources </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">After giving effect to the anticipated net proceeds from this offering, we expect that our existing cash, cash equivalents and short-term investments will be
sufficient to fund our operating expenses, capital expenditure requirements and debt service payments through at least the next 12 months. In the future, we expect we will need to raise additional capital to finance our operations which cannot be
assured. As of September&nbsp;30, 2017, without giving effect to the anticipated net proceeds from this offering, we have concluded that this circumstance raises substantial doubt about our ability to continue as a going concern within one year
after the issuance date of our consolidated financial statements for the year ended September&nbsp;30, 2017. However, our </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">83 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
operating plan may change as a result of factors currently unknown to us, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings or
other sources, such as strategic collaborations. Such financing may result in dilution to stockholders, imposition of debt covenants and repayment obligations, or other restrictions that may adversely affect our business. In addition, we may seek
additional capital due to favorable market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. Our future capital requirements will depend on many factors. See “Risk
factors—We will require additional financing to achieve our goals, and a failure to obtain this necessary capital when needed on acceptable terms, or at all, could force us to delay, limit, reduce or terminate our product manufacturing and
development and other operations.” </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Operating capital requirements </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our primary uses of capital are, and we expect will continue to be for the near future, compensation and related expenses, manufacturing costs, laboratory and related supplies, legal and other regulatory expenses
and general overhead costs. As of September&nbsp;30, 2017, we had $1.3 million in commitments for capital expenditures. As of June&nbsp;30, 2018, we had $1.8&nbsp;million in commitments for capital expenditures. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Cash flows </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table summarizes our sources
and uses of cash and cash equivalents: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="60%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine&nbsp;months&nbsp;ended<br>June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net cash used in operating activities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(38,592</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(39,843</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(49,468</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net cash provided by (used in) investing activities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(33,345</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(9,870</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,461</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,902</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net cash provided by financing activities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">69,648</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">63,802</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">62,740</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">82,239</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net increase (decrease) in cash and cash equivalents</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2,289</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,631</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">27,358</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">59,673</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Operating activities </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Net cash used in operating activities was $39.8 million in the period ended June 30, 2017, and consisted primarily of a net loss of $42.3 million adjusted for
non-cash items including depreciation and amortization expenses of $3.8 million, stock-based compensation expense of $1.0 million, change in operating assets and liabilities of approximately $2.7 million, and other non-cash items of $0.4 million.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Net cash used in operating activities was $49.5 million in the period ended June 30, 2018, and consisted primarily of a net loss of $51.4 million
adjusted for non-cash items including depreciation and amortization expenses of $4.4 million, stock-based compensation expense of $1.9 million, a change in operating assets and liabilities of approximately $4.8 million, and a net increase of
non-cash items of $0.4 million. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Net cash used in operating activities was $38.6 million in 2016, and consisted primarily of a net loss of $44.1 million
adjusted for non-cash items including depreciation and amortization expenses of $4.2 million, stock-based compensation expense of $0.9 million, change in operating assets and liabilities of approximately $0.2 million, and other non-cash items of
$0.2 million. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Net cash used in operating activities was $51.3&nbsp;million in 2017, and consisted primarily of a net loss of $59.3&nbsp;million adjusted
for <font style="white-space:nowrap">non-cash</font> items including depreciation and amortization expenses of $5.0&nbsp;million, stock-based compensation expense of $1.9&nbsp;million, a change in operating assets and liabilities of approximately
$0.1&nbsp;million, and a net increase of non-cash items of $1.2 million. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">84 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Investing activities </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the nine months ended June 30, 2017, our investing activities provided net cash of $4.5 million. Investing activities included the purchases and maturity of investments and purchases of laboratory property,
equipment and computers. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the nine months ended June 30, 2018, our investing activities provided net cash of approximately $26.9 million. Investing
activities included the purchases and maturity of investments and purchases of laboratory property, equipment and computers. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In 2016, our investing
activities used net cash of $33.3&nbsp;million. The investing activity included the purchases of investments, laboratory property and equipment. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In
2017, our investing activities used net cash of approximately $9.9&nbsp;million. The use of net cash resulted primarily from the net impact of purchases and maturity of investments, and purchases of laboratory property, equipment and computers.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Financing activities </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Net cash provided by
financing activities was $62.7 million in the nine months ended June 30, 2017, which consisted of $65.2 million from the issuance of convertible preferred stock, partially offset by the repayment of $2.4 million of debt. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Net cash provided by financing activities was $82.2 million in the nine months ended June 30, 2018, which consisted of $78.9 million from the issuance of
convertible preferred stock, $5.0 million advance receipt of proceeds for convertible preferred stock to be issued to Ever Alpha Fund L.P., $2.0 million in payment of deferred offering costs, and $0.3 million from the issuance of common stock and
exercise of stock options. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Net cash provided by financing activities was $69.6&nbsp;million in 2016, which consisted of $62.3&nbsp;million from the
issuance of convertible preferred stock, $0.2&nbsp;million from the issuance of common stock, and $7.7&nbsp;million from the issuance of debt, partially offset by the repayment of $0.4 million of debt. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Net cash provided by financing activities was $63.8&nbsp;million in 2017, which consisted of $65.6&nbsp;million from the issuance of convertible preferred stock,
$0.2&nbsp;million from the issuance of common stock, $2.2&nbsp;million from additional debt, <font style="white-space:nowrap">off-set</font> by the repayment of $4.2&nbsp;million of debt. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i><font style="white-space:nowrap">Off-Balance</font> Sheet Arrangements </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We do not have any <font style="white-space:nowrap">off-balance</font> sheet arrangements other than our indemnification agreements as described in Note 5 of the condensed consolidated financial statements included elsewhere in this prospectus. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Contractual obligations and other commitments </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Set forth
below is information concerning our contractual commitments and obligations as of September 30, 2017: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="63%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Less&nbsp;than<br>1&nbsp;Year</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Years <br><font style="white-space:nowrap">1-3</font></b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Years<br>3-5</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>After&nbsp;5<br>Years</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Contractual obligations</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Future minimum operating lease payments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,598</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,133</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,465</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Long-term debt obligations</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,032</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">715</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,946</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,371</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="17" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">15,630</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,848</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,411</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,371</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="20" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">85 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table summarizes our outstanding contractual obligations as of the payment due date by period as of
June 30, 2018: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="58%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Less&nbsp;than<br>1&nbsp;Year</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Years <br><font style="white-space:nowrap">1-3</font></b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Years<br>3-5</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>After&nbsp;5<br>Years</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Contractual obligations</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Future minimum operating lease payments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,643</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">540</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,431</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,368</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,304</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Long-term debt obligations</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">11,657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">203</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,062</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,392</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="17" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">40,300</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">743</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">13,493</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">11,760</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,304</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="20" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In September 2016, we entered into a collaboration agreement with Distributed Bio to offer therapeutic antibody design and
optimization services, as well as an exclusive library targeting G-protein coupled receptors to our customers. Upon successful commercialization, our agreement with Distributed Bio requires us to pay $0.3 million to Distributed Bio. In addition, we
also agreed on a profit-sharing and license arrangement for an Antibody Optimization Software and GPCR-Targeting Antibody Library, which includes royalty payments for discovered pharmaceutical products of up to 50% of net income or 20% of revenue on
annual sales less than $5.0&nbsp;million. For annual sales in excess of $5.0 million, we are obligated to make royalty payments ranging from 20% to 35% of net annual revenue on the antibody software and GPCR Antibody Library revenue under the
collaboration agreement. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In March 2018, we entered into a stock purchase agreement related to the sale of additional shares of our Series D convertible
preferred stock for the amount of $70.0 million. Pursuant to a side letter to the stock purchase agreement, we have committed, subject to certain conditions, to using commercially reasonable efforts to invest up to $5.0 million, $10.0 million and
$10.0 million over a three year period in connection with the incorporation, business and/or operations of a wholly owned foreign enterprise in the PRC. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Qualitative and quantitative disclosures about market risk </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate risk and foreign currency risk as follows:
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Interest rate risk </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We had cash and cash
equivalents totaling $55.9&nbsp;million and $90.9&nbsp;million as of June 30, 2017 and 2018, respectively. We had short-term investments totaling $20.1&nbsp;million and $1.6&nbsp;million as of June 30, 2017 and 2018, respectively. Our cash and cash
equivalents consist of cash in bank accounts and money market funds, and short-term investments consist of U.S. government agency bonds, corporate bonds, and commercial paper. The primary objectives of our investment activities are to preserve
principal and provide liquidity without significantly increasing risk. We do not enter into investments for trading or speculative purposes. Due to the relatively short-term nature of our investment portfolio, a hypothetical 100 basis point change
in interest rate would not have a material effect on the fair value of our portfolio for the years presented. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Foreign currency risk
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Substantially all of our revenues and operating expenses are denominated in U.S. dollars. Therefore, we do not believe that our exposure to
foreign currency exchange risk is material to our business, financial condition or results of operations. If a significant portion of our revenue or operating expenses were to become denominated in currencies other than U.S. dollars, we may not be
able to effectively manage this risk, and our business, financial condition and results of operations could be adversely affected by translation to U.S. dollars and by transactional foreign currency conversions. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">86 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Critical accounting policies and estimates </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our management’s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in conformity with U.S. generally
accepted accounting principles, or GAAP. The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions about future events that affect the amounts of assets and liabilities reported,
disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and
assumptions using historical experience and other factors; however, actual results could differ materially from these estimates and could have an adverse effect on our financial statements. We believe that the accounting policies discussed below are
critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">While our significant accounting policies are described in more detail in Note 2 to our consolidated financial statements appearing in this prospectus, we believe that the following accounting policies are the most
critical to the judgments and estimates used in the preparation of our consolidated financial statements. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Revenue recognition </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Effective October&nbsp;1, 2017, we elected to early adopt the requirements of ASC 606 – Revenue from Contracts with Customers using the full retrospective
method. We evaluated the impact on revenues, loss from operations, net loss attributable to common stockholders and basic and diluted earnings per share for all periods presented and concluded that there was no material impact on our consolidated
financial statements for all periods presented. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our revenue is generated through the sale of synthetic biology tools, such as synthetic genes, or clonal
genes and fragments, oligonucleotide pools, or oligo pools, next generation sequencing, or NGS tools and DNA libraries. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified,
payment terms are identified, the contract has commercial substance and collectability of consideration is probable. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Contracts with customers are
generally in the written form of a purchase order or a quotation, which outline the promised goods and the agreed upon price. Such orders are often accompanied by a Master Supply or Distribution Agreement that establishes the terms and conditions,
rights of the parties, delivery terms, and pricing. We assess collectability based on a number of factors, including past transaction history and creditworthiness of the customer. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For all of our contracts to date, the customer orders a specified quantity of a synthetic DNA sequence; therefore, the delivery of the ordered quantity per the purchase order is accounted for as one performance
obligation. Some contracts may contain prospective discounts when certain order quantities are exceeded; however, these future discounts are either not significant, not deemed to be incremental to the pricing offered to other customers, or not
enforceable options to acquire additional goods. As a result, these discounts do not constitute a material right and do not meet the definition of a separate performance obligation. We do not offer retrospective discounts or rebates. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The transaction price is determined based on the agreed upon rates in the purchase order or master supply agreements applied to the quantity of synthetic DNA that
was manufactured and shipped to the customer. Our contracts include only one performance obligation—the delivery of the product to the customer. Accordingly, all of the transaction price, net of any discounts, is allocated to the one
performance obligation. Therefore, upon </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">87 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
delivery of the product, there are no remaining performance obligations. Our shipping and handling activities are performed before the customer obtains control of the goods and therefore are
considered a fulfillment cost. We have elected to exclude all sales and value added taxes from the measurement of the transaction price. We have not adjusted the transaction price for significant financing since the time period between the transfer
of goods and payment is less than one year. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We recognize revenue at a point in time when control of the products is transferred to the customer.
Management applies judgment in evaluating when a customer obtains control of the promised good which is generally when the product is delivered to the customer. Our customer contracts generally include a standard assurance warranty to guarantee that
our products comply with agreed specifications. We reduce revenue by the amount of expected returns which have been insignificant. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have elected the
practical expedient of not disclosing the consideration allocated to remaining performance obligations and an explanation of when those amounts are expected to be recognized as revenue since the duration of our contracts is less than one year.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We do not have any contract assets or contract liabilities as of September&nbsp;30, 2017 and June 30, 2018. For all periods presented, we did not
recognize revenue from amounts that were included in the contract liability balance at the beginning of each period. In addition, for all periods presented, there was no revenue recognized in a reporting period from performance obligations satisfied
in previous periods. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Based on the nature of our contracts with customers which are recognized over a term of less than 12 months, we have elected to use
the practical expedient whereby costs to obtain a contract are expensed as they are incurred. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Stock-based compensation </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Total stock-based compensation expense recognized was as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="70%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months<br>ended June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cost of revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">112</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">202</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">95</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">275</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">261</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">575</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">272</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">521</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Selling, general and administrative</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">484</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,114</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">660</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,079</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total stock-based compensation</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">857</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,891</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,027</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,875</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">During the nine months ended June&nbsp;30, 2017, we granted stock options to employees and non-employees to purchase
625,000&nbsp;shares of common stock with a weighted average grant date fair value of $0.57. During the nine months ended June&nbsp;30, 2018, we granted stock options to employees and non-employees to purchase 8,126,217&nbsp;shares of common stock
with a weighted average grant date fair value of $0.72. We recognized stock-based compensation expense of $1.0&nbsp;million and $1.9&nbsp;million, for the nine months ended June&nbsp;30, 2017 and 2018, respectively. As of June&nbsp;30, 2018, there
was $10.2&nbsp;million of total unrecognized compensation expense related to unvested stock options under the 2013 Plan that is expected to be recognized over a weighted-average period of 3.3 years. As of June&nbsp;30, 2018, there was
$0.8&nbsp;million of total unrecognized compensation expense related to restricted stock under the 2013 Plan that is expected to be recognized over a weighted-average period of 1.9 years. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">During the year ended September&nbsp;30, 2016, we granted stock options to employees and <font style="white-space:nowrap">non-employees</font> to purchase 2,441,000 shares of common stock with a weighted average
grant date fair value of $0.35. During the </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">88 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
year ended September&nbsp;30, 2017, we granted stock options to employees and <font style="white-space:nowrap">non-employees</font> to purchase 8,468,040 shares of common stock with a weighted
average grant date fair value of $0.67. We recognized stock-based compensation expense of $0.9&nbsp;million and $1.9&nbsp;million, for the years ended September&nbsp;30, 2016 and 2017, respectively. As of September&nbsp;30, 2017, there was
$6.7&nbsp;million of total unrecognized compensation expense related to unvested stock options under the 2013 Plan that is expected to be recognized over a weighted-average period of 3.9 years. As of September&nbsp;30, 2017, there was
$1.2&nbsp;million of total unrecognized compensation expense related to restricted stock under the 2013 Plan that is expected to be recognized over a weighted-average period of 2.5 years. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We use the Black-Scholes option pricing model to calculate the grant date fair value of a stock option. The Black-Scholes model requires various assumptions, including expected volatility, expected term, risk-free
interest rate, expected dividend yield and the fair value of our common stock. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The expected volatility of our stock options is estimated from the
historical volatility of selected public companies with comparable characteristics to us, including similarity in size and lines of business. The expected term of stock options represents the period that the options are expected to be outstanding
before being exercised. The risk-free interest rate is based on the implied yield currently available on U.S.&nbsp;treasury notes with terms approximately equal to the expected life of the option. The expected dividend yield is zero as we currently
have no history or expectation of declaring cash dividends on our common stock. The fair value of our common stock is described below under “Determination of the fair value of common stock on grant dates”. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The grant date fair value of options granted during the years ended September&nbsp;30, 2016 and 2017 and nine months ended June&nbsp;30, 2017 and 2018 were
calculated using the weighted average assumptions set forth below: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="69%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine&nbsp;months&nbsp;ended<br>June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Expected term (years)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6.25</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6.25</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6.25</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6.25</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Expected volatility</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">64.4</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">%&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">65.5%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">65.5%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">66.4%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Risk-free interest rate</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1.44</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">%&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2.02%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2.02%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2.81%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Dividend yield</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">%&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We expect the effect of our stock-based compensation expense to grow in future periods due to the potential increases in the fair
value of our common stock and increased number of stock options granted due to anticipated increases in our overall headcount. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June&nbsp;30, 2018,
options (vested and unvested) to purchase 24,000,608 shares of our common stock were outstanding. The aggregate intrinsic value of these options was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
assuming an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, the midpoint of the estimated price range set forth on the cover page of this prospectus, which
was calculated based on the following: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="45%"></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares<br>available</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Options<br>outstanding</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">
<p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="2"><b>Weighted<br>average<br>exercise&nbsp;price</b></font></p> <p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="2"><b>per share</b></font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Weighted average<br>remaining&nbsp;contractual<br>term</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Outstanding as of September&nbsp;30, 2015</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,377,752</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,711,502</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.47</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8.88</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Outstanding as of September&nbsp;30, 2016</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,659,659</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,233,795</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.50</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8.81</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Outstanding as of September&nbsp;30, 2017</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,805,339</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,017,311</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.67</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9.14</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Outstanding as of June&nbsp;30, 2018</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,347,391</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,000,608</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.81</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8.78</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Vested or expected to vest and become exercisable as of June 30, 2018</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,000,608</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.81</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8.78</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">89 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Determination of the fair value of common stock on grant dates </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As there has been no public market for our equity instruments to date, the estimated fair value of our shares of common stock has been determined by our board of
directors and/or our compensation committee as of the grant date, with input from management, considering our most recently available independent third-party valuation of our common stock and our board of directors’ and/or compensation
committee’s assessment of additional objective and subjective factors that it believed were relevant and which may have changed between the effective date of the most recent valuation and the date of the grant. Following the consummation of
this offering, the fair market value of our common stock will be determined based on the quoted market price of our common stock. The independent third-party valuations have generally been performed quarterly in accordance with the guidance outlined
in the AICPA Practice Aid,&nbsp;Valuation of Privately-Held Company Equity Securities Issued as Compensation, or AICPA’s Practice Aid. In conducting the valuations, the independent third-party valuation specialist considered all objective and
subjective factors that it believed to be relevant for each valuation conducted in accordance with AICPA’s Practice Aid, including </font></p>
<p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">management’s best estimate of our business condition, prospects and operating performance at each valuation date. Other significant factors included:
</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the rights, preferences and privileges of our preferred stock as compared to those of our common stock, including the liquidation preferences of our preferred
stock; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our results of operations, financial position and the status of research and development efforts; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">arms-length transactions involving recent rounds of preferred stock financings; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the composition of, and changes to, our management team and board of directors; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the lack of liquidity of our common stock; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our stage of development and business strategy and the material risks related to our business and industry; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the valuation of publicly traded companies in the life sciences and biotechnology sectors, as well as recently completed mergers and acquisitions of peer
companies; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">any external market conditions affecting the life sciences and biotechnology industry sectors; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the likelihood of achieving a liquidity event for the holders of our common stock and stock options, such as an initial public offering, or IPO, or a sale of our
company, given prevailing market conditions; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the state of the IPO market for similarly situated privately held biotechnology companies. </font></p></td></tr></tbody></table>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="2"><b></b>The independent third-party valuations utilized market-based valuation approaches, including the option pricing method, or OPM, the Probability-Weighted
Expected Return Method, or PWERM, and a hybrid methodology utilizing both OPM and PWERM. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The OPM treats the rights of the holders of preferred and
common stock as equivalent to that of call options on any value of the enterprise above certain break points of value based upon the liquidation preferences of the holders of preferred stock, as well as their rights to participation and conversion.
Under OPM, the value of a company’s common stock is determined by estimating the value of its portion of each of these call option rights. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Under
the PWERM, the value of a company’s common stock is estimated based upon an analysis of values for the company assuming various possible future events: IPO, strategic merger or sale, dissolution/no value to common and private company. The per
share value of the company’s common stock is based upon the probability-weighted present value of expected future equity values, under each of the possible future event scenarios, as well as the rights and preferences of each share class.
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">90 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Under the hybrid method, the per share values calculated under the OPM and PWERM are weighted appropriately to
arrive at a final per share fair value of the company’s common stock before the discount for lack of marketability is applied. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The independent
third-party valuations covering fiscal year 2016 through March 31, 2017 were prepared utilizing the OPM as the primary valuation method. The material assumptions used in the OPM include recent rounds of preferred stock financing, estimated future
revenues, and the valuation of peer companies. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Subsequent to March 31, 2017, the independent third-party valuations were prepared utilizing a hybrid
allocation methodology (with both OPM and PWERM used) as the primary allocation method, with the same steps discussed above being applied. The material assumptions used in the hybrid method consist of the weighting of values determined under the OPM
and PWERM. The weighting of the value determined under the PWERM in the hybrid method has increased as the likelihood of an IPO has increased. The material assumptions used in the PWERM include the estimated value, timing and weighting of potential
liquidity events. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">All of our independent third-party valuations also included appropriate discounts to the value of our common stock for lack of
marketability. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Recently issued accounting pronouncements </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have reviewed all recently issued standards and have determined that, other than as disclosed in Note 2 to our unaudited interim condensed consolidated financial statements appearing elsewhere in this
prospectus, such standards will not have a material impact on our financial statements or do not otherwise apply to our operations. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">91 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_11"></a>Business </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Overview </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are a leading and rapidly growing synthetic biology company that has developed a disruptive DNA
synthesis platform to industrialize the engineering of biology. The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. We have combined this
technology with proprietary software, scalable commercial infrastructure and an e-commerce platform to create an integrated technology platform that enables us to achieve high levels of quality, precision, automation, and manufacturing throughput at
a significantly lower cost than our competitors. We are leveraging our unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next generation sample preparation, and antibody libraries
for drug discovery and development. Additionally, we believe our platform will enable new value-add opportunities, such as discovery partnerships for biologic drugs, and will enable new applications for synthetic DNA, such as digital data storage,
which will drive growth in the market for our products. We sell our synthetic DNA and synthetic DNA-based products to a customer base of over 600 customers across a broad range of industries. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">DNA is the fundamental building block of biology. The ability to design DNA and engineer biology, a field known as synthetic biology, is growing rapidly and we believe this field represents one of the most exciting
areas of growth and technological innovation in the 21st&nbsp;century. The ability to modify DNA to serve different purposes is leading to a broad range of applications for synthetic DNA and synthetic DNA-based products across multiple industries,
including: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">healthcare for the discovery and production of new therapeutics and molecular diagnostics; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">industrial chemicals for cost-effective and sustainable production of new and existing specialty chemicals and materials, such as spider silk, nylon, rubber,
fragrances, food flavors and food additives; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">agriculture for more effective and sustainable crop production; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">academic research for a broad range of applications; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">technology for potential use as an alternative long-term data storage medium. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our mission is to be the leading provider of synthetic genes, which are comprised of strands of synthetic DNA, and to leverage the versatility of our platform to expand our portfolio to include other synthetic
DNA-based products and address additional market opportunities. As a leading synthetic DNA provider, we produce an array of different synthetic DNA-based products targeting multiple market opportunities. The following chart represents our target
market opportunities: </font></p> <p style="font-size:1px;margin-top:0px;margin-bottom:0px">&nbsp;</p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p> <p style="margin-top:0px;margin-bottom:0px" align="center">


<img src="./S-1_files/g460243g33t79.jpg" alt="LOGO">
 </p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">92 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">1</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Products addressing this market include clonal, non-clonal genes (gene fragments), oligo pools and DNA libraries </font></td></tr></tbody></table>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">2</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Products addressing this market include NGS exome capture and NGS custom capture </font></td></tr></tbody></table>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">3</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Products addressing this market include custom DNA libraries, our proprietary GPCR-targeting antibody library and our antibody optimization solution </font></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Synthetic genes, DNA libraries and oligo pools </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In
April 2016, we launched the first applications of our platform, synthetic genes and oligo pools, to disrupt the gene synthesis market and make legacy DNA synthesis methods obsolete. Soon thereafter, we added DNA libraries for drug discovery and
development. We estimate the market for synthetic DNA was approximately $1.3 billion in calendar year 2016. We believe that the traditional DNA synthesis methods used by our competitors are inherently limited in scalability and are not optimized to
satisfy the rapidly growing demand for high-quality, <font style="white-space:nowrap">low-cost</font> synthetic DNA. Our silicon-based chip technology is able to increase DNA production by a factor of 9,600 on a footprint similar to that of
traditional DNA synthesis methods. Also, it significantly lowers the volume of required reagents, specifically the most expensive reagent by a factor of 1,000,000 and improves the precision of the synthesis process relative to legacy methods. This
enables us to produce high-quality synthetic DNA on a much larger scale and at a lower cost than competitors. In fiscal 2016, our revenue from synthetic genes was $1.0 million, or approximately 48% of our total revenue, and our revenue from oligo
pools was $0.9 million, or approximately 38% of our total revenue. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In fiscal 2017, we served 286 customers including $0.3 million in sales to seven of
the top 20 pharmaceutical companies by revenue, $4.3 million in sales to Ginkgo Bioworks which we believe is the largest global purchaser of synthetic DNA, $0.3 million in sales to three of the largest agricultural biotechnology companies, $2.7
million in sales to over 100 academic research institutions worldwide, and $7.3 million in sales to innovative customers using synthetic DNA for new and emerging applications, such as Microsoft Corporation and the University of Washington for use of
DNA as a digital data storage medium. To date, we have served over 600 customers across a broad range of industries. In fiscal 2017, our revenue from synthetic genes was $8.1 million, or approximately 75% of our total revenue, and our revenue from
oligo pools was $2.0 million, or approximately 19% of our total revenue. In the nine months ended June 30, 2018, our revenue from synthetic genes was $11.9 million, or approximately 70% of our total revenue, and our revenue from oligo pools was $2.1
million, or approximately 13% of our total revenue. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are also an OEM supplier of synthetic DNA to four synthetic DNA manufacturers that also compete
with us, which we believe is a strong demonstration of the superiority of our platform. We entered into a new agreement with Ginkgo Bioworks in March 2018 (the 2018 Agreement), after the agreement entered into by the parties in 2017 expired pursuant
to its terms, and we are obligated to deliver to Ginkgo Bioworks synthesized DNA sequences that meet certain agreed upon sequence guidelines pursuant to purchase orders placed by Ginkgo Bioworks during the term of the 2018 Agreement. Under the 2018
Agreement, should Ginkgo Bioworks place an order, they shall provide us with genetic sequences to be synthesized. The 2018 Agreement can only be terminated (i) upon mutual agreement of both parties, (ii) by Ginkgo Bioworks upon a specified change of
control, (iii) upon a material breach of the contract by either party, or (iv) unilaterally by us in the event that Ginkgo Bioworks fails to place more than a certain percentage of their required quarterly minimums under the agreement for two
consecutive quarters. The purchase minimums in the 2018 Agreement are considered to create an enforceable obligation only in conjunction with each purchase order. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Next Generation Sequencing sample preparation </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Synthetic DNA is a key product used for target enrichment
during sample preparation in NGS applications. We launched an innovative and comprehensive sample preparation kit for NGS at the Advances in Genome Biology and Technology conference in February 2018. Our kit leverages our platform to precisely
synthesize oligo pools and uniformly amplify the desired target DNA segments, considerably improving the accuracy of the </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">93 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
downstream sequencing analysis. Our proprietary technology also allows us to quickly and cost-effectively customize our NGS kits and simplify the sequencing workflow. This enables our customers
to analyze more samples per sequencing run, without sacrificing accuracy, saving them time and money. We estimate this market opportunity to be approximately $500 million in calendar year 2016. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Biological drug discovery and development </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe
we can leverage our DNA synthesis platform together with our custom libraries and other proprietary tools, such as our anti-GPCR library and antibody optimization solution, to provide an end-to-end solution in biologics drug discovery and early
development, from target to IND application, adding value as a partner to biotechnology and pharmaceutical companies. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><u>Custom DNA libraries</u>
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are developing custom DNA libraries, collections of DNA fragments, which are primarily used by pharmaceutical companies during biological drug
discovery and development. Our platform allows customers to customize every antibody variation and construct a library systematically to target the entire region of therapeutic interest, which we believe represents a significant advantage over
current methodologies and can accelerate drug development and generate new antibody therapeutics. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><u>GPCR drug discovery and early development</u>
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Together with Distributed Bio using in silico design, we have developed a proprietary GPCR-targeting antibody library. GPCRs are cell surface receptors
that traditionally have been difficult to target with antibodies or other biological drugs. We believe our proprietary library improves antibody drug discovery against this difficult class of targets. We plan to partner with biotechnology and
pharmaceutical companies to discover antibodies against GPCRs or out-license the proprietary library to them. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><u>Antibody optimization solution</u>
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Coupling our unique DNA synthesis platform with proprietary software developed by one of our partners, we are now creating and validating a
comprehensive antibody optimization solution that may allow us to form value add partnerships with academic institutions as well as biotechnology and pharmaceutical companies to improve their antibody drug candidates. In addition, this solution may
allow us to discover “bio-better” antibody drugs, which are antibody therapeutics that are similar to an existing antibody with improved tolerability, clinical and/or commercial properties. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">With our custom DNA libraries, proprietary GPCR-targeting antibody library and antibody optimization solutions, we are targeting the biologic drug development
market which we believe to be a large market opportunity. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>DNA as a data storage media </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Due to the explosion of data across many industries, finding efficient long-term storage solutions has become more important. Through the Semiconductor Research
Corporation, many leading semiconductor companies, including Microsoft Corporation, IBM Corporation, Micron Technology, Inc., Autodesk Inc., Mentor Graphics Corporation and GlobalFoundries Inc., are exploring DNA as a long-term, compact form of data
storage with very low energy maintenance requirements and universal read technology that will last hundreds of years. We have strategic relationships with Microsoft Corporation and the University of Washington through which we have demonstrated the
feasibility of storing data on DNA and the unique benefits of longevity, density, and universality of this format. We believe that over time our technology will develop to allow data storage in DNA to become cost competitive with traditional data
storage media, which is necessary to enable us to target several large markets opportunities. The market for digital data storage is more than $35 billion and we believe DNA can address several segments of this market. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">94 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe the growth of the synthetic DNA market is analogous to the trends seen in the next generation
sequencing (NGS) market, where rapid innovation is resulting in the declining costs of sequencing, increased adoption, development of new applications and market expansion. Similarly, tools that combine advanced production technology with modern
digital technology and software capabilities, such as our DNA synthesis platform, are driving growth and market creation for synthetic DNA and synthetic DNA-based products. Therefore, we believe that market estimates understate the potential for our
products as they reflect a market that has historically been limited by the costly, time-consuming, and cumbersome nature of legacy DNA synthesis methods. We are experiencing rapid growth for synthetic DNA and synthetic DNA-based products as we
improve access to affordable tools that encourage adoption of, and foster new applications and markets for, our products. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have built a scalable
commercial platform that enables us to reach a diverse customer base that we estimate consists of over 100,000 synthetic DNA users, and many additional potential customers of our NGS library preparation products today. In order to address this
diverse customer base, we have employed a multi-channel strategy comprised of a direct sales force targeting synthetic DNA customers, a direct sales force focusing on the NGS market and an <font style="white-space:nowrap">e-commerce</font> platform.
Our sales force is focused on customer acquisition, support, and management across industries, and is highly trained on both the technical aspects of our platform and how synthetic DNA can be used in a wide range of industries. We launched our
proprietary, innovative, and <font style="white-space:nowrap"><font style="white-space:nowrap">easy-to-use</font></font> <font style="white-space:nowrap">e-commerce</font> platform in October 2017 to existing customers and expanded access to the
general public in January 2018. Our platform allows customers to design, validate, and place <font style="white-space:nowrap">on-demand</font> orders of customized DNA online, and enable them to receive real-time customized quotes for their products
and track their order status through the manufacturing and delivery process. This is a critical part of our strategy to address our large market and diverse customer base, as well as drive commercial productivity, enhance the customer experience,
and promote loyalty. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Since our formation in 2013, we have grown rapidly and achieved several key milestones that we believe position us for continued
growth and success: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">In 2015, we demonstrated the benefits and validated the commercial utility of our proprietary silicon-based platform for DNA synthesis through a proof-of-concept
program called the Alpha Access program, which provided initial access to our platform to select customers. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">In 2016, we (i) secured a long-term contract with Ginkgo Bioworks to provide up to 100 million base pairs of DNA, which we believe was the largest agreement for
synthetic DNA at that time, (ii) launched our early commercial access program in April called the Beta Access program to select customers and expanded our existing relationship with Ginkgo Bioworks, (iii) acquired Genome Compiler Corporation to add
software design capabilities for our <font style="white-space:nowrap">e-commerce</font> ordering system, (iv) laid the groundwork to pursue an opportunity in biologics drug discovery though a relationship with Distributed Bio, Inc., and (v) supplied
DNA to Microsoft Corporation for its work with the University of Washington to develop DNA as a data storage medium. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">In 2017, we continued to increase penetration with existing customers and expand our customer base, by (i)&nbsp;serving 286 customers (up from 97 customers in
2016), (ii)&nbsp;extending the scope of our relationship with Microsoft Corporation and the University of Washington, (iii)&nbsp;entering into an agreement to supply thousands of genes for public benefit through the BioBricks Foundation,
(iv)&nbsp;successfully achieving industry-leading volumes of synthetic DNA shipped every month, (v)&nbsp;becoming an OEM supplier of synthetic DNA to four synthetic DNA manufacturers that also compete with us, (vi)&nbsp;launching our e-commerce
platform to existing customers in October 2017 and (vii) shipping over 38,000 genes in the fourth quarter of fiscal 2017 compared to approximately 7,600 for the fourth quarter of fiscal 2016, which represents 400% year-over-year growth.
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">In 2018, we continued to experience revenue growth greater than the estimated rate of growth of the synthetic biology market, expanded into new market
opportunities for next-generation sequencing and </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">95 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%"><font size="1">&nbsp;</font></td>
<td valign="top"> <p><font style="font-family:arial" size="2">
antibody biologics discovery, and enhanced our global distribution capabilities by (i)&nbsp;launching our e-commerce platform to the general public, (ii)&nbsp;launching our NGS target enrichment
solutions at a major medical conference, (iii)&nbsp;completing a private financing with funds reserved for building Chinese operations, (iv)&nbsp;signing international distributors in Asia Pacific, (v)&nbsp;expanding our management team to support
our entry into the biologics drug discovery and early development, (vi)&nbsp;signing a new agreement with Ginkgo Bioworks to deliver up to approximately 1.3 billion base pairs over a period of four years, and (vii)&nbsp;shipping 19,794&nbsp;genes in
the third quarter of fiscal 2018 compared to 8,297 for the third quarter of fiscal 2017, which represents 139% year-over-year growth, and compared to shipping 2,650&nbsp;genes in the third quarter of fiscal 2016. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We generated revenue of $2.3&nbsp;million in fiscal 2016 and $10.8&nbsp;million in fiscal 2017, representing 375% year-over-year growth, while incurring net losses
of $44.1&nbsp;million in fiscal 2016 and $59.3&nbsp;million in fiscal 2017. In addition, we generated revenue of $7.3 million and $17.0 million in the nine months ended June 30, 2017 and 2018, representing 133% period-over-period growth, while
incurring net losses of $42.3 million and $51.4 million in the nine months ended June 30, 2017 and 2018. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our headquarters and manufacturing facilities
are located in San Francisco, California. As of June 30, 2018, we had 221 full-time employees worldwide, including three locations in the San Francisco Bay Area and an international location in Tel Aviv, Israel. We also utilize a team of
14&nbsp;dedicated commercial consultants across the European Union and the United Kingdom and five dedicated commercial consultants across Asia. We also recently received private funding to establish production facilities and commercial operations
in Asia. We plan to begin operations in Asia in 2019. As of August 31, 2018, we have raised a total of $291.5&nbsp;million in gross proceeds from the sale of equity securities. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Industry overview </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Engineering of Biology Enables Multiple Market Opportunities </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We operate in the field of synthetic biology, which is undergoing an era of rapid innovation and transformation. Synthetic biology is the engineering of biology to
build new biological systems or <font style="white-space:nowrap">re-design</font> existing biological systems and this emerging field is enabling advances across a broad range of end markets and consumers. For example, in healthcare, synthetic
biology is being used to develop and enable new drugs, via tools such as CRISPR, as well as to improve targeted molecular diagnostics for personalized medicine. In industrial chemical applications, synthetic biology is enabling the production of
renewable, cost-effective chemicals such as nylon, rubber, fragrances, and food flavors or new materials, such as spider silk. In agricultural biotechnology, synthetic biology is being used to improve nutritional content of agricultural goods,
eliminate the need for <font style="white-space:nowrap">oil-based</font> fertilizers, and maximize crop yields. The applications of synthetic biology are constantly growing and new end markets are emerging, driven by continued innovation, our
growing understanding of biology, and access to tools allowing us to modify and build biological systems. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The understanding of, and the ability to use,
synthetic biology continues to vastly improve, accelerated by the adoption of modern research tools, technological advancements in bioinformatics, genomics, computation and automation, coupled with a decrease in DNA sequencing and DNA synthesis
costs. Furthermore the availability and application of artificial intelligence and big data analysis to enhance biological experiments has led to an acceleration of valuable biological insights in a streamlined, automated, and industrialized manner.
This digitization of biology has led to an explosion of new and accessible technologies and has made it possible for small and large organizations alike to conduct synthetic biology research. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">According to BCC Research, the overall market for synthetic biology products was approximately $4.4&nbsp;billion in calendar year 2017 and is expected to grow to over $13.9&nbsp;billion by calendar year 2022. This
industry </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">96 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
momentum creates a significant opportunity for us to grow within our existing markets as well as expand our product offering. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The value chain within the synthetic biology market consists of three areas: enabled products, core technologies and products, and enabling technologies. </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><b><i><u>Enabled products</u></i></b> are the true end products resulting from the use of synthetic biology, which include products such as pharmaceuticals,
agricultural crops, industrial chemicals and materials, and molecular diagnostics. Companies that operate in this segment include pharmaceutical and biotechnology companies, large industrial chemical companies, and agriculture companies.
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><b><i><u>Core technologies and products</u></i></b> include the biological components, integrated systems, and ingredients that form the building blocks for the
enabled products, including synthetic genes and cells, delivery plasmids, and biobrick parts, among others. Companies that operate in this segment include Ginkgo Bioworks and other companies that help engineer biological components to create the
enabled products. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><b><i><u>Enabling technologies</u></i></b> are the tools needed to produce both the core technologies and enabled products. These include technologies such as
DNA synthesis, DNA sequencing, gene editing, workflow automation technologies, bioinformatics, and digital data storage. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our platform
provides flexibility to pursue opportunities across all of these segments. For example, our synthetic gene offering is considered an enabling technology, but our NGS products are considered an enabled product. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Synthetic DNA is the fundamental building block of synthetic biology. Users of synthetic biology can design synthetic DNA to regulate the production of these
proteins and molecules to achieve a specific functional purpose. While humans have been slowly altering the genetic coding of DNA in plants and animals for millennia through selective breeding, synthetic biology is the process of rapidly coding <font style="white-space:nowrap">man-made</font> DNA to build new biological systems or modify the design of existing biological systems. This is implemented by using powerful computational models and advanced engineering to redesign existing biological
systems for new purposes. As the ability to modify DNA has become increasingly accessible, the applications, products, and customer base for synthetic DNA have continued to grow. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Traditional DNA synthesis methods </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">While synthetic DNA (also referred to as recombinant DNA) has been
produced for more than 40 years, the complexities of biology and the production constraints inherent in legacy processes have historically limited the applications and market opportunities for DNA synthesis. DNA synthesis is the process of linking
together naturally occurring nucleotides and their phosphodiester analogs to create DNA strands that are chemically identical to naturally occurring DNA. This process is commonly referred to as phosphoramidite chemistry and was first published in
1982. Traditional methods of DNA synthesis consist of a <font style="white-space:nowrap">two-step</font> process that initially involves the synthesis of oligos, which are short strands of DNA of up to approximately 200 base pairs (bp) in length.
These oligos are then combined to create longer strands of DNA. The length of DNA required for specific research typically depends on the desired end use and can vary from 50bps to more than 100,000bps. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">97 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px" align="center">


<img src="./S-1_files/g460243g26h15.jpg" alt="LOGO">
 </p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Currently, there are two primary methodologies used by others to create synthetic DNA, the 96-well plate method and the
microarray method. Each of these methods has production limitations that we believe make these technologies <font style="white-space:nowrap">sub-optimal</font> to satisfy the rapidly growing demand for synthetic DNA. In addition, because the
synthesis of oligos can introduce errors in the sequence order, all DNA synthesis methods require a process called cloning to produce many identical copies of a strand of DNA, such as a clonal gene. Today, all of our competitors use one of these two
primary methods of DNA synthesis and require cloning for clonal genes. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i><font style="white-space:nowrap">96-well</font> plate method of DNA
synthesis </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Introduced as early as the 1950s, a <font style="white-space:nowrap">96-well</font> plate is a flat plastic plate, roughly the size of
two smartphones, with 8 rows of 12 wells that are used as small test tubes. This plate has become a standard tool used by researchers in multiple industries to conduct tests and also to manufacture synthetic DNA in the form of oligos. Instead of
creating one sequence of DNA at a time in a single test tube, the <font style="white-space:nowrap">96-well</font> plate allows researchers to create 96 oligos in parallel, one in each well. While this process successfully achieves DNA synthesis, it
requires high volumes of phosphoramidites, an expensive raw material, as well as other ancillary reagents. It also produces excessive amounts of the final product, significantly more than is required for most subsequent processes, resulting in
material that is discarded and an unnecessary expense. Additionally, this process is not scalable to produce high volumes, as approximately 100 oligos are needed to assemble one gene and therefore only one gene can be made from each <font style="white-space:nowrap">96-well</font> plate. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Microarray method of DNA synthesis </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Unlike a <font style="white-space:nowrap">96-well</font> plate, a microarray is a flat surface made of plastic or glass, on which DNA is synthesized directly in an
array of discrete locations. Microarrays were initially developed as an analysis tool, to detect the identity and quantity of DNA in a sample. Beginning in the early 2000s, researchers began using microarrays to synthesize oligos. Microarrays allow
large numbers of oligos to be synthesized in parallel, increasing production by up to four orders of magnitude when compared to the <font style="white-space:nowrap">96-well</font> plate. However, DNA synthesis on microarrays presents other
production limitations. In order to assemble the microarray-derived oligos into a gene, the oligos are distributed onto a plastic or glass plate, much like printing, and given unique barcodes for identification. Once printed, the oligos are cleaved
off of the array chip into a single large pool of oligos, which are then amplified using polymerase chain reaction (PCR). Amplification is necessary because only small amounts of oligos can be produced on a microarray, not enough to be assembled
into genes. Oligos are amplified using corresponding primers for their bar codes for separation into smaller pools of approximately 100 oligos. Separation into smaller pools and bar code removal is an expensive and time-consuming process.
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">98 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
The oligos are then stored in the separate wells of a <font style="white-space:nowrap">96-well</font> plate and are then assembled into a gene. While this method can make 100&nbsp;genes in
parallel, it remains difficult to scale, requires many steps and results in significant waste of materials. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Cloning </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Cloning is a tedious process to filter out errors and produce many identical copies of a strand of DNA, such as a gene. While the cloning process results in a
precise sequence, it is incredibly slow and labor intensive and generally takes around 10 business days to complete. As a result, it is time consuming, expensive, and, in many cases, not an efficient use of a researcher’s time. In general, more
accurate DNA synthesis technology results in fewer errors in the sequence order and reduces the time and costs required or allocated to the cloning process. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Example—Cloning Workflow (4 - 10 business days of a researcher’s time) compared to Purchase Workflow (10&nbsp;business day turnaround at Twist Bioscience) </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p> <p style="margin-top:0px;margin-bottom:0px">


<img src="./S-1_files/g460243g30x69.jpg" alt="LOGO">
 </p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Our solution: The Twist Bioscience DNA synthesis platform </u></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We developed the Twist Bioscience DNA synthesis platform to address the limitations of throughput, scalability, and cost inherent in legacy DNA synthesis methods. Our platform stems from extensive analyses of, and
improvements to, the existing gene synthesis and assembly workflows. Our core technologies combine expertise in silicon, software, fluidics, chemistry, and motion and vision control to miniaturize thousands of parallel chemical reactions on silicon
and write thousands of strands of DNA in parallel. With a footprint that is similar to the size of a <font style="white-space:nowrap">96-well</font> plate that produces one gene, we are able to produce 9,600 genes in parallel. Based on current
production needs, we have intentionally designed our latest chip to make 6,144 genes in parallel but we have the current capacity to increase this to 9,600 genes, as needed. We have combined our DNA synthesis technology with propriety software and a
scalable commercial infrastructure to create our </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">99 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
vertically integrated DNA synthesis platform capable of delivering very large volumes of high-quality synthetic DNA at low cost. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>DNA writing on silicon </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Silicon is an excellent medium for DNA synthesis because the properties of
silicon allow us to miniaturize the chemical reactions of DNA synthesis and precisely control the position of fluid on the silicon surface. Silicon is flat and can be aligned, patterned and imaged. Fluids also flow uniformly over the surface.
Silicon is a very hard material and other materials can be added or removed without changing the surface. It conducts heat very well, so the temperature can be controlled quickly, accurately and consistently across the surface. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As discovered and capitalized on by the semiconductor industry, it is possible to grow a thin layer of silicon oxide on the surface of silicon by reacting the
silicon surface with oxygen at a very high temperature. The resulting oxide layer can be etched to produce micro- or nano-structures and the surface energy of the silicon oxide can be modified to be hydrophobic or hydrophilic. These modifications
can also be patterned. We use these oxide-based properties to create an array of discrete devices that are similar in function to the wells on a <font style="white-space:nowrap">96-well</font> plate to control the position of drops of fluid on the
surface, replacing legacy plastic. Our process, which miniaturizes the devices relative to the wells on the <font style="white-space:nowrap">96-well</font> plate, enables us to significantly reduce the volumes of reagents required in the oligo
synthesis reaction, specifically the most expensive reagent (phosphoramidites) by a factor of 1,000,000. In addition, our silicon chip technology allows us to increase DNA production by a factor of 9,600 on a similar footprint to that of traditional
DNA synthesis methods. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Currently, we manufacture DNA on a silicon chip with 6,144 distinct spaces on the chip which we call clusters, each comprised of
121 devices and we have the current capability to increase this to 9,600 genes, as needed. Each device supports the synthesis of a unique oligonucleotide sequence. In parallel, within each cluster, we construct 121 short oligos of 50 to 250 base
pairs in length. Each cluster is individually customized to create and assemble the oligos into a single gene and clone them into final form using small volumes and automated processes. Because we synthesize each oligonucleotide individually, almost
all DNA sequences can be customized to our customer’s specifications, both in terms of volume and amount. This improves production efficiency by enabling the manufacturing of different products in parallel without the need for retooling.
</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="51%"></td>
<td valign="bottom" width="2%"></td>
<td width="47%"></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top" align="center"> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2"><b>Diagram showing each cluster on the chip</b></font></p>
<p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2"><b>containing 121 devices</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2"><b>Optical image showing surface structure of a single cluster</b></font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top" align="center">


<img src="./S-1_files/g460243g75p24.jpg" alt="LOGO">
</td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center">


<img src="./S-1_files/g460243g49r04.jpg" alt="LOGO">
</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe that we are only beginning to realize the benefits of our semiconductor-based production process and expect that, similar
to the semiconductor industry, we will be able to continuously improve our production </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">100 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
process over time and further our technology leadership position. By developing a semiconductor-based platform to harness the power of biology, we believe that we are promoting the digitization
of biology and creating a modern production platform able to satisfy the demands of a rapidly growing industry. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p> <p style="margin-top:0px;margin-bottom:0px" align="center">


<img src="./S-1_files/g460243g31f45.jpg" alt="LOGO">
 </p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition to traditional DNA synthesis methods, some researchers are investigating possible enzymatic DNA synthesis methods
that involve using an enzyme in the synthesis process to manufacture the desired DNA sequence. These methods are in early stages of research and have the potential to significantly improve the DNA synthesis process in many respects. Based on the
published research on these enzymatic synthesis methods, we believe our semiconductor-based DNA synthesis platform could also be applied to these synthesis methods to address limitations on throughput, scalability and cost. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Key advantages of our proprietary DNA synthesis platform </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We designed our DNA synthesis platform to address the diverse needs of our large potential customer base. Given the limitations of traditional DNA synthesis methods, buyers have historically faced trade-offs and
compromises when purchasing from legacy DNA providers. We believe that DNA Buyers are looking for a product and purchasing experience that delivers on a number of key factors. We believe that our platform is uniquely designed to meet these customer
needs and overcome the limitations of legacy DNA synthesis methods to support the growing demand for synthetic DNA: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="32%"></td>
<td valign="bottom" width="2%"></td>
<td width="30%"></td>
<td valign="bottom" width="3%"></td>
<td width="29%"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Customer desires</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Twist Bioscience advantages</b></font></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><i>Quality and accuracy</i></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Quality and accuracy is a basic requirement for all customers. Deviations from
customer specifications can render customers’ downstream uses less productive or ineffective.</font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Synthetic DNA providers are able to supply perfect clonal DNA to the customer.
However, existing DNA synthesis technologies require significant cloning and error filtration to produce perfect clonal DNA. We are able to</font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">101 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="32%"></td>
<td valign="bottom" width="2%"></td>
<td width="30%"></td>
<td valign="bottom" width="3%"></td>
<td width="29%"></td></tr>

<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Customer desires</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Twist Bioscience advantages</b></font></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:0.00em"><font style="font-family:arial" size="2">consistently produce high quality oligos with what we believe is an industry-leading error rate of 1/1000 base pairs.
This enables us to reduce the cloning and error filtration necessary to achieve perfect clonal DNA. The benefits, quality and accuracy of our platform also apply to customers who purchase other synthetic DNA based products, such as antibody
libraries and oligo pools. In each of our market opportunities, we believe the precision of our technology provides the advantage of cost and production throughput.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="10"></td>
<td height="10" colspan="2"></td>
<td height="10" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><i>Cost</i></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Cost is a critical consideration for both large and small-scale customers.
Large-scale commercial DNA purchasers that outsource their DNA supply are becoming increasingly price sensitive due to their growing demand for DNA. On the other hand, smaller-scale users, particularly academic users, have always been price
sensitive and typically have made their own DNA because of limited budgets relative to the prices charged by legacy DNA suppliers.</font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Because we miniaturize the chemical reaction on a silicon chip, require lower
volumes of reagents and automate the production process, we are able to dramatically lower the production cost per base pair of DNA and offer our synthetic DNA at a lower price than competitors. As of September&nbsp;2018, the publicly available
pricing of our competitors for clonal DNA ranged from $0.15—$2.00 per base pair (assuming an order size of 150 base pairs). Our standard pricing for comparable DNA is $0.09 per base pair for genes between 300 and 1,800 base pairs in length. One
of the best demonstrations of our cost advantage is that we supply synthetic DNA to four other competing synthetic DNA providers.</font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">102 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="32%"></td>
<td valign="bottom" width="2%"></td>
<td width="30%"></td>
<td valign="bottom" width="3%"></td>
<td width="29%"></td></tr>

<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Customer desires</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Twist Bioscience advantages</b></font></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><i>Throughput / scale</i></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;As the applications for synthetic biology have expanded, customers are increasingly seeking to purchase large
quantities of DNA in relatively short periods of time, which often cannot be supplied by a single synthetic DNA provider due to production capacity constraints. Ordering from multiple suppliers to fulfill large orders can be costly and
administratively cumbersome for customers.</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Our silicon chip technology is able to increase DNA production by a factor of 9,600 on a footprint similar to
traditional DNA synthesis methods. We currently have the capability to manufacture 20 million oligonucleotides per month that can be combined into high-precision oligo pools of various sizes. These oligonucleotides can be used to create multiple
products including genes. We currently have the capacity to produce more than 45,000 genes per month, which we believe is the highest in the industry. We have agreed to supply up to approximately 1.3 billion base pairs to Ginkgo Bioworks over a
period of four years, which we believe is the largest volume supply commitment in the industry to date.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="10"></td>
<td height="10" colspan="2"></td>
<td height="10" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><i>Turnaround time</i></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;The time between placement of the order and delivery is a key consideration for
customers. For example, pharmaceutical companies are focused on shortening internal R&amp;D timelines and ready availability of high- quality, synthetic DNA to meet their internal timelines is an important factor.</font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Because our platform enables the large-scale production of DNA, our turnaround
time is largely independent of order size. We have enhanced our manufacturing capabilities and expect to reduce turnaround time on large commercial quantities of genes (i.e., orders of over 15,000 genes per month) to 10&nbsp;business
days.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="10"></td>
<td height="10" colspan="2"></td>
<td height="10" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><i>Product offering / complexity</i></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Customers require a broad range of products including different gene lengths,
complicated sequences and a wide range of additional configurations to fulfill a diverse set of applications and uses.</font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Because we synthesize each oligonucleotide individually, we can customize
orders to almost any customer’s specifications. We currently offer genes of up to 3,200 base pairs in length, which we believe satisfies a substantial portion of the market
for</font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">103 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="32%"></td>
<td valign="bottom" width="2%"></td>
<td width="30%"></td>
<td valign="bottom" width="3%"></td>
<td width="29%"></td></tr>

<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Customer desires</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Twist Bioscience advantages</b></font></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:0.00em"><font style="font-family:arial" size="2">synthetic DNA today. For Ginkgo Bioworks, our largest customer, we offer up to 5,000 base pairs in length. We expect to
offer genes of up to 10,000 base pairs in the future. Unlike traditional DNA synthesis technologies, we can also manufacture a broad range of additional products on our same DNA synthesis platform, including antibody libraries and oligo pools, among
others.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="2"></td>
<td height="8" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><i>Reliability</i></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Customers value the reliability of a supplier to deliver on promises of quality
and turnaround time to allow them to plan their downstream workflow and hit internal deadlines.</font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Due to our throughput capability and proprietary integrated production and
ordering process we have been able to consistently meet the specifications and turnaround time that we promise customers.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="2"></td>
<td height="8" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><i><font style="white-space:nowrap">E-commerce</font> capability</i></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;Customers, particularly smaller-scale customers, value an intuitive, seamless <font style="white-space:nowrap">e-commerce</font> experience that tracks orders from placement to delivery to simplify and automate the purchasing process. Some customers also value an application protocol interface, or an API, for electronic integration
into their own procurement systems.</font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">•&#8194;&#8202;While some synthetic DNA providers have an
<font style="white-space:nowrap">e-commerce</font> platform for ordering DNA, we believe we offer the most comprehensive <font style="white-space:nowrap">e-commerce</font> platform consisting of customized quotes, automated feedback on the
feasibility of the sequence and the ability to track orders from placement to delivery. An API is also a core component of our <font style="white-space:nowrap">e-commerce</font> system.</font></p></td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">104 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Our growth strategy </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our objective is to be the leading provider of synthetic DNA worldwide and to leverage the versatility of our platform to build a leadership position in other synthetic DNA-based product markets in which we have a
competitive advantage. We intend to accomplish this objective by executing on the following: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><b><i>Maintain and expand our position as the provider of choice for high-quality, affordable synthetic </i></b><i>genes and</i><b><i> DNA to customers across
multiple industries</i></b><i>:</i> </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Offer an unprecedented combination of quality, cost, throughput and scalability to deliver synthetic DNA to our existing customers and win new customers
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i>Increase our penetration within existing buyers of synthetic DNA, including pharmaceutical and biotechnology companies, industrial chemical companies,
agricultural biotechnology companies and academic institutions</i> </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i></i><b><i>Further expand our addressable market by converting current DNA Makers into DNA Buyers</i></b><i> by offering a compelling value proposition that
saves time and money for DNA users that are currently making their own DNA</i> </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i></i><b><i>Broaden our reach to the more than 100,000 estimated synthetic DNA users</i></b><i> by scaling our multi-channel commercial strategy</i>
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><b><i>Augment our product offering within the gene franchise to include, for example, longer genes, catalog vectors, maxiprep and products for CRISPR screens
</i></b></font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i>Become a leading supplier of NGS sample preparation products:</i> </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Drive adoption of our NGS products by addressing the demand for better sample preparation products that improve the sequencing workflow, increase sequencing
accuracy and lower sequencing costs versus other technologies; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Continue to expand our software capabilities to allow customers to fully customize our NGS products to drive adoption by the broader diagnostic community.
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i>Conduct antibody therapeutic discovery and optimization for our current customers and future partners:</i> </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Leverage our ability to generate customized DNA libraries to reduce the time and cost necessary for lead identification and lead optimization of potential
biological therapeutics for biotechnology and pharmaceutical partners; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Validate and partner a comprehensive antibody optimization solution with academic institutions and biotechnology and pharmaceutical companies to improve their
antibody drug candidates, and discover “bio-better” antibody drugs; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Discover new anti-GPCR antibody candidates for target discovery, antibody candidate selection and antibody candidate optimization through adding value by
partnering with biotechnology and pharmaceutical companies; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">We will look to initiate adding value by partnering with biotechnology and pharmaceutical companies, leveraging our proprietary DNA libraries, antibody
optimization solution and anti-GPCR antibody library, which may include upfront, milestone and royalty payments to us. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i>Continue to explore development of DNA as a digital data storage medium via internal research and government and industry partnerships:</i>
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Leverage existing strategic relationships and seek to develop additional relationships with leading technology companies for product development and as a
potential source of non-dilutive financing for development of DNA as a data storage media; and </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">105 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Continue to develop and explore market opportunities for DNA as a very long-term storage media for market segments, including the WORN (Write Once, Read Never)
and WORSE (Write Once, Read Seldom if Ever) markets. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><b><i>Expand our global presence</i></b><i>:</i> </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Expand our operations into other large global markets in which we believe we can be competitive, including for example, Asia. We have received private funding to
establish a production facility in China to manufacture DNA in China for the Asian market, with operations expected to begin in 2019. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Beyond these opportunities, we are working with industry partners to create new markets for our products by leveraging the versatility of our platform. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Our products </u></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have developed multiple products
derived from synthetic DNA and our versatile DNA synthesis technology. Our current offering consists of four primary products that address different needs of our customers across a variety of applications: synthetic genes, oligo pools, next
generation sequencing tools and DNA libraries. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Synthetic genes </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Synthetic genes are manufactured strands of DNA. Customers order our synthetic genes to conduct a wide range of research, including product development for the healthcare, agricultural, and industrial chemical
industries as well as a multitude of applications within academic research. Virtually all research and development requires trial and error, and our customers require many variations of genes to find the DNA sequence that achieves their objectives.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We offer two primary categories of synthetic genes: genes of perfect quality, clonal genes, in a vehicle to carry the DNA, also called a vector, and
genes of near-perfect quality, non-clonal genes or fragments, that customers can place in their own vector. Within these two categories, customers can order different lengths of DNA depending on their required final gene construct. Customers can
order longer genes or shorter genes and can stitch genes together to create longer or shorter constructs if desired. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Clonal genes in a Twist
Bioscience or customer vector </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our premier gene synthesis offering delivers clonally perfect genes. For our clonally perfect genes, we perform
the cloning on behalf of our customers and deliver DNA in either a customer-supplied vector or a Twist Bioscience vector. Customer-supplied vectors greatly simplify downstream work for our customers, allowing them to take our genes and pass them
directly into their workflows. We have also developed a catalog of our own specific vectors. Currently, we manufacture genes of up to 3,200 base pairs in length, yielding a clonally perfect piece of DNA that our customers can immediately use for
their research. We offer turnaround times of approximately 15 – 20 business days for clonal genes. As of the date of this prospectus, our standard pricing for clonal DNA is $0.09 per base pair for genes between 300 and 1,800 bps in length. We
intend to further expand the length of genes offered to more than 10,000 base pairs and, in parallel, expand our catalog of available vectors to increase flexibility and reduce turnaround times. We also intend to offer express service options for
customers that require genes on an expedited basis. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i><font style="white-space:nowrap">Non-clonal</font> genes </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><font style="white-space:nowrap">Non-clonal</font> genes serve customers who prefer to conduct their own cloning protocols or that do not need, or want, to pay for
perfect quality genes. We offer <font style="white-space:nowrap">non-clonal</font> genes of up to 1,800 base pairs in length, which we </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">106 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
believe addresses the vast majority of demand for <font style="white-space:nowrap">non-clonal</font> genes. From August 2017 through October 2017, we offered average monthly turnaround times of
approximately six to 11 business days for <font style="white-space:nowrap">non-clonal</font> genes. As of the date of this prospectus, our standard pricing for <font style="white-space:nowrap">non-clonal</font> genes is $0.07 per base pair.
</font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Oligonucleotide (Oligo) pools </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Oligo pools, or
high diversity collections of oligonucleotides, are utilized in many applications, including targeted next generation sequencing, or NGS, CRISPR gene editing, mutagenesis experiments, DNA origami (the nanoscale folding of DNA to create <font style="white-space:nowrap">two-</font> and three-dimensional shapes at the nanoscale), DNA computing and data storage in DNA, among others. Our oligo pools are also used for high-throughput reporter assays that are used to study cell signaling
pathways, gene regulation, and the structure of cell regulatory elements. For these applications, we provide customers with accurate and uniform synthetic oligos to precisely match their required designs. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We sell a diverse, customizable set of oligo pools, ranging from a few hundred oligos to over one million and offer oligonucleotides of up to 200 nucleotides in
length and, from October 2017 through December 2017, average monthly turnaround times of five to six business days. As of the date of this prospectus, our standard pricing for oligo pools is between $0.10 to $1.00 per oligo depending primarily on
order size. Because the ability to design oligo pools and customize their experiments is very important to our customers, we have established a <font style="white-space:nowrap">co-marketing</font> agreement with a company that specializes in
developing algorithms which enable customers to design optimized and high-quality oligo pools. Integration of this design capability with our oligo pool synthesis production competency enables our customers to design and receive a high-quality oligo
pool customized to meet their needs. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the future, we expect to offer longer oligonucleotides, cloned pools, and a
<font style="white-space:nowrap">sub-pooling</font> capability which will allow our customers to purchase lower complexity pools and arrayed pools. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Oligo pools for CRISPR gene editing </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">CRISPR is a
recently discovered gene editing tool that has become an area of significant research focus, especially in drug development, and is a rapidly growing application that is contributing to growing demand for our oligo pools. In the CRISPR editing
process, a short sequence of RNA called <font style="white-space:nowrap">guide-RNA</font> (gRNA) binds to its target DNA sequence in a host cell, indicating to an enzyme where to cut and edit the DNA. In order to conduct gene editing research, many
single <font style="white-space:nowrap">guide-RNA</font> must be created. Researchers can use oligo pools for CRISPR gene editing to silence, through editing, DNA locations. This process creates an error at a particular location in the DNA of the
cell, rendering that location unusable, in other words silenced. By studying the relationship between silenced regions and change in phenotype (did the disease get worse or better), researchers can find the genomic regions important to the disease
and identify targets for therapeutics. Similar to our standard oligo pools, we offer oligo pools for CRISPR screening with a diverse and customizable set of specifications, including pool sizes ranging from a few hundred oligos to over one million.
From oligo produced on a single silicon chip, researchers can edit up to 1,000,000 DNA locations. We currently offer oligo pools for CRISPR screening of up to 200 nucleotides in length, which we believe addresses the vast majority of the market for
CRISPR guide library generation. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Next generation sequencing (NGS) tools </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We recently expanded the application of our DNA synthesis technology to develop products targeted at the large next generation sequencing market, or NGS. In particular, we are focused on addressing the demand for
better sample preparation products that improve sequencing workflow, increase sequencing accuracy, and lower sequencing costs. In the target enrichment process, the DNA probes “enrich” a DNA sample by binding to
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">107 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
specified segments of DNA in order to isolate and physically extract the targeted segment of DNA from the sample, prior to downstream sequencing. The targeted segment of DNA can then be copied
uniformly prior to NGS analysis by our customers, yielding a larger volume of targeted segments in the sample used for sequencing. Because we are able to precisely target, extract, and uniformly amplify the target DNA segments, our solution
considerably improves the accuracy of the downstream sequencing analysis. This enables our customers to perform fewer sequencing runs per sample, without sacrificing accuracy, saving them time and money. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe we are the only company to offer double-stranded DNA (dsDNA) probes within a comprehensive target enrichment kit used for exome and targeted sequencing.
Using dsDNA as opposed to single-stranded DNA, or RNA, during next generation sequencing preparation avoids the problem of deamination (removal of an amino group). Deamination interferes with the detection of infrequent gene mutations, and may
hinder genetic results and clinical diagnosis, particularly in cancer. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our NGS products are primarily used for diagnostic testing, research for
population genetics and biomarker discovery, translational research, microbiology and applied markets. Our customers are primarily diagnostic companies and hospitals, research institutions, agricultural biotechnology companies, and consumer genetics
companies conducting diagnostic tests for a wide range of applications. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition to our DNA probes, we have created a comprehensive sample
preparation kit that combines these probes for NGS target enrichment with all the reagents and consumables necessary to process a sample into sequencing-ready material. This improves the NGS library preparation workflow and is a cost-effective
solution that reduces sequencing costs, improves time to results, enhances sequencing coverage, and provides quality control on every DNA probe. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have
launched a kit for sequencing of the exome, or NGS exome capture, the entire known coding region of the genome, and expect to launch a software tool to allow customers to customize their own kit, or NGS custom capture. We expect the development of
this software tool, combined with our <font style="white-space:nowrap">e-commerce</font> platform, will simplify the design process for our customers and provide broader market access to our products. We currently deliver this exome kit within two
to three weeks for our customers. Our NGS tools pricing is based on the numbers of reactions and pools requested by a customer. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>DNA libraries
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">DNA libraries are collections of DNA fragments that are primarily used by pharmaceutical companies during antibody discovery and development. During
the drug discovery phase, a pharmaceutical company typically has a biological target or function of interest. In order to find antibodies that best bind to that target in a specific region of a gene and deliver a therapeutic effect, it may be
necessary to test many variants of an antibody. Synthetic DNA libraries become useful in this process, as they produce customized, controllable groups of antibodies from specific DNA sequences to run through assays that assess function, toxicity and
binding affinity. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Traditionally, pharmaceutical companies have generated antibody libraries through a process called “random mutagenesis.”
This uses a technique called polymerase chain reaction (PCR) mutagenesis, where PCR is used to introduce many sequence errors, or variations, within the copies of the antibody. While this generates many different antibody variants, the changes are
entirely random and are unknown until the antibody DNA is sequenced. In addition, because of the random approach, there is no guarantee that the resulting antibodies will target the desired region of interest. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our platform allows customers to customize every antibody variation and construct a precise library systematically to target the entire region of interest. We can
create single site libraries in which we change one </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">108 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
single amino acid (a group of three DNA bases) within the sequence or single site saturation libraries in which we change every amino acid within the sequence for a more comprehensive approach.
We can also generate combinatorial libraries in which we introduce changes to multiple sites within the same gene in specific ratios and combinations. These libraries can be used for antibody engineering, affinity maturation, and humanization, which
simplifies downstream screening and identifies more lead molecules. Our libraries are explicitly developed for a specific area of the genome or tailored to a specific disease, with antibody compounds evenly represented across all areas of the genome
desired. In the future, we expect to add digital library design tools to our <font style="white-space:nowrap">e-commerce</font> platform that will facilitate rapid library design. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">To support our efforts to add further value for our customers and potential partners, we are in the process of creating a comprehensive antibody optimization solution to enable simultaneous optimization of multiple
characteristics of a given antibody. Working with Distributed Bio, we developed custom software for the optimization of antibody hits, antibody compounds that meet pre-specified criteria for therapeutic development. We are now working to add our
high throughput and hyper-variant antibody library capabilities to create a comprehensive antibody optimization solution for potential partners. We plan to use this solution to design, build and test hyper-variant, tightly controlled antibody
libraries that follow the rules of the human repertoire and mitigate the pitfalls associated with traditional optimization methods. By following the rules of the human repertoire, which means including only DNA sequences known to occur in humans,
these libraries will be natural in composition and are expected to generate better drug development candidates. The libraries also have a large degree of synthetic variation, enabling simultaneous optimization of several antibody characteristics and
the discovery of antibodies with high affinity and specificity to drug targets. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In parallel with the development of our antibody optimization solution,
we are conducting a proof-of-concept project to validate whether we are able to identify a “bio-better” (or improved) antibody of icrucumab, an anti-VEGFR1 antibody that has failed in clinical studies to show improvement in clinical
outcomes. If we succeed in identifying an improved antibody of a previously unsuccessful antibody candidate as proof-of-concept, we would seek to license our design and build library capabilities to provide improved therapeutic antibodies for
pharmaceutical and biotechnology partners. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Additionally, we plan to leverage our ability to rapidly generate custom libraries to discover novel
therapeutic antibodies against biological targets that have traditionally been difficult for biological drug development. Specifically, through a collaboration with Distributed Bio we have developed a proprietary antibody library targeting a major
class of proteins known as GPCRs. GPCRs are important receptors that control and drive the biology of nearly all disease classes, including inflammation, cancer, metabolism, respiratory, and pain. According to a recent publication in Molecular
Pharmacology, approximately 700 approved therapeutics target GPCRs, representing approximately 35% of all approved drugs. However, they remain a difficult class of targets for antibody development due to the lack of exposed protein surfaces to bind.
We are now validating this GPCR library of highly designed antibodies and screening it against three GPCR targets and we may partner with other technology providers to advance development of our anti-GPCR antibody discovery efforts. If we are
successful in validating the utility of our DNA library synthesis capabilities to address this traditionally difficult class of antibody targets, we may also develop libraries for screening and selection of other biological therapeutic targets such
as ion channels and membrane based transporters. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe we have several avenues available to monetize our antibody discovery program. For example,
we anticipate that successful discovery of a novel therapeutic antibody against any single GPCR target would attract significant partnership interest from academic institutions as well as biotechnology and pharmaceutical companies given the
difficult nature of this class of antibody targets. These partnerships may include upfront, milestone and royalty payments to us for access to our GPCR library. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">109 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>End markets for Twist Bioscience products </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our current product set addresses customers across a range of major applications. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="14%"></td>
<td valign="bottom" width="7%"></td>
<td width="47%"></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Product offered</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Healthcare</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Industrial<br>chemicals</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Agriculture</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Academic<br>research</b></font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top" rowspan="2"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Genes</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Clonal genes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><font style="white-space:nowrap">Non-clonal</font> genes</font></p>
<p style="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">(Gene fragments)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top" rowspan="2"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Oligo pools</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Oligonucleotide</font></p>
<p style="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">pools</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Oligo pools for</font></p>
<p style="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">CRISPR gene editing</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top" rowspan="2"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>NGS tools</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">NGS exome capture</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">NGS custom capture</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Libraries</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Antibody and protein</font></p>
<p style="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Variant libraries</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">X</font></td></tr>
<tr style="font-size:1px">
<td colspan="11" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td></tr>
</tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Our target markets </u></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our currently marketed product offering addresses a market opportunity that was approximately $1.8&nbsp;billion in calendar year 2016. We believe that current
market estimates underestimate the potential for synthetic DNA because they reflect the costly, time-consuming and cumbersome nature of legacy DNA synthesis technologies. We believe our solution has the potential to materially expand our initial
market by providing end users access to high-quality and lower cost tools, encouraging adoption and facilitating new applications for our products. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>DNA synthesis—DNA Buyers and DNA Makers </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our core
DNA synthesis market includes our synthetic DNA, oligo pools and DNA libraries. We believe that our current market opportunity for synthetic DNA was approximately $1.3&nbsp;billion in calendar year 2016. The market consists of those who buy DNA, or
DNA Buyers, and those who make their own DNA, or DNA Makers. Driven by access to more affordable and high-quality synthetic DNA, we believe that there is a strong trend of DNA Makers converting to DNA Buyers. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>DNA Buyers </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">DNA Buyers are generally commercial users
in the healthcare, industrial, agricultural and academic fields who require large amounts of DNA. These customers value speed, throughput, and reliability and are increasingly price sensitive given the volume of DNA that they purchase. According to
BCC Research, the size of the buyer market in 2016 was approximately $300&nbsp;million and is growing at a rate of approximately 20% annually as existing DNA Buyers develop new uses for synthetic DNA and existing DNA Makers convert to DNA Buyers.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>DNA Makers </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">DNA Makers purchase supplies
in order to make their own DNA. They typically require only a few genes at a time and are very price sensitive. While the consumables required to make DNA are relatively inexpensive, it is a time-consuming and labor-intensive task. The steps include
copying and pasting each DNA sequence from one vector to another using restriction enzymes, and mutagenizing the sequence of interest to obtain the desired variant and cloning DNA. Our customers in this market segment are predominantly small-scale
synthetic DNA users, which typically include emerging biopharmaceutical companies, academic institutions and research organizations. We estimate our market opportunity in the DNA Maker market to be approximately $950&nbsp;million </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">110 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">with estimated annual growth of approximately 10%. Our market estimate is based on the market sizes for products
used in manual DNA synthesis, including the cloning and restriction digestion enzyme market in 2016, according to a report on Molecular Biology by Markets and Markets. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Cloning one gene is a cumbersome process which typically involves 11 discrete steps and generally takes around 4 - 10 business days to complete. However, most small scale researchers have historically made their
own DNA due to the prohibitively high cost of purchasing synthetic DNA in small batches. Given the inefficiency of making DNA, we are increasingly seeing DNA Makers transition to DNA Buyers as we provide broader access to affordable DNA. In
addition, as we increase the size of the DNA that we offer, we expect to convert certain researchers who are both DNA Buyers and DNA Makers that buy multiple genes and stitch them together for longer constructs. We also expect the implementation of
our intuitive <font style="white-space:nowrap">e-commerce</font> platform to provide enhanced access to the relatively untapped market of DNA Makers. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We
believe that the DNA synthesis market is in the early stages of a growth acceleration that is similar to the growth experienced by the DNA sequencing industry over the last two decades, where initial demand was severely limited by the high cost and
time required to sequence genes. The Human Genome Project, which resulted in the sequencing of the full human genome in 2003, cost $2.7&nbsp;billion in government funding. At that time, the cost to sequence an entire genome was $50&nbsp;million. An
enormous reduction in cost was required before human genome sequencing could realistically be used as a medical research tool. With innovation in sequencing technology, the first $1,000 genome was achieved in 2014, and costs are significantly lower
today. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As the cost of sequencing has decreased, both the size of the market and the number of applications have expanded exponentially. Over the last
five years, the market size has more than doubled. DeciBio LLC estimates that by 2016 the total market for sequencing technology had grown to approximately $2.4&nbsp;billion and expects the market to continue to grow at 17% annually to approximately
$4.5&nbsp;billion by 2019. We believe the synthetic DNA market is undergoing a comparable transformation. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Products for next generation sequencing
applications (exome and custom capture tools) </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our NGS products target a market opportunity for NGS sample preparation that was approximately
$500&nbsp;million in calendar year 2016 and growing at approximately 20% annually, according to market research provided by Kalorama Information, a division of marketresearch.com. As the cost of sequencing genes has decreased significantly, the
applications of sequencing and the utilization of sequencing technology has increased rapidly. Today, sequencing is used in many fields, including the study of population genetics to discover disease specific markers and the diagnosis of
patient-specific mutations. However, in many cases, the sequencing of an entire genome is undesirable and custom targeted sequencing, which focuses on specific regions of the genome, is preferable, as it results in a lower cost per sample and deeper
coverage. For example, cancer samples are notoriously heterogeneous, and sequencing them multiple times to achieve the desired result, otherwise known as deep sequencing, would be too costly using whole genome sequencing. Similarly, a growing
clinical application for cancer treatment called minimal residual disease analysis requires following the evolution of a few genetic locations to instruct physicians when they have successfully managed the disease and can stop therapy. In this
application, and many others, it is significantly more cost-effective to use exome sequencing and custom targeted sequencing rather than whole genome sequencing. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are focused on addressing the demand for better sample preparation products that improve the sequencing workflow, increase sequencing accuracy and lower sequencing costs. We offer kits consisting of
double-stranded DNA probes and a comprehensive set of reagents that are used for exome sequencing and custom targeted sequencing. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">111 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Pharmaceutical biologics drug discovery </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the field of pharmaceutical biologics drug discovery, we believe our platform can significantly accelerate the time it takes researchers to go from target identification to an IND application. We believe the
integral role of synthetic DNA in the drug discovery and development process along with our DNA synthesis platform uniquely positions us to capture a larger portion of this value chain. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the initial stages of drug development, our oligo pools can be used to increase the probability of identifying a specific drug target. Our genes and gene fragments can be used to validate the specific function
of this drug target. Our DNA libraries can be used in the drug discovery process to identify high value biological therapeutic drug leads. As a biological lead moves towards clinical development, our genes, gene fragments, and antibody libraries can
again aid in the lead optimization process. In the clinic, our NGS target enrichment offering may also play a role in patient selection and stratification. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Through our partnership with Distributed Bio, we are beginning to generate proprietary content in biologics with an initial focus on G-protein-coupled receptors, or GPCRs. We also are seeking to establish
partnerships to develop content related to additional target areas with other pharmaceutical companies. </font></p> <p style="margin-top:8px;margin-bottom:0px;padding-bottom:0px; "><font style="font-family:arial" size="2">Current antibody discovery
and development methods rely on the creation of very large number of antibody variations (approximately &gt;10</font><font style="font-family:arial" size="1"><sup style="vertical-align:baseline; position:relative; bottom:.8ex">10</sup></font><font style="font-family:arial" size="2">) in a format that can be screened, or tested, rapidly. These libraries consist of DNA sequences expressed into proteins (antibodies) and screened for desired functions which usually requires multiple iterations of
designing, constructing and testing antibodies. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Today, many of our pharmaceutical and biotechnology customers use random mutagenesis to generate
diversity in their antibody libraries. Random mutagenesis has the following disadvantages: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">The random mutations created through this process may not be found in the human body and therefore may be unlikely to behave well in a clinical setting, may be
immunogenic, may aggregate or not express well </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Libraries created from random mutagenesis lack synthetic control in their fabrication and therefore are incapable of enabling researchers to systematically
explore changing to individual DNA bases across the DNA sequence and the impact on the antibody </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In contrast to the traditional library
synthesis methods described above, we are leveraging our DNA synthesis platform to precisely control the design and synthesis of the library, changing each base individually, rather than each codon (group of three bases), creating controlled,
predictable library diversity. We believe this will allow researchers to explore the desired sequence variations and combinations desired to facilitate their discovery efforts more effectively. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>DNA data storage R&amp;D </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Due to the explosion of data
across many industries, finding efficient means of storage has become more important. Through the Semiconductor Research Corporation, many leading semiconductor companies, including Microsoft Corporation, IBM Corporation, Micron Technology, Inc.,
Autodesk Inc., Mentor Graphics Corporation and GlobalFoundries Inc., are exploring DNA as a data storage medium. The market for digital data storage, including solid-state disk, magnetic disk, magnetic tape and optical disc storage, is currently
estimated at over $35 billion. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">While DNA is currently too expensive for routine storage, we believe that our modern, silicon-based process to synthesize
DNA has the potential to make DNA cost-competitive with additional research and development efforts. If the cost of writing and reading data in DNA becomes equivalent to or lower than magnetic tape, we believe DNA will have the advantage in serving
several data storage markets, including the storage of deeply cold data, in particular the WORN (Write Once, Read Never) and WORSE (Write Once, Read Seldom if Ever) </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">112 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
markets, and the market for digital preservation where latency and the cost of reading the data are minor considerations. Typical <font style="white-space:nowrap">end-markets</font> for these
storage applications include the media and entertainment industries, healthcare/pharmaceutical record storage, cultural/heritage organizations, scientific data records storage, intelligence/defense information, and libraries/museum collections.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Through our relationship with Microsoft Corporation and the University of Washington, we have demonstrated the feasibility of storing data on DNA and
the unique benefits of longevity, density, and universality of this format. We believe that over time our technology will develop to allow data storage in DNA to become cost competitive with traditional data storage media, which is necessary to
enable us to target several large markets within data storage. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In order to reduce the cost of synthesizing DNA, we are focused on innovating our
proprietary platform to synthesize DNA at an even higher throughput, moving from a platform capable of storing megabytes of data to a platform capable of storing terabytes of data. Taking into account trends and internal projections for the cost of
synthesizing oligo pools, sequencing price, hard drive price and tape price, we believe new DNA technologies and cost efficiencies could surpass mature information technology hardware solutions in three to five years. We are employing advanced
techniques from the semiconductor industry to further miniaturize the chemistry and fluid movement to pursue this opportunity. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Complementing the
reduction in cost for making DNA, we are also developing a system to manage the data flow; that is, from binary data to DNA and back to binary data. The equivalent of a computer operating system, it will be responsible for accessing a digital data
file of 0s and 1s, applying an encoding scheme to convert the digital data into DNA sequences for synthesis and storage, and, after the stored DNA is sequenced, applying a decoding scheme to retrieve the original digital data file. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Commercial strategy, sales and distribution </u></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have
built a scalable commercial platform with a multi-channel strategy designed to address a diverse customer base consisting of an estimated more than 100,000 synthetic DNA users today. This platform is comprised of a direct sales force and an <font style="white-space:nowrap">e-commerce</font> platform. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our sales force is focused on customer acquisition, support, and management and is highly trained
on both the technical aspects of our platform and how synthetic DNA is used in a wide range of industries. Their goal is to articulate our value proposition, drive pilot programs and increase the adoption of our product offerings while maintaining
close working relationships with customers. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In January 2018, we launched our multi-channel commercial strategy through our proprietary, innovative, and <font style="white-space:nowrap"><font style="white-space:nowrap">easy-to-use</font></font> <font style="white-space:nowrap">e-commerce</font> platform to current customers. Based on initial usage data, we believe that this
<font style="white-space:nowrap">e-commerce</font> platform will enhance the productivity of our sales force and expand our customer reach by allowing customers to design, validate, and place <font style="white-space:nowrap">on-demand</font> orders
of customized DNA online. We have built our <font style="white-space:nowrap">e-commerce</font> platform to allow our customers to receive real-time customized quotes for their sequence as well as track their order status through the manufacturing
and delivery process, providing them improved flexibility to plan their budgets and internal timelines. This platform is a critical part of our strategy to address our potential large and diverse customer base, as well as drive commercial
productivity, enhance the customer experience and promote loyalty. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We target customers of our NGS products through a direct sales team focused on the
NGS tools market and which is separate from our synthetic DNA sales force. We launched early commercial access for our NGS sample preparation tools to select customers in August 2017. Our direct NGS sales representatives are focused on supporting
our early adopters and providing a high level of service in order to familiarize customers with our </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">113 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
product offering. In the first half of fiscal year 2019, we plan to initiate a full commercial launch for NGS customers including a specific application of our
<font style="white-space:nowrap">e-commerce</font> platform for customized NGS sample preparation kits in order to drive adoption by the broader diagnostic community. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For our antibody discovery efforts, under the guidance of two experienced executives, we are building a team of scientists to conduct library screening and optimization services. We intend to leverage our DNA
synthesis platform to create antibody libraries for these purposes, and initiate partnering activities initially for enabling technology. Subsequently, we intend to establish partnerships with biotechnology and pharmaceutical companies to identify
and/or optimize novel antibody candidates. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe that the market for storing digital data on DNA will be one that evolves based on the unique
features (durability, small size, readability and low energy maintenance requirements) of DNA, similar to the way flash memory created its own market segment. Initially, we intend to pursue items of significance including cultural heritage projects
(i.e. Montreux Jazz Festival archives) as well as government needs. We intend to pursue very long-term storage opportunities for both of these market segments initially - the WORN and WORSE data - and then expand into shorter term projects as the
technology and market demands. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Our customers </u></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our products serve the needs of customers across multiple growing end markets. We categorize our customers as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><b><i>Healthcare</i></b> companies include pharmaceutical, biotechnology and diagnostics companies that utilize synthetic biology in target discovery, target
validation, drug discovery, drug development, manufacturing, clinical trial stratification, DNA sequencing and diagnostics. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><b><i>Industrial Chemical</i></b> companies that apply synthetic biology to increase the use of cost-effective and sustainable, specialty chemicals and raw
materials, as well as new protein-based and protein-inspired chemicals and materials that are inaccessible through traditional industrial organic chemistry. </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><b><i>Agriculture</i></b> customers include companies that apply synthetic biology to improve crop traits, increase resistance to existing and emerging diseases,
increase resistance to extremes of weather and replace oil and natural <font style="white-space:nowrap">gas-derived</font> fertilizer with synergistic bacteria, leading to better food security and nutrition. </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><b><i>Academic Research</i></b> customers include institutions that perform research across a wide range of applications, both basic and applied. For purposes of
financial reports, we consider the customers we are working with to develop long-term data storage applications using DNA as part of this category. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For the year ended September 30, 2017, the composition of our revenue by customer type was as follows: healthcare revenue of $1.2&nbsp;million, industrial chemicals revenue of $6.7&nbsp;million, agriculture revenue
of $0.1&nbsp;million and academic research revenue of $2.7&nbsp;million. </font></p> <p style="font-size:0px;margin-top:0px;margin-bottom:0px">&nbsp;</p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<p style="margin-top:0px;margin-bottom:0px" align="center">


<img src="./S-1_files/g460243g85b70.jpg" alt="LOGO">
 </p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">114 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, for the nine months ended June 30, 2018, the composition of our revenue by customer type was as
follows: healthcare revenue of $0.03&nbsp;million, industrial chemicals revenue of $12.4&nbsp;million, agriculture revenue of $0.4&nbsp;million and academic research revenue of $4.2&nbsp;million. </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p> <p style="margin-top:0px;margin-bottom:0px" align="center">


<img src="./S-1_files/g460243g54i45.jpg" alt="LOGO">
 </p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The benefits and versatility of our platform are exemplified by our expanding relationships with various partners across a
variety of customers and end markets, for example: </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Ginkgo Bioworks </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe Ginkgo Bioworks is the largest purchaser of synthetic DNA globally. Ginkgo Bioworks, the organism company, is bringing biotechnology to consumer goods markets, enabling fragrance, cosmetic, nutrition,
food, agriculture and pharmaceuticals to make better products. Ginkgo Bioworks also recently partnered with Bayer to form a new company focused on sustainable agriculture. We began working with Ginkgo Bioworks as one of our initial commercial
customers in 2015. In March 2016, we signed an agreement with Ginkgo Bioworks to supply up to 100 million base pairs of DNA, which we believe accounted for approximately 10% of the total synthetic DNA market at the time. In March 2018, we signed a
new agreement with Ginkgo Bioworks to supply to Ginkgo Bioworks up to approximately 1.3 billion base pairs over a period of four years, which we believe is the largest volume supply commitment in the industry. This new agreement can only be
terminated unilaterally by Ginkgo Bioworks if we undergo a change of control with certain specified parties or commit a material breach of the new agreement. This new agreement may be terminated unilaterally by us if Ginkgo Bioworks fails to place
orders for more than a certain percentage of specified quarterly minimums for two consecutive quarters or commits a material breach. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Top 3
pharmaceutical company </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For the last two years we have been working closely with one of the top three pharmaceutical companies by revenue,
generating bespoke synthetic antibody libraries with ratio controlled amino acid representation at defined positions. Workflow optimization has enabled us to bring the turn-around time for library delivery down to four weeks with no compromise on
quality. Outsourcing to us has freed up valuable researcher time for the pharmaceutical company’s collaborators, enabling downstream assay development to occur in parallel to library synthesis. In addition, our platform has allowed this company
to avoid library enrichment with carry over parental template during the selection process, which can present an issue with more traditional methods of primer-based amplification and assembly. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Syngenta AG </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In 2016, Syngenta AG, or Syngenta, a leading agricultural technology company, placed an
order to purchase both genes and libraries for research into pesticide resistance. We have been able to offer these&nbsp;genes and&nbsp;libraries at very competitive prices while maintaining high-quality standards that allow Syngenta to
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">115 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
improve their research and development process. Syngenta has continued to increase the volume and diversity of products they order from us, consistent with our increase in
capabilities.</font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Case studies demonstrating conversion of makers to buyers </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Centre for the Commercialization of Antibodies and Biologics </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Since August 2016, we have been working
with the Centre for the Commercialization of Antibodies and Biologics (CCAB), which is taking promising therapeutic compounds and providing initial validation and <font style="white-space:nowrap">scale-up</font> services for these molecules prior to
licensing them to biotechnology companies. CCAB was attracted to us because of our low price for their genes of interest and our ability to supply these genes in CCAB’s own vector systems. Importantly, CCAB decided not to hire additional staff
for cloning, given their satisfaction with our products, which allowed them to focus staffing resources on other aspects of development within their lab. Given their positive experience, CCAB has continued to expand their business with us and has
referred other Toronto academic laboratories to us. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Antibody drug development company </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are working with an antibody drug development company that develops fully human antibody drugs, who uses our synthetic genes for some of its antibody discovery
and development. They find that they are able to make better therapeutics using a targeted synthetic approach and have switched to buying synthetic DNA from us. They continue to order larger quantities of our DNA over time. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><u>Competition </u></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our markets are characterized by significant
technological changes, frequent new product introductions and enhancements, and evolving customer demands. We face competition from a broad range of providers of core synthetic biology products such as GenScript Biotech Corporation, GENEWIZ, Inc.,
Integrated DNA Technologies, Inc., DNA 2.0 Inc. d/b/a ATUM, GeneArt (owned by Thermo Fisher Scientific Inc.), Eurofins Genomics LLC, <font style="white-space:nowrap">Sigma-Aldrich</font> Corporation (an indirect wholly owned subsidiary of Merck
&amp; Company, Inc.), Promega Corporation, OriGene Technologies, Inc., Blue Heron Biotech, LLC and others. Additionally, we compete with both large and emerging providers in the life sciences tools and diagnostics industries focused on sample
preparation for next generation sequencing such as Thermo Fisher Scientific Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Agilent and Roche NimbleGen, Inc. In the antibody discovery market, we compete with clinical research organizations,
such as LakePharma, Inc. (mouse hybridoma, llama immune libraries, XOMA phage display library) and Aldevron, LLC (genetic mouse immunization coupled with hybridoma), and antibody discovery biotechnology companies, such as Iontas Ltd (human phage
display libraries, human phage display library focused on ion channels), Adimab, LLC (human synthetic yeast display libraries), and Distributed Bio (human synthetic phage display library, lead optimization libraries). In the field of DNA digital
data storage, we compete with Catalog Technologies, Inc., ETH Zurich, Helixworks Technologies Limited, Iridia, Inc., North Shore Bio and Roswell Biotechnologies. Many of our competitors have greater financial, technical, research and/or other
resources than we do. They may also have larger and more established manufacturing capabilities and marketing, sales, and support functions. The competition is intense within this market and we believe that the principal defining factors driving
competition in our market will continue to be quality, cost, throughput and scalability, turnaround time, product offering and complexity, reliability, <font style="white-space:nowrap">e-commerce</font> capabilities, customer satisfaction and
convenience. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe that we compete favorably against our competitors based on our proprietary, integrated DNA synthesis platform, which enables us
to achieve high levels of quality, precision, automation, and manufacturing throughput at a significantly lower cost as compared to our competitors. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">116 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">In order for us to successfully compete against others in our industry, we will need to continue to demonstrate
that our products deliver superior performance and value as a result of these key differentiators, and continue to expand the breadth and depth of current and future products and applications. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We also believe that as a large-scale participant in the industry, we have gained experience and brand recognition across the sectors in which we operate, and have achieved a competitive advantage over existing
market participants and new entrants. These advantages include: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i>Substantial capital investment</i>—As of August 31, 2018, we had raised a total of $291.5&nbsp;million in gross proceeds from the sale of equity
securities and we have in turn made substantial capital investments in our disruptive DNA synthesis platform. We believe we are the first and only company to harness the highly scalable production and processing infrastructure of the semiconductor
industry to industrialize the production of a wide range of synthetic DNA-based products, we believe we are significantly ahead of current and future competitors. </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i>Economies of scale</i>—Customers are usually price sensitive and economies of scale allow providers to reduce production costs which result in lower
pricing for customers. When more genes are produced on a larger scale yet with fewer input costs, as we are able to do with our DNA synthesis technology, economies of scale are achieved. </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i>Accumulated technical <font style="white-space:nowrap">know-how</font> and operational expertise</i>—The synthetic biology industry is characterized by
rapid and significant changes in technologies and requires precision, years of accumulated technical <font style="white-space:nowrap">know-how</font> and operational expertise. Our senior executive team has an average of over 25 years of experience
across the synthetic biology, semiconductor, software and pharmaceutical industries. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i>Biotechnology expertise and research and development talent</i>—Because the synthetic biology industry requires continuous innovation to keep up with
emerging new technologies, the productivity and success of providers’ research and development is highly dependent on the quality and quantity of the employees and consultants recruited and the ability of executive management.
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i>Strong brand and market recognition</i>—Customers generally select well-recognized providers with proven technology for large-scale and
technically-demanding projects. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i>Customer experience</i>—Customers value an intuitive, seamless <font style="white-space:nowrap">e-commerce</font> experience to simplify and automate the
purchase process as well as electronic integration to their own procurement systems. Customers also value quality customer service which we believe we satisfy with our multi-channel commercial approach and direct sales force.
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><i>Patents</i>—We have developed a comprehensive portfolio of issued patents and patent applications that cover our commercial products and technologies in
development. Our patent strategy includes each aspect of our technology, from hardware to <font style="white-space:nowrap">e-commerce</font> to DNA storage, in order to create robust intellectual property barriers to entry for competitors.
</font></p></td></tr></tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Suppliers </u></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We procure
the raw materials we utilize in our production process from a number of different suppliers. Although most of the raw materials required for our business are typically readily available, we rely on one single source supplier for a critical component
of our production process. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Pursuant to a supply agreement, FUJIFILM Dimatix, Inc., or FUJIFILM, is our single source supplier, for specialized print
heads and related jetting assemblies which we use as part of our DNA synthesis platform. The FUJIFILM supply agreement has an effective date of November 5, 2015 for a term of 10 years, which term will
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">117 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
thereafter be automatically extended by one year on each anniversary of the effective date unless either party notifies the other party 90 days prior to the anniversary that the agreement will
terminate on the last day of the then current renewal period. The materials obtained pursuant to the agreement are obtained on a purchase order basis, and the agreement has no minimum requirements on either side, although we provide FUJIFILM
six-month rolling forecasts detailing our expected product requirements. As of May 31, 2018, we had a reserve of FUJIFILM products which we estimate should last us approximately two years at our current usage rate. We estimate that it would take us
approximately nine months to locate and validate an alternative supplier of the products we currently purchase from FUJIFILM. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We do not have long-term
supply agreements with most of our suppliers but secure our raw materials on a purchase order basis. Because most of the raw materials used in our business are readily available in the market from many suppliers, we believe that we can within a
reasonable period of time make satisfactory alternative arrangements in the event of an interruption of supply from any vendor. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We procure various raw
materials such as reagents, plastic lab ware, and spare parts for use in our DNA synthesis process and we use reagents, plastic lab ware, and packaging in our gene production service. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For fiscal 2016 and fiscal 2017, our cost of raw materials accounted for approximately 27% and 30%, respectively, of the total cost of sales. For the nine months ended June 30, 2018, the costs of our raw materials
accounted for approximately 30% of the total costs of sales. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our procurement department manages our raw materials inventory levels by monitoring our
sales orders, production and manufacturing output, purchase orders and <font style="white-space:nowrap">e-commerce</font> requests. We typically advise our suppliers of our needs one to three months in advance and we procure raw materials on a
monthly basis while maintaining one to two months’ worth of inventory. We procure raw materials for our customized services and products on an <font style="white-space:nowrap">as-needed</font> basis. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We select our suppliers based on the following: technology, quality, delivery, cost, and service. Performance of raw materials from suppliers is monitored at least
every six months using data from incoming inspection, <font style="white-space:nowrap">non-conformance</font> reports, service reports, <font style="white-space:nowrap">on-time</font> delivery reports and customer complaints. Any quality or
performance issues are addressed via a quality management conference call or an <font style="white-space:nowrap">on-site</font> supplier audit. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We pay
for our purchases in cash or on credit and in some cases, we prepay for our purchases. Credit terms with our suppliers range between 30 and 90 days. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Manufacturing </u></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our manufacturing facilities are
located at our headquarters in San Francisco and in South San Francisco, California. We currently manufacture all of our products and multiple <font style="white-space:nowrap">sub-assemblies</font> at these facilities. As of June&nbsp;30, 2018, we
had 88 full-time employees dedicated to manufacturing our synthetic genes, oligo pools, NGS tools, and DNA libraries. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">All of our products originate from
synthetic DNA obtained from nanostructured clusters fabricated on our proprietary silicon technology platform. As of July 31, 2018, we have the capacity to synthesize oligos on more than 184,000 nanostructured clusters per month, which corresponds
to approximately 230,000 <font style="white-space:nowrap">96-well</font> plates on the legacy equipment used by our competitors. Our DNA synthesis process has been meticulously fine-tuned to yield high-quality DNA. In July 2018, we had an average
error rate, of one error per 1,000 DNA bps, which we believe is a significantly lower rate than our competitors. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have also built a large-scale
parallel process that transforms nanostructured clusters into synthetic genes (clonal and <font style="white-space:nowrap">non-clonal)</font> using a mix of proprietary and <font style="white-space:nowrap">over-the</font> counter-laboratory
equipment. Synthetic genes </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">118 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
are an <font style="white-space:nowrap">on-demand</font> product for which customers increasingly demand fast turnaround time. We have enhanced our manufacturing capabilities and we expect to
reduce turnaround time on large commercial quantities of genes (i.e., orders of over 15,000 per month) to 10&nbsp;business days. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Due to its <font style="white-space:nowrap">on-demand</font> nature, the gene synthesis business requires manufacturing operations to be in operation 24 hours a day, seven days a week, 365 days per year. For synthetic genes, we have built a highly scalable gene
production process with what we believe is industry-leading capacity of more than 45,000 genes per month to address the growing demand of scalable, high-quality, affordable synthetic genes. In July 2018, we only utilized approximately a third of
this production capacity for synthetic genes and oligos. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition to synthetic genes, we are combining nanostructured clusters into oligo pools. If
our production was dedicated entirely to the oligos, we currently have the capacity to produce more than 20&nbsp;million high-quality oligos per month that can be combined into high-precision oligo pools of various sizes. The pooling process has
been fully automated through a mixture of custom proprietary and <font style="white-space:nowrap"><font style="white-space:nowrap">over-the-counter</font></font> liquid handling equipment. We are currently only utilizing approximately a third of
this production capacity for synthetic genes and oligos. We intend to increase our shipments to leverage our production capacity through our <font style="white-space:nowrap">e-commerce</font> platform, which we believe will expand both our market
opportunity and our customer base. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The manufacturing process for our NGS tools is highly flexible and scalable and requires minimal fixed costs and
direct labor given the efficiency of our production capability. We have automated the entire workflow using proprietary and <font style="white-space:nowrap"><font style="white-space:nowrap">over-the-counter</font></font> laboratory equipment. We
have built dedicated production capabilities for our NGS products, which began operation in October 2017. We plan to have the full NGS workflow International Organization for Standardization 13,485 certified in 2018 to comply with diagnostic
industry regulatory requirements. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Over time, to further improve our production process, we intend to outsource various
<font style="white-space:nowrap">sub-assemblies</font> to third-party manufacturers. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Research and development </u></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June 30, 2018, we had 56 full-time employees dedicated to research and development. Of these employees, 26 hold advanced degrees in engineering and biology or
other sciences, including either a Ph.D. or master’s degree. We incurred expenses of $19.2&nbsp;million expenses for the year ended September&nbsp;30, 2017 on research and development activities. Our primary research and development operations
are located in leased laboratory facilities in San Francisco and South San Francisco, California. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Intellectual property </u></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our core technology originated as a collaboration between two of our <font style="white-space:nowrap">co-founders,</font> Bill Banyai, Ph.D., and Bill Peck, Ph.D.,
based on the idea that the synthetic DNA market could be revolutionized through a new oligonucleotide synthesis and gene assembly technology. Applying their engineering expertise, Drs. Banyai and Peck conceived—and later refined through
collaboration with several of our other accomplished researchers and engineers—innovative silicon-structure based technologies and other innovations for synthesizing nucleic acids that allowed for the manufacture of DNA at greater yields than
existing technology allowed. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our patent strategy is to seek broad patent protection on new developments in nucleic acid synthesis technology and then
later file patent applications covering new implementations of the technology and downstream applications utilizing the technology. As part of our strategy, we include each aspect of our technology, from hardware to
<font style="white-space:nowrap">e-commerce</font> to DNA storage, in order to create robust intellectual property barriers to entry for competitors. As these technologies are implemented, we file new patent applications
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">119 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
covering scientific methodology enabled by our technology. Additionally, where appropriate, we file new patent applications covering instrumentation and software that are used in conjunction with
our systems for oligo synthesis and gene assembly. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have developed our own comprehensive portfolio of issued patents and patent applications that
cover each step of our commercial products and technologies in development. For example, in part because of our pioneering development efforts in the field of nucleic acid libraries, we have six issued patents and many patent applications pending
relating to different aspects of our technology including our devices, our low error rate for oligo synthesis, our large, accurate nucleic acid libraries and their synthesis. We have additional patent filings directed to nucleic acid design and
ordering, devices for low error rate nucleic acid synthesis, nucleic acid based data storage, and diversified biologics encoding libraries. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June
30, 2018, we own nine issued U.S. patents and two issued international patents in China. We have 81&nbsp;pending patent applications, including 39 in the United States, 31 international applications and 11 applications filed under the Patent
Cooperation Treaty. The U.S. issued patents expire between 2034 and 2036. The term of individual patents depends upon the legal term of the patents in the countries in which they are obtained. In most countries in which we file, the patent term is
20 years from the date of filing the <font style="white-space:nowrap">non-provisional</font> application or PCT application. In the United States, a patent’s term may be lengthened by patent term adjustment, which compensates a patentee for
administrative delays by the USPTO in granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier-expiring patent. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The
patent positions of companies like ours are generally uncertain and involve complex legal and factual questions. Our patents may not enable us to obtain or keep any competitive advantage. Our pending U.S. and foreign patent applications may not
issue as patents or may not issue in a form that will be advantageous to us. Any patents we have obtained or do obtain may be challenged by <font style="white-space:nowrap">re-examination,</font> opposition or other administrative proceeding, or may
be challenged in litigation, and such challenges could result in a determination that the patent is invalid. In addition, competitors may be able to design alternative methods or devices that avoid infringement of our patents. To the extent our
intellectual property protection offers inadequate protection, or is found to be invalid, we are exposed to a greater risk of direct competition. If our intellectual property does not provide adequate protection against our competitors’
products, our competitive position could be adversely affected, as could our business. Both the patent application process and the process of managing patent disputes can be time consuming and expensive. Furthermore, the laws of some foreign
countries may not protect our intellectual property rights to the same extent as do the laws of the United States. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition to pursuing patents on
our technology, we have taken steps to protect our intellectual property and proprietary technology by entering into confidentiality agreements and intellectual property assignment agreements with our employees, consultants, corporate partners and,
when needed, our advisors. Such agreements may not be enforceable or may not provide meaningful protection for our trade secrets or other proprietary information in the event of unauthorized use or disclosure or other breaches of the agreements, and
we may not be able to prevent such unauthorized disclosure. Monitoring unauthorized disclosure is difficult, and we do not know whether the steps we have taken to prevent such disclosure are, or will be, adequate. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Legal proceedings </u></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On February&nbsp;3, 2016 Agilent
filed a lawsuit against us and our Chief Executive Officer, Ms.&nbsp;Emily Leproust, in the Superior Court of California, Santa Clara County, or the Court. The complaint also names Does 1 through 20, which are fictitious placeholder defendants. As
discussed below in more detail, Agilent has filed a motion for leave to amend its complaint, including to add two individuals as defendants, and Agilent may seek to amend its complaint to name additional defendants in the future. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">120 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Agilent’s complaint alleges three claims: (1)&nbsp;alleged breach of contract, related to the use of
confidential information and alleged breach of <font style="white-space:nowrap">non-solicitation</font> obligations against Ms.&nbsp;Leproust; (2)&nbsp;alleged breach of a duty of loyalty against Ms.&nbsp;Leproust; and (3)&nbsp;alleged
misappropriation of trade secrets under the California Uniform Trade Secrets Act, or CUTSA, against all defendants. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Agilent’s specific allegations
against Twist and Ms. Leproust are set forth in its first amended complaint, which was filed on October 31, 2016. With regard to the misappropriation claim, Agilent alleges, among other things, that Twist and Ms. Leproust misappropriated trade
secrets relating to Agilent’s oligonucleotide synthesis technology and used those secrets to develop Twist’s technology and identify personnel to hire from Agilent. With regard to the breach of loyalty claim, Agilent alleges, among other
things, that Ms. Leproust improperly withheld strategic business and technological plans from Agilent and diverted those plans to Twist instead. With regard to the breach of contract claim, Agilent alleges, among other things, that Ms. Leproust
violated her contractual obligations under her employment agreement with Agilent, including by failing to disclose the aforementioned plans and by soliciting one or more Agilent employees to terminate their employment within two years of her
resignation. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Agilent’s requested relief in its amended complaint includes: compensatory damages; injunctive relief; punitive and/or statutory
exemplary damages; a constructive trust upon allegedly misappropriated assets and gains derived from alleged breaches of agreements; and its attorneys’ fees and costs. Defendants have responded to Agilent’s allegations and asserted
numerous affirmative defenses in their answer, filed January 30, 2017, and furthermore deny Agilent’s claims have merit or entitle it to any relief. On August&nbsp;22, 2018, Agilent filed a motion for leave to amend its complaint, including to
add two individuals as defendants. On September 12, 2018, Agilent filed a supplemental declaration in support of its motion to amend, which attached a new, proposed Second Amended Complaint that revised certain allegations in paragraph 2 of the
document. The motion for leave will be heard by the Court on December&nbsp;7, 2018 and until then the First Amended Complaint remains operative. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We and
Ms.&nbsp;Leproust currently believe that we have substantial and meritorious defenses to Agilent’s claims and intend to vigorously defend our position, including through the trial and appellate stages if necessary. The outcome of any
litigation, however, is inherently uncertain and there can be no assurance that the outcome of the case or the costs of litigation, regardless of outcome, will not have a material adverse effect on our business. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We may also be subject to various other legal proceedings and claims arising in the ordinary course of business. Although occasional adverse decisions or
settlements may occur, management believes that the final disposition of such matters will not have a material adverse effect on our business, financial position, results of operations or cash flows. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Government regulation </u></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The synthetic biology industry
and our current product portfolio is largely unregulated by governmental bodies such as the FDA. Our products are also not intended to be components or incorporated into our customers’ products. Rather, our synthetic DNA products enable our
customers to develop a wide spectrum of commercial products, some of which may require governmental approval. If a customer’s product requires governmental approval, as would be the case with the development of medical diagnostics and
therapeutic drugs, it is the customer who seeks and obtains the required governmental approval to commercialize those products. However, in the future we may be subject to a variety of specialized regulatory requirements, including potential
regulation by the FDA, any of which could have a material effect on the business. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">“Research Use Only” is a term limited to our target
enrichment products for the next-generation sequencing market, and is specifically applied only to kits sold to this market segment, and is intended to restrict use of the kits to non-in vitro diagnostic purposes. The RUO label is not affixed to any
other products. Our NGS target enrichment and library preparation products are used in a more comprehensive workflow for next generation </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">121 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
sequencing. It is this larger workflow that can become an in vitro diagnostic, after undergoing the appropriate regulatory processes. As noted above, our NGS products target a market opportunity
for NGS sample preparation that was approximately $500 million in calendar year 2016 and growing at approximately 20% annually, according to market research provided by Kalorama Information, a division of marketresearch.com. This market estimate
represents the NGS target enrichment products which are limited solely to the RUO component of target enrichment and library preparation and does not include the full in vitro diagnostic workflow. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">While most of the current laws and regulations concerning synthetic biology relate to the end products produced using synthetic biology, this may change. For
example, in December 2010, the Presidential Commission for the Study of Bioethical Issues recommended that the federal government oversee, but not regulate, synthetic biology research. The Presidential Commission also recommended that the federal
government lead an ongoing review of developments in the synthetic biology field and that the federal government conduct a reasonable risk assessment before the field release of synthetic organisms. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">While we and our subsidiaries maintain regulatory compliance practices, we rely on our customers’ compliance with laws and regulations applicable to the
products they produce. We do not independently monitor whether our customers comply with applicable laws and regulations. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>FDA.</i>&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to its authority under the Federal Food, Drug, and Cosmetic Act, or the FDC Act, the FDA has jurisdiction over medical
devices. The FDA regulates, among other things, the research, testing, manufacturing, safety, labeling, storage, recordkeeping, premarket clearance or approval, marketing and promotion and sales and distribution of medical devices in the United
States to ensure that medical products distributed domestically are safe and effective for their intended uses. In addition, the FDA regulates the import and export of medical devices. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The FDC Act classifies medical devices into one of three categories based on the risks associated with the device and the level of control necessary to provide reasonable assurance of safety and effectiveness.
Devices deemed by the FDA to pose the greatest risk, such as life-sustaining, life-supporting or implantable devices, or devices deemed not substantially equivalent to a previously 510(k) cleared device are categorized as Class III. These devices
typically require submission and approval of a Premarket Approval Application, or PMA. Devices deemed to pose lower risk are categorized as either Class I or II. Class II classification usually requires the manufacturer to submit to the FDA a
premarket notification submission requesting clearance of the device for commercial distribution in the United States pursuant to Section 510(k) of the FDC Act, referred to as 510(k) clearance. Most Class I devices are exempt from this requirement,
as are some lower risk Class II devices. When a 510(k) is required, the manufacturer must submit to the FDA a premarket notification submission demonstrating that the device is “substantially equivalent” to: (i) a device that was legally
marketed prior to May 28, 1976, for which PMA approval is not required, (ii) a legally marketed device that has been reclassified from Class III to Class II or Class I, or (iii) another legally marketed, similar device that has been cleared through
the 510(k) process. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In vitro diagnostics, or IVDs, are a category of medical devices that include reagents, instruments, and systems intended for use in
diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. IVDs are intended for use in the collection, preparation, and examination of specimens
taken from the human body. A research use only, or RUO, IVD product is an IVD product that is in the laboratory research phase of development. As such, an RUO IVD is not intended for use in clinical investigations or in clinical practice. Such RUO
products do not require premarket clearance or approval from the FDA, provided that they be labeled “For Research Use Only. Not for use in diagnostic procedures” pursuant to FDA regulations. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As presently contemplated, none of our IVD products are intended for clinical or diagnostic use, and we market them to academic institutions, life sciences and
clinical research laboratories that conduct research, and biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Our current IVD </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">122 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
products are marketed and labeled as RUO, and are provided to our customers solely for their internal research use. Accordingly, we believe that our current IVD products are subject only to
limited regulation with respect to labeling by the FDA, and we have not sought clearance or approval from the FDA to market our products. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In November
2013, the FDA issued final guidance indicating that merely including the RUO labeling statement will not necessarily render the device exempt from FDA premarket clearance, approval, or other regulatory requirements if the totality of circumstances
surrounding the distribution of the product indicate that the manufacturer intended its IVDs for diagnostic use. Such circumstances may include, but are not limited to, the product’s advertising, labeling, or promotion, or the
manufacturer’s assistance of a clinical laboratory in validating or verifying a test that incorporates products labeled RUO. We do not believe any of these circumstances apply to our current product portfolio. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">While we believe that none of our current IVD products require FDA approval or clearance, we may in the future develop and commercialize a subset of our products or
related applications that could become subject to additional regulation by the FDA. If we market our products for use in performing clinical diagnostics, thus subjecting them to additional regulation by the FDA, including premarket and post market
control as medical devices, we would be required to obtain either prior 510(k) clearance or prior pre-market approval from the FDA before commercializing the product, unless an exemption applies. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">International sales of medical devices are subject to foreign government regulations, which vary substantially from country to country. Outside of the European
Union, or EU, regulatory approval needs to be sought on a <font style="white-space:nowrap"><font style="white-space:nowrap">country-by-country</font></font> basis in order to market medical devices. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>FSAP</i>.&nbsp;&nbsp;&nbsp;&nbsp;The federal Centers for Disease Control and Prevention and the Animal and Plant Health Inspection Service administer
requirements of the Federal Select Agent Program, or FSAP. FSAP requirements govern possession, use, and transfer of biological select agents and toxins that have the potential to pose a severe threat to public, animal or plant health or to animal
or plant products. It is our policy generally not to produce or otherwise work with material that is subject to FSAP requirements. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Export
controls</i>.&nbsp;&nbsp;&nbsp;&nbsp;International shipments of DNA sequences that we produce are potentially licensable under export controls, although in our experience so far exports of DNA sequences that we have produced have not required
licenses. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Given the evolving nature of our industry, legislative bodies or regulatory authorities may adopt additional regulation or expand existing
regulation to include our service. Changes to the current regulatory framework, including the imposition of additional or new regulations, could arise at any time, and we may be unable to obtain or maintain comparable regulatory approval or
clearance of our service, if required. These regulations and restrictions may materially and adversely affect our business, financial condition, and results of operations. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Facilities </u></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our principal executive offices are located in San Francisco, California, where we lease
approximately 13,000 square feet under a lease that expires in September&nbsp;30, 2019. We believe that our facilities are sufficient to meet our current needs and that suitable additional space will be available as and when needed. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><u>Our team </u></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June 30, 2018, we had 221 full-time
employees and a team of 14 dedicated commercial consultants across the European Union and United Kingdom and five dedicated commercial consultants across Asia. Of these full-time employees, 56 full-time employees are engaged in research and
development activities. None of our employees is represented by a labor union or covered by a collective bargaining agreement. We consider our relationship with our employees to be good. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">123 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_12"></a>Management </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Executive officers and directors </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The names and ages of our executive officers and directors as of August 31,
2018, are as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="26%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td valign="bottom" width="2%"></td>
<td width="64%"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Name</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Age</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Position(s)</b></font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="2"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Executive officers:</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Emily M. Leproust</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">45</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">President and Chief Executive Officer</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">William Banyai</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">63</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Chief Operating Officer and Director</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">James M. Thorburn</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">62</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Chief Financial Officer</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Mark Daniels</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">56</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">General Counsel, Secretary and Chief Ethics and Compliance Officer</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Paula Green</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">51</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Vice President of Human Resources</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Patrick Finn</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">47</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Vice President of Sales and Marketing</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Patrick Weiss</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">48</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Vice President of Operations</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Bill Peck</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">57</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Chief Technology Officer</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b><font style="white-space:nowrap">Non-Employee</font> directors:</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Robert Chess</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">61</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Director</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Paul A. Conley</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">50</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Director</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Keith Crandell</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">58</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Director</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Fredrick Craves</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">73</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Director</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Xiaoying Mai</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">30</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Director</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Robert Ragusa</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">58</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Director</font></td></tr>
<tr style="font-size:1px">
<td colspan="7" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Member of audit committee </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(2)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Member of compensation committee </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(3)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Member of nominating and corporate governance committee </font></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Executive officers </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Emily M. Leproust,
Ph.D.</i></b> has served as our President and Chief Executive Officer and as a member of our board of directors since April 2013, and she was appointed as Chair of our board of directors effective as of the effective time of this registration
statement. Prior to <font style="white-space:nowrap">co-founding</font> Twist Bioscience, Ms.&nbsp;Leproust served in various positions at Agilent most recently as its Director, Applications and Chemistry R&amp;D from February 2009 to April 2013.
Ms.&nbsp;Leproust holds a M.Sc. in Industrial Chemistry from the Lyon School of Industrial Chemistry and a Ph.D. in Organic Chemistry from the University of Houston. Our board of directors believes that Ms.&nbsp;Leproust is qualified to serve as a
director because of her operational and historical expertise gained from serving as our President and Chief Executive Officer, and her extensive professional and educational experience in the biotechnology industry. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>William Banyai, Ph.D.</i></b> has served as our Chief Operating Officer and as a member of our board of directors since February 2013. Prior to <font style="white-space:nowrap">co-founding</font> Twist Bioscience, from April 2006 to March 2013, Mr.&nbsp;Banyai was the Vice President of Hardware Engineering at Complete Genomics Inc., a life sciences company that developed and commercialized a
platform for sequencing and analyzing human genomes. Mr.&nbsp;Banyai was also previously a </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">124 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
director at Glimmerglass Networks, a supplier of SDN enabled Intelligent Optical Switching and Optical Network Management solutions. Mr.&nbsp;Banyai holds a B.S. in Physics and an M.S. in
Electrical Science from the University of Michigan, an Engineer of Electrical Engineering degree from the University of Southern California and a Ph.D. in Optical Science from the University of Arizona. Our board of directors believes that
Mr.&nbsp;Banyai’s experience as our Chief Operating Officer and extensive executive and professional experience in the biotechnology industry, as well as his previous director experience and expertise in corporate governance, qualify him to
serve as a director. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Mark Daniels</i></b> has served as our General Counsel since August 2016, as our Chief Ethics and Compliance Officer since
May&nbsp;1, 2017 and as our Secretary since September 2018. Prior to joining us, from January 2013 to May 2016, Mr.&nbsp;Daniels was at Broadcom Corporation, a semiconductor manufacturer and producer of wireless and broadband products, where his
most recent position was Vice President, Law and Deputy Chief Corporate Compliance Officer. Before that, he spent 20 years in positions of increasing responsibility in the legal department at Amgen, Inc., a producer of biopharmaceuticals, where his
last role was Vice President and Associate General Counsel. Mr.&nbsp;Daniels received his B.S. with honors in Industrial and Labor Relations from Cornell University and a J.D., cum laude, from Harvard Law School. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Patrick Finn</i></b><i>, Ph.D. </i>has served as our Vice President of Sales and Marketing since March 2015. Prior to joining us, Mr.&nbsp;Finn was Vice
President of Sales at Enzymatics Inc., a developer, manufacturer, and marketer of enzymes for molecular biology applications, sold predominantly to manufacturers in research and diagnostic markets from January 2012 to March 2015. Mr.&nbsp;Finn holds
a B.Sc. in Chemistry from Heriot-Watt University and a Ph.D. in Chemistry from the University of Southampton. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Paula Green</i></b> has served as
our Vice President of Human Resources since March 2016. Prior to joining us, Ms.&nbsp;Green was Vice President of Human Resources at Qiagen, N.V., a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and
pharmaceutical research from March 2001 to September 2015. Ms.&nbsp;Green holds a B.S. Organizational Behavior from the University of San Francisco. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Bill Peck, Ph.D. </i></b>has been our Chief Technology Officer since February 2013. Prior to <font style="white-space:nowrap">co-founding</font> Twist
Bioscience, Mr.&nbsp;Peck was the Director of Fluidic Systems at Complete Genomics Inc. from April 2008 to February 2013. Mr.&nbsp;Peck holds a B.Sc., M.Sc., and Ph.D. in Mechanical Engineering from the University of Alberta. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>James M. Thorburn </i>has served as our Chief Financial Officer since April 2018. Prior to joining us, Mr. Thorburn served as a member of the board of directors
of IXYS Corporation, a publicly traded semiconductor company from March 2007 to January 2018. Mr. Thorburn was also Chief Sales Officer and Co-Head of International at Televerde, a demand generation and sales acceleration enterprise, from August
2014 to February 2018. Prior to Televerde, he served as interim CFO of several public and private companies including Enercore, Next Autoworks, Fisker Automotive and Numonyx. Mr. Thorburn served as Chief Executive Officer of Zilog from March 2001
until August 2006. Prior to serving as Chief Executive Officer of Zilog, Mr. Thorburn held various executive positions including Chief Operating Officer of ON Semiconductor, operating consultant with Texas Pacific Group, Chief Financial Officer at
Zilog and various management positions at National Semiconductor Corporation. Mr. Thorburn holds a B.Sc. (Hons.) degree from University of Glasgow and passed the Chartered Institute of Management Accountant exams in the United Kingdom. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Patrick Weiss</i></b> has served as our Vice President of Operations since January 2014. Prior to joining us, between April 2010 and December 2013,
Mr.&nbsp;Weiss served as an outside consultant to various technology companies. Mr.&nbsp;Weiss holds an M.Sc. in Chemistry from E.T.H. Zurich. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i><font style="white-space:nowrap">Non-employee</font> directors </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Robert Chess</i></b> has served on our board of directors since July 2014.
Mr.&nbsp;Chess is Chairman of the board of directors of Nektar Therapeutics, a publicly traded therapeutics company. He has served on the board of Nektar </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">125 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
Therapeutics as either CEO and/or Chairman since 1992 and has held the Chairman position since 1999. Mr.&nbsp;Chess has also served on the board of directors of Pharsight Corp., a publicly traded
company that provides software and scientific consulting services to pharmaceutical and biotechnology companies, and CoTherix, Inc., a publicly traded biopharmaceutical company. Mr.&nbsp;Chess currently serves as a lecturer at the Stanford Graduate
School of Business, a position he has held since 2004. Mr.&nbsp;Chess holds a B.S. in Engineering with Honors from the California Institute of Technology and an M.B.A. from Harvard University. Our board of directors believes that Mr.&nbsp;Chess
brings extensive board and executive experience managing the operations of biotechnology companies, and his service on a number of public company boards provides important industry and corporate governance experience, which qualifies him to serve as
one of our directors. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Keith Crandell</i></b> has served on our board of directors since October 2013. Mr.&nbsp;Crandell is the Managing Director
of Arch Venture Corporation, a venture capital firm focused on early-stage technology companies, since 1994.&nbsp;Mr.&nbsp;Crandell is a director of several private companies and he also serves on the board of directors of Adesto Technologies Corp.,
a provider of low power, smart <font style="white-space:nowrap">non-volatile</font> memory products which is a publicly traded company and Quanterix, a publicly traded life science instrument company. Mr.&nbsp;Crandell holds a B.S. in Chemistry and
Mathematics from St. Lawrence University, an M.S. in Chemistry from the University of Texas, Arlington, and an M.B.A. from the University of Chicago. Our board of directors believes that Mr.&nbsp;Crandell brings extensive experience in the
technology industry and that his service on a number of boards provides an important perspective on operations, finance and corporate governance matters, which qualifies him to serve as one of our directors. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Frederick Craves, Ph.D.</i></b> has served on our board of directors since May 2014. Mr.&nbsp;Craves is the Founder of Bay City Capital, one of the
world’s premier life science investment firms, and has been Managing Director since its founding in September 1996. Over the course of his career, Mr.&nbsp;Craves has worked in executive management of a multinational pharmaceutical company and
founded and managed several biotech companies. He previously served on the boards of several private and public companies, including Reliant Pharmaceuticals, Medarex Pharmaceuticals and Incyte Pharmaceuticals. His current board memberships include
two publicly traded companies, Madrigal Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, where he is lead director and Dermira, Inc. a dermatological biotechnology company. Mr.&nbsp;Craves holds a B.S. in Biology from Georgetown
University, an M.S. in Biochemical Pharmacology from Wayne State University, and a Ph.D. in Pharmacology and Toxicology from the University of California, San Francisco. Our board of directors believes that in addition to his educational background,
Mr.&nbsp;Craves brings extensive experience in the biotechnology industry and his service on a number of boards of public and private companies provides an important perspective on operations and corporate governance matters, which qualifies him to
serve as one of our directors. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Paul A. Conley, Ph.D.</i></b> has served on our board of directors since July 2013. Mr.&nbsp;Conley is a Partner
and Managing Director at Paladin Capital Group, a prominent venture capital investment firm, a position he has held since November 2007. Mr.&nbsp;Conley also serves on the board of directors of many companies, several in the biotechnology and
related fields, including 10x Genomics, Inc., TOMA Bioscience, Inc., and General Automation Laboratory Technologies, Inc. Mr.&nbsp;Conley holds a B.S. in Mechanical Engineering and an M.S. in Mechanical&nbsp;&amp; Aerospace from the University of
Virginia, an M.S. in Bioengineering and a Ph.D. in Applied Physics from the University of California, San Diego. Our board of directors believes that Mr.&nbsp;Conley brings extensive experience in the biotechnology industry and his service on a
number of boards provides an important perspective on operations and corporate governance matters, as well as his education in biotechnology, which qualifies him to serve as one of our directors. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Xiaoying Mai</i></b> has served on our board of directors since July 2018. Ms. Mai is an Investment Director of GF Xinde Investment Management Co. Ltd, a
venture capital investment firm based in China that specializes in investing in biotechnology companies, a position she has held since June 2015. Ms. Mai previously served as a financial </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">126 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
manager for Guangfa Securities Co., Ltd, a publicly listed company in Hong Kong from December 2012 to June 2015, where she specialized in preparing financial information for public disclosure and
tax management.</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Ms. Mai has also served as a member of the IPSAS program-international public sector accounting standard and worked with the United
Nations in 2011. Ms. Mai holds a B.A. in Business Management from the Guangdong University of Foreign Studies and a M.A. in accountancy from George Washington University. Our board of directors believes that Ms. Mai brings extensive experience in
the biotechnology industry and her experience with the Asian markets will help us to expand into such markets, which qualifies her to serve as one of our directors. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Robert Ragusa</i></b> has served on our board of directors since February 2017. Mr.&nbsp;Ragusa is currently the Senior Vice President, Global Quality and Operations, at Illumina, Inc., a strategic commercial
partner of Twist Bioscience Corporation and a publicly traded corporation, where he has worked since December 2013. Prior to joining Illumina, Inc., from April 2010 to November 2013, Mr.&nbsp;Ragusa was Executive Vice President, Global Operations
and Service at Accuray Incorporated, a radiation oncology company that develops, manufactures, sells and supports cancer treatment solutions. Mr.&nbsp;Ragusa holds a B.S. in Biomedical and Electrical Engineering and an M.B.A. from the University of
Connecticut, and an M.S. in Biomedical and Electrical Engineering from Carnegie-Mellon University. Our board of directors believes that Mr.&nbsp;Ragusa brings extensive experience in important ecosystem partners and managing operations of large
public companies, and this, in addition to his education in biotechnology, finance and management, qualifies him to serve as one of our directors. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">There
are no family relationships among any of our directors or executive officers. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Code of business conduct and ethics </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have adopted a code of business conduct and ethics that will apply to all of our employees, officers and directors beginning on the effective date of the
registration statement of which this prospectus forms a part. Immediately prior to the effectiveness of this offering, the full text of our code of business conduct and ethics will be posted on the investor relations section of our website at
www.twistbioscience.com. We expect that any amendment to the code, or any waivers of its requirements, will be disclosed on our website to the extent required by the applicable rules and exchange requirements. The inclusion of our website in this
prospectus does not include or incorporate by reference the information on our website into this prospectus. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Board of directors </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our board of directors is currently comprised of eight members. Subject to the rights of holders of any series of preferred stock, our amended and restated bylaws
permit our board of directors to establish by resolution the authorized number of directors, and eight directors are currently authorized. Upon completion of this offering our board of directors will consist
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; members, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of whom will qualify as
“independent” under the listing standards of the Nasdaq Global Market. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Voting arrangements </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The election of the members of our board of directors is currently governed by the amended and restated stockholders agreement that we entered into with certain
holders of our common stock and certain holders of our convertible preferred stock in January 2016, as amended in March 2018, and the related provisions of our amended and restated certificate of incorporation. Pursuant to the stockholders agreement
and these provisions, Messrs.&nbsp;Banyai, Chess, Conley, Crandell, Craves and Ragusa and Mesdames Leproust and Mai have been designated to serve on our board of directors. </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Mr.&nbsp;Crandell was designated by ARCH Ventures Fund VII, LP and elected by the holders of our Series A convertible preferred stock;
</font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">127 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Mr.&nbsp;Craves was designated by Tao Invest LLC, and elected by the holders of our Series B convertible preferred stock; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Mr.&nbsp;Ragusa was designated by Illumina, Inc., and elected by the holders of our Series C convertible preferred stock; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Mr.&nbsp;Conley was designated and elected by the holders of a majority of our Series D convertible preferred stock at the time of his designation, and his
designation was approved by the holders of a majority of our common stock; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Ms.&nbsp;Mai was designated by the holders of a majority of our Series D convertible preferred stock held collectively by Ever Alpha Fund L.P. and Bay City
Capital GF Xinde International Life Sciences USD Fund, L.P. at the time of her designation, and elected by the holders of a majority of our Series D convertible preferred stock at the time of her designation; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Mr.&nbsp;Banyai was elected to the board of directors by the holders of our common stock; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Mr.&nbsp;Chess was elected to the board of directors by a majority the holders of our common stock and convertible preferred stock, each voting as a single
class; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Ms.&nbsp;Leproust was elected to the board of directors as our chief executive officer. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The holders of shares of our common stock and convertible preferred stock who are parties to our stockholders agreement are obligated to vote for such designees
indicated above. The provisions of this stockholders agreement will terminate upon the closing of this offering and our certificate of incorporation will be amended and restated, after which there will be no further contractual obligations or
charter provisions regarding the election of our directors. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our directors hold office until their successors have been elected and qualified or
appointed, or the earlier of their death, resignation or removal. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Classified board </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In connection with the closing of this offering, we will file our amended and restated certificate of incorporation which will provide that our board of directors
will be divided into three classes, with staggered three-year terms. Only one class of directors will be elected at each annual meeting of our stockholders, with the other classes of directors continuing for the remainder of their respective
three-year terms. Upon the expiration of the term of a class of directors, a director in that class will be eligible to be elected for a new three-year term at the annual meeting of stockholders in the year in which their term expires. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our directors will be divided among the three classes as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the Class&nbsp;I directors will be &nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and
&nbsp;&nbsp;&nbsp;&nbsp;, and their terms will expire at the annual meeting of stockholders to be held in 2019; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the Class&nbsp;II directors will be&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;&nbsp;&nbsp;&nbsp; and
&nbsp;&nbsp;&nbsp;&nbsp;, and their terms will expire at the annual meeting of stockholders to be held in 2020; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the Class&nbsp;III directors will be &nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp; and &nbsp;&nbsp;&nbsp;&nbsp;, and their terms will expire at the annual
meeting of stockholders to be held in 2021. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, our amended and restated bylaws and amended and restated certificate of
incorporation will provide that, subject to the rights of holders of any series of preferred stock, (i)&nbsp;only the board of directors may fill vacancies on the board of directors until the next annual meeting of stockholders and (ii)&nbsp;the
number of our </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">128 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
directors shall be fixed from time to time by a resolution of the majority of our board of directors. Any additional directorships resulting from an increase in the number of directors will be
distributed among the three classes so that, as nearly as possible, each class will consist of <font style="white-space:nowrap">one-third</font> of the total number of directors. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">This classification of the board of directors and the provisions described above may have the effect of delaying or preventing changes in our control or management. See “Description of capital
stock—Anti-takeover effects of Delaware law and our amended and restated certificate of incorporation and amended and restated bylaws.” </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Role of the board in risk oversight </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">One of the key
functions of our board of directors is informed oversight of our risk management process. Our board of directors does not have a standing risk management committee, but rather administers this oversight function directly through the board of
directors as a whole, as well as through its standing committees that address risks inherent in their respective areas of oversight. In particular, our board of directors is responsible for monitoring and assessing strategic risk exposure. Our audit
committee is responsible for reviewing and discussing our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies with respect to risk assessment and risk
management. Our audit committee also monitors compliance with legal and regulatory requirements, in addition to oversight of the performance of our external audit function. Our nominating and corporate governance committee monitors the effectiveness
of our governance guidelines. Our compensation committee reviews and discusses the risks arising from our compensation philosophy and practices applicable to all employees that are reasonably likely to have a materially adverse effect on us.
</font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Director independence </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In connection with this
offering, we are applying to list our common stock on the Nasdaq Global Market. Under the rules of the Nasdaq Global Market, independent directors must comprise a majority of a listed company’s board of directors within a specified period of
time after completion of such company’s initial public offering. In addition, the rules of require that, subject to specified exceptions, each member of a listed company’s audit, compensation, and nominating committees be independent.
Under the rules of Nasdaq Global Market, a director will only qualify as an “independent” director if, in the determination of that company’s board of directors, that director does not have a relationship that would interfere with the
exercise of independent judgment in carrying out the responsibilities of a director with the listed company. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Audit committee members must also satisfy
the independence criteria set forth in <font style="white-space:nowrap">Rule&nbsp;10A-3</font> under the Exchange Act. In order to be considered independent for purposes of <font style="white-space:nowrap">Rule&nbsp;10A-3,</font> each member of the
audit committee of a listed company may not, other than in his or her capacity as a member of such committee, the board of directors, or any other board committee: (i)&nbsp;accept, directly or indirectly, any consulting, advisory, or other
compensatory fees from the listed company or any of its subsidiaries; or (ii)&nbsp;be an affiliated person of the listed company or any of its subsidiaries. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our board of directors has undertaken a review of its composition, the composition of its committees, and the independence of each director and considered whether any director has a material relationship with us
that could compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities. Based on information provided by each director concerning his or her background, employment, and affiliations, including family
relationships, our board of directors has determined that each of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and that
each of these directors is “independent” as that term is defined under the applicable rules and regulations of the Securities and Exchange </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">129 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
Commission, and the listing standards of the Nasdaq Global Market. In making these determinations, our board of directors considered the current and prior relationships that each <font style="white-space:nowrap">non-employee</font> director has with our company and all other facts and circumstances our board of directors deemed relevant in determining their independence, including the beneficial ownership of our capital stock by
each <font style="white-space:nowrap">non-employee</font> director, and the transactions involving them described in the section titled “Certain relationships and related party transactions.” </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Committees of the board of directors </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our board of directors
has established an audit committee, a compensation committee and a nominating and corporate governance committee. The composition and responsibilities of each committee are described below. Upon completion of this offering, copies of the charters
for each committee will be available on the investor relations portion of our website at www.twistbioscience.com. Members serve on these committees until their resignations, removal or until his or her successor had been duly appointed by our board
of directors. The inclusion of our website in this prospectus does not include or incorporate by reference the information on our website into this prospectus. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Audit committee </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our audit committee is comprised of Messrs.&nbsp;Chess, Conley and Craves, and,
effective upon the completion of this offering, our audit committee will consist of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, with &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; serving as audit committee chairperson. Our board of directors has determined that each of the
members of our audit committee satisfies the requirements for independence and financial literacy under the current listing standards of the Nasdaq Global Market&nbsp;and Securities and Exchange Commission rules and regulations, including Rule <font style="white-space:nowrap">10A-3.</font> Our board of directors has also determined that &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; is an audit committee financial expert within the meaning of Item&nbsp;407(d) of
Regulation <font style="white-space:nowrap">S-K</font> of the Securities Act. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our audit committee will be responsible for, among other things:
</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">selecting a qualified firm to serve as independent registered public accounting firm to audit our financial statements; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">helping to ensure the independence and performance of the independent registered public accounting firm; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the independent
accountants, our interim and <font style="white-space:nowrap">year-end</font> operating results; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">developing procedures for employees to submit concerns anonymously about questionable accounting or audit matters; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">reviewing related party transactions; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">reviewing our policies on risk assessment and risk management; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">approving all audit and all permissible <font style="white-space:nowrap">non-audit</font> services, to be performed by the independent registered public
accounting firm; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">reviewing the audit committee report required by Securities and Exchange Commission rules to be included in our annual proxy statement.
</font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our audit committee will operate under a written charter, to be effective on the date of this offering, which satisfies the applicable
rules of the Securities and Exchange Commission and the listing standards of the Nasdaq Global Market, and which will be available on our website upon completion of this offering. All audit services to be provided to us and all permissible <font style="white-space:nowrap">non-audit</font> services, other than <i>de minimis</i> <font style="white-space:nowrap">non-audit</font> services, to be provided to us by our independent registered public accounting firm will be approved in advance by
our audit committee. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">130 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Compensation Committee </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our compensation committee is comprised of Messrs. Chess, Crandell and Craves, and, effective upon the completion of this offering, our compensation committee will consist
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
with&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; serving as compensation committee chairperson. Our board of directors has determined that each member of the compensation committee is a
<font style="white-space:nowrap">non-employee</font> director, as defined pursuant to <font style="white-space:nowrap">Rule&nbsp;16b-3</font> promulgated under the Exchange Act. Our board has determined
that&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp; and &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; meet the requirements
for independence under the listing standards of the Nasdaq Global Market and Securities and Exchange Commission rules and regulations. Our compensation committee will be responsible for, among other things: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">reviewing and approving the compensation of our chief executive officer and other executive officers; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">reviewing the compensation paid to our directors and making recommendations to our board of directors; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">reviewing, adopting, amending, and administering our equity incentive plans and granting awards to eligible persons and determining the terms of such awards;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">reviewing, approving, amending, and terminating any change in control, severance or termination agreement, plan or arrangement for our executive officers;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">reviewing in conjunction with the nominating and corporate governance committee, succession planning for our chief executive officer and other executive officers
and evaluating potential successors; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">assessing whether our compensation policies and practices create risks that are reasonably likely to have a material adverse effect on us.
</font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our compensation committee will operate under a written charter, to be effective on the date of this offering, which satisfies the
applicable rules of the Securities and Exchange Commission and the listing standards of the Nasdaq Global Market. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Nominating and corporate
governance committee </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Effective upon the completion of this offering, our nominating and corporate governance committee will consist of Messrs.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, each of whom is a <font style="white-space:nowrap">non-employee</font> member of our board of directors, with Mr.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; serving as the nominating and corporate governance committee
chairperson. Our board of directors has determined that &nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;meet the requirements for independence under the listing standards of the Nasdaq Global Market&nbsp;and Securities and Exchange Commission rules and
regulations. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our nominating and corporate governance committee will be responsible for, among other things: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">identifying, evaluating and making recommendations to our board of directors regarding, nominees for election to our board of directors, and individuals to fill
any vacancies on our board of directors, between meetings of our stockholders at which directors are to be elected; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">identifying, evaluating and making recommendations to our board of directors regarding the chairmanship and membership of each of its committees;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">considering and making recommendations to our board of directors regarding the composition of our board of directors and its committees;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">assessing the effectiveness of any diversity policy our board of directors may determine to implement; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">reviewing in conjunction with the compensation committee, succession planning for our chief executive officer and other executive officers and evaluating
potential successors; and </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">131 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">reviewing and assessing the adequacy of our corporate governance guidelines and recommending any proposed changes to our board of directors.
</font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The nominating and corporate governance committee will operate under a written charter, to be effective on the date of this offering,
which satisfies the applicable listing requirements and rules of the Nasdaq Global Market. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our board of directors may from time to time establish other
committees. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Compensation committee interlocks and insider participation </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">During fiscal 2017, our compensation committee consisted of Messrs. Chess, Crandell and Craves. None of the members of our compensation committee has at any time been one of our officers or employees. None of our
executive officers currently serves, or during fiscal 2017 has served, as a member of our board of directors or the compensation committee (or other board committee performing equivalent functions) of any entity that has one or more of its executive
officers who served on our board of directors or our compensation committee during fiscal 2017. Certain members of our compensation committee are affiliated with entities that purchased our preferred stock. Please see “Equity financings”
for more information. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Director compensation </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Historically, we have neither had a formal compensation policy for our <font style="white-space:nowrap">non-employee</font> directors, nor have we had a formal
policy of reimbursing expenses incurred by our <font style="white-space:nowrap">non-employee</font> directors in connection with their board service. However, we have reimbursed our <font style="white-space:nowrap">non-employee</font> directors for
reasonable expenses incurred in connection with their attendance at board of directors or committee meetings and occasionally granted stock options. Other than as described below, we did not provide our
<font style="white-space:nowrap">non-employee</font> directors, in their capacities as such, with any cash, equity or other compensation in fiscal 2018. Neither Emily Leproust, our President and Chief Executive Officer, nor William Banyai, our Chief
Operating Officer, received separate compensation for services as a director. Ms.&nbsp;Leproust and Mr.&nbsp;Banyai’s compensation is discussed in the section titled “Executive compensation.” </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table sets forth certain information regarding the compensation of our <font style="white-space:nowrap">non-employee</font> directors for fiscal 2018:
</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="79%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Name</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Option<br>awards<br>($)(1)(2)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total<br>($)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Robert Chess</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">208,515</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">(3)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">208,515</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Paul A. Conley</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Keith Crandell</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Frederick Craves</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Xiaoying Mai</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Robert Ragusa</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The amount reported in this column represents the aggregate grant date fair value for financial statement reporting purposes of stock options granted in fiscal 2018 under our
2013 Plan, as determined in accordance with FASB ASC Topic 718. This amount reflects our accounting expense for these stock options and does not represent the actual economic value that may be realized by each
<font style="white-space:nowrap">non-employee</font> director. There can be no assurance that this amount will ever be realized. For information on the assumptions used in valuing this award, refer to Note 15 to the consolidated financial statements
included elsewhere in this prospectus. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(2)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The number of shares underlying outstanding stock options held by each <font style="white-space:nowrap">non-employee</font> director as of September&nbsp;30, 2018, was as
follows: Mr.&nbsp;Chess (351,700); Mr.&nbsp;Conley (0); Mr.&nbsp;Crandell (0); Mr.&nbsp;Craves (0); Ms. Mai (0) and Mr.&nbsp;Ragusa (0). </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(3)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="1">This represents the grant date fair value of an option to purchase 281,360 shares of common stock granted on September 13, 2018 with an exercise price of $1.20
per share. The option grant is subject to a 4-year vesting schedule, with 10% of the shares vesting on September&nbsp;13, </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">132 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p><font style="font-family:arial" size="1">
2018, 15% of the shares vesting on March 24, 2019 and 1/48th of the shares vesting monthly thereafter, subject to continuous service through each applicable vesting date. The option has a term of
ten years. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In September 2018, our board of directors approved a non-employee director compensation policy that will become effective
upon the closing of this offering. Under this policy, we will pay our non-employee directors a cash retainer for service on the board of directors and an additional cash retainer for service on each committee on which the director is a member, which
will be paid quarterly in arrears. The chairman of each committee will receive higher retainers for such service. The fees paid to non-employee directors for service on the board of directors and for service on each committee of the board of
directors on which the director is a member are as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="82%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Member<br>Annual<br>Retainer</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" nowrap="" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Chairman<br>or Lead<br>Director<br>Annual<br>Retainer</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Board of Directors</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">40,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">60,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Audit Committee</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">16,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Compensation Committee</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">13,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Nominating and Corporate Governance Committee</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, each non-employee director elected to our board of directors following the completion of this offering will, upon the
date of his or her initial election or appointment to be a non-employee director, be granted an option to purchase a number of shares of common stock having a grant date fair value of $340,000. One-third of the shares subject to such initial option
grant will vest on each anniversary of the date of grant, subject to the director providing service through each vesting date. Further, at the close of business on the date of each annual stockholder meeting following the initial public offering,
each person who is currently and has been a non-employee director for at least three (3) months will be granted an option to purchase a number of shares of common stock having a grant date fair value of $170,000. 100% of the shares subject to such
annual option grant will vest in full on the earlier of the one year anniversary of the grant date and the next annual stockholder meeting, subject to the director providing service through the vesting date. All stock option awards to non-employee
directors following the completion of this offering are expected to be made pursuant to the 2018 Plan. For additional information, see “Executive compensation — 2018 equity incentive plan.” </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We will also continue to reimburse our non-employee directors for reasonable travel and out-of-pocket expenses incurred in connection with attending our board of
director and committee meetings. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The non-employee director compensation program is intended to provide a total compensation package that enables us to
attract and retain qualified and experienced individuals to serve as directors and to align our directors’ interests with those of our stockholders. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Board diversity </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Upon consummation of this offering, our
nominating and corporate governance committee will be responsible for reviewing with the board of directors, on an annual basis, the appropriate characteristics, skills and experience required for the board of directors as a whole and its individual
members. In evaluating the suitability of individual candidates (both new candidates and current members), the nominating and corporate governance committee, in recommending candidates for election, and the board of directors, in approving (and, in
the case of vacancies, appointing) such candidates, may take into account many factors, including, but not limited to, diversity of personal and professional background, perspective and experience; personal and professional integrity, ethics and
values; experience in corporate management, operations or finance; experience relevant to our industry and with relevant social policy concerns; experience as a board member or </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">133 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
executive officer of another publicly held company; relevant academic expertise or other proficiency in an area of our operations; practical and mature business judgment; and any other relevant
qualifications, attributes or skills. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Currently, our board of directors evaluates, and following the consummation of this offering will evaluate, each
individual in the context of the board of directors as a whole, with the objective of assembling a group that can best maximize the success of the business and represent stockholder interests through the exercise of sound judgment using its
diversity of experience in these various areas. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Limitation of liability and indemnification of directors and officers </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our amended and restated certificate of incorporation, which will become effective upon the closing of this offering, will contain provisions that limit the
liability of our directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as
directors, except liability for the following: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">any breach of their duty of loyalty to our company or our stockholders; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section&nbsp;174 of the DGCL; or </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">any transaction from which they derived an improper personal benefit. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our amended and restated bylaws, which will become effective upon the closing of this offering, will provide that we shall indemnify, to the fullest extent permitted by law, any person who is or was a party or is
threatened to be made a party to any action, suit or proceeding, by reason of the fact that he or she is or was one of our directors or officers or is or was serving at our request as a director or officer of another corporation, partnership, joint
venture, trust or other enterprise. Our amended and restated bylaws will provide that we may indemnify to the fullest extent permitted by law any person who is or was a party or is threatened to be made a party to any action, suit or proceeding, by
reason of the fact that he or she is or was one of our employees or agents or is or was serving at our request as an employee or agent of another corporation, partnership, joint venture, trust or other enterprise. Our amended and restated bylaws
will also provide that we must advance expenses incurred by or on behalf of a director or officer in advance of the final disposition of any action or proceeding, subject to very limited exceptions. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Prior to the closing of this offering, we intend to obtain insurance policies under which, subject to the limitations of the policies, coverage is provided to our
directors and officers against loss arising from claims made by reason of breach of fiduciary duty or other wrongful acts as a director or officer, including claims relating to public securities matters, and to us with respect to payments that may
be made by us to these officers and directors pursuant to our indemnification obligations or otherwise as a matter of law. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Prior to the closing of this
offering, we intend to enter into indemnification agreements with each of our directors and executive officers that may be broader than the specific indemnification provisions contained in the DGCL. These indemnification agreements may require us,
among other things, to indemnify our directors and executive officers against liabilities that may arise by reason of their status or service. These indemnification agreements may also require us to advance all expenses incurred by the directors and
executive officers in investigating or defending any such action, suit or proceeding. We believe that these agreements are necessary to attract and retain qualified individuals to serve as directors and executive officers. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">134 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The underwriting agreement provides for indemnification by the underwriters of us and our officers, directors and
employees for certain liabilities arising under the Securities Act, or otherwise. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers or persons controlling our company pursuant to the foregoing provisions, we have been informed that, in the opinion of the Securities and Exchange Commission, such indemnification is against
public policy as expressed in the Securities Act and is therefore unenforceable. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">135 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_13"></a>Executive compensation </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Overview </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As an emerging growth company, we have opted to comply with the executive compensation disclosure
rules applicable to “smaller reporting companies,” as such term is defined in the rules promulgated under the Securities Act. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our named
executive officers for fiscal 2018 were: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Emily M. Leproust, our President and Chief Executive Officer; </font></p></td></tr></tbody></table>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">James M. Thorburn, Chief Financial Officer; and </font></p></td></tr></tbody></table>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Mark Daniels, General Counsel, Secretary and Chief Ethics and Compliance Officer. </font></p></td></tr></tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Summary compensation table </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table sets forth certain information regarding the compensation of
our named executive officers for fiscal 2017 and fiscal 2018: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="42%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Name and principal position</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Year</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Salary<br>($)(1)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Bonus<br>($)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Option<br>awards<br>($)(2)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b><font style="white-space:nowrap">Non-equity</font><br>incentive&nbsp;
plan<br>compensation<br>($)(3)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="2"><b>All other</b></font></p>
<p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="2"><b>compensation<br>($)</b></font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total<br>($)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Emily M. Leproust<br><i>President and Chief Executive Officer</i></font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2018</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">362,250</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">43,107</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">405,357</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2017</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">340,001</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,445,057</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">87,150</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,872,208</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">James M. Thorburn<br><i>Chief Financial Officer (4)</i></font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2018</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">134,015</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,286,756</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,420,771</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Mark Daniels<br><i>General Counsel, Secretary and Chief Ethics and Compliance Officer (4)</i></font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2018</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">325,000</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">214,968</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">44,687</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">584,655</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="28" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The amounts reported in this column represent salary earned by each of our named executive officers in fiscal 2017 and fiscal 2018. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(2)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The amounts reported in this column reflect the aggregate grant date fair value for financial statement reporting purposes of stock options granted in fiscal 2017 and fiscal 2018
as determined in accordance with FASB ASC Topic 718. These amounts reflect our accounting expense for these stock options and do not represent the actual economic value that may be realized by each named executive officer. There can be no assurance
that these amounts will ever be realized. For information on the assumptions used in valuing these awards, refer to Note 15 to the consolidated financial statements included elsewhere in this prospectus. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(3)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Represents annual bonuses earned by each named executive officer under our annual cash incentive plan for executive officers for fiscal 2017 and fiscal 2018; provided that for
2018, the amount reflected here represents the bonus payable for the first half of fiscal 2018 and the second half bonus has not been approved yet. The amounts reported represent performance-based cash incentives earned by each named executive
officer based on the achievement of certain revenue goals and strategic objectives and the named executive officer’s target incentive compensation amount. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(4)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Fiscal 2018 is the first year as a named executive officer. </font></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">136 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Outstanding equity awards as of September&nbsp;30, 2018 </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table provides information regarding the unexercised stock options and restricted stock awards held by each of our named executive officers as of
September&nbsp;30, 2018: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="32%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td colspan="2" valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Option awards(1)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Stock awards(1)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Name</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Grant date</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="2"><b>Number
of<br>securities<br>underlying<br>unexercised<br>options (#)<br>exercisable</b></font></p> <p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="2"><b>(2)</b></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Number of<br>securities<br>underlying<br>unexercised<br>options (#)<br>unexercisable<br>(3)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Option<br>exercise<br>price or<br>per<br>share<br>purchase<br>price<br>($)(4)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Option<br>expiration<br>date</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="2"><b>Number&nbsp;of<br>shares or<br>units of<br>stock
that<br>have not<br>vested</b></font></p> <p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="2"><b>(#)(5)</b></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="2"><b>Market<br>value&nbsp;of<br>shares&nbsp;or<br>units
of<br>stock&nbsp;that<br>have not<br>vested</b></font></p> <p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="2"><b>($)(6)</b></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Emily M. Leproust</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8/7/2013</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">(7)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.04</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">N/A</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,013,171</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9/29/2015</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">(8)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">750,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">250,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.60</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9/28/2025</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9/29/2017</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">(9)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">571,275</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,713,825</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.89</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9/28/2027</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">James&nbsp;M. Thorburn</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6/7/2018</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">(10)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,750,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1.17</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6/6/2028</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td>
<td height="8" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Mark Daniels</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8/30/2016</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">(11)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">390,625</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">359,375</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.60</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8/29/2026</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9/29/2017</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">(9)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">44,775</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">134,325</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.89</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9/28/2017</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2/2/2018</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">(12)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">317,317</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1.08</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2/1/2028</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="28" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">All awards were granted under our 2013 Plan. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="1">(2)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Because all stock options granted to our named executive officers under the 2013 Plan are early exercisable, and early exercised shares are subject to a repurchase right in favor
of the Company which lapses as the option vests, this column reflects the number of options held by our named executive officers that were exercisable and vested as of September&nbsp;30, 2018. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="1">(3)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Because all stock options granted to our named executive officers under the 2013 Plan are early exercisable, and early exercised shares are subject to a repurchase right in favor
of the Company which lapses as the option vests, this column reflects the number of options held by our named executive officers that were exercisable and unvested as of September&nbsp;30, 2018. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="1">(4)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">This column represents the fair market value of a share of our common stock on the date of grant, as determined by our board of directors. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="1">(5)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The shares in this column represent shares of restricted stock issued pursuant to the exercise of a restricted stock purchase right or upon the early exercise of stock options,
in each case that remained unvested as of September&nbsp;30, 2018. We have a right to repurchase any unvested shares subject to each such award if the holder of the award ceases to provide services to us prior to the applicable vesting dates.
</font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="1">(6)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The market value of our common stock is based upon the assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="1">(7)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">All of restricted shares are subject to certain restrictions as set forth in a restricted stock purchase agreement between the named executive officer and the Company dated
September 26, 2013. The named executive officer retains the right to vote but not the right to dispose of such shares while such shares remain subject to such restrictions. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="1">(8)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The option grant is subject to a <font style="white-space:nowrap">4-year</font> vesting schedule, with 25% of the shares vesting on September&nbsp;1, 2016 and 1/48th of the
shares vesting monthly thereafter, subject to continuous service through each applicable vesting date. The option grant is also subject to a 50% single trigger acceleration provision and a 100% double trigger acceleration provision (in each case, as
described below). </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="1">(9)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The option grant is subject to a <font style="white-space:nowrap">4-year</font> vesting schedule, with 10% of the shares vesting on September&nbsp;29, 2017, 15% of the shares
vesting on September&nbsp;28, 2018 and 1/48th of the shares vesting monthly thereafter, subject to continuous service through each applicable vesting date. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="1">(10)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The option grant is subject to a <font style="white-space:nowrap">4-year</font> vesting schedule, with 25% of the shares vesting on April&nbsp;23, 2019 and 1/48th of the shares
monthly thereafter, subject to continuous service through each applicable vesting date. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="1">(11)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The option grant is subject to a 4-year vesting schedule, with 25% of the shares vesting on August 8, 2017 and 1/48th of the shares thereafter, subject to continuous service
through each applicable vesting date. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="1">(12)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">The option grant is subject to a 4-year vesting schedule, with 25% of the shares vesting on January 4, 2019 and 1/48th of the shares thereafter, subject to continuous service
through each applicable vesting date. </font></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Base salary </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We use base salaries to recognize the experience, skills, knowledge and responsibilities required of all our employees, including our named executive officers. None of our named executive officers is currently
party to an employment agreement or other agreement or arrangement that provides for automatic or scheduled increases in base salary. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">137 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Annual bonus </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have an annual objective-setting and review process for our named executive officers that is the basis for the determination of potential annual bonuses. Our board of directors reviews and approves both the
annual objectives and the payment of annual bonuses for our executives. Each of our named executive officers is eligible for annual performance-based bonuses of up to a specific percentage of their salary, subject to approval by our board of
directors or the compensation committee. The performance-based bonus is tied to a set of specified goals and strategic objectives for our named executive officers and we conduct an annual performance review to determine the attainment of such goals
and objectives. Our management may propose bonus awards to our board of directors primarily based on such review process. Our board of directors or the compensation committee makes the final determination of the achievement of both the specified
corporate and strategic objectives and the eligibility requirements for and the amount of such bonus awards. For fiscal 2017 and the first half of fiscal 2018, bonuses were paid out based on the satisfaction of certain revenue goals and strategic
objectives. The bonuses for the second half of fiscal 2018 will be paid on the same basis as prior bonuses. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Equity-based incentive awards
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our equity-based incentive awards are designed to align our interests and the interests of our stockholders with those of our employees and
consultants, including our named executive officers. Our board of directors or the compensation committee is responsible for approving equity grants to employees and consultants. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Prior to this offering, we have granted all equity incentive awards pursuant to our 2013 Plan. Following this offering, we will grant equity incentive awards under the terms of our 2018 Plan. The terms of our
equity plans are described below under “Equity incentive plans.” </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">All stock options are granted with an exercise price per share that is no
less than the fair market value of our common stock on the date of grant of each award. Our stock option awards generally vest over a four-year period and may be subject to acceleration of vesting and exercisability under certain termination and
corporate transaction events. </font></p> <p style="margin-top:8px;margin-bottom:0px;padding-bottom:0px; "><font style="font-family:arial" size="2">On September&nbsp;29, 2017, the compensation committee granted stock options to Emily Leproust to
purchase 2,285,100 shares, at an exercise price of $0.89 per share. Ten percent of the shares subject to each option grant were vested on the date of grant and 15% of the shares will vest on September&nbsp;28, 2018, and 1/48</font><font style="font-family:arial" size="1"><sup style="vertical-align:baseline; position:relative; bottom:.8ex">th</sup></font><font style="font-family:arial" size="2"> of the shares will vest on each monthly anniversary thereafter, subject to the named
executive officer’s continuous service through each applicable vesting date. On February 2, 2018 and June 6, 2018, the compensation committee granted stock options to Mr. Thorburn (1,750,000 shares at an exercise price of $1.17 per share) and
Mr. Daniels (317,317 shares at an exercise price of $1.08 per share), respectively. Each option vests as to 25% of the shares on the one year anniversary of the vesting commencement date (April 23, 2018 for Mr. Thornburn and January&nbsp;4, 2018 for
Mr. Daniels), and 1/48th of the shares will vest on each monthly anniversary thereafter, subject to the named executive officer’s continuous service through each applicable vesting date. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Employment agreements </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In connection with the offering, we entered into an amended and restated employment
agreement with each of the named executive officers, effective as of the effective time of the registration statement. These agreements provide for <font style="white-space:nowrap">at-will</font> employment and establish the named executive
officer’s base salary, eligibility to participate in an incentive bonus plan and standard employee benefits. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">These amended and restated employment
agreements also provide for certain severance payments and benefits in connection with each named executive officer’s termination of employment under various circumstances, including in connection with a change in control of the Company. The
material terms and </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">138 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
conditions of these provisions are summarized below in “—Potential Payments Upon Termination or Change in Control.” The severance and change in control benefits described below
will be in effect for <u>3</u> years from the effective date of the registration statement. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Potential payments upon termination or change in control
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Involuntary Termination of Employment Not in Connection with Change in Control </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the event that we terminate a named executive officer’s employment without “cause” or such named executive officer dies, experiences a
“disability” or resigns for “good reason,” in each case, other than in connection with or during the 12-month period following, a change in control, such named executive officer will be eligible to receive the following severance
benefits, subject to, among other things, executing a general release of claims in favor of the Company and complying with the terms of his or her confidentiality agreement: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">a cash payment equal to 12&nbsp;months of her then-current base salary in the case of Ms. Leproust and 6&nbsp;months of his then-current base salary in the case
of Mr.&nbsp;Thorburn and Mr.&nbsp;Daniels, payable in installments over such period according to our regular payroll schedule;&nbsp;and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">a pro-rata incentive bonus for the year of termination (days worked relative to 365 days) based on actual performance and paid when bonuses are normally paid.
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">COBRA premiums for a period of 12 months in the case of Ms. Leproust and 6 months in the case of Mr.&nbsp;Thorburn and Mr.&nbsp;Daniels.
</font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Involuntary Termination of Employment in Connection with Change in Control </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the event that we terminate a named executive officer’s employment without “cause” or such named executive officer dies, experiences a
“disability” or resigns for “good reason,” in each case, in connection with or during the 12-month period following a change in control, such named executive officer will be eligible to receive the following severance benefits,
subject to, among other things, executing a general release of claims in favor of the Company and complying with the terms of his or her confidentiality agreement: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">a cash payment equal to 24 months of her then-current base salary in the case of Ms. Leproust and 12&nbsp;months of his then-current base salary in the case of
Mr.&nbsp;Thorburn and Mr.&nbsp;Daniels, payable in installments over such period according to our regular payroll schedule; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">a cash payment equal to two times her average bonus for the two years prior to the termination in the case of Ms.&nbsp;Leproust and one times in the case of
Mr.&nbsp;Thorburn and Mr.&nbsp;Daniels, which will be paid pro-rata in equal installments with the cash severance; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">COBRA premiums for a period of 24 months in the case of Ms. Leproust and 12 months in the case of Mr.&nbsp;Thorburn and Mr.&nbsp;Daniels; and
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">100% immediate vesting acceleration of all of the shares of our common stock underlying any then-outstanding unvested stock options and other unvested equity
awards. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Each named executive officer’s employment agreement contains a “better after-tax” provision, which provides
that if any of the payments to an executive constitutes a parachute payment under Section 280G of the Code, the payments will either be (i) reduced or (ii) provided in full to the executive, whichever results in the named executive officer receiving
the greater amount after taking into consideration the excise tax under Section 4999 of the Code and any interest or penalties associated with such excise tax. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As defined in each named executive officer’s employment agreement, “cause” means the named executive officer’s (i) material breach of the employment agreement any other written agreement with
the Company, </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">139 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
which breach to the extent deemed curable by the board of directors is not cured within 10 business days after written notice thereof from the Company; (ii) material failure to comply with the
Company’s written policies or rules, which breach to the extent deemed curable by the board of directors is not cured within ten (10) business days after written notice thereof from the Company; (iii) repeated failure to follow reasonable and
lawful instructions from the board of directors, which failure is not cured within 10 business days after written notice thereof from the Company; (iv) commission, conviction of, or a plea of “guilty” or “no contest” to, a felony
under the laws of the United States or any state if such felony is work-related, impairs his or her ability to perform services for the Company in accordance with the employment agreement, or results in a loss to the Company or damage to the
reputation of the Company; (v) misappropriation of funds or property of the Company; (vi) gross neglect of his or her duties; (vii) act or omission that results directly or indirectly in material financial accounting improprieties for the Company;
(viii) failure to cooperate with a government investigation; or (ix) gross or willful misconduct resulting in a loss to the Company or damage to the reputation of the Company. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As defined in each named executive officer’s employment agreement, “good reason” means a resignation by the named executive officer within 90 days after one of the following conditions has come into
existence without his or her written consent: (i) a material diminution in executive’s authority, duties or responsibilities; (ii) a material reduction of executive’s annual base salary unless there is a corresponding reduction in the base
salaries of all other executive officers of the Company; or (iii) a material change in the geographic location at executive you must perform services. A condition shall not be considered “good reason” unless executive gives the Company
written notice of the condition within 30 days after the condition comes into existence and the Company fails to remedy the condition within 30 days after receiving executive’s written notice. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As defined in each named executive officer’s employment agreement, “disability” means that the named executive officer is unable to perform the
essential functions of his or her position, with or without reasonable accommodation, for a period of at least 120 consecutive days because of a physical or mental impairment. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Option agreements </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The stock option award granted to Emily Leproust on September 29, 2015, provides that
in the event of a “corporate transaction” (as defined in the 2013 Plan) that occurs during the executive officer’s service, 50% of the then unvested shares subject to the stock option shall vest as of immediately prior to such
corporate transaction. In addition, if the executive officer is terminated (A) upon the consummation of, or within 12&nbsp;months following, a corporate transaction and (B) by the Company without “cause” or by the executive officer for
“good reason” (each, as defined below), then 100% of the then unvested shares subject to the option shall immediately vest as of the date of such termination. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For purposes of the stock options granted to Emily Leproust on September 29, 2015, “cause” exists if the executive officer is terminated as a result of the following: (i)&nbsp;dishonest statements or acts
of the executive officer with respect to the Company that are materially injurious to the Company; (ii)&nbsp;commission by the executive officer of, or indictment of the executive officer for, (A)&nbsp;a felony or (B)&nbsp;a misdemeanor involving
moral turpitude, deceit, dishonesty or fraud; (iii)&nbsp;commission of an act involving a violation of material procedures or policies of the Company, which, if curable, remain uncured for more than 30 days after the executive officer’s
knowledge of such violation; (iv)&nbsp;material and sustained failure of the executive officer to perform the duties and responsibilities assigned under her or his employment agreement, which if curable, remain uncured for more than 30 days after
the executive officer is given notice of such breach; (v)&nbsp;gross negligence, willful misconduct or insubordination of the executive officer with respect to the Company or any affiliate of the Company that is materially injurious to the Company;
(vi)&nbsp;a material breach by the executive officer of any of her or his obligations under the employment agreement or any other agreement with the Company; or (vii)&nbsp;termination by the executive officer of her or his employment upon less than
60 days advance written notice. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">140 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">For purposes of the stock options granted to Emily Leproust on September 29, 2015, “good reason” means
a resignation of the employment by the applicable executive officer after the occurrence of any of the following events: (i)&nbsp;a material reduction in the executive officer’s then current base salary except in certain limited circumstances;
(ii)&nbsp;a material reduction in the executive officer’s authority, duties, or responsibilities except in certain limited circumstances; or (iii)&nbsp;a relocation of the executive officer’s principal office to a location which increases
the executive officer’s commute more than 50 miles from the location of the executive officer’s principal office. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Equity incentive plans
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>2018 equity incentive plan </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>General.</i><b><i></i></b>&nbsp;Our 2018 Equity Incentive Plan, or 2018 Plan, was adopted by our board of directors on September&nbsp;26, 2018 and approved by
our stockholders on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. The 2018 Plan will become effective on the day immediately prior to the date that the registration statement of which this
prospectus forms a part becomes effective. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Share Reserve.</i><b><i></i></b>&nbsp;The maximum aggregate number of shares that may be issued under the
2018 Plan is 57,985,208&nbsp;shares of our common stock, which number is the sum of (i)&nbsp;24,700,000 shares of our common stock plus (ii)&nbsp;any shares remaining available for issuance under the 2013 Stock Plan at the time the 2018 Plan becomes
effective, in an amount not to exceed 9,197,766&nbsp;shares, plus (iii)&nbsp;any shares subject to awards under the 2013 Plan that otherwise would have been returned to the 2013 Plan on account of the expiration, cancellation or forfeiture of such
awards following the effectiveness of the 2018 Plan, in an amount not to exceed 24,087,442&nbsp;shares. In addition, the number of shares reserved for issuance under the 2018 Plan will be increased automatically on the first day of each fiscal year,
following the fiscal year in which the 2018 Plan becomes effective, by a number equal to the least of: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">9,900,000 shares; </font></p></td></tr></tbody></table>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">4% of the shares of common stock outstanding at that time;&nbsp;or </font></p></td></tr></tbody></table>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">such number of shares determined by our board of directors. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">If an award expires, is forfeited or becomes unexercisable for any reason without having been exercised in full, or is surrendered pursuant to an exchange program, the unissued shares that were subject to the award
will, unless the 2018 Plan is terminated, continue to be available under the 2018 Plan for issuance pursuant to future awards.&nbsp;In addition, any shares which are retained by the Company upon exercise of an award in order to satisfy the exercise
or purchase price for such award or any withholding taxes due with respect to such award will be treated as not issued and will continue to be available under the 2018 Plan for issuance pursuant to future awards.&nbsp;Shares issued under the 2018
Plan and later forfeited to the Company due to the failure to vest or repurchased by the Company at the original purchase price paid to the Company for the shares (including, without limitation, upon forfeiture to or repurchase by the Company in
connection with a participant ceasing to be a service provider) will again be available for future grant under the 2018 Plan. To the extent an award under the 2018 Plan is paid out in cash rather than shares, such cash payment will not result in
reducing the number of Shares available for issuance under the 2018 Plan.</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Plan
administration</i><b><i>.</i></b><b><i></i></b>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors has delegated its authority to administer the 2018 Plan to our compensation committee. Subject to the provisions of our 2018 Plan, the administrator has
the power to determine the terms of awards, including the recipients, the exercise price, if any, the number of shares subject to each award, the fair market value of a share of our common stock, the vesting schedule applicable to the awards,
together with any vesting acceleration, and the form of consideration, if any, payable upon exercise of the award and the terms of the award agreement for use under the 2018 Plan. The administrator also has the
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">141 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
authority, subject to the terms of the 2018 Plan, to amend existing awards, to prescribe rules and to construe and interpret the 2018 Plan and awards granted thereunder and to institute an
exchange program by which outstanding awards may be surrendered in exchange for awards of the same type which may have a lower exercise price or different terms, awards of a different type and/or cash subject to stockholder approval. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Eligibility.&nbsp;&nbsp;&nbsp;&nbsp;</i>Employees, members of our board of directors who are not employees and consultants are eligible to participate in our
2018 Plan. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Types of award.</i>&nbsp;&nbsp;&nbsp;&nbsp;Our 2018 Plan provides for the grant of incentive stock options, within the meaning of
Section&nbsp;422 of the Code, to our employees and the employees of our subsidiaries, and for the grant of nonstatutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance units, and performance shares to
our employees, directors, and consultants and the employees and consultants of our subsidiaries. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Stock
options.</i><b><i></i></b>&nbsp;&nbsp;&nbsp;&nbsp;The administrator may grant incentive and/or <font style="white-space:nowrap">non-statutory</font> stock options under our 2018 Plan, provided that incentive stock options may only be granted to
employees. The exercise price of such options must generally be equal to at least the fair market value of our common stock on the date of grant. The term of an option may not exceed 10 years; provided, however, that an incentive stock option held
by a participant who owns more than 10% of the total combined voting power of all classes of our stock, or of certain of our subsidiary corporations, may not have a term in excess of five years and must have an exercise price of at least 110% of the
fair market value of our common stock on the grant date. The administrator will determine the methods of payment of the exercise price of an option, which may include cash, shares or other property acceptable to the administrator. Subject to the
provisions of our 2018 Plan, the administrator determines the remaining terms of the options (e.g.,&nbsp;vesting). After the termination of service of an employee, director or consultant, the participant may exercise his or her option, to the extent
vested, for the period of time stated in his or her option agreement. Generally, if termination is due to death or disability, the option will remain exercisable for 12 months. In the event of a termination for cause, options generally terminate
immediately upon the termination of the participant for cause. In all other cases, the option will generally remain exercisable for three months following the termination of service. However, in no event may an option be exercised later than the
expiration of its term. The maximum aggregate number of shares of our common stock that may be issued under the 2018 Plan pursuant to incentive stock options may not exceed the maximum number of shares initially reserved under the 2018 Plan and to
the extent allowable under Section&nbsp;422 of the Internal Revenue Code, or the Code, any other shares that become available for issuance or reissuance pursuant to the terms of the 2018 Plan. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Stock appreciation rights.</i><b><i></i></b>&nbsp;&nbsp;&nbsp;&nbsp;Stock appreciation rights may be granted under our 2018 Plan. Stock appreciation rights allow the recipient to receive the appreciation in the
fair market value of our common stock between the date of grant and the exercise date. Subject to the provisions of our 2018 Plan, the administrator determines the terms of stock appreciation rights, including when such rights vest and become
exercisable and whether to settle such awards in cash or with shares of our common stock, or a combination thereof, except that the per share exercise price for the shares to be issued pursuant to the exercise of a stock appreciation right will be
no less than 100% of the fair market value per share on the date of grant. The specific terms will be set forth in an award agreement. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Restricted
stock.</i><b><i></i></b>&nbsp;&nbsp;&nbsp;&nbsp;Restricted stock may be granted under our 2018 Plan. Restricted stock awards are grants of shares of our common stock that are subject to various restrictions, including restrictions on transferability
and forfeiture provisions. Shares of restricted stock will vest and the restrictions on such shares will lapse, in accordance with terms and conditions established by the administrator. Such terms may include, among other things, vesting upon the
achievement of specific performance goals determined by the administrator and/or continued service. The administrator, in its sole discretion, may accelerate the time at which any restrictions
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">142 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
will lapse or be removed. Recipients of restricted stock awards generally will have voting and dividend rights with respect to such shares upon grant without regard to vesting, unless the
administrator provides otherwise. Shares of restricted stock that do not vest for any reason will be subject to our right of repurchase or forfeited by the recipient and will revert to us. The specific terms will be set forth in an award agreement.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Restricted stock units.</i><b><i></i></b>&nbsp;&nbsp;&nbsp;&nbsp;Restricted stock units may be granted under our 2018 Plan, and may include the right
to dividend equivalents, as determined in the discretion of the administrator. Each restricted stock unit granted is a bookkeeping entry representing an amount equal to the fair market value of one share of our common stock. The administrator
determines the terms and conditions of restricted stock units, including the vesting criteria, which may include achievement of specified performance criteria and/or continued service, and the form and timing of payment. The administrator, in its
sole discretion, may accelerate the time at which any restrictions will lapse or be removed. The administrator determines, in its sole discretion, whether an award will be settled in stock, cash or a combination of both. The specific terms will be
set forth in an award agreement. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Performance units/performance shares.</i><b><i></i></b>&nbsp;&nbsp;&nbsp;&nbsp;Performance units and performance
shares may be granted under our 2018 Plan. Performance units and performance shares are awards that will result in a payment to a participant only if performance goals established by the administrator are achieved and any other applicable vesting
provisions are satisfied. The administrator will establish organizational or individual performance goals in its discretion, which, depending on the extent to which they are met, will determine the number and/or the value of performance units and
performance shares to be paid out to participants. For purposes of such awards, the performance goals may be based on one or more of the following performance criteria and any adjustment(s) thereto, in each case as determined by the administrator:
(i)&nbsp;sales or <font style="white-space:nowrap">non-sales</font> revenue; (ii)&nbsp;return on revenues; (iii)&nbsp;operating income; (iv)&nbsp;income or earnings including operating income; (v)&nbsp;income or earnings before or after taxes,
interest, depreciation, and/or amortization; (vi)&nbsp;income or earnings from continuing operations; (vii)&nbsp;net income; <font style="white-space:nowrap">(viii)&nbsp;pre-tax</font> income or <font style="white-space:nowrap">after-tax</font>
income; (ix)&nbsp;net income excluding amortization of intangible assets, depreciation and impairment of goodwill and intangible assets, and/or excluding charges attributable to the adoption of new accounting pronouncements; (x)&nbsp;raising of
financing or fundraising; (xi)&nbsp;project financing; (xii)&nbsp;revenue backlog; (xiii)&nbsp;gross margin; (xiv)&nbsp;operating margin or profit margin; (xv)&nbsp;capital expenditures, cost targets, reductions and savings, and expense management;
(xvi)&nbsp;return on assets (gross or net), return on investment, return on capital or invested capital, or return on stockholder equity; (xvii)&nbsp;cash flow, free cash flow, cash flow return on investment (discounted or otherwise), net cash
provided by operations, or cash flow in excess of cost of capital; (xviii)&nbsp;performance warranty and/or guarantee claims; (xix)&nbsp;stock price or total stockholder return; (xx)&nbsp;earnings or book value per share (basic or diluted); (xxi)
economic value created; <font style="white-space:nowrap">(xxii)&nbsp;pre-tax</font> profit or <font style="white-space:nowrap">after-tax</font> profit; (xxiii)&nbsp;strategic business criteria, consisting of one or more objectives based on meeting
specified market penetration or market share, completion of strategic agreements such as licenses, funded collaborations, joint ventures, acquisitions, and the like, geographic business expansion, objective customer satisfaction or information
technology goals, and/or intellectual property asset metrics; (xxiv)&nbsp;objective goals relating to divestitures, joint ventures, mergers, acquisitions, and similar transactions; (xxv)&nbsp;objective goals relating to staff management, results
from staff attitude and/or opinion surveys, staff satisfaction scores, staff safety, staff accident and/or injury rates, compliance headcount, performance management, and completion of critical staff training initiatives; (xxvi)&nbsp;objective goals
relating to projects, including project completion timing and/or achievement of milestones, project budget, and technical progress against work plans; (xxvii)&nbsp;key regulatory objectives or milestones; and (xxviii)&nbsp;enterprise resource
planning. However, awards issued to participants may take into account other factors (including subjective factors). In addition, performance goals may differ from participant to participant, performance period to performance period, and from award
to award. Any criteria used may be measured, as applicable, (i)&nbsp;in absolute terms, (ii)&nbsp;in relative terms (including, but not limited to, any increase (or decrease) over the passage of time and/or any measurement against other companies or
financial or business or stock index metrics particular to us), (iii) on a per share and/or share per capita basis, (iv)&nbsp;against </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">143 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
our performance as a whole or against any of our affiliate(s), or a particular segment(s), a business unit(s) or a product(s) of ours or individual project company, (v)&nbsp;on a <font style="white-space:nowrap">pre-tax</font> or <font style="white-space:nowrap">after-tax</font> basis, and/or (vi)&nbsp;using an actual foreign exchange rate or on a foreign exchange neutral basis. After the grant of a performance unit or performance
share, the administrator, in its sole discretion, may reduce or waive any performance objectives or other vesting provisions for such performance units or performance shares. Performance units shall have an initial dollar value established by the
administrator prior to the grant date. Performance shares shall have an initial value equal to the fair market value of our common stock on the grant date. The administrator, in its sole discretion, may pay earned performance units or performance
shares in the form of cash, in shares, or in some combination thereof. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i><font style="white-space:nowrap">Non-transferability</font> of
awards.</i><b><i></i></b>&nbsp;&nbsp;&nbsp;&nbsp;Unless the administrator provides otherwise, our 2018 Plan generally does not allow for the transfer of awards and only the recipient of an option or stock appreciation right may exercise such an
award during his or her lifetime. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Certain adjustments</i><b><i>.</i></b><b><i></i></b>&nbsp;&nbsp;&nbsp;&nbsp;In the event of certain corporate
events or changes in our capitalization, to prevent diminution or enlargement of the benefits or potential benefits available under the 2018 Plan, the administrator will make adjustments to one or more of the number, kind and class of securities
that may be delivered under the 2018 Plan and/or the number, kind, class and price of securities covered by each outstanding award. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Liquidation or
dissolution</i><b><i>.</i></b>&nbsp;&nbsp;&nbsp;&nbsp;In the event of our proposed winding up, liquidation or dissolution, the administrator will notify participants as soon as practicable and all awards will terminate immediately prior to the
consummation of such proposed transaction. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Corporate transaction.</i>&nbsp;&nbsp;&nbsp;&nbsp;Our 2018 Plan provides that in the event of certain
significant corporate transactions, including: (1)&nbsp;a transfer of all or substantially all of our assets, (2)&nbsp;a merger, consolidation or other capital, reorganization or business combination transaction of the Company with or into another
corporation, entity or person, or (3)&nbsp;the consummation of a transaction, or series of related transactions, in which any person becomes the beneficial owner, directly or indirectly, of more than 50% of the Company’s then outstanding
capital stock, each outstanding award will be treated as the administrator determines. Such determination may provide that such awards will be (i)&nbsp;continued if we are the surviving corporation, (ii)&nbsp;assumed by the surviving corporation or
its parent, (iii)&nbsp;substituted by the surviving corporation or its parent for a new award, (iv)&nbsp;canceled in exchange for a payment equal to the excess of the fair market value of our shares subject to such award over the exercise price or
purchase price paid for such shares, or if such award is “underwater” canceled for no consideration, if any, or (v)&nbsp;in the case of options, accelerated prior to the consummation of the corporate transaction and cancelled for no
consideration if not exercised. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Change of control.&nbsp;&nbsp;&nbsp;&nbsp;</i>The administrator may provide, in an individual award agreement or in
any other written agreement between a participant and us that the stock award will be subject to additional acceleration of vesting and exercisability in the event of a change of control. Under the 2018 Plan, a “change of control” is
generally (1)&nbsp;a merger, consolidation, or any other corporate reorganization in which our stockholders immediately before the transaction do not own, directly or indirectly, more than a majority of the combined voting power of the surviving
entity (or the parent of the surviving entity), (2)&nbsp;the consummation of the sale, transfer or other disposition of all or substantially all of our assets, (3)&nbsp;an unapproved change in the majority of the board of directors, and (4)&nbsp;the
acquisition by any person or company of more than 50% of the total voting power of our then outstanding stock. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Clawback/recovery</i>.&nbsp;&nbsp;&nbsp;&nbsp;Stock awards granted under the 2018 Plan will be subject to recoupment in accordance with any clawback policy we
may be required to adopt pursuant to applicable law and listing requirements. In addition, the administrator may impose such other clawback, recovery or recoupment provisions in any stock award agreement as it determines necessary or appropriate.
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">144 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Amendment or termination.</i>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors has the authority to amend,
suspend or terminate the 2018 Plan provided such action does not impair the existing rights of any participant. Our 2018 Plan will automatically terminate in 2028, unless we terminate it sooner. We will obtain stockholder approval of any amendment
to our 2018 Plan as required by applicable law or listing requirements. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>2013 stock plan </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>General</i><b><i>.</i></b><b><i></i></b>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors adopted, and our stockholders approved, our 2013 Stock Plan, or the 2013
Plan, on February&nbsp;4, 2013. The 2013 Plan was last amended on June&nbsp;1, 2017. Our 2013 Stock Plan, or 2013 Plan, will be terminated effective immediately prior to the effectiveness of the registration statement of which this prospectus forms
a part, and no new awards will be granted under our 2013 Plan following this offering, but previously granted awards will continue to be subject to the terms and conditions of the 2013 Plan and the stock award agreements pursuant to which such
awards were granted. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Share reserve.</i><b><i></i></b>&nbsp;&nbsp;&nbsp;&nbsp;Under our 2013 Plan, we have reserved for issuance an aggregate of
34,306,102 shares. In general, if an award granted under our 2013 Plan is canceled or terminated or otherwise forfeited by a participant, then the number of shares underlying such award will again become available for awards under the 2013 Plan.
Following the effectiveness of our 2018 Plan, such shares will again become available for awards under the 2018 Plan. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Plan
administration.</i><i></i>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors has administered the 2013 Plan before this offering. Our board of directors has delegated its authority to administer the 2013 Plan to our compensation committee following this
offering. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Eligibility</i>.&nbsp;&nbsp;&nbsp;&nbsp;Employees, members of our board of directors who are not employees and consultants are eligible to
participate in our 2013 Plan. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Types of award.</i>&nbsp;&nbsp;&nbsp;&nbsp;Our 2013 Plan provides for incentive and nonstatutory stock options to
purchase shares of our common stock and restricted stock awards. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Stock options.</i>&nbsp;&nbsp;&nbsp;&nbsp;The administrator may grant incentive
and/or <font style="white-space:nowrap">non-statutory</font> stock options under our 2013 Plan, provided that incentive stock options are only granted to employees. The exercise price of such options must generally be equal to at least the fair
market value of our common stock on the date of grant except for certain grants made to certain foreign employees. The term of an option must not exceed 10 years; provided, however, that an incentive stock option held by a participant who owns more
than 10% of the total combined voting power of all classes of our stock, or of certain of our subsidiary corporations, must not have a term in excess of 5 years and must have an exercise price of at least 110% of the fair market value of our common
stock on the grant date. The administrator determines the methods of payment of the exercise price of an option. In addition, the administrator determines the vesting schedule applicable to options, together with any vesting acceleration, and the
terms of the option agreements for use under our 2013 Plan. After the termination of service of an employee, director or consultant, the participant may exercise his or her option, to the extent vested, for the period of time stated in his or her
option agreement. Generally, if termination is due to death or disability, the option will remain exercisable for 12 months. In the event of a termination for cause, options generally terminate immediately upon the termination of the participant for
cause. In all other cases, the option will generally remain exercisable for 3 months following the termination of service. However, in no event may an option be exercised later than the expiration of its term. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Restricted stock</i>.&nbsp;&nbsp;&nbsp;&nbsp;Restricted stock may be granted under our 2013 Plan. Restricted stock awards are grants of shares of our common
stock that are subject to various restrictions, including restrictions on transferability and forfeiture provisions. Shares of restricted stock will vest and the restrictions on such shares will lapse, in accordance with terms and conditions
established by the administrator. The administrator, in its sole </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">145 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
discretion, may accelerate the time at which any restrictions will lapse or be removed. Recipients of restricted stock awards generally will have the same rights as other shareholders with
respect to such shares upon grant without regard to vesting, subject to any applicable agreements. Shares of restricted stock that do not vest for any reason will be subject to our right of repurchase or forfeited by the recipient and will revert to
us. The specific terms will be set forth in an award agreement. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i><font style="white-space:nowrap">Non-transferability</font> of
awards.</i><b><i></i></b>&nbsp;&nbsp;&nbsp;&nbsp;Unless the administrator provides otherwise, our 2013 Plan generally does not allow for the transfer of awards and only the recipient of an option or stock appreciation right may exercise such an
award during his or her lifetime. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Certain adjustments</i><b><i>.</i></b><b><i></i></b>&nbsp;&nbsp;&nbsp;&nbsp;In the event of certain corporate
events or changes in our capitalization, to prevent diminution or enlargement of the benefits or potential benefits available under the 2013 Plan, the administrator will make adjustments to one or more of the number, kind and class of securities
that may be delivered under the 2013 Plan and/or the number, kind, class and price of securities covered by each outstanding award. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Liquidation or
dissolution</i><b><i>.</i></b>&nbsp;&nbsp;&nbsp;&nbsp;In the event of our proposed winding up, liquidation or dissolution, all awards will terminate immediately prior to the consummation of such proposed transaction. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Corporate transaction.</i>&nbsp;&nbsp;&nbsp;&nbsp;The 2013 Plan provides that in the event of certain significant corporate transactions, including: (1)&nbsp;a
transfer of all or substantially all of our assets, (2)&nbsp;a merger, consolidation or other capital, reorganization or business combination transaction of the Company with or into another corporation, entity or person, or (3)&nbsp;the consummation
of a transaction, or series of related transactions, in which any person becomes the beneficial owner, directly or indirectly, of more than 50% of the Company’s then outstanding capital stock, each outstanding award will be treated as the
administrator determines. Such determination may provide that such awards will be (i)&nbsp;continued if we are the surviving corporation, (ii)&nbsp;assumed by the surviving corporation or its parent, (iii)&nbsp;substituted by the surviving
corporation or its parent for a new award, (iv)&nbsp;canceled in exchange for a payment equal to the excess of the fair market value of our shares subject to such award over the exercise price or purchase price paid for such shares, or if such award
is “underwater” canceled for no consideration, if any, or (v)&nbsp;in the case of options, accelerated prior to the consummation of the corporate transaction and cancelled for no consideration if not exercised. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Amendment or termination.</i>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors may amend or terminate the 2013 Plan at any time. If our board of directors amends a
plan, it does not need to ask for stockholder approval of the amendment unless such amendment increases the number of shares available for issuance under the 2013 Plan or as otherwise required by applicable law. No further awards will be made under
the 2013 Plan after this offering. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Employee stock purchase plan </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>General</i>.&nbsp;&nbsp;&nbsp;&nbsp;Our Employee Stock Purchase Plan, or 2018 ESPP, was adopted by our board of directors on September&nbsp;26, 2018 and approved by our stockholders
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. The 2018 ESPP will become effective on the day immediately prior to the date that the registration statement of which this prospectus forms a part
becomes effective. The 2018 ESPP is intended to qualify as an “employee stock purchase plan” within the meaning of Section&nbsp;423 of the Code for U.S. employees. In addition, the 2018 ESPP authorizes grants of purchase rights that do not
comply with Section&nbsp;423 of the Code under a separate <font style="white-space:nowrap">non-423</font> component for non-U.S. employees and certain non-U.S. service providers. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Share reserve</i>.&nbsp;&nbsp;&nbsp;&nbsp;We have reserved 2,725,000&nbsp;shares of our common stock for issuance under the ESPP. The number of shares reserved for issuance under the ESPP will be increased
automatically on the first day of each fiscal year for a period of up to ten years, starting with the fiscal year following the year in which the ESPP becomes effective, by a number equal to the least of: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">2,470,000 shares; </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">146 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">1% of the shares of common stock outstanding at that time;&nbsp;or </font></p></td></tr></tbody></table>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">such number of shares determined by our board of directors. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of the date hereof, no shares of our common stock have been purchased under the ESPP. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Plan
administration</i>.&nbsp;&nbsp;&nbsp;&nbsp;The ESPP will be administered by our board of directors or a committee designated by our board of directors. Our board of directors has delegated its authority to administer the ESPP to our compensation
committee. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Eligibility.&nbsp;&nbsp;&nbsp;&nbsp;</i>Generally, all regular employees, including executive officers, employed by us or by any of our
designated affiliates and certain non-U.S. service providers may participate in the ESPP. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Employees may have to satisfy one or more of the following
service requirements before participating in the ESPP, as determined by the administrator, including: (1)&nbsp;being customarily employed for more than 20 hours per week, (2)&nbsp;being customarily employed for more than five months per calendar
year, or (3)&nbsp;continuous employment with us or one of our affiliates for a period of time (not to exceed two years). No employee may purchase shares under the ESPP at a rate in excess of $25,000 worth of our common stock based on the fair market
value per share of our common stock at the beginning of an offering for each year such a purchase right is outstanding. Finally, no employee will be eligible for the grant of any purchase rights under the ESPP if immediately after such rights are
granted, such employee has voting power over 5% or more of our outstanding capital stock measured by vote or value under Section&nbsp;424(d) of the Code. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Non-U.S. service providers must provide bona fide services to the Company and may be subject to additional eligibility criteria as the administrator may determine
even if such criteria is not consistent with Section 423 of the Code. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Offerings</i>.&nbsp;&nbsp;&nbsp;&nbsp;The 2018 ESPP is implemented through a
series of offerings under which participants are granted purchase rights to purchase shares of our common stock on specified dates during such offerings. Under the 2018 ESPP, we may specify offerings with durations of not more than 27 months, and
may specify shorter purchase periods within each offering. Each offering will have one or more purchase dates on which shares of our common stock will be purchased for participants in the offering. An offering under the 2018 ESPP may be terminated
under certain circumstances. The administrator will have the discretion to structure an offering so that if the fair market value of a share of our common stock on the first trading day of a new purchase period within that offering is less than or
equal to the fair market value of a share of our common stock on the offering date for that offering, then that offering will terminate immediately as of that first trading day, and the participants in such terminated offering will be automatically
enrolled in a new offering beginning on the first trading day of such new offering period. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Payroll
deductions</i>.&nbsp;&nbsp;&nbsp;&nbsp;Participants who are employees may contribute, normally through payroll deductions, up to 15% of their earnings (as defined in the 2018 ESPP) for the purchase of our common stock under the ESPP. Participants
who are not employees will contribute on an after-tax basis in a manner determined by the administrator. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Unless otherwise determined by the
administrator, common stock will be purchased for the accounts of participants in the 2018 ESPP at a price per share that is at least the lesser of (1) 85% of the fair market value of a share of our common stock on the first date of an offering, or
(2) 85% of the fair market value of a share of our common stock on the date of purchase. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Certain adjustments</i>.&nbsp;&nbsp;&nbsp;&nbsp;In the event
that there occurs a change in our capital structure through such actions as a stock split, reverse stock split, stock dividend, combination, consolidation, recapitalization (including a recapitalization through a large nonrecurring cash dividend) or
reclassification of our common stock, </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">147 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
subdivision of our common stock, a rights offering, a reorganization, merger, <font style="white-space:nowrap">spin-off,</font> <font style="white-space:nowrap">split-up,</font> repurchase, or
exchange of our common stock or other significant corporate transaction, or other change affecting our common stock, the administrator will make appropriate adjustments to: (1)&nbsp;the classes) and maximum number of shares reserved under the 2018
ESPP, (2)&nbsp;the class(es) and maximum number of shares by which the share reserve may increase automatically each year, (3)&nbsp;the class(es) and number of shares and purchase price of all outstanding purchase rights, and (4)&nbsp;the class(es)
and number of shares that are subject to purchase limits under ongoing offerings. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Dissolution or liquidation</i>.&nbsp;&nbsp;&nbsp;&nbsp;In the event
of our proposed winding up, liquidation or dissolution, any offering period then in progress will be shortened by setting a new purchase date, and will terminate immediately prior to the consummation of such proposed dissolution or liquidation,
unless provided otherwise by the administrator. The administrator will notify each participant that the purchase date has been changed and that the participant’s purchase right will be exercised automatically on the new purchase date unless
prior to such date the participant has withdrawn from the offering period. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Corporate transactions.&nbsp;&nbsp;&nbsp;&nbsp;</i>The 2018 ESPP provides
that in the event of certain significant corporate transactions, including: (1)&nbsp;a transfer of all or substantially all of our assets, (2)&nbsp;a merger, consolidation or other capital, reorganization or business combination transaction of the
Company with or into another corporation, entity or person, or (3)&nbsp;the consummation of a transaction, or series of related transactions, in which any person becomes the beneficial owner, directly or indirectly, of more than 50% of the
Company’s then outstanding capital stock, a successor corporation may assume or substitute each outstanding purchase right. If the successor corporation refuses to assume or substitute the purchase right, the offering period then in progress
will be shortened, and a new purchase date will be set. The administrator will notify each participant that the purchase date has been changed and that the participant’s purchase right will be exercised automatically on the new purchase date
unless prior to such date the participant has withdrawn from the offering period. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Amendment or termination</i>.&nbsp;&nbsp;&nbsp;&nbsp;The
administrator has the authority to amend, suspend or terminate our ESPP, except that, subject to certain exceptions described in our ESPP, no such action may adversely affect any outstanding rights to purchase stock under our ESPP without the
holder’s consent. We will obtain stockholder approval of any amendment to our ESPP as required by applicable law or listing requirements. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Executive incentive bonus plan </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our Executive
Incentive Bonus Plan, or Bonus Plan, was adopted by our board of directors on September&nbsp;26, 2018. The Bonus Plan will become effective on the day immediately prior to the date that the registration statement of which this prospectus forms a
part becomes effective. The purpose of the Bonus Plan is to motivate and reward eligible officers and employees for their contributions toward the achievement of certain performance goals. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Administration</i>.&nbsp;&nbsp;&nbsp;&nbsp;The Bonus Plan will be administered by the compensation committee, which shall have the discretionary authority to interpret the provisions of the Bonus Plan, including
all decisions on eligibility to participate, the establishment of performance goals, the amount of awards payable under the plan, and the payment of awards. The compensation committee, in its sole discretion and on such terms and conditions as it
may provide, may delegate all or part of its authority and powers under the Bonus Plan to one or more directors and/or officers of the Company. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Eligibility</i>.&nbsp;&nbsp;&nbsp;&nbsp;Officers and other key employees of the Company designated by the compensation committee to participate in the Bonus Plan
will be eligible to participate in this Bonus Plan, provided the compensation committee has not, in its sole discretion, withdrawn such designation and he or she meets the following conditions: (a)&nbsp;is a full-time regular employee of the Company
as of the last day of the applicable performance </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">148 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
period; and (b)&nbsp;is not subject to disciplinary action, is in good standing with the Company and is not subject to a performance improvement plan. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Performance criteria</i>.&nbsp;&nbsp;&nbsp;&nbsp;Commencing with fiscal 2019, we expect the compensation committee to establish cash bonus targets and corporate
performance metrics for a specific performance period pursuant to the Bonus Plan. Corporate performance goals may be based on one or more of the following criteria, as determined by our compensation committee and any adjustments thereto established
by the compensation committee: (i)&nbsp;sales or <font style="white-space:nowrap">non-sales</font> revenue; (ii)&nbsp;return on revenues; (iii)&nbsp;operating income; (iv)&nbsp;income or earnings including operating income; (v)&nbsp;income or
earnings before or after taxes, interest, depreciation, and/or amortization; (vi)&nbsp;income or earnings from continuing operations; (vii)&nbsp;net income; <font style="white-space:nowrap">(viii)&nbsp;pre-tax</font> income or <font style="white-space:nowrap">after-tax</font> income; (ix)&nbsp;net income excluding amortization of intangible assets, depreciation, and impairment of goodwill and intangible assets and/or excluding charges attributable to the adoption of new
accounting pronouncements; (x)&nbsp;raising of financing or fundraising; (xi)&nbsp;project financing; (xii)&nbsp;revenue backlog; (xiii)&nbsp;gross margin; (xiv)&nbsp;operating margin or profit margin; (xv)&nbsp;capital expenditures, cost targets,
reductions, and savings and expense management; (xvi)&nbsp;return on assets (gross or net), return on investment, return on capital or invested capital, or return on stockholder equity; (xvii)&nbsp;cash flow, free cash flow, cash flow return on
investment (discounted or otherwise), net cash provided by operations, or cash flow in excess of cost of capital; (xviii)&nbsp;performance warranty and/or guarantee claims; (xix)&nbsp;stock price or total stockholder return; (xx)&nbsp;earnings or
book value per share (basic or diluted); (xxi) economic value created; <font style="white-space:nowrap">(xxii)&nbsp;pre-tax</font> profit or <font style="white-space:nowrap">after-tax</font> profit; (xxiii)&nbsp;strategic business criteria,
consisting of one or more objectives based on meeting specified market penetration or market share, completion of strategic agreements such as licenses, funded collaborations, joint ventures acquisitions, and the like, geographic business expansion,
objective customer satisfaction or information technology goals, or intellectual property asset metrics; (xxiv)&nbsp;objective goals relating to divestitures, joint ventures, mergers, acquisitions, and similar transactions; (xxv)&nbsp;objective
goals relating to staff management, results from staff attitude and/or opinion surveys, staff satisfaction scores, staff safety, staff accident and/or injury rates, compliance, headcount, performance management, or completion of critical staff
training initiatives; (xxvi)&nbsp;objective goals relating to projects, including project completion, timing and/or achievement of milestones, project budget, or technical progress against work plans; (xxvii)&nbsp;key regulatory objectives or
milestones; and (xxviii)&nbsp;enterprise resource planning. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">However, awards issued to participants may take into account other factors (including
subjective factors). Performance goals may differ from participant to participant, performance period to performance period, and from award to award. Any criteria used may be measured, as applicable, (i)&nbsp;in absolute terms, (ii)&nbsp;in relative
terms (including, but not limited to, any increase (or decrease) over the passage of time and/or any measurement against other companies or financial or business or stock index metrics particular to us), (iii) on a per share and/or share per capita
basis, (iv)&nbsp;against our performance as a whole or against any of our affiliate(s), or a particular segment(s), a business unit(s) or a product(s) of ours or individual project company, (v)&nbsp;on a
<font style="white-space:nowrap">pre-tax</font> or <font style="white-space:nowrap">after-tax</font> basis, and/or (vi)&nbsp;using an actual foreign exchange rate or on a foreign exchange neutral basis. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Service requirement</i>.&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise determined by the compensation committee, a participant must be actively employed and in good
standing with the Company on the date the award is paid. The compensation committee may make exceptions to this requirement in the case of retirement, death or disability, an unqualified leave of absence or under other circumstances, as determined
by the compensation committee in its sole discretion. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Limits</i><i>.</i>&nbsp;&nbsp;&nbsp;&nbsp;The total awards under the Bonus Plan may not exceed
$15 million in the aggregate during the applicable reliance period (within the meaning of Section 162(m) of the Code). </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">149 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Amendment or termination</i>.&nbsp;&nbsp;&nbsp;&nbsp;The compensation committee may terminate the Bonus Plan
at any time, provided such termination shall not affect the payment of any awards accrued under the Bonus Plan prior to the date of the termination. The compensation committee may, at any time, or from time to time, amend or suspend and, if
suspended, reinstate, the Bonus Plan in whole or in part. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Perquisites, health, welfare and retirement benefits </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our named executive officers are eligible to participate in our employee benefit plans, including our medical, dental, vision, group life, disability and accidental
death and dismemberment insurance plans, in each case on the same basis as all of our other employees, except that beginning in fiscal 2018, our named executive officers along with certain other key employees will be eligible to participate in a
supplemental disability plan for which we will pay premiums. We provide a 401(k) plan to our employees, including our current named executive officers, as discussed in the section below entitled “—401(k) Plan.” </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We generally do not provide perquisites or personal benefits to our named executive officers, except in limited circumstances. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>401(k) plan </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We maintain a
<font style="white-space:nowrap">tax-qualified</font> retirement plan (401(k) plan) that provides eligible employees with an opportunity to save for retirement on a tax advantaged basis. Eligible employees are able to defer eligible compensation
subject to applicable annual Code limits. Employees are immediately and fully vested in their contributions. The 401(k) plan permits us to make matching contributions and profit sharing contributions to eligible participants, although we have not
made any such contributions to date. We intend for our 401(k) plan to qualify under Sections 401(a) and 501(a) of the Code so that contributions by employees to the 401(k) plan, and earnings on those contributions, are not taxable to employees until
withdrawn from the 401(k) plan. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Pension benefits </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">None of our named executive officers participate in or have an account balance in any qualified or <font style="white-space:nowrap">non-qualified</font> defined
benefit plan sponsored by us. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Nonqualified deferred compensation </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have not offered any nonqualified deferred compensation plans or arrangements or entered into any such arrangements with any of our named executive officers </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Rule <font style="white-space:nowrap">10b5-1</font> sales plans </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We expect that some of our executive officers and directors may enter into stock selling plans in accordance with Rule <font style="white-space:nowrap">10b5-1</font> of the Securities Exchange Act of 1934, as
amended, and our insider trading policy. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">150 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_14"></a>Certain relationships and related party transactions </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition to the compensation arrangements, including employment, termination of employment and change in control arrangements, and indemnification arrangements,
discussed, when required, in the sections titled “Management” and “Executive compensation” and the registration rights described in the section titled “Description of capital stock—Registration rights,” the
following is a description of each transaction since October&nbsp;1, 2014 and each currently proposed transaction in which: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">we have been or are to be a participant; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the amount involved exceeded or will exceed $120,000; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">any of our directors, executive officers, or holders of more than 5% of any class of our voting securities, or any immediate family member of, or person sharing
the household with, any of these persons, had or will have a direct or indirect material interest. </font></p></td></tr></tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Equity financings
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Series A convertible preferred stock financing </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In three closings between July 2013 and January 2014, we sold an aggregate of 27,898,391 shares of our Series&nbsp;A convertible preferred stock at a purchase price of $0.3290 per share and upon conversion of
certain convertible promissory notes with an aggregate conversion amount of approximately $610,000, for an aggregate purchase price of approximately $9.1&nbsp;million. Each share of our Series&nbsp;A convertible preferred stock will convert
automatically into one share of our common stock immediately prior to the completion of our initial public offering. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table summarizes the
Series A convertible preferred stock purchased by our directors, executive officers and beneficial holders of more than 5% of our capital stock. The terms of these purchases, notwithstanding the conversion terms of the convertible promissory notes,
were the same for all purchasers of our Series A convertible preferred stock. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="53%"></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Name of stockholder*</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares&nbsp;of&nbsp;series&nbsp;A<br>convertible&nbsp;preferred<br>stock</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total purchase<br>price (cash)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total&nbsp;purchase<br>price&nbsp;(conversion&nbsp;of<br>indebtedness)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with ARCH Venture Partners(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">11,709,369</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,399,999.83</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">407,144.31</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Illumina, Inc.(2)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,368,361</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,539,999.65</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">203,572.01</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with Paladin Capital Group(3)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,133,737</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,359,999.48</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.00</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="12" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">*</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Owners of more than 5% of our common stock </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Keith Crandell, a member of our board of directors, is a managing director at ARCH Venture Partners VII, LLC, which is affiliated with ARCH Venture Fund VII, L.P. Consists of
shares held by ARCH Venture Fund VII, L.P. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(2)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Robert Ragusa, a member of our board of directors, is Senior Vice President, Global Quality and Operations of Illumina, Inc. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(3)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Paul Conley, a member of our board of directors, is a managing director of Paladin Capital Management, LLC, which is affiliated with the Paladin funds holding our shares but Mr.
Conley does not beneficially own any of the shares held by the Paladin funds. Consists of shares held by Paladin III (CA), LP, Paladin III (Cayman Islands) LP, Paladin III (HR), LP, Paladin III (NY City), LP, Paladin III <font style="white-space:nowrap">Co-Investment,</font> LLC and Paladin III, LP. </font></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Series B convertible preferred stock financing
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In May 2014, we sold an aggregate of 32,828,281 shares of our Series B convertible preferred stock at a purchase price of $0.7920 per share for
an aggregate purchase price of approximately $26.0&nbsp;million. Each share of our Series B convertible preferred stock will convert automatically into one share of our common stock immediately prior to the completion of our initial public offering.
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">151 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table summarizes the Series B convertible preferred stock purchased by our directors, executive
officers and beneficial holders of more than 5% of our capital stock. The terms of these purchases were the same for all purchasers of our Series B convertible preferred stock. </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="59%"></td>
<td valign="bottom" width="10%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="10%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Name of Stockholder*</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares&nbsp;of&nbsp;series&nbsp;B<br>convertible&nbsp;preferred&nbsp;
stock</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total&nbsp;purchase&nbsp;price</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with ARCH Venture Partners(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,111,643</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,632,421.26</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Illumina, Inc.(2)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,260,455</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,582,280.36</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with Paladin Capital Group(3)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,134,841</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,274,794.07</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with Tao Capital Partners(4)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,532,828</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,549,999.78</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">*</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Owners of more than 5% of our common stock </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Keith Crandell, a member of our board of directors, is a managing director at ARCH Venture Partners VII, LLC, which is affiliated with ARCH Venture Fund VII, L.P. Consists of
shares held by ARCH Venture Fund VII, L.P. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(2)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Robert Ragusa, a member of our board of directors, is Senior Vice President, Global Quality and Operations of Illumina, Inc. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(3)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Paul Conley, a member of our board of directors, is a managing director of Paladin Capital Management, LLC, which is affiliated with the Paladin funds holding our shares but Mr.
Conley does not beneficially own any of the shares held by the Paladin funds. Consists of shares held by Paladin III (CA), LP, Paladin III (Cayman Islands) LP, Paladin III (HR), LP, Paladin III (NY City), LP, Paladin III <font style="white-space:nowrap">Co-Investment,</font> LLC and Paladin III, LP. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(4)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Frederick Craves, a member of our board of directors, was appointed to the board by Tao Invest LLC but Mr. Craves does not beneficially own any of the shares held by Tao Invest
LLC. </font></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Series&nbsp;C convertible preferred stock financing </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In May 2015, we sold an aggregate of 24,668,310 shares of our Series C convertible preferred stock at a purchase price of $1.4999 per share for an aggregate purchase price of approximately $37.0&nbsp;million. Each
share of our Series C convertible preferred stock will convert automatically into one share of our common stock immediately prior to the completion of our initial public offering. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table summarizes the Series C convertible preferred stock purchased by our directors, executive officers and beneficial holders of more than 5% of our capital stock. The terms of these purchases were
the same for all purchasers of our Series C convertible preferred stock. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="59%"></td>
<td valign="bottom" width="9%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Name of Stockholder*</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares&nbsp;of&nbsp;series&nbsp;C<br>convertible&nbsp;preferred&nbsp;
stock</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total&nbsp;purchase&nbsp;price</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with ARCH Venture Partners(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,641,354</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,961,766.86</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Illumina, Inc.(2)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,667,111</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,999,999.79</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with Paladin Capital Group(3)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,160,419</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,740,512.46</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with Tao Capital Partners(4)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,337,843</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,006,630.72</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with Fidelity Select Portfolios(5)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,000,666</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,999,998.94</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">*</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Owners of more than 5% of our common stock </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Keith Crandell, a member of our board of directors, is a managing director at ARCH Venture Partners VII, LLC, which is affiliated with ARCH Venture Fund VII, L.P. Consists of
shares held by ARCH Venture Fund VII, L.P. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(2)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Robert Ragusa, a member of our board of directors, is Senior Vice President, Global Quality and Operations of Illumina, Inc. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(3)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Paul Conley, a member of our board of directors, is a managing director of Paladin Capital Management, LLC, which is affiliated with the Paladin funds holding our shares but Mr.
Conley does not beneficially own any of the shares held by the Paladin funds. Consists of shares held by Paladin III (CA), LP, Paladin III (Cayman Islands) LP, Paladin III (HR), LP, Paladin III (NY City), LP, Paladin III <font style="white-space:nowrap">Co-Investment,</font> LLC and Paladin III, LP. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(4)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Frederick Craves, a member of our board of directors, was designated to our board by Tao Invest LLC but Mr. Craves does not beneficially own any of the shares held by Tao Invest
LLC. </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(5)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of shares held by Fidelity Advisor Series VII: Fidelity Advisor Biotechnology Fund and Fidelity Select Portfolios: Biotechnology Portfolio. </font></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Series&nbsp;D convertible preferred stock financing </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In multiple closings between January 2016 and July 2018, we sold an aggregate of 102,242,652 shares of our Series D convertible preferred stock at a purchase price
of $2.1457 per share for an aggregate purchase price of </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">152 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
approximately $291.5 million. Each share of our Series D convertible preferred stock will convert automatically into one share of our common stock immediately prior to the completion of our
initial public offering. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table summarizes the Series D convertible preferred stock purchased by our directors, executive officers and
beneficial holders of more than 5% of our capital stock. The terms of these purchases were the same for all purchasers of our Series D convertible preferred stock. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="59%"></td>
<td valign="bottom" width="9%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Name of stockholder*</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares&nbsp;of&nbsp;series&nbsp;D<br>convertible&nbsp;preferred&nbsp;
stock</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total&nbsp;purchase&nbsp;price</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with ARCH Venture Partners(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">11,077,949</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,769,955.17</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Illumina, Inc.(2)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,556,590</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,339,975.16</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with Paladin Capital Group(3)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,405,825</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,016,478.70</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with Fidelity Select Portfolios(4)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,429,930</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,213,900.80</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with Tao Capital Partners(5)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,086,725</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,477,485.83</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Ever Alpha Fund L.P.(6)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,623,385</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">69,999,997.21</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">*</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Owners of more than 5% of our common stock </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Keith Crandell, a member of our board of directors, is a managing director at ARCH Venture Partners VII, LLC, which is affiliated with ARCH Venture Fund VII, L.P. and a managing
director at ARCH Venture Partners VIII, LLC, which is affiliated with ARCH Venture Fund VII Overage, L.P. Consists of shares held by ARCH Venture Fund VII, L.P. and ARCH Venture Fund VII Overage, L.P. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(2)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Robert Ragusa, a member of our board of directors, is Senior Vice President, Global Quality and Operations of Illumina, Inc. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(3)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Paul Conley, a member of our board of directors, is a managing director of Paladin Capital Management, LLC, which is affiliated with the Paladin funds holding our shares but Mr.
Conley does not beneficially own any of the shares held by the Paladin funds. Consists of shares held by Paladin III (CA), LP, Paladin III (Cayman Islands) LP, Paladin III (HR), LP, Paladin III (NY City), LP, Paladin III <font style="white-space:nowrap">Co-Investment,</font> LLC and Paladin III, LP. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(4)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of shares held by Fidelity Advisor Series VII: Fidelity Advisor Biotechnology Fund and Fidelity Select Portfolios: Biotechnology Portfolio. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(5)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Frederick Craves, a member of our board of directors, was designated to our board by Tao Invest LLC but Mr. Craves does not beneficially own any of the shares held by Tao Invest
LLC. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(6)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Xiaoying Mai, a member of our board of directors, is an Investment Director of GF Xinde Investment Management Co. Ltd, which is affiliated with Ever Alpha Fund L.P. but Ms. Mai
does not beneficially own any of the shares held by Ever Alpha Fund L.P. </font></td></tr></tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Side Letter with Ever Alpha Fund. L.P. </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In March 2018, in connection with Ever Alpha Fund L.P.’s purchase of Series&nbsp;D convertible preferred stock, we entered into a side letter with Ever Alpha
Fund L.P. pursuant to which, among other things, we have committed to using commercially reasonable efforts to invest up to $5.0&nbsp;million, $10.0&nbsp;million and $10.0&nbsp;million over a three year period in connection with the incorporation,
business and/or operations of a wholly owned foreign enterprise in the PRC, subject to and contingent upon the approval of our board of directors and any applicable regulatory agencies in the PRC and U.S., and compliance with any applicable laws and
regulations. The foreign enterprise will be exclusively owned and controlled by us through a subsidiary that we will wholly own, and Ever Alpha Fund L.P. will not have any direct economic, voting or other interests in this enterprise or any of our
subsidiaries. Ever Alpha Fund L.P.’s interests in this enterprise are limited to its equity interest as a stockholder in the Company and its belief that expanding our manufacturing capacity and growing our sales organization in China will have
a positive impact on our business and long-term value. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Indemnification agreements and directors’ and officers’ liability insurance
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have entered into or intend to enter into indemnification agreements with each of our directors and executive officers. The indemnification
agreements and our certificate of incorporation and bylaws require us to indemnify our directors and officers to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys’ fees, judgments, penalties
fines and settlement amounts incurred by the director or executive officer in any action or proceeding, including any action or proceeding by or in right of us, arising out of the person’s services as a director or executive officer. We have
obtained an insurance policy that insures our directors and officers against certain liabilities, including liabilities arising under applicable securities laws. For more information regarding these indemnification agreements, see “Executive
compensation—Limitation of liability and indemnification of directors and officers.” </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">153 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Registration rights agreement </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In January 2016, we entered into an amended and restated registration rights agreement, as amended in March 2018, with certain holders of our convertible preferred stock, including entities affiliated with Arch
Venture Partners, Fidelity Advisor, Illumina, Inc., Paladin Holdings, and Tao Invest LLC, which each hold more than 5% of our capital stock and some of which certain of our directors are affiliated. Pursuant to the amended and restated registration
rights agreement, these holders are entitled to rights with respect to the registration of their shares following this offering under the Securities Act. For a more detailed description of these registration rights, see “Description of capital
stock—Registration rights.” </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Stockholders agreement </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In January 2016, we entered into an amended and restated stockholders agreement, as amended in March 2018, under which certain holders of our capital stock, including entities with which certain of our directors
are affiliated, have agreed to vote their shares on certain matters, including with respect to the election of directors. This agreement grants certain of our investors the right of <font style="white-space:nowrap">co-sale</font> with respect to
proposed transfers of our securities by certain stockholders. This agreement will terminate upon the completion of this offering and thereafter none of our stockholders will have any special rights regarding the election or designation of members of
our board of directors, <font style="white-space:nowrap">co-sale</font> or the voting of our capital stock. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Other transactions </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have granted stock options and other equity awards to our executive officers and certain of our directors. For a description of these options and equity awards,
see “Executive Compensation—Outstanding equity awards as of September 30” and <font style="white-space:nowrap">“Management—Non-employee</font> director compensation Table.” </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have entered into certain employment arrangements or agreements with some of our executive officers that provide for severance and change in control benefits. We
intend to amend such agreements in connection with the completion of this offering and we will disclose the terms of such agreements once finalized. For a description of the current employment arrangements, see “Executive
compensation—Executive employment arrangements.” </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On November&nbsp;10, 2017, we entered into a separation and release agreement with Solange
Glaize in connection with her resignation as our Chief Financial Officer on October&nbsp;23, 2017. Pursuant to the terms of her separation and release agreement, she received approximately $160,000 in severance benefits, which consisted of cash
severance and reimbursements for COBRA premiums and legal fees. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We purchase certain reagents and equipment from Illumina, Inc., a company that owns more
than five percent of our outstanding capital stock and where Robert Ragusa, one of our board members, serves as the Senior Vice President, Global Quality and Operations. Purchases from Illumina, Inc. amounted to $1.0 million and $2.0&nbsp;million
for the years ended September&nbsp;30, 2016 and 2017, respectively. Purchases from Illumina, Inc. amounted to $1.3 million and $1.8 million for the nine months ended June 30, 2017 and 2018, respectively. We do not currently have an agreement with
Illumina, Inc., for the purchase of reagents but we acquire them on a purchase order basis. We believe that the prices we pay to Illumina, Inc. for reagents and equipment are comparable to prices available from third parties selling similar reagents
and equipment of similar quality. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Policies and procedures for related party transactions </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our audit committee charter will be effective when we complete this offering. The charter states that our audit committee is responsible for reviewing and approving
in advance any related party transaction. Our board of </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">154 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
directors intends to adopt a written related person transaction policy to set forth the policies and procedures for the review and approval or ratification of related person transactions by the
audit committee. Pursuant to the policy, all of our directors, officers and employees will be required to report to the audit committee prior to entering into any transaction, arrangement or relationship, or any series of similar transactions,
arrangements or relationships in which we are to be a participant, the amount involved exceeds $120,000 and a related person had or will have a direct or indirect material interest, including purchases of goods or services by or from the related
person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and employment by us of a related person. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We believe that we have executed all of the transactions set forth under the section entitled “Certain Relationships and Related Party Transactions” on
terms no less favorable to us than we could have obtained from unaffiliated third parties. It is our intention to ensure that all future transactions between us and our officers, directors and principal stockholders and their affiliates, are
approved by the audit committee of our board of directors, and are on terms no less favorable to us than those that we could obtain from unaffiliated third parties. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">155 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_15"></a>Principal stockholders </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table and footnotes set forth information with respect to the beneficial ownership of our common stock as of August&nbsp;31, 2018, subject to certain assumptions set forth in the footnote and as
adjusted to reflect the sale of the shares of common stock offered in the public offering under this prospectus for: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">each holder of 5% or more of the outstanding shares of our common stock; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">each of our named executive officers; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">each of our directors; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">all of our executive officers and directors as a group. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In accordance with SEC rules, each listed person’s beneficial ownership includes: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">all shares the investor actually owns beneficially or of record; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">all shares over which the investor has or shares voting or dispositive control (such as in the capacity as a general partner of an investment fund); and
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">all shares the investor has the right to acquire beneficial ownership of within 60 days after August 31, 2018. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our calculation of the percentage of beneficial ownership prior to this offering is based on 219,614,309&nbsp;shares of common stock outstanding as of August 31,
2018, assuming the automatic conversion of all outstanding shares of our convertible preferred stock on a <font style="white-space:nowrap"><font style="white-space:nowrap">one-for-one</font></font> basis into 187,637,634 shares of common stock and
shares outstanding after completion of this offering. The percentage ownership information assumes no exercise of the underwriters’ option to purchase additional shares. Shares of common stock that a person has the right to acquire within 60
days after August 31, 2018 are deemed outstanding for purposes of computing the percentage ownership of the person holding such rights, but are not deemed outstanding for purposes of computing the percentage ownership of any other person, except
with respect to the percentage ownership of all directors and executive officers as a group. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Unless otherwise indicated, we believe, based on the
information furnished to us, that the persons named in the table below have sole voting and investment power with respect to all securities that they beneficially own, subject to community property laws where applicable. Unless otherwise noted
below, the business address of the stockholders listed below is the address of our principal executive office, 455&nbsp;Mission Bay Boulevard South. Suite 545, San Francisco, CA 94158. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">156 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="40%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares beneficially<br>owned<br>prior to the offering</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares beneficially<br>owned<br>after the offering</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Name of beneficial owner</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Common<br>stock</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Options<br>exercisable<br>within 60<br>days</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Aggregate<br>number of<br>shares<br>beneficially<br>owned</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Aggregate<br>number of<br>shares<br>beneficially<br>owned</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>%</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b></b><b><i>5% or more stockholders:</i></b><b></b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Ever Alpha Fund L.P.(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,623,385</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,623,385</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14.9%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with ARCH Venture Partners(2)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,540,315</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,540,315</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14.8%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Illumina, Inc.(3)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">16,852,517</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">16,852,517</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7.7%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with Tao Capital Partners(4)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,957,396</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,957,396</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5.9%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with Fidelity Select Portfolios(5)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,430,596</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,430,596</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5.7%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Entities affiliated with Paladin Capital Group(6)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,834,822</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,834,822</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4.9%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b></b><b><i>Named executive officers and directors:</i></b><b></b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Emily M. Leproust(7)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,013,171</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,285,100</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,298,271</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4.6%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">James M. Thorburn(8)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,750,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,750,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Mark Daniels(9)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,246,817</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,246,817</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Robert Chess(10)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">691,315</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">70,340</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">761,655</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Frederick B. Craves(11)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">661,122</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">661,122</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Paul A. Conley(12)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Keith Crandell(1)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,540,315</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,540,315</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14.8%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Xiaoying Mai(13)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Robert Ragusa(2)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">16,852,517</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">16,852,517</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7.7%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">All directors and executive officers as a group(14) (14 persons)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">72,324,659</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">13,185,134</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">85,509,793</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">36.7%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td colspan="24" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">*</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Represents beneficial ownership of less than one percent of the outstanding shares of our common stock. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of 32,623,385 shares held of record by Ever Alpha Fund L.P. Ever Glory Limited is the general partner of Ever Alpha Fund L.P. Ever Glory Limited is a wholly owned
subsidiary of Guangfa Xinde Capital Management Limited. Guangfa Xinde Capital Management Limited is a wholly owned subsidiary of Guangfa Investment (Hong Kong) Company Limited. Guangfa Investment (Hong Kong) Company Limited is a wholly owned
subsidiary of Guangfa Holding (Hong Kong) Corporation Limited. Guangfa Holding (Hong Kong) Corporation Limited is the wholly owned subsidiary of Guangfa Securities Co., Ltd, a publicly listed company in Hong Kong. Sun Shuming, Lin Zhihai, Qin Li,
Sun Xiaoyan, Yang Xiong, Tang Xin. Chan Kalok, Shang Shuzhi, Li Xiulin, Li Yanxi and Liu Xuetao serve on the Board of Directors of Guangfa Securities Co., Ltd and may be deemed to share voting and dispositive power over the shares held by Ever Alpha
Fund L.P. The address of Ever Alpha Fund L.P. is Fl 16th, 183rd Tianhebei Rd, Guangzhou, PR China. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(2)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of (i) 23,687,378 shares held of record by ARCH Venture Fund VII, L.P., or ARCH VII and (ii) 8,852,937 shares held of record by ARCH Venture Fund VIII Overage, L.P., or
ARCH VIII Overage. ARCH Venture Partners VII, L.P., or the GPLP, is the sole general partner of ARCH VII and ARCH Venture Partners VII, LLC, or the GPLLC, is the sole general partner of the GPLP. ARCH Venture Partners VIII, LLC, or ARCH VIII
Partners, is the sole general partner of ARCH VIII Overage. Keith Crandell, Clinton Bybee and Robert Nelsen are the managing directors of the GPLLC and ARCH VIII Partners, and therefore, may be deemed to share voting and dispositive power over the
shares held of record by ARCH VII and ARCH VIII Overage. The address for each of the entities identified in this footnote is 8755 West Higgins Road, Suite 1025, Chicago, IL 60631. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(3)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of 16,852,517 shares held of record by Illumina, Inc. Robert Ragusa is Senior Vice President, Global Quality and Operations of Illumina, Inc., and has sole voting and
dispositive power over the shares held of record by Illumina, Inc. The address of Illumina, Inc. is 25861 Industrial Boulevard, Hayward, CA 94545. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(4)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="1">Consists of (i) 12,067,486 shares held of record by Tao Invest, LLC and (ii) 889,910 shares held of record by Tao Invest II, LLC, or collectively, the Tao Funds.
Tao Capital Management LP is the managing member of each of the Tao Funds. Tao Capital Management Inc. is the general partner of Tao Capital Management LP. Nicholas J. Pritzker is the chairman and Joseph I. Perkovich is the president of Tao Capital
Management Inc. and </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">157 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p><font style="font-family:arial" size="1">
each may be deemed to have voting and dispositive power over the shares held of record by the Tao Funds. The address of Tao Invest LLC is 1 Letterman Drive, San Francisco, CA 94129.
</font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(5)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of (i) 2,320,378 shares held of record by Fidelity Advisor Series VII: Fidelity Advisor Biotechnology Fund and (ii) 10,110,218 shares held of record by Fidelity Select
Portfolios: Biotechnology Portfolio, or collectively, the Fidelity Funds. The Fidelity Funds are managed by direct or indirect subsidiaries of FMR LLC. Edward C. Johnson 3d is a Director and the Chairman of FMR LLC and Abigail P. Johnson is a
Director, the Vice Chairman and the President of FMR LLC. Members of the family of Edward C. Johnson 3d, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing
49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders’ voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote
of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders’ voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to
form a controlling group with respect to FMR LLC. Neither FMR LLC nor Edward C. Johnson 3d nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the
Investment Company Act advised by Fidelity Management&nbsp;&amp; Research Company, or FMR Co, a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds’ Boards of Trustees. Fidelity Management&nbsp;&amp; Research Company
carries out the voting of the shares under written guidelines established by the Fidelity Funds’ Boards of Trustees. The address for each of the entities identified in this footnote is 525 Washington Boulevard, New Jersey, NJ 07310.
</font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(6)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of (i) 988,543 shares held of record by Paladin III (CA), LP, (ii) 1,990,272 shares held of record by Paladin III (Cayman Islands), LP, (iii) 988,543 shares held of
record by Paladin III (HR), LP, (iv) 2,897,892 shares held of record by Paladin III (NY City), LP, (v) 3,433,546 shares held of record by Paladin III, LP, or collectively, the Paladin Funds, and (vi) 536,026 shares held of record by Paladin III <font style="white-space:nowrap">Co-Investment,</font> LLC. Paladin Holdings III, L.P. is the general partner of the Paladin Funds and Managing Member of Paladin III <font style="white-space:nowrap">Co-Investment,</font> LLC and its Investment Committee,
which consists of Michael Steed and Mark Maloney, may be deemed to have voting and dispositive power over the shares held of record by the Paladin Funds and Paladin III Co-Investment LLC. The address for each of the entities identified in this
footnote is c/o Paladin Capital Management, LLC, 2020 K Street, NW - Suite 620, Washington, DC 20006. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(7)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of (i) 7,013,171 shares of common stock and (ii) 3,285,100 shares issuable upon the exercise of early-exercisable stock options, 1,389,714 of which would be vested
within 60 days after August 31, 2018. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(8)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of 1,750,000 shares issuable upon the exercise of early-exercisable stock options, none of which would be vested within 60 days after August 31, 2018.
</font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(9)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of 1,246,817 shares issuable upon the exercise of early-exercisable stock options, 454,756 of which would be vested within 60 days after August 31, 2018.
</font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(10)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of (i) 691,315 shares of common stock and (ii) 70,340 shares issuable upon the exercise of early-exercisable stock options, 19,050 of which would be vested within 60
days after August 31, 2018. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(11)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of 661,122 shares held of record by The Craves Family Foundation. Fred Craves may be deemed to hold sole voting and dispositive power with respect to the shares held by
The Craves Family Foundation. Mr. Craves does not have voting and dispositive power over the shares held of record by the Tao Funds. Mr.&nbsp;Craves’ address is 750 Battery Street, Suite 400, San Francisco, CA 94111. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(12)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Paul Conley does not have voting and dispositive power over the shares held of record by the Paladin Funds and Paladin III Co-Investment LLC. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(13)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Xiaoying Mai does not have voting and dispositive power over the shares held of record by Ever Alpha Fund L.P. </font></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">(14)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Consists of (i) 22,270,705 shares of common stock, (ii) 5,391,233 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of August
31, 2018 and (iii) 50,053,954 shares of common stock issuable upon conversion of preferred stock. </font></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">158 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_16"></a>Description of capital stock </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>The following is a description of the material terms of our amended and restated certificate of incorporation and amended and restated bylaws as each will be in
effect as of the completion of this offering, and of specific provisions of Delaware law. The following description is intended as a summary only and is qualified in its entirety by reference to our amended and restated certificate of incorporation,
our amended and restated bylaws and the DGCL. Copies of our amended and restated certificate of incorporation and amended and restated bylaws have been filed as exhibits to the registration statement of which this prospectus is a part.
</i></font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>General </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Immediately following the closing
of this offering, our authorized capital stock will consist of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock, $0.00001 par value per share, and
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of preferred stock, $0.00001 par value per share, all of which preferred stock will be undesignated. The following information reflects the filing of our amended and
restated certificate of incorporation and the conversion of all outstanding shares of our preferred stock into shares of common stock immediately prior to the closing of this offering. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Upon the closing of this offering and based on 213,961,940 shares of our common stock outstanding as of June&nbsp;30,
2018,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock will be outstanding, assuming the conversion of all outstanding shares of our convertible preferred stock into
182,045,056 shares of our common stock immediately prior to the closing of this offering. As of June 30, 2018, we had 196 stockholders of record. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Common stock </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June 30, 2018, we had 213,961,940 shares
of common stock issued and outstanding assuming the conversion of all outstanding shares of our convertible preferred stock into 182,045,056 shares of our common stock as if such conversion had occurred on June 30, 2018. The holders of our common
stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders. Cumulative voting for the election of directors is not provided for in our amended and restated certificate of incorporation, which
means the holders of a majority of our shares of common stock can elect all of the directors then standing for election. Subject to preferences that may be applicable to any outstanding convertible preferred stock, holders of common stock are
entitled to receive ratably such dividends as may be declared by the board of directors out of funds legally available for that purpose. See “Dividend policy.” In the event of liquidation, dissolution or winding up of the company, the
holders of our common stock are entitled to share ratably in all assets remaining after payment of liabilities, subject to the prior distribution rights of any outstanding convertible preferred stock. The common stock has no preemptive or conversion
rights or other subscription rights. The outstanding shares of common stock are, and the shares of common stock to be issued upon completion of this offering will be, fully paid and <font style="white-space:nowrap">non-assessable.</font> </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Preferred stock </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June 30, 2018, there were 182,045,056
shares of convertible preferred stock outstanding, which will automatically convert, immediately prior to the completion of this offering, into 182,045,056 shares of our common stock. After the closing of this offering, the board of directors will
have the authority, without further action by the stockholders, to issue up to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of preferred stock, $0.00001 par value per share, in one or more series. The board of
directors will also have the authority to designate the rights, preferences, privileges and restrictions of each such series, including dividend rights, preferences, privileges and restrictions of each such series, including dividend rights,
dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences, sinking fund terms and the number of shares constituting any series. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">159 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The issuance of preferred stock may have the effect of delaying, deferring or preventing a change in control of
the company without further action by the stockholders. The issuance of convertible preferred stock with voting and conversion rights may also adversely affect the voting power of the holders of common stock and the likelihood that such holders will
receive dividend payments and payments upon liquidation. In certain circumstances, an issuance of preferred stock could have the effect of decreasing the market price of the common stock. As of the closing of the offering, no shares of convertible
preferred stock will be outstanding. We currently have no plans to issue any shares of convertible preferred stock. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Warrants </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June 30, 2018, we had warrants outstanding to purchase 1,421,515 shares of our common stock, assuming the conversion of our convertible preferred stock into
common stock, and which will become exercisable for an additional 634,920 shares of our common stock at an exercise price of $0.63 per share upon the drawing down of additional loans under our credit facility, at exercise prices ranging from
approximately $0.329 to $2.1457 per share. Each outstanding warrant contains provisions for the adjustment of the exercise price and the number of shares issuable upon exercise in the event of stock dividends, stock splits, reorganizations and
reclassifications, consolidations and the like. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Options </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June 30, 2018, we had outstanding options to purchase 24,000,608 shares of our common stock under our 2013 Plan and 9,347,391 shares remained available for future awards. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Registration rights </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Based on the number of shares
outstanding as of June 30, 2018, under our amended and restated registration rights agreement, after the consummation of this offering, the holders of up to approximately 203.4&nbsp;million shares of common stock, or their affiliates or transferees,
have the right to require us to register their shares under the Securities Act so that those shares may be publicly resold, or to include their shares in any registration statement we file, in each case as described below. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The registration rights terminate with respect to the registration rights of an individual holder on the earliest to occur of (i)&nbsp;five years following the
consummation of this offering, (ii)&nbsp;the liquidation, dissolution or indefinite cessation of the business operations of our company, or the closing of a deemed liquidation, dissolution or winding up of our company pursuant to our amended and
restated certificate of incorporation, or (iii)&nbsp;such time as Rule 144 or another similar exemption under the Securities Act is available for the sale of such stockholder’s shares. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Demand registration rights </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Based on the number of shares outstanding as of June 30, 2018, after the
consummation of this offering, the holders of approximately 182.4 million shares of our common stock (on an <font style="white-space:nowrap">as-converted</font> basis), or their transferees, will be entitled to certain demand registration rights. At
any time after one hundred eighty (180)&nbsp;days following the effectiveness of the registration statement of which this prospectus is a part, the holders of at least a majority of the registrable securities may demand that we effect a registration
under the Securities Act covering the public offering and sale of at least the number of registrable securities held by such stockholders having an anticipated aggregate offering price, net of underwriting discounts and commissions, of at least
$10,000,000. Upon any such demand, we must effect the registration of such registrable securities that have been requested to register together with all other registrable securities that we may have been requested to register by other stockholders
pursuant to the incidental registration rights described below. We are only obligated to effect two registrations in response to these demand registration rights. In the event we are </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">160 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
required to effect such a demand registration, we may not effect any other registration of securities for sale for our own account (other than a registration effected solely to implement an
employee benefit plan or in certain business combination transactions) within 120 days following the effective date of the demand registration. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Piggyback registration rights </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In connection with this
offering, certain holders were entitled to, and the necessary percentage of holders waived, their rights to notice of this offering and to include their shares of registrable securities in this offering. If we register any securities for public sale
in another offering, including pursuant to any stockholder initiated demand registration, holders of such registrable securities will have the right to include their shares in the registration statement for such offering, subject to certain
exceptions. The underwriters of any underwritten offering will have the right to limit the number registrable securities to be included in the registration statement, subject to certain restrictions. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Form <font style="white-space:nowrap">S-3</font> registration rights </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Following this offering, we are required to use our best efforts to qualify and remain qualified to register securities pursuant to a registration statement on Form <font style="white-space:nowrap">S-3</font> under
the Securities Act. At any time after we are qualified to file a registration statement on Form <font style="white-space:nowrap">S-3,</font> the holders of registrable securities anticipated to have an aggregate sale price, net of underwriting
discounts and commission, in excess of $5,000,000 may request in writing an unlimited number of registration statements on Form <font style="white-space:nowrap">S-3</font> for the registrable securities held by such requesting holder or holders, and
we are required to use our best efforts to effect such registrations. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Expenses of registration </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We will pay all registration expenses related to any demand, piggyback or Form <font style="white-space:nowrap">S-3</font> registration, including reasonable fees
and disbursements of one special counsel for the holders of such registrable securities, other than underwriting fees, discounts or commissions (if any), which will be borne by the holders of such registrable securities. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Anti-takeover effects of Delaware law and our amended and restated certificate of incorporation and amended and restated bylaws </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our amended and restated certificate of incorporation and our amended and restated bylaws, which will be in effect upon the completion of this offering, will
contain certain provisions that could have the effect of delaying, deterring or preventing another party from acquiring control of us. These provisions and certain provisions of Delaware law, which are summarized below, are expected to discourage
coercive takeover practices and inadequate takeover bids. These provisions are also designed, in part, to encourage persons seeking to acquire control of us to negotiate first with our board of directors. We believe that the benefits of increased
protection of our potential ability to negotiate more favorable terms with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire us. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Undesignated preferred stock </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As discussed above, our board of directors will have the ability to issue
preferred stock with voting or other rights or preferences that could impede the success of any attempt to change control of us. These and other provisions may have the effect of deterring hostile takeovers or delaying changes in control or
management of our company. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Limits on ability of stockholders to act by written consent or call a special meeting </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our amended and restated certificate of incorporation will provide that our stockholders may not act by written consent, which may lengthen the amount of time
required to take stockholder actions. As a result, a holder </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">161 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
controlling a majority of our capital stock would not be able to amend our bylaws or remove directors without holding a meeting of our stockholders called in accordance with our bylaws.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, our amended and restated bylaws will provide that special meetings of the stockholders may be called only by the majority of our board of
directors. Stockholders may not call a special meeting, which may delay the ability of our stockholders to force consideration of a proposal or for holders controlling a majority of our capital stock to take any action, including the removal of
directors. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Requirements for advance notification of stockholder nominations and proposals </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our amended and restated bylaws will establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as
directors, other than nominations made by or at the direction of our board of directors or a committee of our board of directors. These provisions may have the effect of precluding the conduct of certain business at a meeting if the proper
procedures are not followed. These provisions may also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of our company.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Board classification </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Upon the closing of
the offering, our board of directors will be divided into three classes, one class of which is elected each year by our stockholders. The directors in each class will serve three-year terms. For more information on the classified board, see
“Management—Board of directors.” A third party may be discouraged from making a tender offer or otherwise attempting to obtain control of us as it is it more difficult and time-consuming for stockholders to replace a majority of the
directors on a classified board. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>No cumulative voting </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our amended and restated certificate of incorporation and amended and restated bylaws will not provide for cumulative voting in the election of directors. Cumulative voting allows a stockholder to vote a portion or
all of its shares for one or more candidates for seats on the board of directors. Without cumulative voting, a minority stockholder may not be able to gain as many seats on our board of directors as the stockholder would be able to gain if
cumulative voting were permitted. The absence of cumulative voting makes it more difficult for a minority stockholder to gain a seat on our board of directors to influence our board’s decision regarding a takeover. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Amendment of charter and bylaws provisions </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The
amendment of the above provisions of our amended and restated certificate of incorporation will require approval by holders of at least two thirds of our outstanding capital stock entitled to vote generally in the election of directors. The
amendment of certain provisions of our bylaws will also require approval by the holders of at least two thirds of our outstanding capital stock entitled to vote generally in the election of directors. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Delaware anti-takeover statute </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are subject to the
provisions of Section&nbsp;203 of the DGCL regulating corporate takeovers. In general, Section&nbsp;203 prohibits a publicly held Delaware corporation from engaging, under certain circumstances, in a business combination with an interested
stockholder for a period of three years following the date the person became an interested stockholder unless: </font></p> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">prior to the date of the transaction, our board of directors approved either the business combination or the transaction which resulted in the stockholder
becoming an interested stockholder; </font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the
voting stock of the corporation outstanding at the time the transaction commenced, calculated as provided under Section&nbsp;203; or </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">162 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">at or subsequent to the date of the transaction, the business combination is approved by our board of directors and authorized at an annual or special meeting of
stockholders, and not by written consent, by the affirmative vote of at least <font style="white-space:nowrap">two-thirds</font> of the outstanding voting stock which is not owned by the interested stockholder. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Generally, a business combination includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. An
interested stockholder is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, did own 15% or more of a corporation’s outstanding voting stock. We expect
the existence of this provision to have an anti-takeover effect with respect to transactions our board of directors does not approve in advance. We anticipate that Section&nbsp;203 may also discourage attempts that might result in a premium over the
market price for the shares of common stock held by stockholders. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The provisions of Delaware law and the provisions of our amended and restated
certificate of incorporation and amended and restated bylaws, as amended upon the completion of this offering, could have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they might also inhibit temporary
fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These provisions might also have the effect of preventing changes in our management. It is possible that these provisions could
make it more difficult to accomplish transactions that stockholders might otherwise deem to be in their best interests. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our amended and restated
certificate of incorporation to be in effect upon completion of this offering provides that the Court of Chancery of the State of Delaware is the sole and exclusive forum for any derivative action or proceeding brought on our behalf, any action
asserting a breach of fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders, any action asserting a claim against us arising pursuant to any provisions of the DGCL, our amended and restated certificate of
incorporation or our amended and restated bylaws to be in effect upon completion of this offering, any action or proceeding asserting a claim as to which the Delaware General Corporation Law confers jurisdiction upon the Court of Chancery of the
State of Delaware or any action asserting a claim against us that is governed by the internal affairs doctrine, subject in each case to the Court of Chancery having personal jurisdiction over the parties named as defendants therein. Our amended and
restated certificate of incorporation to be in effect upon completion of this offering further provides that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising
under the Securities Act. Although our amended and restated certificate of incorporation contains the choice of forum provision described above, it is possible that a court could find that such a provision is inapplicable for a particular claim or
action or that such provision is unenforceable. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Transfer agent and registrar </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Upon the completion of this offering, the transfer agent and registrar for our common stock will be American Stock Transfer &amp; Trust Company, LLC.&nbsp;The transfer agent and registrar’s address is 6201
15th Avenue, Brooklyn, NY 11219, and its telephone number is (718) 921-8124. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Listing </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are applying to list our common stock on the Nasdaq Global Market under the trading symbol “TWST.” </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">163 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_17"></a>Shares eligible for future sale </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Prior to this offering, there has not been any public market for our common stock, and we make no prediction as to the effect, if any, that market sales of shares
of common stock or the availability of shares of common stock for sale will have on the market price of common stock prevailing from time to time. Nevertheless, sales of substantial amounts of common stock in the public market, or the perception
that such sales could occur, could adversely affect the market price of common stock and could impair our future ability to raise capital through the sale of equity securities. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Sale of restricted shares </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Based on the number of shares outstanding as of June 30, 2018, when this offering is
complete, we will have an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock outstanding. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Of the outstanding shares, all of the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares sold in this offering will be freely tradable. The
remaining&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock will be deemed “restricted securities” as defined in Rule 144. Restricted securities may be sold in the public
market only if registered or if they qualify for an exemption from registration under Rule 144 or Rule 701, promulgated under the Securities Act, which rules are summarized below. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As a result of the contractual restrictions described below and the provisions of Rules 144 and 701, the restricted shares will be available for sale in the public market as follows: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">no shares will be eligible for sale when this offering is complete; and </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares will be eligible for sale upon the expiration of the <font style="white-space:nowrap">lock-up</font> agreements, described below, beginning 181 days after the date of this prospectus. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In
addition, of the 24,000,608 shares of our common stock that were subject to stock options outstanding as of June 30, 2018, options to purchase 7,429,126 shares of common stock were vested as of June 30, 2018 and will be eligible for sale 181 days
following the date of this prospectus. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><font style="white-space:nowrap">Lock-up</font> agreements and obligations </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We, all of our directors, officers and all of our securityholders have entered into <font style="white-space:nowrap">lock-up</font> agreements that generally
provide that these holders will not offer, pledge, sell, agree to sell, directly or indirectly, or otherwise dispose of any shares of common stock or any securities convertible into or exchangeable for shares of common stock without the prior
written consent of J.P. Morgan Securities LLC and Cowen and Company, LLC for a period of 180 days from the date of this prospectus, subject to certain exceptions. These agreements, and the exceptions thereto, are described beginning on page 164 of
this prospectus in the section titled “Underwriting.” </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, each grant agreement under our 2013 Plan contains restrictions similar to
those set forth in the <font style="white-space:nowrap">lock-up</font> agreements described above limiting the disposition of securities issuable pursuant to those plans for a period of 180 days following the date of this prospectus. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Rule 144 </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In general, under Rule 144 as currently in effect,
once we have been subject to public company reporting requirements for at least 90 days, a person who is not deemed to have been one of our affiliates for purposes of the Securities Act at any time during the 90 days preceding a sale and who has
beneficially owned the shares proposed to be sold for at least six months, including the holding period of any prior owner other than our </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">164 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
affiliates, is entitled to sell such shares without complying with the manner of sale, volume limitation or notice provisions of Rule&nbsp;144, subject to compliance with the public information
requirements of Rule&nbsp;144. If such a person has beneficially owned the shares proposed to be sold for at least one year, including the holding period of any prior owner other than our affiliates, then such person is entitled to sell such shares
without complying with any of the requirements of Rule&nbsp;144. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In general, under Rule 144, as currently in effect, our affiliates or persons selling
shares on behalf of our affiliates are entitled to sell upon expiration of the <font style="white-space:nowrap">lock-up</font> agreements described above, within any three-month period beginning 90 days after the date of this prospectus, a number of
shares that does not exceed the greater of: </font></p> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">1% of the number of shares of our common stock then outstanding, which will equal approximately shares, assuming no exercise of the underwriters’ option to
purchase additional shares of common stock, immediately after this offering; or </font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the average weekly trading volume of our common stock on the Nasdaq Global Market during the four calendar weeks preceding the filing of a notice on Form 144
with respect to such sale. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Sales under Rule 144 by our affiliates or persons selling shares on behalf of our affiliates are also
subject to certain manner of sale provisions and notice requirements and to the availability of current public information about us. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Rule 701
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Rule 701, as presently in effect, generally allows a stockholder who purchased shares of our common stock pursuant to a written compensatory plan or
contract and who is not deemed to have been an affiliate of our company during the immediately preceding 90 days to sell these shares in reliance upon Rule 144, but without being required to comply with the public information, holding period, volume
limitation, or notice provisions of Rule 144. Rule 701 also permits affiliates of our company to sell their Rule 701 shares under Rule 144 without complying with the holding period requirements of Rule 144. All holders of Rule 701 shares, however,
are required to wait until 90 days after the date of the· prospectus before selling such shares pursuant to Rule 701. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June 30, 2018,
10,737,541 shares of our outstanding stock had been issued in reliance on Rule&nbsp;701 as a result of exercises of stock options and stock awards. These shares will be eligible for resale in reliance on this rule upon expiration of the <font style="white-space:nowrap">lock-up</font> agreements described above. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Stock options </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We intend to file a registration statement on Form <font style="white-space:nowrap">S-8</font> under the Securities Act covering all of the shares of our common stock subject to options outstanding or reserved for
issuance under our stock plans, and shares of our common stock issued upon the exercise of options by employees. We expect to file this registration statement as soon as permitted under the Securities Act. Shares covered by this registration
statement will be eligible for sale in the public market, upon the expiration or release from the terms of the <font style="white-space:nowrap">lock-up</font> agreements, and subject to vesting of such shares. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Registration rights </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">When this offering is complete, the
holders of an aggregate of 203,420,957 shares of our common stock, or their transferees, will be entitled to rights with respect to the registration of their shares under the Securities Act. Registration of these shares under the Securities Act
would result in these shares becoming freely tradeable without restriction under the Securities Act immediately upon the effectiveness of such registration. For a further description of these rights, see “Description of capital
stock—Registration rights.” </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">165 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_18"></a>Material U.S. federal income tax considerations for
<font style="white-space:nowrap">non-U.S.</font> holders </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">This section discusses certain material U.S. federal income tax consequences of the
ownership and sale, exchange or other taxable disposition of our common stock sold pursuant to this offering to a <font style="white-space:nowrap">“non-U.S.</font> holder” (as defined below). This discussion does not provide a complete
analysis of all potential tax considerations. The information provided below is based upon provisions of the Internal Revenue Code of 1986, as amended, or Code, Treasury regulations promulgated thereunder, administrative rulings and judicial
decisions currently in effect. These authorities may change at any time, possibly on a retroactive basis, or the Internal Revenue Service, or IRS, might interpret the existing authorities differently. In either case, the U.S. federal income tax
considerations of owning or disposing of our common stock could differ from those described below. As a result, we cannot assure you that the U.S. federal income tax considerations described in this discussion will not be challenged by the IRS or
will be sustained by a court if challenged by the IRS. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">This discussion does not address the tax considerations arising under the alternative minimum
tax, the net investment income tax, the laws of any state, local or <font style="white-space:nowrap">non-U.S.</font> jurisdiction, or under U.S. federal gift and estate tax laws. In addition, this discussion does not address tax considerations
applicable to an investor’s particular circumstances or to investors that may be subject to special tax rules, including, without limitation: </font></p> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">banks, insurance companies or other financial institutions; </font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">partnerships or entities or arrangements treated as partnerships or other pass-through entities for U.S. federal income tax purposes (or investors in such
entities); </font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">corporations that accumulate earnings to avoid U.S. federal income tax; </font></p></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2"><font style="white-space:nowrap">tax-exempt</font> or governmental organizations or <font style="white-space:nowrap">tax-qualified</font> retirement plans;
</font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">real estate investment trusts or regulated investment companies; </font></p></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">controlled foreign corporations or passive foreign investment companies; </font></p></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">persons who acquired our common stock pursuant to the exercise of an employee stock option or otherwise as compensation for services;
</font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">dealers in securities or currencies; </font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">traders in securities that elect to use a <font style="white-space:nowrap"><font style="white-space:nowrap">mark-to-market</font></font> method of accounting for
their securities holdings; </font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">persons that own, or are deemed to own, more than 5% of our capital stock (except to the extent specifically set forth below); </font></p></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">certain former citizens or long-term residents of the United States; </font></p></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">persons who hold our common stock as a position in a hedging transaction, “straddle,” “conversion transaction” or other risk reduction
transaction; </font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">persons who do not hold our common stock as a capital asset within the meaning of Section&nbsp;1221 of the Code (generally, for investment purposes); or
</font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">persons deemed to sell our common stock under the constructive sale provisions of the Code. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, if a partnership or entity classified as a partnership for U.S. federal income tax purposes is a beneficial owner of our common stock, the tax
treatment of a partner in the partnership or an owner of the entity will depend upon the status of the partner or other owner and the activities of the partnership or other entity. Accordingly, this discussion does not address U.S. federal income
tax considerations applicable to partnerships that hold our common stock, and partners in such partnerships should consult their tax advisors. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b>Investors considering the purchase of our common stock should consult their own tax advisors regarding the application of the U.S. federal income, gift and
estate tax laws to their particular situations and the consequences of <font style="white-space:nowrap">non-U.S.,</font> state or local laws, and tax treaties. </b></font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">166 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b><font style="white-space:nowrap">Non-U.S.</font> holder defined </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For purposes of this section, a <font style="white-space:nowrap">“non-U.S.</font> holder” is any holder of our common stock, other than an entity taxable
as a partnership for U.S. federal income tax purposes, that is not: </font></p> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">an individual who is a citizen or resident of the United States for U.S. federal income tax purposes; </font></p></td></tr></tbody></table>
<p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">a corporation, or other entity taxable as a corporation for U.S. federal income tax purposes, created or organized under the laws of the United States, any state
therein or the District of Columbia or otherwise treated as such for U.S. federal income tax purposes; </font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">a trust that (1)&nbsp;is subject to the primary supervision of a U.S. court and one or more U.S.&nbsp;persons have authority to control all substantial decisions
of the trust or (2)&nbsp;has a valid election in effect under applicable Treasury regulations to be treated as a U.S. person; or </font></p></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">an estate whose income is subject to U.S. federal income tax regardless of source. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">If you are a <font style="white-space:nowrap">non-U.S.</font> citizen who is an individual, you may, in many cases, be deemed to be a resident alien, as opposed to a nonresident alien, by virtue of being present in
the United States for at least 31 days in the calendar year and for an aggregate of at least 183 days during a three-year period ending in the current calendar year. For these purposes, all the days present in the current year, <font style="white-space:nowrap">one-third</font> of the days present in the immediately preceding year, and <font style="white-space:nowrap">one-sixth</font> of the days present in the second preceding year are counted. Resident aliens are subject to
U.S. federal income tax as if they were U.S. citizens. Such an individual is urged to consult his or her own tax advisor regarding the U.S. federal income tax consequences of the ownership and sale, exchange or other taxable disposition of our
common stock. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Distributions </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We do not
anticipate paying any distributions in the foreseeable future. If we do make any distributions on shares of our common stock, however, such distributions will constitute dividends for U.S. federal income tax purposes to the extent paid from our
current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of our current and accumulated earnings and profits will constitute a return of capital that is applied against and reduces,
but not below zero, a <font style="white-space:nowrap">non-U.S.</font> holder’s adjusted tax basis in shares of our common stock. Any remaining excess will be treated as gain realized on the sale, exchange or other taxable disposition of our
common stock. See “—Sale of common stock.” </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Subject to the discussion below regarding the Foreign Account Tax Compliance Act, or FATCA,
and backup withholding, any distribution made to a <font style="white-space:nowrap">non-U.S.</font> holder on our common stock that is not effectively connected with a <font style="white-space:nowrap">non-U.S.</font> holder’s conduct of a trade
or business in the United States will generally be subject to U.S. withholding tax at a 30% rate. The withholding tax might not apply, however, or might apply at a reduced rate, under the terms of an applicable income tax treaty between the United
States and the <font style="white-space:nowrap">non-U.S.</font> holder’s country of residence. You should consult your tax advisors regarding your entitlement to benefits under a relevant income tax treaty. Generally, in order for us or our
paying agent to withhold tax at a lower treaty rate, a <font style="white-space:nowrap">non-U.S.</font> holder must certify its entitlement to treaty benefits. A <font style="white-space:nowrap">non-U.S.</font> holder generally can meet this
certification requirement by providing an IRS Form <font style="white-space:nowrap">W-8BEN,</font> <font style="white-space:nowrap"><font style="white-space:nowrap">W-8BEN-E</font></font> (or any successor form to the IRS Form <font style="white-space:nowrap">W-8BEN</font> or <font style="white-space:nowrap"><font style="white-space:nowrap">W-8BEN-E)</font></font> to us or our paying agent. If the <font style="white-space:nowrap">non-U.S.</font> holder holds the stock through a
financial institution or other agent acting on the <font style="white-space:nowrap">non-U.S.</font> holder’s behalf, the <font style="white-space:nowrap">non-U.S.</font> holder will be required to provide appropriate documentation to the agent.
The <font style="white-space:nowrap">non-U.S.</font> holder’s agent will then be required to provide certification to us or our paying agent, either directly or through other intermediaries. If you are eligible for a reduced rate of U.S.
federal withholding tax under an income tax treaty, you may obtain a refund or credit from the IRS of any excess amounts withheld by filing an appropriate claim for a refund with the IRS in a timely manner. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">167 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Distributions received by a <font style="white-space:nowrap">non-U.S.</font> holder that are effectively
connected with a U.S. trade or business conducted by the <font style="white-space:nowrap">non-U.S.</font> holder, and, if required by an applicable income tax treaty between the United States and the <font style="white-space:nowrap">non-U.S.</font>
holder’s country of residence, are attributable to a permanent establishment maintained by the <font style="white-space:nowrap">non-U.S.</font> holder in the United States, are not subject to such withholding tax. To obtain this exemption, a <font style="white-space:nowrap">non-U.S.</font> holder must provide us with an IRS Form <font style="white-space:nowrap">W-8ECI</font> properly certifying such exemption. Such effectively connected distributions, although not subject to U.S. withholding
tax, are generally taxed at the same graduated rates applicable to U.S. persons, net of certain deductions and credits. In addition to the graduated tax described above, distributions received by corporate
<font style="white-space:nowrap">non-U.S.</font> holders that are effectively connected with a U.S. trade or business of the corporate <font style="white-space:nowrap">non-U.S.</font> holder may also be subject to a branch profits tax equal to 30%
of its effectively connected earnings and profits for the taxable year, as adjusted for certain items, although an applicable income tax treaty between the United States and the <font style="white-space:nowrap">non-U.S.</font> holder’s country
of residence might provide for a lower rate. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Sale of common stock </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Subject to the discussion below regarding FATCA and backup withholding, <font style="white-space:nowrap">non-U.S.</font> holders will generally not be subject to U.S. federal income tax on any gains realized on the
sale, exchange or other taxable disposition of our common stock unless: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the gain (1)&nbsp;is effectively connected with the conduct by the <font style="white-space:nowrap">non-U.S.</font> holder of a U.S. trade or business and
(2)&nbsp;if required by an applicable income tax treaty between the United States and the <font style="white-space:nowrap">non-U.S.</font> holder’s country of residence, is attributable to a permanent establishment (or, in the case of an
individual, a fixed base) maintained by the <font style="white-space:nowrap">non-U.S.</font> holder in the United States (in which case the special rules described below apply); </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the <font style="white-space:nowrap">non-U.S.</font> holder is an individual who is present in the United States for 183 days or more in the taxable year of the
sale, exchange or other taxable disposition of our common stock, and certain other requirements are met (in which case the gain would be subject to a flat 30% tax, or such reduced rate as may be specified by an applicable income tax treaty, which
may be offset by U.S.-source capital losses, even though the individual is not considered a resident of the United States, provided that the <font style="white-space:nowrap">non-U.S.</font> holder has timely filed U.S. federal income tax returns
with respect to such losses); or </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the rules of the Foreign Investment in Real Property Tax Act, or FIRPTA, treat the gain as effectively connected with a U.S. trade or business.
</font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The FIRPTA rules may apply to a sale, exchange or other taxable disposition of our common stock if we are at the time of the sale,
exchange, or other taxable disposition, or were within the shorter of the five-year period preceding the disposition and the <font style="white-space:nowrap">non-U.S.</font> holder’s holding period, a “United States real property holding
corporation,” or USRPHC. In general, we would be a USRPHC if the value of our interests in U.S. real property comprised at least half of the value of our business assets and our U.S. and <font style="white-space:nowrap">non-U.S.</font> real
property interests. If we are or become a USRPHC, as long as our common stock is regularly traded on an established securities market, such common stock will be treated as U.S. real property interests subject to the FIRPTA rules only if a <font style="white-space:nowrap">non-U.S.</font> holder actually owns or constructively holds more than 5% of our outstanding common stock at any time within the shorter of the five-year period preceding the disposition and the <font style="white-space:nowrap">non-U.S.</font> holder’s holding period. Currently, we believe we are not, and do not anticipate becoming, a USRPHC. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">If
any gain from the sale, exchange or other taxable disposition of our common stock, (1)&nbsp;is effectively connected with a U.S. trade or business conducted by a <font style="white-space:nowrap">non-U.S.</font> holder and (2)&nbsp;if required by an
applicable income tax treaty between the United States and the <font style="white-space:nowrap">non-U.S.</font> holder’s country of residence, is attributable to a permanent establishment (or, in the case of an individual, a fixed base)
maintained by such <font style="white-space:nowrap">non-U.S.</font> holder in </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">168 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
the United States, then the gain generally will be subject to U.S. federal income tax at the same graduated rates applicable to U.S. persons, net of certain deductions and credits. If the <font style="white-space:nowrap">non-U.S.</font> holder is a corporation, under certain circumstances, that portion of its earnings and profits that is effectively connected with its U.S. trade or business, subject to certain adjustments, generally would
be subject to a “branch profits tax.” The branch profits tax rate is equal to 30% of its effectively connected earnings and profits for the taxable year, as adjusted for certain items, although an applicable income tax treaty between the
United States and the <font style="white-space:nowrap">non-U.S.</font> holder’s country of residence might provide for a lower rate. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Backup
withholding and information reporting </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Payments of dividends on our common stock will not be subject to backup withholding, provided the <font style="white-space:nowrap">non-U.S.</font> holder certifies its <font style="white-space:nowrap">non-U.S.</font> status, such as by furnishing a valid IRS Form <font style="white-space:nowrap">W-8BEN,</font> <font style="white-space:nowrap"><font style="white-space:nowrap">W-8BEN-E</font></font> or <font style="white-space:nowrap">W-8ECI</font> (and we or our paying agent do not have actual knowledge or reason to know the holder is a U.S. person or that the conditions of any other exemption
are not, in fact, satisfied), or otherwise establishes an exemption. However, information returns are required to be filed with the IRS in connection with any dividends on our common stock paid to the <font style="white-space:nowrap">non-U.S.</font>
holder, regardless of whether any tax was actually withheld. Copies of these reports may be made available to tax authorities in the country where the <font style="white-space:nowrap">non-U.S.</font> holder resides. In addition, proceeds of the sale
or other taxable disposition of our common stock within the United States or conducted through certain U.S.-related brokers generally will not be subject to backup withholding or information reporting, if the applicable withholding agent receives
the certification described above or the <font style="white-space:nowrap">non-U.S.</font> holder otherwise establishes an exemption. Proceeds of a disposition of our common stock conducted through a <font style="white-space:nowrap">non-U.S.</font>
office of a <font style="white-space:nowrap">non-U.S.</font> broker that does not have certain enumerated relationships with the United States generally will not be subject to backup withholding or information reporting. The backup withholding rate
is currently 24%. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Backup withholding is not an additional tax. Any amounts withheld from a payment to a holder of our common stock under the backup
withholding rules can be credited against any U.S. federal income tax liability of the holder and may entitle the holder to a refund from the IRS, provided that the required information is furnished to the IRS in a timely manner. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Foreign account tax compliance act, or FATCA </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">FATCA imposes
U.S. federal withholding tax of 30% on certain types of U.S. source “withholdable payments” (including dividends and the gross proceeds from the sale, exchange or other taxable disposition of U.S. stock) to foreign financial institutions,
which are broadly defined for this purpose, and other <font style="white-space:nowrap">non-U.S.</font> entities that fail to comply with certain certification and information reporting requirements regarding U.S. account holders or owners of such
institutions or entities. The obligation to withhold under FATCA applies to any dividends on our common stock, and will apply to gross proceeds from the sale, exchange or other taxable disposition of our common stock paid after December&nbsp;31,
2018 and to certain “pass-thru” payments received with respect to instruments held through foreign financial institutions after the later of December&nbsp;31, 2018 and the date on which applicable final Treasury regulations are issued. An
intergovernmental agreement between the United States and an applicable foreign country may modify the requirements described in this paragraph. <font style="white-space:nowrap">Non-U.S.</font> holders should consult their own tax advisors regarding
the possible implications of FATCA on their investment in our common stock. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b>The preceding discussion of U.S. federal income tax considerations is for
general information only. It is not tax advice. Each prospective investor should consult its own tax advisor regarding the particular U.S. federal, state, local and <font style="white-space:nowrap">non-U.S.</font> tax consequences of the sale,
exchange or other taxable disposition of our common stock, including the consequences of any proposed change in applicable laws. </b></font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">169 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_19"></a>Underwriting </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are offering the shares of common stock described in this prospectus through a number of underwriters. J.P. Morgan Securities LLC and Cowen and Company, LLC are acting as joint book-running managers of the
offering and as representatives of the underwriters. We have entered into an underwriting agreement with the underwriters. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriters, and each
underwriter has severally agreed to purchase, at the public offering price less the underwriting discounts and commissions set forth on the cover page of this prospectus, the number of shares of common stock listed next to its name in the following
table: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="90%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Name</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Number&nbsp;of<br>shares</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">J.P. Morgan Securities LLC</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cowen and Company, LLC</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Allen&nbsp;&amp; Company LLC</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Robert W. Baird&nbsp;&amp; Co. Incorporated</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td colspan="4" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The underwriters are committed to purchase all the shares of common stock offered by us if they purchase any shares. The
underwriting agreement also provides that if an underwriter defaults, the purchase commitments of <font style="white-space:nowrap">non-defaulting</font> underwriters may also be increased or the offering may be terminated. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The underwriters propose to offer the shares of common stock directly to the public at the initial public offering price set forth on the cover page of this
prospectus and to certain dealers at that price less a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. Any such dealers may resell shares to certain other
brokers or dealers at a discount of up to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share from the initial public offering price. After the initial offering of the shares to the public, the
offering price and other selling terms may be changed by the underwriters. Sales of shares made outside of the United States may be made by affiliates of the underwriters. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The underwriters have an option to buy up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of common stock from us solely to cover sales of shares
by the underwriters which exceed the number of shares specified in the table above. The underwriters have 30 days from the date of this prospectus to exercise this option to purchase additional shares. If any shares are purchased with this option to
purchase additional shares, the underwriters will purchase shares in approximately the same proportion as shown in the table above. If any additional shares of common stock are purchased, the underwriters will offer the additional shares on the same
terms as those on which the shares are being offered. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The underwriting fee is equal to the public offering price per share of common stock less the
amount paid by the underwriters to us per share of common stock. The underwriting fee is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. The following table shows the per share and total
underwriting discounts and commissions to be paid to the underwriters assuming both no exercise and full exercise of the underwriters’ option to purchase additional shares. </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="68%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Without<br>exercise&nbsp;of&nbsp;option<br>to purchase<br>additional
shares</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>With full<br>exercise&nbsp;of&nbsp;option<br>to purchase<br>additional
shares</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Per share</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We estimate that the total expenses of this offering, including registration, filing and listing fees, printing fees and legal and
accounting expenses, but excluding the underwriting discounts and commissions, will be </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">170 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; . We have agreed to reimburse the underwriters for expenses relating to the
clearance of this offering with the Financial Industry Regulatory Authority, Inc. (in an amount not to exceed $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;). </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">A prospectus in electronic format may be made available on the web sites maintained by one or more underwriters, or selling group members, if any, participating in
the offering. The underwriters may agree to allocate a number of shares to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the representatives to underwriters and
selling group members that may make Internet distributions on the same basis as other allocations. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have agreed that we will not (i)&nbsp;offer,
pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, or file with the
Securities and Exchange Commission a registration statement under the Securities Act of 1933, as amended, or the Securities Act, relating to, any shares of our common stock or any securities convertible into or exchangeable or exercisable for any
shares of our common stock, or publicly disclose the intention to make any offer, sale, pledge, disposition or filing, or (ii)&nbsp;enter into any swap or other arrangement that transfers all or a portion of the economic consequences associated with
the ownership of any shares of common stock or any such other securities (regardless of whether any of these transactions are to be settled by the delivery of shares of common stock or such other securities, in cash or otherwise), in each case
without the prior written consent of J.P. Morgan Securities LLC and Cowen and Company, LLC for a period of 180 days after the date of this prospectus, other than (i)&nbsp;the shares of our common stock to be sold hereunder, or (ii)&nbsp;any shares
of our common stock issued upon the exercise of options granted under our existing equity incentive plans. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Our directors and executive officers, and all
of our stockholders have entered into <font style="white-space:nowrap">lock-up</font> agreements with the underwriters prior to the commencement of this offering pursuant to which each of these persons or entities, with limited exceptions, for a
period of 180 days after the date of this prospectus, may not, without the prior written consent of J.P. Morgan Securities LLC and Cowen and Company, LLC, (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase,
purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of our common stock or any securities convertible into or exercisable or exchangeable
for our common stock (including, without limitation, common stock or such other securities which may be deemed to be beneficially owned by such directors, executive officers and stockholders in accordance with the rules and regulations of the
Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or warrant), or publicly disclose the intention to make any offer, sale, pledge or disposition, (2)&nbsp;enter into any swap or other agreement
that transfers, in whole or in part, any of the economic consequences of ownership of our common stock or such other securities, whether any such transaction described in clause (1)&nbsp;or (2)&nbsp;above is to be settled by delivery of common stock
or such other securities, in cash or otherwise or (3)&nbsp;make any demand for or exercise any right with respect to the registration of any shares of our common stock or any security convertible into or exercisable or exchangeable for our common
stock. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The restrictions described in the immediately preceding paragraph do not apply to, among other items: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">transfers or dispositions of shares of common stock: </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">as a bona fide gift; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">to any trust for the direct or indirect benefit of the party subject to the <font style="white-space:nowrap">lock-up</font> restrictions or the immediate family
of such person; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">to any corporation, partnership, limited liability company or other entity under the ownership of the party subject to the
<font style="white-space:nowrap">lock-up</font> restrictions or the immediate family of such person; </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">171 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">by will, other testamentary document or intestate succession to the legal representative, heir, beneficiary or a member of the immediate family of the party
subject to the lockup restrictions; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">as distributions to partners, members or stockholders of the party subject to the <font style="white-space:nowrap">lock-up</font> restrictions; and
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">as transfers to affiliates, investment funds or other entities controlled or managed by the party subject to the <font style="white-space:nowrap">lock-up</font>
restrictions, </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>provided</i> that in the case of any transfer or distribution pursuant to the above six subclauses, (i)&nbsp;each
transferee, donee or distributee shall sign and deliver a <font style="white-space:nowrap">lock-up</font> letter in the form executed by the party subject to the lock up restrictions and (ii)&nbsp;no filing or other public announcement under
Section&nbsp;16(a)of the Exchange Act of 1934, as amended, or the Exchange Act shall be required or shall be voluntarily made during the restricted period (other than a filing on Form 5 or a required filing on a Schedule 13F or 13G); </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the transfer pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction made to all holders of our common stock
involving a change of control; provided that in the event such tender offer, merger, consolidation or other such transaction is not completed, the shares of our common stock shall remain subject to the <font style="white-space:nowrap">lock-up</font>
restrictions; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the exercise of outstanding warrants or options to purchase shares of common stock granted under any stock incentive plan or stock purchase plan of the Company,
provided that the underlying shares shall continue to be subject to the <font style="white-space:nowrap">lock-up</font> restrictions; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the establishment of a trading plan pursuant to Rule <font style="white-space:nowrap">10b5-1</font> under the Exchange Act for the transfer of shares of common
stock, provided that (i)&nbsp;such plan does not provide for the transfer of shares of common stock during the restricted period and (ii)&nbsp;no filing under the Exchange Act or other public announcement shall be required or voluntarily made by or
on behalf of the party subject to the <font style="white-space:nowrap">lock-up</font> restrictions regarding the establishment of such plan; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the transfer or disposition of shares of common stock acquired in this offering or on the open market following this offering, provided that no filing under the
Exchange Act or other public announcement shall be required or voluntarily made in connection with such transfer or disposition during the restricted period (other than a required filing on a Schedule 13F or 13G); </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">transfers or surrenders to us of shares of common stock pursuant to any contractual arrangement that provides us with an option to repurchase such shares in
connection with the termination of the party subject to the <font style="white-space:nowrap">lock-up’s</font> employment or service relationship with us, or pursuant to a right of first refusal with respect to transfers of such shares of common
stock or other securities, or on a cashless or “net exercise” basis or to cover tax withholding obligations of the party subject to the <font style="white-space:nowrap">lock-up,</font> in connection with the vesting or exercise of such
shares of common stock or other securities, provided that any filing under Section&nbsp;16 of the Exchange Act shall clearly indicate in the footnotes thereto that the filing relates to such circumstances described above and no other public
announcement shall be required or voluntarily made in connection with such transfers or surrenders; and </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">transfers or dispositions of shares of common stock by operation of law pursuant to a qualified domestic order or in connection with a divorce settlement or
other court order, provided that the recipient of such shares shall execute and deliver to J.P. Morgan Securities LLC and Cowen and Company, LLC a <font style="white-space:nowrap">lock-up</font> letter in the form of this Letter Agreement, provided,
further that any filing under Section&nbsp;16 of the Exchange Act shall clearly indicate in the footnotes that the filing relates to the circumstances described above and no other public announcement shall be required or voluntarily made in
connection with such transfer or disposition. </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">172 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the
Securities Act. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We are applying to list shares of our common stock on the Nasdaq Global Market under the symbol “TWST.” </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In connection with this offering, the underwriters may engage in stabilizing transactions, which involves making bids for, purchasing and selling shares of common
stock in the open market for the purpose of preventing or retarding a decline in the market price of the common stock while this offering is in progress. These stabilizing transactions may include making short sales of the common stock, which
involves the sale by the underwriters of a greater number of shares of common stock than they are required to purchase in this offering, and purchasing shares of common stock on the open market to cover positions created by short sales. Short sales
may be “covered” shorts, which are short positions in an amount not greater than the underwriters’ option to purchase additional shares referred to above, or may be “naked” shorts, which are short positions in excess of that
amount. The underwriters may close out any covered short position either by exercising their option to purchase additional shares, in whole or in part, or by purchasing shares in the open market. In making this determination, the underwriters will
consider, among other things, the price of shares available for purchase in the open market compared to the price at which the underwriters may purchase shares through the option to purchase additional shares. A naked short position is more likely
to be created if the underwriters are concerned that there may be downward pressure on the price of the common stock in the open market that could adversely affect investors who purchase in this offering. To the extent that the underwriters create a
naked short position, they will purchase shares in the open market to cover the position. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The underwriters have advised us that, pursuant to Regulation
M of the Securities Act, they may also engage in other activities that stabilize, maintain or otherwise affect the price of the common stock, including the imposition of penalty bids. This means that if the representatives of the underwriters
purchase common stock in the open market in stabilizing transactions or to cover short sales, the representatives can require the underwriters that sold those shares as part of this offering to repay the underwriting discount received by them.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">These activities may have the effect of raising or maintaining the market price of the common stock or preventing or retarding a decline in the market
price of the common stock, and, as a result, the price of the common stock may be higher than the price that otherwise might exist in the open market. If the underwriters commence these activities, they may discontinue them at any time. The
underwriters may carry out these transactions on the Nasdaq Global Market, in the <font style="white-space:nowrap"><font style="white-space:nowrap">over-the-counter</font></font> market or otherwise. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Prior to this offering, there has been no public market for our common stock. The initial public offering price will be determined by negotiations between us and
the representatives of the underwriters. In determining the initial public offering price, we and the representatives of the underwriters expect to consider a number of factors including: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the information set forth in this prospectus and otherwise available to the representatives of the underwriters; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our prospects and the history and prospects for the industry in which we compete; </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">an assessment of our management; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">our prospects for future earnings; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the general condition of the securities markets at the time of this offering; </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">173 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">the recent market prices of, and demand for, publicly traded common stock of generally comparable companies; and </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">other factors deemed relevant by the underwriters and us. </font></p></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Neither we nor the underwriters can assure investors that an active trading market will develop for our common shares, or that the shares will trade in the public market at or above the initial public offering
price. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Selling restrictions </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Other than in the
United States, no action has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this
prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction,
except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions
relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a
solicitation is unlawful. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in the European economic area </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a “Relevant Member State”), with effect from and including the date on which the
Prospectus Directive is implemented in that Relevant Member State, no offer of shares may be made to the public in that Relevant Member State other than: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">a)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">to any legal entity which is a qualified investor as defined in the Prospectus Directive; </font></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">b)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Directive), subject to obtaining the prior consent of the underwriters; or
</font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">c)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">in any other circumstances falling within Article 3(2) of the Prospectus Directive, </font></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">provided that no such offer of shares shall require the Company or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the
Prospectus Directive and each person who initially acquires any shares or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with each of the underwriters and the Company that it is a “qualified
investor” within the meaning of the law in that Relevant Member State implementing Article 2(1)(e) of the Prospectus Directive. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the case of any
shares being offered to a financial intermediary as that term is used in Article 3(2) of the Prospectus Directive, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares acquired by it in the
offer have not been acquired on <font style="white-space:nowrap">a&nbsp;non-discretionary&nbsp;basis</font> on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer
of any shares to the public other than their offer or resale in a Relevant Member State to qualified investors as so defined or in circumstances in which the prior consent of the representatives has been obtained to each such proposed offer or
resale. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For the purposes of this provision, the expression an “offer of shares to the public” in relation to any shares in any Relevant Member
State means the communication in any form and by means of sufficient information on </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">174 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
the terms of the offer and the shares to be offered so as to enable an investor to decide to purchase shares, as the same may be varied in that Member State by any measure implementing the
Prospectus Directive in that Member State, the expression “Prospectus Directive” means Directive 2003/71/EC (as amended, including by Directive 2010/73/EU), and includes any relevant implementing measure in the Relevant Member State.
</font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in the United Kingdom </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, and any offer subsequently made may only be directed at persons who are “qualified investors” (as
defined in the Prospectus Directive)&nbsp;(i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended, or the Order
and/or (ii)&nbsp;who are high net worth companies (or persons to whom it may otherwise be lawfully communicated) falling within Article 49(2)(a) to (d)&nbsp;of the Order (all such persons together being referred to as “relevant persons”)
or otherwise in circumstances which have not resulted and will not result in an offer to the public of the shares in the United Kingdom within the meaning of the Financial Services and Markets Act 2000. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Any person in the United Kingdom that is not a relevant person should not act or rely on the information included in this document or use it as basis for taking any
action. In the United Kingdom, any investment or investment activity that this document relates to may be made or taken exclusively by relevant persons. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in Canada </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The shares may be
sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National <font style="white-space:nowrap">Instrument&nbsp;45-106&nbsp;Prospectus</font> Exemptions or subsection 73.3(1) of the
Securities Act (Ontario), and are permitted clients, as defined in National <font style="white-space:nowrap">Instrument&nbsp;31-103&nbsp;Registration</font> Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares must
be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Securities
legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or
damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser’s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the
purchaser’s province or territory for particulars of these rights or consult with a legal advisor. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Pursuant to section 3A.3 of National <font style="white-space:nowrap">Instrument&nbsp;33-105&nbsp;Underwriting</font> Conflicts <font style="white-space:nowrap">(NI&nbsp;33-105),&nbsp;the</font> underwriters are not required to comply with the disclosure requirements of <font style="white-space:nowrap">NI&nbsp;33-105&nbsp;regarding</font> underwriter conflicts of interest in connection with this offering. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to
prospective investors in Switzerland </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange, or SIX
or on any other stock exchange or regulated trading facility in Switzerland. This document does not constitute a prospectus within the meaning of, and has been prepared without regard to the disclosure standards for issuance prospectuses under art.
652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither
this document nor any other offering or marketing material relating to the shares or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">175 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Neither this document nor any other offering or marketing material relating to the offering, the Company or the
shares has been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of shares will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA, or
FINMA, and the offer of shares has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes, or CISA. The investor protection afforded to acquirers of interests in collective investment schemes under the CISA
does not extend to acquirers of shares. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in the Dubai international financial centre, or DIFC </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">This document relates to an Exempt Offer in accordance with the Markets Rules 2012 of the Dubai Financial Services Authority, or DFSA. This document is intended for
distribution only to persons of a type specified in the Markets Rules 2012 of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt
Offers. The DFSA has not approved this prospectus supplement nor taken steps to verify the information set forth herein and has no responsibility for this document. The securities to which this document relates may be illiquid and/or subject to
restrictions on their resale. Prospective purchasers of the securities offered should conduct their own due diligence on the securities. If you do not understand the contents of this document you should consult an authorized financial advisor.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In relation to its use in the DIFC, this document is strictly private and confidential and is being distributed to a limited number of investors and
must not be provided to any person other than the original recipient, and may not be reproduced or used for any other purpose. The interests in the securities may not be offered or sold directly or indirectly to the public in the DIFC. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in the United Arab Emirates </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The shares have not been, and are not being, publicly offered, sold, promoted or advertised in the United Arab Emirates (including the Dubai International Financial
Centre) other than in compliance with the laws of the United Arab Emirates (and the Dubai International Financial Centre) governing the issue, offering and sale of securities. Further, this prospectus does not constitute a public offer of securities
in the United Arab Emirates (including the Dubai International Financial Centre) and is not intended to be a public offer. This prospectus has not been approved by or filed with the Central Bank of the United Arab Emirates, the Securities and
Commodities Authority or the Dubai Financial Services Authority. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in Australia </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">This prospectus:</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">does not constitute a product disclosure document or a prospectus under Chapter 6D.2 of the Corporations Act 2001 (Cth) of the Corporations Act;
</font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">has not been, and will not be, lodged with the Australian Securities and Investments Commission, or ASIC, as a disclosure document for the purposes of the
Corporations Act and does not purport to include the information required of a disclosure document under Chapter 6D.2 of the Corporations Act; </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">does not constitute or involve a recommendation to acquire, an offer or invitation for issue or sale, an offer or invitation to arrange the issue or sale, or an
issue or sale, of interests to a “retail client” (as defined in section 761G of the Corporations Act and applicable regulations) in Australia; and </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">may only be provided in Australia to select investors who are able to demonstrate that they fall within one or more of the categories of investors, or Exempt
Investors, available under section&nbsp;708 of the Corporations Act. </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">176 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The shares may not be directly or indirectly offered for subscription or purchased or sold, and no invitations to
subscribe for or buy the shares may be issued, and no draft or definitive offering memorandum, advertisement or other offering material relating to any shares may be distributed in Australia, except where disclosure to investors is not required
under Chapter 6D of the Corporations Act or is otherwise in compliance with all applicable Australian laws and regulations. By submitting an application for the shares, you represent and warrant to us that you are an Exempt Investor. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As any offer of shares under this document will be made without disclosure in Australia under Chapter 6D.2 of the Corporations Act, the offer of those securities
for resale in Australia within 12 months may, under section 707 of the Corporations Act, require disclosure to investors under Chapter 6D.2 if none of the exemptions in section 708 applies to that resale. By applying for the shares you undertake to
us that you will not, for a period of 12 months from the date of issue of the shares, offer, transfer, assign or otherwise alienate those securities to investors in Australia except in circumstances where disclosure to investors is not required
under Chapter 6D.2 of the Corporations Act or where a compliant disclosure document is prepared and lodged with ASIC. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective
investors in Japan </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The shares have not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial Instruments and Exchange
Act. Accordingly, none of the shares nor any interest therein may be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any “resident” of Japan (which term as used herein means any person resident in Japan,
including any corporation or other entity organized under the laws of Japan), or to others <font style="white-space:nowrap">for&nbsp;re-offering&nbsp;or</font> resale, directly or indirectly, in Japan or to or for the benefit of a resident of Japan,
except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Act and any other applicable laws, regulations and ministerial guidelines of Japan in effect at the
relevant time. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in Hong Kong </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The shares have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than (a)&nbsp;to “professional investors” as defined in the Securities and Futures
Ordinance (Cap. 571) of Hong Kong and any rules made under that Ordinance; or (b)&nbsp;in other circumstances which do not result in the document being a “prospectus” as defined in the Companies (Winding Up and Miscellaneous Provisions)
Ordinance (Cap. 32) of Hong Kong or which do not constitute an offer to the public within the meaning of that Ordinance. No advertisement, invitation or document relating to the shares has been or may be issued or has been or may be in the
possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities
laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to persons outside Hong Kong or only to “professional investors” as defined in the Securities and Futures Ordinance and any rules made
under that Ordinance. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Warning </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The contents of
this document have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation to the offer. If you are in any doubt about any of the contents of this document, you should obtain independent
professional advice. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in Singapore </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation
for </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">177 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
subscription or purchase, of shares may not be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether
directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor under Section&nbsp;274 of the Securities and Futures Act, Chapter 289 of Singapore, or the SFA, (ii)&nbsp;to a relevant person pursuant to
Section&nbsp;275(1), or any person pursuant to Section&nbsp;275(1A), and in accordance with the conditions specified in Section&nbsp;275 of the SFA, or (iii)&nbsp;otherwise pursuant to, and in accordance with the conditions of, any other applicable
provision of the SFA. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Where the shares are subscribed or purchased under Section&nbsp;275 of the SFA by a relevant person which is: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">a)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole business of which is to hold investments and the entire share capital of
which is owned by one or more individuals, each of whom is an accredited investor; or </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">b)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited
investor, </font></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">securities (as defined in Section&nbsp;239(1) of the SFA) of that corporation or the beneficiaries’ rights and interest
(howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the shares pursuant to an offer made under Section&nbsp;275 of the SFA except: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">a)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">to an institutional investor or to a relevant person defined in Section&nbsp;275(2) of the SFA, or to any person arising from an offer referred to in Section&nbsp;275(1A) or
Section&nbsp;276(4)(i)(B) of the SFA; </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">b)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">where no consideration is or will be given for the transfer; </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">c)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">where the transfer is by operation of law; </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">d)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">as specified in Section&nbsp;276(7) of the SFA; or </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">e)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures) Regulations 2005 of Singapore. </font></td></tr></tbody></table>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in Bermuda </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Shares may be
offered or sold in Bermuda only in compliance with the provisions of the Investment Business Act of 2003 of Bermuda which regulates the sale of securities in Bermuda.
<font style="white-space:nowrap">Additionally,&nbsp;non-Bermudian&nbsp;persons</font> (including companies) may not carry on or engage in any trade or business in Bermuda unless such persons are permitted to do so under applicable Bermuda
legislation. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in Saudi Arabia </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">This document may not be distributed in the Kingdom of Saudi Arabia except to such persons as are permitted under the Offers of Securities Regulations as issued by the board of the Saudi Arabian Capital Market
Authority, or CMA pursuant to resolution <font style="white-space:nowrap"><font style="white-space:nowrap">number&nbsp;2-11-2004&nbsp;dated</font></font> 4&nbsp;October 2004 as amended by resolution <font style="white-space:nowrap"><font style="white-space:nowrap">number&nbsp;1-28-2008,&nbsp;as</font></font> amended, or the CMA Regulations. The CMA does not make any representation as to the accuracy or completeness of this document and expressly disclaims any liability whatsoever
for any loss arising from, or incurred in reliance upon, any part of this document. Prospective purchasers of the securities offered hereby should conduct their own due diligence on the accuracy of the information relating to the securities. If you
do not understand the contents of this document, you should consult an authorised financial adviser. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in the British
Virgin Islands </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The shares may be offered to persons located in the British Virgin Islands who are “qualified investors” for the purposes
of SIBA. Qualified investors include (i)&nbsp;certain entities which are regulated by the Financial Services </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">178 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
Commission in the British Virgin Islands, including banks, insurance companies, licensees under SIBA and public, professional and private mutual funds; (ii)&nbsp;a company, any securities of
which are listed on a recognised exchange; and (iii)&nbsp;persons defined as “professional investors” under SIBA, which is any person (a)&nbsp;whose ordinary business involves, whether for that person’s own account or the account of
others, the acquisition or disposal of property of the same kind as the property, or a substantial part of the property of the Company; or (b)&nbsp;who has signed a declaration that he, whether individually or jointly with his spouse, has net worth
in excess of US$1,000,000 and that he consents to being treated as a professional investor. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in China </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">This prospectus does not constitute a public offer of shares, whether by sale or subscription, in the People’s Republic of China, or the PRC. The shares are
not being offered or sold directly or indirectly in the PRC to or for the benefit of, legal or natural persons of the PRC. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Further, no legal or natural
persons of the PRC may directly or indirectly purchase any of the shares or any beneficial interest therein without obtaining all prior PRC’s governmental approvals that are required, whether statutorily or otherwise. Persons who come into
possession of this document are required by the issuer and its representatives to observe these restrictions. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in
Korea </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The shares have not been and will not be registered under the Financial Investments Services and Capital Markets Act of Korea and the decrees
and regulations thereunder, or the FSCMA, and the shares have been and will be offered in Korea as a private placement under the FSCMA. None of the shares may be offered, sold or delivered directly or indirectly, or offered or sold to any person <font style="white-space:nowrap">for&nbsp;re-offering&nbsp;or</font> resale, directly or indirectly, in Korea or to any resident of Korea except pursuant to the applicable laws and regulations of Korea, including the FSCMA and the Foreign Exchange
Transaction Law of Korea and the decrees and regulations thereunder, or the FETL. Furthermore, the purchaser of the shares shall comply with all applicable regulatory requirements (including but not limited to requirements under the FETL) in
connection with the purchase of the shares. By the purchase of the shares, the relevant holder thereof will be deemed to represent and warrant that if it is in Korea or is a resident of Korea, it purchased the shares pursuant to the applicable laws
and regulations of Korea. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in Malaysia </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">No prospectus or other offering material or document in connection with the offer and sale of the shares has been or will be registered with the Securities Commission of Malaysia, or Commission for the
Commission’s approval pursuant to the Capital Markets and Services Act 2007. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares may not
be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Malaysia other than (i)&nbsp;a closed end fund approved by the
Commission; (ii)&nbsp;a holder of a Capital Markets Services Licence; (iii)&nbsp;a person who acquires the shares, as principal, if the offer is on terms that the shares may only be acquired at a consideration of not less than RM250,000 (or its
equivalent in foreign currencies) for each transaction; (iv)&nbsp;an individual whose total net personal assets or total net joint assets with his or her spouse exceeds RM3&nbsp;million (or its equivalent in foreign currencies), excluding the value
of the primary residence of the individual; (v)&nbsp;an individual who has a gross annual income exceeding RM300,000 (or its equivalent in foreign currencies) per annum in the preceding twelve months; (vi)&nbsp;an individual who, jointly with his or
her spouse, has a gross annual income of RM400,000 (or its equivalent in foreign currencies), per annum in the preceding twelve months; </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">179 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
(vii)&nbsp;a corporation with total net assets exceeding RM10&nbsp;million (or its equivalent in a foreign currencies) based on the last audited accounts; (viii)&nbsp;a partnership with total net
assets exceeding RM10&nbsp;million (or its equivalent in foreign currencies); (ix)&nbsp;a bank licensee or insurance licensee as defined in the Labuan Financial Services and Securities Act 2010; (x)&nbsp;an Islamic bank licensee or takaful licensee
as defined in the Labuan Financial Services and Securities Act 2010; and (xi)&nbsp;any other person as may be specified by the Commission; provided that, in the each of the preceding categories&nbsp;(i) to (xi), the distribution of the shares is
made by a holder of a Capital Markets Services Licence who carries on the business of dealing in securities. The distribution in Malaysia of this prospectus is subject to Malaysian laws. This prospectus does not constitute and may not be used for
the purpose of public offering or an issue, offer for subscription or purchase, invitation to subscribe for or purchase any securities requiring the registration of a prospectus with the Commission under the Capital Markets and Services Act 2007.
</font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in Taiwan </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The
shares have not been and will not be registered with the Financial Supervisory Commission of Taiwan pursuant to relevant securities laws and regulations and may not be sold, issued or offered within Taiwan through a public offering or in
circumstances which constitutes an offer within the meaning of the Securities and Exchange Act of Taiwan that requires a registration or approval of the Financial Supervisory Commission of Taiwan. No person or entity in Taiwan has been authorised to
offer, sell, give advice regarding or otherwise intermediate the offering and sale of the shares in Taiwan. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Notice to prospective investors in South
Africa </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Due to restrictions under the securities laws of South Africa, the shares are not offered, and the offer shall not be transferred, sold,
renounced or delivered, in South Africa or to a person with an address in South Africa, unless one or other of the following exemptions applies: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">a)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">the offer, transfer, sale, renunciation or delivery is to: </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">i)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">persons whose ordinary business is to deal in securities, as principal or agent; </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">ii)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">the South African Public Investment Corporation; </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">iii)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">persons or entities regulated by the Reserve Bank of South Africa; </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">iv)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">authorised financial service providers under South African law; </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">v)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">financial institutions recognised as such under South African law; </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">vi)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">a wholly-owned subsidiary of any person or entity contemplated in (c), (d) or (e), acting as agent in the capacity of an authorised portfolio manager for a pension fund or
collective investment scheme (in each case duly registered as such under South African law); or </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="4%"><font size="1">&nbsp;</font></td>
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">vii)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">any combination of the person in (a)&nbsp;to (f); or </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">b)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">the total contemplated acquisition cost of the securities, for any single addressee acting as principal is equal to or greater than ZAR 1,000,000. </font></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">No “offer to the public” (as such term is defined in the South African Companies Act, No.&nbsp;71 of 2008 (as amended
<font style="white-space:nowrap">or&nbsp;re-enacted),</font> or the South African Companies Act) in South Africa is being made in connection with the issue of the shares. Accordingly, this document does not, nor is it intended to, constitute a
“registered prospectus” (as that term is defined in the South African Companies Act) prepared and registered under the </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">180 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
South African Companies Act and has not been approved by, and/or filed with, the South African Companies and Intellectual Property Commission or any other regulatory authority in South Africa.
Any issue or offering of the shares in South Africa constitutes an offer of the shares in South Africa for subscription or sale in South Africa only to persons who fall within the exemption from “offers to the public” set out in section
96(1)(a) of the South African Companies Act. Accordingly, this document must not be acted on or relied on by persons in South Africa who do not fall within section 96(1)(a) of the South African Companies Act (such persons being referred to as
“SA Relevant Persons”). Any investment or investment activity to which this document relates is available in South Africa only to SA Relevant Persons and will be engaged in South Africa only with SA relevant persons. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_20"></a>Legal matters </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The validity of
the issuance of our common stock offered in this prospectus will be passed upon for us by Orrick, Herrington&nbsp;&amp; Sutcliffe LLP, 1000 Marsh Road, Menlo Park, California 94025. Latham&nbsp;&amp; Watkins LLP, 140 Scott Drive, Menlo Park,
California 94025, is acting as counsel for the underwriters in connection with this offering. Orrick, Herrington&nbsp;&amp; Sutcliffe LLP and certain attorneys and investment funds affiliated with the firm own shares of our preferred stock which
will be converted into an aggregate of 376,717 shares of common stock immediately prior to the completion of this offering. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_21"></a>Experts </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The consolidated
financial statements as of September&nbsp;30, 2017 and 2016 and for each of the two years in the period ended September&nbsp;30, 2017 included in this prospectus have been so included in reliance on the report (which contains an explanatory
paragraph relating to the Company’s ability to continue as a going concern as described in Note&nbsp;1 to the consolidated financial statements) of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the
authority of said firm as experts in auditing and accounting. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_22"></a>Where you can find more information </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">We have filed with the Securities and Exchange Commission a registration statement on Form <font style="white-space:nowrap">S-1</font> under the Securities Act with
respect to this offering of our common stock. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement, some items of which are contained in exhibits to
the registration statement as permitted by the rules and regulations of the Securities and Exchange Commission. For further information with respect to us and our common stock, we refer you to the registration statement, including the exhibits and
the financial statements and notes filed as a part of the registration statement. Statements contained in this prospectus concerning the contents of any contract or any other document are not necessarily complete. If a contract or document has been
filed as an exhibit to the registration statement, please see the copy of the contract or document that has been filed. Each statement in this prospectus relating to a contract or document filed as an exhibit is qualified in all respects by the
filed exhibit. The exhibits to the registration statement should be referenced for the complete contents of these contracts and documents. You may obtain copies of this information by mail from the Public Reference Section of the Securities and
Exchange Commission, 100 F Street, N.E., Room 1580, Washington, D.C. 20549, at prescribed rates. You may obtain information on the operation of the public reference rooms by calling the Securities and Exchange Commission at <font style="white-space:nowrap"><font style="white-space:nowrap"><font style="white-space:nowrap">1-800-SEC-0330.</font></font></font> The Securities and Exchange Commission also maintains an Internet website that contains reports, proxy statements and
other information about issuers, like us, that file electronically with the Securities and Exchange Commission. The address of that website is www.sec.gov. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">181 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">As a result of this offering, we will become subject to the information and reporting requirements of the
Exchange Act and, in accordance with this law, will file periodic reports, proxy statements and other information with the Securities and Exchange Commission. These periodic reports, proxy statements and other information will be available for
inspection and copying at the Securities and Exchange Commission’s public reference facilities and the website of the Securities and Exchange Commission referred to above. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">182 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b>Twist Bioscience Corporation </b></font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="toc460243_23"></a>Index to consolidated financial statements </b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="94%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>INDEX TO AUDITED CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2016 AND 2017</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#fin460243_1">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">F-2</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#fin460243_1a">CONSOLIDATED BALANCE SHEETS AS OF SEPTEMBER 30, 2016 AND 2017 </a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2"><font style="white-space:nowrap">F-3</font></font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#fin460243_2">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS FOR THE YEARS ENDED SEPTEMBER 30, 2016 AND 2017
</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2"><font style="white-space:nowrap">F-4</font></font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#fin460243_3">CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT AS OF SEPTEMBER 30, 2016
AND 2017 </a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2"><font style="white-space:nowrap">F-5</font></font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#fin460243_4">CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED SEPTEMBER 30, 2016 AND<br>2017 </a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2"><font style="white-space:nowrap">F-6</font></font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#fin460243_5">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED SEPTEMBER 30, 2016 AND 2017 </a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2"><font style="white-space:nowrap">F-7</font></font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2018 AND FOR THE NINE MONTHS ENDED JUNE 30, 2017 AND
2018</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#fin460243_7">CONDENSED CONSOLIDATED BALANCE SHEETS AS OF SEPTEMBER 30, 2017 AND JUNE 30, 2018 (UNAUDITED) </a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">F-37</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#fin460243_8">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS FOR THE NINE MONTHS ENDED JUNE 30, 2017 AND 2018
 (UNAUDITED)</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">F-38</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#fin460243_9">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE NINE MONTHS ENDED JUNE 30, 2017 AND 2018
(UNAUDITED)</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">F-39</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#fin460243_10">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED JUNE&nbsp;
30, 2017 AND 2018 (UNAUDITED)</a></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">F-40</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-1 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="5"><b><a name="fin460243_1"></a>Report of Independent Registered Public Accounting Firm
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">To the Board of Directors and Stockholders of Twist Bioscience Corporation </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In our opinion, the accompanying consolidated balance sheets and the related consolidated statements of operations and comprehensive loss, of redeemable convertible preferred stock and stockholders’ deficit
and of cash flows present fairly, in all material respects, the financial position of Twist Bioscience Corporation and its subsidiaries as of September&nbsp;30, 2017 and 2016, and the results of their operations and their cash flows for the years
then ended in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these
financial statements based on our audits. We conducted our audits of these financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the
consolidated financial statements, the Company has generated net losses and negative cash flows since inception that raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are
also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As discussed
in Note 2 to the consolidated financial statements, the Company changed the manner in which it accounts for revenue from contracts with customers in 2018. </font></p> <p style="margin-top:24px;margin-bottom:0px"><font style="font-family:arial" size="2">/s/ PricewaterhouseCoopers LLP </font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">San Jose, California </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">February 8, 2018, except for the effects of the change in the manner in which the Company accounts for revenue from contracts with customers as discussed in Note 2 to the consolidated financial statements, as to
which the date is September 11, 2018. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-2 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="4"><b>Twist Bioscience Corporation </b></font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="4"><b><a name="fin460243_1a"></a>Consolidated balance sheets </b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="81%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>(In thousands, except share and per share amounts)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>September&nbsp;30,<br>2016</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>September&nbsp;30,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td colspan="2" valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td colspan="2" valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1"><b>Assets</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Current assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Cash and cash equivalents</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">28,596</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">31,227</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Short-term investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">27,324</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">30,977</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Accounts receivable, net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">723</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,346</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Inventory</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,228</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,827</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Prepaid expenses and other current assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,168</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,492</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total current assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">59,039</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">67,869</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Property and equipment, net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">14,617</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">14,834</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Goodwill</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,138</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,138</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Intangible assets, net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,133</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">920</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Restricted cash, <font style="white-space:nowrap">non-current</font></font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">322</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">202</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Other <font style="white-space:nowrap">non-current</font> assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">214</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">694</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">76,463</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">85,657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Current liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Accounts payable</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,337</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,849</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Accrued expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,218</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,092</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Accrued payroll</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,403</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">3,470</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Current portion of long-term debt</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,367</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Other current liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">353</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,066</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total current liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">8,678</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9,477</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Redeemable convertible preferred stock warrant liability</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">383</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">644</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Long-term debt, net of current portion</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9,814</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9,154</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Other <font style="white-space:nowrap">non-current</font> liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">162</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">107</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">19,037</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">19,382</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Commitments and contingencies (Note 8)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Redeemable convertible preferred stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Series A redeemable convertible preferred stock, $0.00001 par value—28,263,133 shares authorized as of September&nbsp;30, 2016 and
2017; 27,898,391 shares issued and outstanding as of September&nbsp;30, 2016 and 2017. (Liquidation preference of $9,111 as of September&nbsp;30, 2016 and 2017)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9,141</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9,141</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Series B redeemable convertible preferred stock, $0.00001 par value—32,988,887 shares authorized as of September&nbsp;30, 2016 and
2017; 32,828,281 shares issued and outstanding as of September&nbsp;30, 2016 and 2017. (Liquidation preference of $26,000 as of September&nbsp;30, 2016 and 2017)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">25,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">25,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Series C redeemable convertible preferred stock, $0.00001 par value—24,854,989 shares authorized as of September&nbsp;30, 2016 and
2017; 24,668,310 shares issued and outstanding as of September&nbsp;30, 2016 and 2017. (Liquidation preference of $37,000 as of September&nbsp;30, 2016 and 2017)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">36,726</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">36,726</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Series D redeemable convertible preferred stock, $0.00001 par value—30,442,280 and 64,124,559 shares authorized as of
September&nbsp;30, 2016 and 2017, respectively; 29,096,365 and 59,743,942 shares issued and outstanding as of September&nbsp;30, 2016 and 2017, respectively. (Liquidation preference of $62,432 and $128,193 as of September&nbsp;30, 2016 and 2017,
respectively)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">62,270</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">127,866</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total redeemable convertible preferred stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">134,037</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">199,633</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Stockholders’ equity (deficit)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Common stock, $0.00001 par value—165,000,000 and 210,000,000 shares authorized at September&nbsp;30, 2016 and September&nbsp;30, 2017,
respectively; 31,151,358 and 31,474,045 shares issued and outstanding at September&nbsp;30, 2016 and 2017, respectively. </font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Additional <font style="white-space:nowrap">paid-in</font> capital</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">3,689</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">6,228</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Accumulated other comprehensive income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">33</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Accumulated deficit</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(80,309</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(139,619</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total stockholders’ equity (deficit)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(76,611</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(133,358</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">76,463</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">85,657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">The accompanying notes are an integral part of these consolidated financial statements. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-3 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b>Twist Bioscience Corporation </b></font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="fin460243_2"></a>Consolidated statements of operations and comprehensive loss </b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="72%"></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Year ended September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(In thousands, except share and per share amounts)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,767</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Operating expenses:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cost of revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,421</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,230</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">19,169</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Selling, general and administrative</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,274</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,060</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total operating expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">45,925</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">69,249</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss from operations</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(43,656</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(58,482</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">241</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">412</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest expense</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(746</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(905</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other income (expense), net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">73</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(55</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss before income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,030</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Provision for income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(280</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other comprehensive loss:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Change in unrealized gain (loss) on investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(9</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Foreign currency translation adjustment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">33</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Comprehensive loss</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,079</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,286</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss per share attributable to common stockholders—basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2.38</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2.47</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Weighted average shares used in computing net loss per share attributable to common stockholders—basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,511,202</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,982,605</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Pro forma net loss per share—basic and diluted (unaudited)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(0.39</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">Pro forma weighted-average shares used in computing pro forma net loss per share—basic and diluted (unaudited)</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">152,397,059</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">The accompanying notes are an integral part of these consolidated financial statements. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-4 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="4"><b>Twist Bioscience Corporation </b></font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="4"><b><a name="fin460243_3"></a>Consolidated statements of redeemable convertible preferred stock and stockholders’ deficit </b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="32%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom"></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Series
A</b></font><br><font style="font-family:arial" size="1"><b>convertible</b></font><br><font style="font-family:arial" size="1"><b>preferred stock</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Series
B</b></font><br><font style="font-family:arial" size="1"><b>convertible</b></font><br><font style="font-family:arial" size="1"><b>preferred stock</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Series
C</b></font><br><font style="font-family:arial" size="1"><b>convertible</b></font><br><font style="font-family:arial" size="1"><b>preferred stock</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Series
D</b></font><br><font style="font-family:arial" size="1"><b>convertible</b></font><br><font style="font-family:arial" size="1"><b>preferred stock</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-RIGHT:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Common stock</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" rowspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Additional</b></font><br><font style="font-family:arial" size="1"><b>paid-in</b></font><br><font style="font-family:arial" size="1"><b>capital</b></font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" rowspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Other</b></font><br><font style="font-family:arial" size="1"><b>comprehensive</b></font><br><font style="font-family:arial" size="1"><b>income</b></font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" rowspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Accumulated</b></font><br><font style="font-family:arial" size="1"><b>deficit</b></font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" rowspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Total</b></font><br><font style="font-family:arial" size="1"><b>stockholders’</b></font><br><font style="font-family:arial" size="1"><b>deficit</b></font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>(In thousands, except share data)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>Shares</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>Amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>Shares</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>Amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>Shares</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>Amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>Shares</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>Amount</b></font></td>
<td valign="bottom" style=" BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>Shares</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>Amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Balances as of September 30, 2015</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">27,898,391</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9,141</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">32,828,281</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">25,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">24,668,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">36,726</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">23,665,455</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">315</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(36,221</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(35,906</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="53" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Issuance of Series D redeemable convertible preferred stock, net of financing costs of $162</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1"><b></b>&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1"><b></b>—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1"><b></b>&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1"><b></b>&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1"><b></b>—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1"><b></b>&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">29,096,365</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">62,270</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Issuance of common stock to owners of Genome Compiler Corporation</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">3,990,593</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,400</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,400</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Issuance of restricted common stock to employees</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">3,170,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">160</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">160</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Vesting of restricted common stock issued to member of the Board of Directors</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">7</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">7</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Exercise of stock options</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">390,727</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">110</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">110</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Repurchase of early exercised stock options</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(65,417</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Stock based compensation</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">697</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">697</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Other comprehensive income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Net loss</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(44,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(44,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="53" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Balances as of September 30, 2016</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">27,898,391</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9,141</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">32,828,281</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">25,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">24,668,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">36,726</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">29,096,365</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">62,270</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">31,151,358</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">3,689</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(80,309</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(76,611</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="53" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Issuance of Series D redeemable convertible preferred stock, net of financing costs of $165</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">30,647,577</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">65,596</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Vesting of restricted common stock issued to member of the Board of Directors</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">4</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">4</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Exercise of stock options</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">322,687</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">162</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">162</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Issuance of common stock warrants</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">486</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">486</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Stock based compensation</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,887</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,887</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Other comprehensive income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">24</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">24</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Net loss</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(59,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(59,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="53" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Balances as of September 30, 2017</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">27,898,391</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9,141</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">32,828,281</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">25,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">24,668,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">36,726</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">59,743,942</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">127,866</font></td>
<td nowrap="" valign="bottom" style="BORDER-RIGHT:1px solid #000000"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">31,474,045</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">6,228</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">33</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(139,619</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(133,358</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="56" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">The accompanying notes are an integral part of these consolidated financial statements. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-5 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b>Twist Bioscience Corporation </b></font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="fin460243_4"></a>Consolidated statements of cash flows </b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="82%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Year ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Cash flows from operating activities</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Adjustments to reconcile net loss to net cash used in operating activities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Depreciation and amortization</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,229</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,021</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss on disposal of property and equipment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">507</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Stock-based compensation</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">857</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,891</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><font style="white-space:nowrap">Non-cash</font> interest expense</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">160</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">363</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Change in fair value of redeemable convertible preferred stock warrant liability</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(68</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">261</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Amortization of debt discount</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">78</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">95</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Changes in assets and liabilities, net of impact of business combination:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accounts receivable</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(702</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1,623</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Inventory</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1,228</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(599</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Prepaid expenses and other current assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(318</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(324</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other <font style="white-space:nowrap">non-current</font> assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(221</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(481</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accounts payable</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">466</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">560</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accrued expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,016</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">621</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accrued payroll</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">982</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,067</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">245</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">650</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net cash used in operating activities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(38,592</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Cash flows from investing activities</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Purchases of property and equipment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(6,229</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(6,594</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Proceeds from sale of property and equipment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">266</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Purchases of investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(27,290</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(40,587</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Maturity of investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">36,925</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Change in restricted cash</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(80</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">120</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash acquired through business combination</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">254</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net cash used in investing activities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(33,345</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(9,870</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Cash flows from financing activities</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Proceeds from issuance of common stock and exercise of stock options</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">152</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">205</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">62,270</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">65,596</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Borrowings of long-term debt</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,652</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,174</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Repayments on long-term debt</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(426</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(4,173</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net cash provided by financing activities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">69,648</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">63,802</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net increase (decrease) in cash and cash equivalents</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2,289</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,631</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash and cash equivalents at beginning of year</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">30,885</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,596</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash and cash equivalents at end of period</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,596</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">31,227</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td colspan="8" valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Supplemental disclosure of cash flow information</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest paid</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">391</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">702</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Income taxes paid</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b><font style="white-space:nowrap">Non-cash</font> investing and financing activities</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Property and equipment additions included in accrued liabilities and accounts payable</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,079</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">285</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Fair value of warrants issued in connection with debt</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">182</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">486</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Fair value of common stock issued to owners of Genome Compiler Corporation</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,400</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">The accompanying notes are an integral part of these consolidated financial statements. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-6 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b>Twist Bioscience Corporation </b></font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="fin460243_5"></a>Notes to consolidated financial statements </b></font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>1. The company </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Twist Bioscience Corporation (the Company) was incorporated in the state of Delaware on February&nbsp;4, 2013. The Company is a synthetic biology company that has
developed a disruptive DNA synthesis platform. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">DNA is used in many applications across different industries: industrial chemicals, academic, healthcare
and agriculture. For the first two years of its existence, the Company focused on business planning, research, recruiting, raising capital, building prototypes, proving its technology, and preparing for commercial launch. The Company began
generating revenues from the sale of synthetic DNA in April 2016. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In April 2016, the Company acquired Genome Compiler Corporation (GCC), a company with
research and development operations in Israel, to supplement the Company’s digital biology workflow. Aggregate consideration of 4.0&nbsp;million&nbsp;shares of the Company’s common stock were issued to the holders of the outstanding shares
of the acquired company in connection with the acquisition. The Company is utilizing GCC’s technology and expertise to grow its digital products portfolio, including its <font style="white-space:nowrap">e-commerce</font> solution with gene
design capabilities. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company has a limited operating history and its prospects are subject to risks, expenses and uncertainties frequently
encountered by companies in this industry. These risks include, but are not limited to, the uncertainty of availability of additional financing, market acceptance of its products, the ability to retain and attract new customers, and the uncertainty
of achieving future profitability. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company has generated net losses in all periods since inception. As of September&nbsp;30, 2017, the Company had
an accumulated deficit of $139.6&nbsp;million and has not generated positive cash flows from operations since inception. Losses are expected to continue as the Company continues to invest in product development, manufacturing, and sales and
marketing. Based on its recurring losses from operations incurred since inception, expectation of continuing operating losses for the foreseeable future, and need to raise additional capital to finance its future operations, the Company has
concluded that there is substantial doubt about its ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company has raised multiple rounds of debt and equity financing, including an aggregate of $65.6&nbsp;million from the sale of preferred stock between March and September of 2017. However, there can be no
assurance that additional financing will be successful in raising additional capital or that such capital, if available, will be on terms which are acceptable to us. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">If the Company is unable to obtain funding, the Company could be forced to delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or commercialization efforts,
which could adversely affect its business prospects, or the Company may be unable to continue operations.&nbsp;&nbsp;&nbsp;&nbsp;Failure to raise additional capital or generate sufficient cash flows from operations could have a material adverse
effect on the Company’s ability to achieve its intended business objectives. Although management continues to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to
the Company to fund continuing operations, if at all. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The accompanying consolidated financial statements do not include any adjustments that might
result from the outcome of this uncertainty. Accordingly, the consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction
of liabilities and commitments in the ordinary course of business. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-7 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>2. Summary of significant accounting policies </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Basis of presentation and use of estimates </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The presentation of consolidated financial statements in
conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and
liabilities as of the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates include the valuation of deferred tax assets, stock-based compensation expense, and the
fair value of the Company’s common stock and redeemable convertible preferred stock warrant liabilities. Actual results could differ from those estimates. The Company’s consolidated financial statements include its wholly-owned
subsidiaries. All intercompany balances and accounts are eliminated in consolidation. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Risks and uncertainties </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company relies on third parties for the supply and manufacture of its products, as well as third-party logistics providers. In instances where these parties
fail to perform their obligations, the Company may be unable to find alternative suppliers to satisfactorily deliver its products to its customers on time, if at all. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company operates in a dynamic and highly competitive industry and believes that changes in any of the following areas could have a material adverse effect on the Company’s future financial position,
results of operations, or cash flows; ability to obtain future financing; advances and trends in new technologies and industry standards; market acceptance of the Company’s products; development of sales channels; certain strategic
relationships; litigation or claims against the Company regarding intellectual property, patent, product, regulatory, or other factors; and the ability to attract and retain employees necessary to support its growth. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company has expended and expects to continue to expend substantial funds to complete the research and development of its production process. The Company may
require additional funds to commercialize its products and may be unable to entirely fund these efforts with its current financial resources. Additional funds may not be available on acceptable terms, if at all. If adequate funds are unavailable on
a timely basis from operations or additional sources of financing, the Company may have to delay the sale of the Company’s products and services which would materially and adversely affect its business, financial condition and operations.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Concentration of credit risk </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Financial
instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, short-term investments and accounts receivable. Substantially all of the Company’s cash is held by one financial
institution that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits. The Company’s investment policy addresses the level of credit exposure by establishing a minimum allowable credit
rating and by limiting the concentration in any one investment. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company’s accounts receivable is derived from customers located principally in
the United States. The Company maintains credit insurance for certain of its customer balances, performs ongoing credit evaluations of its customers, and maintains allowances for potential credit losses on customers’ accounts when deemed
necessary. The Company does not typically require collateral from its customers. Credit losses historically have not been material. The Company continuously monitors customer payments and maintains an allowance for doubtful accounts based on its
assessment of various factors including historical experience, age of the receivable balances, and other current economic conditions or other factors that may affect customers’ ability to pay. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-8 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Customer concentration </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Customers that accounted for equal to or greater than 10% of total revenues were as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="86%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Customer A</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">30%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">40%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Customer B</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">11%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">One customer accounted for greater than 10% of net accounts receivable as follows: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="86%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Customer A</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">41%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">35%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Cash and cash equivalents </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Cash equivalents that are readily convertible to cash are stated at cost, which approximates fair value. The Company considers all highly liquid investments with an original or remaining maturity of three months or
less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of investments in money market funds as of September&nbsp;30, 2016 and 2017. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Short-term investments </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company invests in various types of securities, including United States
government, commercial paper, and corporate debt securities. It classifies its investments as <font style="white-space:nowrap"><font style="white-space:nowrap">available-for-sale</font></font> and records them at fair value based upon market prices
at period end. Unrealized gains and losses that are deemed temporary in nature are recorded in accumulated other comprehensive income (loss) as a separate component of stockholders’ equity (deficit). Dividend and interest income are recognized
when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of investments sold. The Company may sell these securities at any time for use in current operations.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Accounts receivable </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Trade receivables
include amounts billed and currently due from customers, recorded at the net invoice value and are not interest bearing. The amounts due are stated at their net estimated realizable value. The Company maintains an allowance for doubtful accounts to
provide for the estimated amounts of receivables that will not be collected. The allowance is based upon an assessment of customer creditworthiness, historical payment experience, the age of outstanding receivables and collateral to the extent
applicable. The Company <font style="white-space:nowrap">re-evaluates</font> such allowance on a regular basis and adjusts its allowance as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the allowance. The
Company did not record any allowance for doubtful accounts as of September 30, 2016 and 2017. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company’s accounts receivable balance consists of
the following: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="86%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Trade Receivables</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">664</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,237</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other Receivables</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">59</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">109</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accounts Receivable</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">723</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,346</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-9 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company has a short
<font style="white-space:nowrap"><font style="white-space:nowrap">order-to-invoice</font></font> lifecycle, as most products can be manufactured within one month. Upon delivery of the products to the customer, the Company invoices the customer. The
typical timing of payment is net 30 days, with some customers having payment terms of net 90 days. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Fair value of financial instruments
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The carrying amounts of the Company’s financial instruments including cash equivalents, accounts payable and accrued liabilities
approximate fair value due to their relatively short maturities. The carrying amounts of the redeemable convertible preferred stock warrant liability represent their fair values. Based on the borrowings rates currently available to the Company for
loans with similar terms, the carrying value of the Company’s long-term debt approximates its fair value (level 2 within the fair value hierarchy). </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Inventory </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Inventory is stated at the lower of cost or
net realizable value. Cost is determined using the <font style="white-space:nowrap">first-in,</font> <font style="white-space:nowrap">first-out</font> method. Determining net realizable value of inventory involves judgments and assumptions,
including projecting selling prices and costs to sell. Provisions are made to reduce excess and obsolete inventories to their estimated net realizable value based on forecasted demand, past experience, the age and nature of inventories. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Property and equipment </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Property and equipment are
stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets or the remaining lease term of the respective leasehold improvements assets, if any. The Company recorded depreciation expense of
$4.1&nbsp;million and $4.8&nbsp;million as of September&nbsp;30, 2016 and 2017, respectively. Estimated lives of property and equipment are as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="51%"></td>
<td valign="bottom" width="2%"></td>
<td width="47%"></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top" style="BORDER-TOP:2px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Laboratory equipment</font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000"><font style="font-family:arial" size="2">5 Years</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Furniture, fixtures and other equipment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">5 Years</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Computer equipment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">3 Years</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Computer software</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">3 Years</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Leasehold improvements</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">Lesser of useful life or facilities’ lease term.</font></td></tr>
<tr style="font-size:1px">
<td colspan="3" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized and depreciated through
the life of the lease. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in operations in the period realized. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Capitalized software development costs </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Costs
associated with <font style="white-space:nowrap">internal-use</font> software systems, including those <font style="white-space:nowrap">to&nbsp;improve&nbsp;e-commerce</font> capabilities, during the application development stage are capitalized.
Capitalization of costs begins when the preliminary project stage is completed, management has committed to funding the project, and it is probable that the project will be completed and the software will be used to perform the function intended.
Capitalization ceases at the point when the project is substantially complete and is ready for its intended purpose. The capitalized amounts are included in property and equipment, net on the consolidated balance sheets. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Capitalized software development costs, net, were $1.3&nbsp;million as of September&nbsp;30, 2017. The Company did not have any capitalized software development
costs in prior years. Capitalized costs are amortized using the straight-line method over an estimated useful life of the assets, which is three years. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-10 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Long-lived assets </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company reviews property and equipment and intangibles for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured
by comparison of the carrying amount to the future undiscounted cash flows which the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying
amount of the assets exceeds the projected discounted future net cash flows arising from the asset. There have been no such impairments of long-lived assets during the years ended September&nbsp;30, 2016 and 2017. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Business combinations </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Assets acquired and liabilities
assumed as part of a business combination are generally recorded at their fair value at the date of acquisition. The excess of purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Determining the
fair value of identifiable assets, particularly intangible assets acquired, and liabilities assumed requires management to make estimates, which are based on all available information and in some cases assumptions with respect to the timing and
amount of future revenues and expenses associated with an asset. Costs to effect an acquisition are recorded in general and administrative expenses in the consolidated statements of operations and comprehensive loss as the expenses are incurred.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Goodwill and purchased intangible assets </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Goodwill is evaluated for impairment annually or more frequently if events or changes in circumstances indicate that the carrying value of the asset may not be
recoverable. If, based on a qualitative assessment, the Company determines it is more likely than not that goodwill is impaired, a quantitative assessment is performed to determine if the fair value of the Company’s sole reporting unit is less
than its carrying value. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Purchased intangible assets with finite lives are generally amortized over their estimated useful lives using the straight-line
method. The Company reviews intangible assets for impairment whenever events or changes in business circumstances indicate that the carrying amounts of the assets may not be fully recoverable. Impairment assessments inherently involve judgment as to
assumptions about expected future cash flows and the impact of market conditions on those assumptions. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Segment information </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company has one business activity, which is manufacturing of synthetic DNA using its semiconductor based silicon platform and operates as one reportable and
operating segment. The Company’s chief operating decision-maker, its Chief Executive Officer (CEO), reviews the Company’s operating results on an aggregate basis for purposes of allocating resources and evaluating financial performance.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Revenue recognition </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Effective
October&nbsp;1, 2017, the Company elected to early adopt the requirements of Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts with Customers</i> using the full retrospective method. The Company evaluated the impact on revenues,
loss from operations, net loss attributable to common stockholders and basic and diluted earnings per share for all periods presented and concluded that there was no material impact on the Company’s consolidated financial statements for all
periods presented. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company’s revenue is generated through the sale of synthetic biology tools, such as synthetic genes, or clonal genes and
fragments, oligonucleotides pools, or oligo pools, next generation sequencing, or NGS tools and DNA libraries. The Company accounts for a contract when it has approval and commitment from both
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-11 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Contracts with customers are generally in the written form of a purchase order or a quotation, which outline the promised goods and the agreed upon price. Such
orders are often accompanied by a Master Supply or Distribution Agreement that establishes the terms and conditions, rights of the parties, delivery terms, and pricing. The Company assesses collectability based on a number of factors, including past
transaction history and creditworthiness of the customer. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For all of the Company’s contracts to date, the customer orders a specified quantity of a
synthetic DNA sequence; therefore, the delivery of the ordered quantity per the purchase order is accounted for as one performance obligation. Some contracts may contain prospective discounts when certain order quantities are exceeded; however,
these future discounts are either not significant, not deemed to be incremental to the pricing offered to other customers, or not enforceable options to acquire additional goods. As a result, these discounts do not constitute a material right and do
not meet the definition of a separate performance obligation. The Company does not offer retrospective discounts or rebates. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The transaction price is
determined based on the agreed upon rates in the purchase order or master supply agreements applied to the quantity of synthetic DNA that was manufactured and shipped to the customer. The Company’s contracts include only one performance
obligation – the delivery of the product to the customer. Accordingly, all of the transaction price, net of any discounts, is allocated to the one performance obligation. Therefore, upon delivery of the product, there are no remaining
performance obligations. The Company’s shipping and handling activities are considered a fulfillment cost. The Company has elected to exclude all sales and value added taxes from the measurement of the transaction price. The Company has not
adjusted the transaction price for significant financing since the time period between the transfer of goods and payment is less than one year. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The
Company recognizes revenue at a point in time when control of the products is transferred to the customer. Management applies judgment in evaluating when a customer obtains control of the promised good which is generally when the product is shipped
or delivered to the customer. The Company’s customer contracts generally include a standard assurance warranty to guarantee that its products comply with agreed specifications. The Company reduces revenue by the amount of expected returns which
have been insignificant. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company has elected the practical expedient to not disclose the consideration allocated to remaining performance
obligations and an explanation of when those amounts are expected to be recognized as revenue since the duration of the contracts is less than one year. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Refer to Note 17 for the disaggregation of revenues by geography and by product. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Revenues by industry were as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="77%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years&nbsp;ended&nbsp;September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Industrial chemicals</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">960</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,702</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Academic research</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">830</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,709</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Healthcare</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">461</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,226</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Agricultural</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">130</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,767</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company does not have any contract assets or contract liabilities as of September&nbsp;30, 2016 and 2017. For all periods
presented, the Company did not recognize revenue from amounts that were included in the contract </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-12 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
liability balance at the beginning of each period. In addition, for all periods presented, there was no revenue recognized in a reporting period from performance obligations satisfied in previous
periods. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Based on the nature of the Company’s contracts with customers which are recognized over a term of less than 12 months, the Company has
elected to use the practical expedient whereby costs to obtain a contract are expensed as they are incurred. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Research and development
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Research and development expenses consist of compensation costs, employee benefits, subcontractors, research supplies, allocated facility
related expenses and allocated depreciation and amortization. All research and development costs are expensed as incurred. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Advertising costs
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Costs related to advertising and promotions are expensed to sales and marketing as incurred. Advertising and promotion expenses for the years
ended September&nbsp;30, 2016 and 2017, were $0.2&nbsp;million and $0.1&nbsp;million, respectively. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Government contract payments
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company recognizes payments received from its funded research and development agreement with Defense Advanced Research Projects Agency
(DARPA) when milestones are achieved and records them as a reduction of research and development expenses. In the year ended September&nbsp;30, 2016, milestones met and recorded as a reduction of research and development costs totaled
$2.4&nbsp;million. There were no DARPA payments received during the year ended September&nbsp;30, 2017. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Redeemable convertible preferred stock
warrant liability </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Outstanding warrants that are related to the Company’s redeemable convertible preferred stock are classified as
liabilities on the balance sheet. As the warrants to purchase redeemable convertible preferred stock are exercisable into shares of convertible preferred stock, the Company has recognized a liability for the fair value of its warrants on the
consolidated balance sheets upon issuance and subsequently remeasures the liability to fair value at the end of each reporting period until the earlier of the expiration or exercise of the warrants. In connection with the closing of an initial
public offering, all of the outstanding warrants to purchase redeemable convertible preferred stock will automatically convert to warrants to purchase common stock, which qualify for equity classification and no further measurement will be required
thereafter. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Common stock warrants </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Warrants to purchase the Company’s common stock issued in conjunction with debt are recorded as additional <font style="white-space:nowrap"><font style="white-space:nowrap">paid-in-capital</font></font> and classified as equity on the consolidated balance sheets. During the year ended September&nbsp;30, 2017, the Company recorded $0.5&nbsp;million in additional
<font style="white-space:nowrap"><font style="white-space:nowrap">paid-in-capital</font></font> for the fair value of warrants to purchase common stock issued in connection with long-term debt. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Stock-based compensation </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company maintains
performance incentive plans under which incentive and nonqualified stock options are granted primarily to employees and may be granted to members of the Board of Directors and certain <font style="white-space:nowrap">non-employee</font> consultants.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company recognizes stock compensation in accordance with ASC&nbsp;718, <i>Compensation — Stock Compensation</i>. ASC&nbsp;718 requires the
recognition of compensation expense, using a fair value based method, for costs related to all <font style="white-space:nowrap">stock-based</font> payments including stock options. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-13 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company recognizes fair value of stock options granted to
<font style="white-space:nowrap">non-employees</font> as a stock-based compensation expense over the period in which the related services are received. The Company recognizes forfeitures as they occur. The Company believes that the estimated fair
value of stock options is more readily measurable than the fair value of the services rendered. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Net loss per share attributable to common
stockholders </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company calculates its basic and diluted net loss per share attributable to common stockholders in conformity with <font style="white-space:nowrap">the&nbsp;two-class&nbsp;method</font> required for companies with participating securities. In computing diluted net loss attributable to common stockholders, undistributed earnings
<font style="white-space:nowrap">are&nbsp;re-allocated&nbsp;to</font> reflect the potential impact of dilutive securities. The Company’s basic net loss per share attributable to common stockholders is calculated by dividing the net loss
attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. For purposes of the calculation of diluted net loss per share attributable to common stockholders, convertible preferred stock,
unvested shares of common stock issued upon the early exercise of stock options, warrants to purchase redeemable convertible preferred stock, warrants to purchase common stock, unvested restricted common stock and stock options to purchase common
stock are considered potentially dilutive securities but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is antidilutive.</font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Basic and diluted net loss per share of common stock attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders
by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase, and excludes any dilutive effects of employee stock-based awards and warrants. Because the Company has reported a net loss for
the years ended September&nbsp;30, 2016 and 2017, diluted net loss per common share is the same as the basic net loss per share for those years.</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The
Company considers all series of its convertible preferred stock to be participating securities as they are entitled to receive noncumulative dividends prior and in preference to any dividends on shares of common stock. Due to the Company’s net
losses, there is no impact on the loss per share calculation in applying <font style="white-space:nowrap">the&nbsp;two-class&nbsp;method</font> since the participating securities have no legal obligation to share in any losses.</font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Unaudited pro forma net loss per share</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Pro forma net
loss per share, basic and diluted was computed to give effect to the conversion of the Series A, Series B, Series&nbsp;C and Series D convertible preferred stock using the <font style="white-space:nowrap">as-if</font> converted method into common
shares as though the conversion had occurred as of the beginning of the period or the original date of issuance, if later. Also, the numerator has been adjusted to reverse the fair value adjustments related to the redeemable convertible preferred
stock warrants as they will become common stock warrants and at such time will no longer require periodic revaluation.</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Income taxes
</i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company accounts for income taxes using the asset and liability method whereby deferred tax asset and liability accounts are determined
based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are currently in effect. Valuation allowances are established where necessary to reduce deferred tax
assets to the amounts expected to be realized. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Recent accounting pronouncements </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) <font style="white-space:nowrap">2014-09,</font> <i>Revenue from Contracts with Customers (Topic 606)</i>, which
provides accounting guidance for all </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-14 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
revenue arising from contracts with customers, and supersedes most current revenue recognition guidance. The core principle of the new standard is that a company should recognize revenue to
depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The two permitted transition methods under the new
standard are the full retrospective method, in which case the standard would be applied to each prior reporting period presented and the cumulative effect of applying the standard would be recognized at the earliest period shown, or the modified
retrospective method, in which case the cumulative effect of applying the standard would be recognized at the date of initial application. The Company has adopted the new revenue standard using the full retrospective method. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In August 2014, the FASB issued <font style="white-space:nowrap">ASU&nbsp;2014-15,</font><i> Presentation of Financial Statements—Going Concern</i> which
requires an entity’s management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the
financial statements are issued or available to be issued and requires disclosure of those conditions and management’s plans. This standard is effective for the annual period ending after December&nbsp;15, 2016, with early adoption permitted.
The Company has adopted this standard for the year ended September&nbsp;30, 2017. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In April 2015, the FASB issued ASU
<font style="white-space:nowrap">2015-03,</font> <i>Simplifying the Presentation of Debt Issuance Costs</i>. The standard requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying amount of the
related debt liability, similar to debt discounts. The standard will be effective for financial statements issued for annual periods beginning after December&nbsp;15, 2015, and interim periods within those annual periods. Adoption of this new
standard did not have a material impact on the Company’s consolidated financial statements. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In September 2015, the FASB issued ASU <font style="white-space:nowrap">2015-16,</font> <i>Business Combinations</i>, to simplify accounting for adjustments made to provisional amounts recognized in a business combination by eliminating the requirement to retrospectively account for those
adjustments. This ASU is effective for financial statements issued for fiscal years beginning after December&nbsp;15, 2015, and interim periods within those fiscal years with early adoption permitted. The amendments in this ASU require that the
acquirer record, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization or other income effects as a result of changes to provisional amounts, calculated as if the accounting had been
completed at the acquisition date. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In November 2015, the FASB issued ASU <font style="white-space:nowrap">2015-17,</font><i>&nbsp;Balance Sheet Classification of Deferred Taxes</i>. The new standard
requires that the Company classify all deferred tax assets and liabilities as <font style="white-space:nowrap">non-current.</font> The new standard is effective for fiscal years beginning after December&nbsp;15, 2016, though early adoption is
permitted as of the beginning of an earlier interim or annual reporting period. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In February&nbsp;2016, the FASB issued new lease accounting guidance in <font style="white-space:nowrap">ASU&nbsp;2016-02,</font> <i>Leases</i>. Under the new
guidance, lessees will be required to recognize for all leases (with the exception of short-term leases) at the commencement date: (1)&nbsp;a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured
on a discounted basis; and (2)&nbsp;a <font style="white-space:nowrap"><font style="white-space:nowrap">right-of-use</font></font> asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for
the lease term. The new lease guidance is effective for fiscal years beginning after December&nbsp;15, 2018, including interim periods within those fiscal years. Early application is permitted. The Company is currently evaluating the impact that the
adoption of this standard will have on its consolidated financial statements. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-15 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">In March 2016, the FASB issued ASU <font style="white-space:nowrap">2016-09,</font> <i>Improvements to Employee
Share-Based Payment Accounting</i>, which impacts the accounting for stock-based payment transactions, including income tax consequences. The standard requires the tax impacts of stock-based awards to be reflected in the income statement and also
requires excess tax benefits to be classified as an operating cash flow. The standard also allows an entity to elect to account for forfeitures of stock-based awards as they occur. The standard is effective for the annual period beginning after
December&nbsp;15, 2017, with early adoption permitted. The Company early adopted this standard for the year ended September&nbsp;30, 2016 with no material impact on its consolidated financial statements. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In August 2016, the FASB issued ASU <font style="white-space:nowrap">2016-15,</font> <i>Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts
and Cash Payments</i>, which was intended to reduce diversity in practice in how certain cash receipts and payments are presented and classified in the statement of cash flows. The standard provides guidance in a number of situations including,
among others, settlement of zero-coupon bonds, contingent consideration payments made after a business combination, proceeds from the settlement of insurance claims, and distributions received from equity method investees. The ASU also provides
guidance for classifying cash receipts and payments that have aspects of more than one class of cash flows. The ASU is effective for fiscal years beginning after December&nbsp;15, 2017, and interim period within those fiscal years, with early
adoption permitted. The amendments in this update should be applied in retrospective transition for each period presented. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial
statements. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In November 2016, the FASB has issued ASU <font style="white-space:nowrap">2016-18,</font><i>&nbsp;Statement of Cash Flows (Topic 230):
Restricted Cash</i>.&nbsp;This ASU applies to all entities that have restricted cash or restricted cash equivalents and are required to present a statement of cash flows. The ASU requires that a statement of cash flows explain the change during the
period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. As a result, amounts generally described as restricted cash and restricted cash equivalents should be included with
cash and cash equivalents when reconciling the <font style="white-space:nowrap"><font style="white-space:nowrap">beginning-of-period</font></font> and <font style="white-space:nowrap"><font style="white-space:nowrap">end-of-period</font></font>
total amounts shown on the statement of cash flows. This ASU is effective for fiscal years beginning after December&nbsp;15, 2017, and interim periods within those fiscal years with early adoption is permitted. The Company is currently evaluating
the impact that the adoption of this standard will have on its consolidated financial statements. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In January 2017, the FASB has issued ASU <font style="white-space:nowrap">2017-01,</font><i>&nbsp;Business Combinations (Topic 805)</i>: <i>Clarifying the Definition of a Business</i>,&nbsp;clarifying the definition of a business. The ASU affects all companies and other reporting organizations
that must determine whether they have acquired or sold a business. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The ASU is effective for annual periods beginning after
December&nbsp;15, 2017, including interim periods within those periods. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In January 2017, the FASB issued ASU <font style="white-space:nowrap">2017-04,</font> <i>Intangibles — Goodwill and Other (Topic 350): Simplifying the Test for
Goodwill Impairment.</i> This ASU simplifies the subsequent measurement of goodwill. The ASU eliminates step&nbsp;2 from the goodwill impairment test, including for reporting units with a zero or negative carrying amount that fail a qualitative
test. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. This ASU should be applied on a prospective basis. This ASU is effective for annual or any
interim goodwill impairment tests in fiscal years beginning after December&nbsp;15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January&nbsp;1, 2017. The Company has not yet
determined whether it will early adopt this ASU. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-16 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">In May 2017, the FASB issued ASU
<font style="white-space:nowrap">2017-09,</font><i>&nbsp;Compensation</i><i></i>&nbsp;—<i>&nbsp;Stock Compensation (Topic 718): Scope of Modification Accounting</i>, which clarifies when to account for a change to the terms or conditions of a
stock-based payment award as a modification.&nbsp;Under ASU <font style="white-space:nowrap">2017-09,</font> modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or
liability) changes as a result of the change in terms or conditions. This standard is effective for all entities for annual reporting periods beginning after December&nbsp;15, 2017, including interim periods within that reporting period. Early
adoption is permitted. The Company is evaluating the impact that this standard will have on its consolidated financial statements. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>3. Acquisition
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In April 2016, pursuant to the terms of an agreement and plan of merger, the Company acquired&nbsp;100%&nbsp;of the outstanding shares of GCC. GCC
was incorporated in Delaware with one subsidiary (Genome Compiler Israel Ltd.) in Tel Aviv, Israel. GCC provided software for genetic engineers and molecular and synthetic biologists. The acquisition of GCC provided the Company with a gene design
tool as well as an experienced and highly skilled workforce to complement the Company’s operations and develop a digital products portfolio, including an <font style="white-space:nowrap">e-commerce</font> solution with synthetic DNA design
capabilities. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The results of GCC’s operations from the acquisition date forward and the fair values of the acquired assets and liabilities assumed
have been included in the consolidated financial statements. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The acquisition was completed in exchange for 4.0 million shares of common stock of the
Company which were valued at $2.4&nbsp;million at the time of the closing of the acquisition. The following table summarizes the fair values of assets acquired, liabilities assumed and goodwill. </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="92%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td colspan="2" valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash and cash equivalents</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">254</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">137</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Property and equipment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Goodwill</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,138</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Intangible assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,240</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Total assets acquired</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,776</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accounts payable</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(180</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accrued expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(173</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(23</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Net assets acquired</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2"><b>$</b></font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2"><b>2,400</b></font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2"><b>&nbsp;</b></font></td></tr>
<tr style="font-size:1px">
<td colspan="4" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The fair value of the intangible assets was estimated by determining the present value of estimated future operating cash flows
generated from existing technology. The fair values of the intangible assets were estimated by applying the income approach. The income approach is used to estimate fair value based on the income stream, such as cash flows or earnings that an asset
can be expected to generate over its useful life. Refer to Note 6 for further discussion on intangible assets acquired from the acquisition. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Goodwill is
not deductible for tax purposes and represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired. The goodwill is attributable to the workforce of the acquired business and the synergies expected
from the acquisition. Goodwill will not be amortized and will be tested for impairment at least annually. The pro forma effect of this acquisition as if it had occurred at the beginning of the year was not material to the consolidated financial
statements. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-17 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>4. Fair value measurement </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company assesses the fair value of financial instruments based on the provisions of ASC 820, <i>Fair Value Measurements</i>. ASC 820 defines fair value as the exchange price that would be received for an asset
or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy
which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Level 1</i>—Quoted prices in active markets for identical assets or liabilities. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Level 2</i>—Observable inputs other than Level&nbsp;1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can
be corroborated by observable market data for substantially the full term of the assets or liabilities. The Company short-term investments primarily utilizes broker quotes in a <font style="white-space:nowrap">non-active</font> market for valuation
of its short term investments. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><i>Level 3</i>—Unobservable inputs that are supported by little or no market activity and that are significant to
the fair value of the assets or liabilities. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable
inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table sets forth the cash, cash equivalents, and short-term investments as of September&nbsp;30, 2016: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="62%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Amortized<br>cost</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Gross<br>unrealized<br>gains</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Gross<br>unrealized<br>losses</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Fair<br>value</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash and cash equivalents</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,596</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,596</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Short-term investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">27,315</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">27,324</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">55,911</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">55,920</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table sets forth the cash, cash equivalents, and short-term investments as of September&nbsp;30, 2017: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="62%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Amortized<br>cost</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Gross<br>unrealized<br>gains</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Gross<br>unrealized<br>losses</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Fair<br>value</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash and cash equivalents</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">31,227</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">31,227</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Short-term investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">30,977</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">30,977</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">62,204</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">62,204</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-18 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">As of September&nbsp;30, 2016, financial assets and liabilities measured and recognized at fair value are as
follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="67%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Level&nbsp;1</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Level&nbsp;2</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Level&nbsp;3</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Fair&nbsp;value</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Assets</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Money market funds</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,596</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,596</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Corporate bonds</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,004</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,004</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Commercial paper</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,500</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,500</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">U.S. government treasury bonds</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">13,820</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">13,820</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,596</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">27,324</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">55,920</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Liabilities</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Redeemable convertible preferred</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">stock warrant liability</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">383</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">383</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of September 30, 2017, financial assets and liabilities measured and recognized at fair value are as follows: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="67%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Level 1</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Level 2</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Level&nbsp;3</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Fair&nbsp;value</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Assets</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash and cash equivalents<b></b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2"><b></b>$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2"><b></b>3,793</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2"><b></b>&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,793</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Money market funds</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">21,494</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">21,494</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Corporate bonds</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,707</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,707</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Commercial paper</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">22,742</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">22,742</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">U.S. government treasury bills</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,468</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,468</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">37,755</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,449</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">62,204</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Liabilities</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Redeemable convertible preferred</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">stock warrant liability</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">644</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">644</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Unrealized losses on cash equivalents and available–for–sale securities, which have been in an unrealized loss position
for greater than twelve months, were not material as of September 30, 2016 and 2017. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Contractual maturities of short–term investments held at
September 30, 2017 consists of amounts due within one year with an average maturity of 5.5 months. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-19 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i></i></b><b>Redeemable convertible preferred stock warrants</b><b><i> </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table provides a reconciliation of beginning and ending balances of the Level 3 instruments during the years ended September 30, 2016 and 2017:
</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="66%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Series&nbsp;A</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Series&nbsp;B</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Series&nbsp;C</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Series&nbsp;D</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Redeemable convertible preferred stock warrant liability:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Fair value at September 30, 2015</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">214</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">55</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Fair value related to issuance of redeemable convertible preferred stock warrants in connection with a loan agreement</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">–</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">141</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">41</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">182</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Changes in fair value recorded in other income (expense), net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(30</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(33</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(7</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(68</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="17" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Fair value as of September 30, 2016</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">184</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">57</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">108</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">34</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">383</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Change in fair value recorded in other income (expense), net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">147</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">53</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">44</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">261</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="17" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Fair value as of September 30, 2017</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">331</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">110</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">152</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">51</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">644</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>5. Balance sheet components </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Inventory consists of the following: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="84%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Raw Materials</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">847</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,243</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><font style="white-space:nowrap"><font style="white-space:nowrap">Work-in-process</font></font></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">266</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">385</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Finished Goods</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">115</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">199</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,228</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,827</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Property and Equipment, net consists of the following: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="80%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Laboratory equipment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">15,062</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">16,652</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Furniture, fixtures and other equipment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">398</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">553</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Computer equipment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,839</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,018</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Computer software</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,082</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,171</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Leasehold improvements</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,441</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Construction in progress</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,136</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,080</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">21,958</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,775</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Less: Accumulated depreciation and amortization</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(7,341</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(11,941</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,617</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,834</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>6. Goodwill and intangible assets </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company’s goodwill and intangible assets balances are the result of the acquisition of GCC (see Note 3). The Company recorded goodwill of $1.1&nbsp;million during the year ended September&nbsp;30, 2016 and
there were no changes to the carrying value of goodwill during the year ended September&nbsp;30, 2017. Total amortization </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-20 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
expense related to intangible assets was&nbsp;$0.1&nbsp;million for the year ended September&nbsp;30, 2016 and $0.2&nbsp;million for the year ended September&nbsp;30, 2017. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The intangible assets balances are presented below: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="61%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30, 2016</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except for years)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Useful&nbsp;lives<br>in years</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Gross<br>carrying<br>amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Accumulated<br>amortization</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Net&nbsp;book<br>value</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Developed Technology</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,220</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(102</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,118</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Tradenames&nbsp;&amp; Trademarks</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">20</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(5</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">15</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total indefinite-lived intangible assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,240</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(107</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,133</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr></tbody></table> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="63%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>

<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30, 2017</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Useful&nbsp;lives<br>in years</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Gross<br>carrying<br>amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Accumulated<br>amortization</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Net&nbsp;book<br>value</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Developed Technology</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,220</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(305</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">915</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Tradenames&nbsp;&amp; Trademarks</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">20</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(15</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total indefinite-lived intangible assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,240</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(320</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">920</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Future annual amortization expense is as follows (in thousands): </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="93%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top" style="BORDER-TOP:2px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2018</font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000" align="right"><font style="font-family:arial" size="2">208</font></td>
<td nowrap="" valign="bottom" style="BORDER-TOP:2px solid #000000"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2019</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">203</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2020</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">203</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2022</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">203</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Thereafter</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">103</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$920</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="4" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>7. Long-term debt </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In
October 2013, the Company entered into a Loan and Security Agreement (the First Loan) with Silicon Valley Bank (SVB) for loan amounts aggregating up to $3.0&nbsp;million in a series of up to three advances. The first advance was $2.0&nbsp;million
and the remaining two advances were $0.5&nbsp;million, each upon achieving the milestone of receiving a minimum of an additional $4.0&nbsp;million in Series A convertible preferred stock financing through September&nbsp;30, 2014. Each loan bore
interest at a fixed rate equal to 2.25% plus the Prime Rate as published by the Wall Street Journal but not less than 5.5% at the funding date of each advance. The debt provided interest-only payments from October 2013 through September 2014. A
final payment fee of $0.2&nbsp;million was due the earlier of the maturity date of March 2017 or the prepayment, acceleration demand by SVB, or termination of the loan. As part of the agreement, the Company issued a warrant to SVB to purchase
364,742 shares of Series&nbsp;A redeemable convertible preferred stock at an exercise price of $0.329 per share. In October&nbsp;2013, the Company drew down $2.0&nbsp;million of the loan at an interest rate of 5.5% as the prime rate was 3.25% at the
time. In February 2014, the Company drew down the remaining $1.0&nbsp;million of the First Loan, also at an interest rate of 5.5% as the prime rate was 3.25% at the time. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In September 2014, the Company entered into an Amended and Restated Loan and Security Agreement (the Second Loan) with SVB for loan amounts aggregating up to $10.0&nbsp;million in a series of up to three advances.
The first advance was in the amount of $3.2&nbsp;million. The second advance was up to $3.8&nbsp;million at any time after </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-21 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
the Company achieved a specified product launch through December&nbsp;31, 2015. The third advance was up to $3.0&nbsp;million at any time after the Company achieved cumulative revenue of
$5.0&nbsp;million. Each loan bore interest at the greater of the Prime Rate as published by the Wall Street Journal at the time or 3.25%. The debt provided interest-only payments during the first twelve months. A final payment fee of 3.75% of the
aggregate amount loaned was due the earlier of 42 months after the final tranche or the prepayment, acceleration demand by SVB, or termination of the loan. The Second Loan contained a subjective acceleration clause under which the loan could become
due and payable to SVB in the event of a material adverse change in the Company’s business, as determined by SVB. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">At the time of the Second Loan,
the Company drew down $3.2&nbsp;million to refinance the First Loan balance of $3.0&nbsp;million and the final payment fee of $0.2&nbsp;million. The Prime Rate and interest rate of the loan was 3.25%. As part of the Second Loan agreement, the
Company issued a warrant to SVB to purchase 160,606 shares of Series B redeemable convertible preferred stock at an exercise price of $0.792 per share. The Company accounted for this transaction as a debt modification. The Company did not incur any
gains or losses relating to the debt modification. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In April 2015, the Company entered into a Master Loan and Security Agreement with a separate lender
for loan amounts not to exceed $3.0 million. In May 2015, the Company borrowed $0.9&nbsp;million using certain computer equipment as collateral. The term of the loan was 24&nbsp;months and carried an interest rate of 4.44% with a final payment
amount representing 10% of the principal amount of the loan. The loan was paid-off in 2017. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In December 2015, the Company entered into a Second Amended
and Restated Loan and Security Agreement with SVB (the Third Loan), for loan amounts aggregating up to $15.0&nbsp;million in a series of three advances. The Third Loan contained an acceleration clause under which the loan could become due and
payable to SVB in certain events of default, including in the event of a material adverse change in the Company’s business. The term of the loan was 41 months with an interest rate equal to the greater of (i)&nbsp;the prime rate or
(ii)&nbsp;3.25%, and a final payment fee of 6% of the principal amount loaned. In addition, the Company obtained a revolving loan facility from SVB of up to $5.0&nbsp;million for which the principal amount outstanding under the revolving line would
accrue interest at a floating per annum rate equal to 1.00% above the Prime Rate, which interest was payable monthly. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The first advance, totaling
$7.0&nbsp;million, was drawn in December 2015 and comprised $3.3&nbsp;million to refinance the Second Loan and a new advance of $3.7&nbsp;million. The debt provided interest-only payments through December 31, 2016 at which time monthly principal
payments become due. In connection with this advance, the Company issued a warrant to purchase 186,679 shares of Series C redeemable convertible preferred stock at an exercise price of $1.4999 per share. The Company accounted for this transaction as
a debt modification and did not incur any gains or losses relating to the modification. The second advance, totaling $4.0&nbsp;million, was drawn in March 2016. In connection with this advance, the Company issued a warrant to purchase 74,567 shares
of Series D redeemable convertible preferred stock at an exercise price of $2.1457 per share. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In April 2016, the Company entered into a Third Amended
and Restated Loan and Security Agreement to include GCC as co-borrower on the loan. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In September 2017, the Company entered into a Fourth Amended and
Restated Loan and Security Agreement (the Fourth Loan) with SVB for loan amounts aggregating up to $20.0&nbsp;million in a series of three advances. The first advance provides a principal amount of $10.0 million, the second advance provides a
principal amount of $5.0 million and the third advance provides a principal amount of $5.0&nbsp;million during their respective draw down periods. In connection with the first advance the Company issued a warrant to purchase 634,921 shares of common
stock at an exercise price of $0.63 per share. If the Company draws down the second and third advances, the warrants would become exercisable for an additional 634,920 shares of common stock at an
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-22 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
exercise price of $0.63 per share. The Fourth Loan contains a subjective acceleration clause under which the Fourth Loan could become due and payable to SVB in the event of a material adverse
change in the Company’s business. The term of the loan was 51 months with an interest rate of prime plus 3.00% and a final payment fee of $0.7&nbsp;million. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The first advance, totaling $10.0&nbsp;million, was drawn in September 2017 and comprised $7.8&nbsp;million to refinance the Third Loan and a new advance of $2.2&nbsp;million. The debt provides for interest only
payments through December&nbsp;31, 2018 at which time monthly principal payments become due. In addition, the Company obtained a revolving loan facility for a principal amount of up to $10.0&nbsp;million for which the principal amount outstanding
under the revolving line would accrue interest at a floating per annum rate equal to one percentage point (1.00%) above the prime rate, which interest shall be payable monthly. The Company accounted for this transaction as a debt modification and
did not incur any gain or loss relating to the modification. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company’s credit facilities contain customary representations and warranties and
customary affirmative and negative covenants applicable to the Company and its subsidiaries, including, among other things, restrictions on changes in business, management, ownership or business locations, indebtedness, encumbrances, investments,
mergers or acquisitions, dispositions, maintenance of collateral accounts, prepayment of other indebtedness, distributions and transactions with affiliates. The credit facilities contain customary events of default subject in certain cases to grace
periods and notice requirements, including (a)&nbsp;failure to pay principal, interest and other obligations when due, (b)&nbsp;material misrepresentations, (c)&nbsp;breach of covenants, conditions or agreements in the credit facilities,
(d)&nbsp;default under material indebtedness, (e)&nbsp;certain bankruptcy events, (f)&nbsp;a material adverse change; (g)&nbsp;attachment, levy or restraint on business, (h)&nbsp;default with respect to subordinated debt, (i)&nbsp;cross default
under the Company’s credit facilities, and (j)&nbsp;government approvals being revoked. As of September 30, 2017, all rights, title and interest to the Company’s personal property with the exception of the Company’s intellectual
property, have been pledged as collateral, including cash and cash equivalents, short-term investments, accounts receivable, contractual rights to payment, license agreements, general intangibles, inventory and equipment. The Company was in
compliance with all covenants under the loan and security agreement with SVB as of September&nbsp;30, 2016 and September&nbsp;30, 2017. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Future
maturities of the loan as of September&nbsp;30, 2017 are as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="73%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Principal</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Interest</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Year ending September&nbsp;30,</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2018</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">715</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">715</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2019</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,500</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">673</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,173</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2020</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,333</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">440</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,773</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2021</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,333</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">194</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,527</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2022</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">834</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">844</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,032</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,032</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Less: Interest</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2,032</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total amount of loan principal</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Less unamortized debt discount</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(860</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Add accretion of final payment fee</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,154</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="12" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-23 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>8. Commitments and contingencies </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Litigation </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In February 2016, a complaint was filed in the Superior Court of the State of California
(County of Santa Clara), dated February&nbsp;3, 2016 on behalf of Agilent Technologies, Inc. (Agilent), against the Company and its CEO (the Complaint) alleging (i)&nbsp;breach of contract against the CEO, (ii)&nbsp;breach of duty of loyalty against
the CEO, and (iii)&nbsp;misappropriation of trade secrets by the Company and the CEO. The Company believes that the complaint is without merit, and intends to vigorously defend itself. The Company is currently unable to predict the ultimate outcome
of this matter or estimate a reasonably possible loss or range of loss, and no amounts have been accrued in the consolidated financial statements. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Indemnifications </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the ordinary course of business,
the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend the indemnified parties for losses suffered or incurred by the indemnified party. Some
of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to
make under these provisions is not determinable. To date, the Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. The Company has also entered into indemnification agreements with
its directors and officers that may require it to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by corporate law. The Company
also has directors’ and officers’ insurance. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Leases </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In July 2013, the Company entered into a non-cancelable operating lease agreement for office space in San Francisco with an expiration date of July 2016. In July 2014, the Company entered into a non-cancelable
operating sublease agreement for additional office space in the same building. In May 2015, the Company entered into an amendment to the lease agreement to increase the rentable premises with a new expiration date of September 2016. In June 2015,
the sublease agreement was terminated and the lease agreement was amended to include the additional office space. In January 2016, the Company extended the term of the lease for an additional three years with a new expiration date of September
2019.</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In July 2014, the Company entered into a non-cancelable operating sublease agreement for office space in San Francisco with an expiration date of
September 2016. In November 2015, the Company extended the term of this sublease by two years with a new expiration date of September 2018. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In May 2016,
the Company entered into a <font style="white-space:nowrap">non-cancelable</font> operating lease agreement for additional space in South San Francisco that expires in May 2019. Future minimum lease payments under all
<font style="white-space:nowrap">non-cancelable</font> operating leases as of September&nbsp;30, 2017 are as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="90%"></td>
<td valign="bottom" width="5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Operating<br>leases</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Years ended September&nbsp;30,</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2018</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,133</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2019</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,322</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2020</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">143</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total minimum lease payments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,598</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="4" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-24 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">Rent expense was $1.6&nbsp;million and $2.2&nbsp;million for the years ended September&nbsp;30, 2016 and 2017,
respectively. Rent expense is measured based upon amortizing minimum lease payments, including rent escalations under the lease term, using the straight-line method over the term of the lease. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The deferred rent liability was $0.1&nbsp;million as of September&nbsp;30, 2016 and 2017. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>9. Related party
transactions </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">During the year ended September&nbsp;30, 2016, the Company sold 1,252,176 shares of Series D redeemable convertible preferred stock.
The Company also purchased raw materials from a related party investor in the amount of $1.0&nbsp;million. Payable balances and receipts and receivable balances with the related party were immaterial as of September&nbsp;30, 2016. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">During the year ended September&nbsp;30, 2017, the Company sold 1,684,018 shares of Series D redeemable convertible preferred stock. The Company also purchased raw
materials from a related party investor in the amount of $2.0&nbsp;million. Payable balances and receipts and receivable balances with the related party were immaterial as of September&nbsp;30, 2017. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>10. Government research agreement </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In April 2014, the
Company entered into a fixed fee research agreement with DARPA to develop the capability for large-scale, high-throughput construction of genetic designs. The total initial value of the agreement is $2.4&nbsp;million which is comprised of eight base
milestones with each milestone assigned a certain fixed fee over a <font style="white-space:nowrap">12-month</font> period. The agreement also includes an additional ten optional milestones totaling $2.8&nbsp;million to be completed over a <font style="white-space:nowrap">12-month</font> period. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In July 2015, the DARPA agreement was amended to extend the project through the option period of an
additional year. In June 2016, the DARPA agreement was amended to remove two remaining milestones from the project reducing the value of the project by $0.6&nbsp;million. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">For the year ended September&nbsp;30, 2016 a total of $2.4&nbsp;million was recorded as a reduction in research and development costs. There were no DARPA payments received during the year ended September&nbsp;30,
2017. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>11. Income taxes </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company recorded an
immaterial provision for income taxes during the year ended September&nbsp;30, 2016 and $0.3&nbsp;million for the year ended September&nbsp;30, 2017.</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-25 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The significant components of the Company’s deferred tax assets and liabilities are as follows: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="80%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net operating loss carryforwards</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,854</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">50,312</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development credit carryforwards</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,581</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,050</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accruals</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">436</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">724</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">307</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">819</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><font style="white-space:nowrap">Sub-total</font></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">31,178</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">54,905</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Less: Valuation allowance</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(30,324</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(54,273</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net deferred tax assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">854</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">632</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Fixed assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(444</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(274</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Intangible assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(410</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(358</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net deferred tax liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(854</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(632</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total net deferred tax assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following is a reconciliation of the statutory federal income tax rate to the Company’s effective tax rate: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="86%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Tax expense computed at the federal statutory rate</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">35%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">35%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Change in valuation allowance</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(34)%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(35)%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development credit benefit</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1)%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1)%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total income tax expense</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">—%</font><br></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font><br></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Based on the available objective evidence, management believes it is more likely than not that the deferred tax assets will not be
fully realizable. Accordingly, the Company has provided a full valuation allowance against its deferred tax assets at September&nbsp;30, 2016 and 2017. For the year ended September&nbsp;30, 2016, the valuation allowance increased by
$14.7&nbsp;million due to increases in the Company’s deferred tax assets against which the Company records a full valuation allowance. The increase is comprised primarily of a $14.6&nbsp;million increase related to net operating loss
carryforwards and a $0.4&nbsp;million increase in research and development credits offset by an increase in deferred tax liabilities for intangible assets and fixed assets of $0.5&nbsp;million. For the year ended September&nbsp;30, 2017, the
valuation allowance increased by $24.0&nbsp;million due to increases in the Company’s deferred tax assets against which the Company records a full valuation allowance. The increase is comprised primarily of a $21.5&nbsp;million increase related
to net operating loss carryforwards and a $1.5&nbsp;million increase in research and development credits. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of September&nbsp;30, 2016, the Company had
net operating loss carryforwards of approximately $77.9&nbsp;million and $32.0&nbsp;million available to reduce future taxable income, if any, for federal and state income tax purposes, respectively. As of September&nbsp;30, 2017, the Company had
net operating loss carryforwards of approximately $134.9&nbsp;million and $81.2&nbsp;million available to reduce future taxable income, if any, for federal and state income tax purposes, respectively. The net operating losses will begin to expire in
2033. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company also had federal and state research and development credit carryforwards of approximately $2.6&nbsp;million and $2.7&nbsp;million,
respectively, at September&nbsp;30, 2017 and $1.3&nbsp;million and $1.4&nbsp;million, respectively, at September&nbsp;30, 2016. The federal credits will expire starting in 2033 if not utilized. The California research
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-26 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
and development credits have no expiration date. Utilization of the net operating losses and tax credits is subject to annual limitation due to the ownership change limitations provided by the
Internal Revenue Code and similar state provisions. Such annual limitations may result in the expiration of the net operating losses and tax credits before utilization. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The provisions of ASC <font style="white-space:nowrap">740-10,</font> <i>Accounting for Uncertainty in Income Taxes</i>, prescribe a comprehensive model for the recognition, measurement, and presentation and
disclosure in financial statements of any uncertain tax positions that have been taken or expected to be taken on a tax return. The Company has identified uncertain tax positions related to federal and state research and development credits. It is
unlikely that the amount of unrecognized tax benefits will materially change over the next year. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The aggregate changes in the balance of gross
unrecognized tax benefits are as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="91%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Federal<br>and&nbsp;state</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Balance as of September&nbsp;30, 2015</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">626</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Increases related to tax positions taken during 2016</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">196</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Balance as of September&nbsp;30, 2016</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">822</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Increases related to tax positions taken during 2017</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">562</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Increases related to tax positions in prior years</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">241</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Balance as of September&nbsp;30, 2017</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,625</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="4" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">It is the Company’s policy to include penalties and interest expense related to income taxes as a component of other expense
and interest expense, respectively, as necessary. The Company’s management determined that no accrual for interest and penalties was required as of September&nbsp;30, 2016 and 2017 due to the availability of net operating losses to offset any
tax adjustment. The Company’s tax years from 2013 through 2016 will remain open for examination by the federal and state authorities for three and four years, respectively, from the date of utilization of any net operating loss or tax credits.
The Company does not have federal or state tax examinations in progress. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>12. Warrants </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In connection with its long-term debt agreements, the Company issued warrants for its redeemable convertible preferred stock and common stock as follows: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="34%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except share and<br>per share data)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="2"><b>Number
of<br>shares<br>underlying<br>warrants</b></font></p> <p style="font-size:4px;margin-top:0px;margin-bottom:1px" align="left"><font size="1">&nbsp;</font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="2"><b>Fair<br>value</b></font></p>
<p style="font-size:4px;margin-top:0px;margin-bottom:1px" align="left"><font size="1">&nbsp;</font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td colspan="2" valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td colspan="2" valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td colspan="2" valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Warrant class/series:</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30,&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Issuance date</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Expiration date</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Exercise&nbsp;price<br>per share</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Series A</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">364,742</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">331</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">October&nbsp;8,&nbsp;2013</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">October&nbsp;8,&nbsp;2023</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.329</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Series B</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">160,606</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">110</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">September&nbsp;2,&nbsp;2014</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">September&nbsp;2,&nbsp;2024</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.792</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Series C</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">186,679</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">152</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">December,&nbsp;22,&nbsp;2015</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">December&nbsp;22,&nbsp;2025</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1.500</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Series D</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">74,567</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">51</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">March 28, 2016</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">March 28, 2026</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2.146</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total preferred stock warrants</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">786,594</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">644</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Common stock warrants</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">634,921</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">486</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">September&nbsp;6, 2017</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">September&nbsp;6, 2027</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.630</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="20" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The fair value of the Company’s warrant to purchase redeemable convertible preferred stocks was derived from values as
determined by management and approved by the Board of Directors. Management has determined </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-27 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
the fair value based primarily on analyses performed by the Company’s third-party valuation specialists under a hybrid valuation method which incorporates the per share values calculated
under the Option Pricing Method (OPM) and the Probability-Weighted Expected Return Method (PWERM) weighted appropriately to arrive at a fair market value of the warrants. Valuations performed by third-party valuation specialists were done
contemporaneously and used the methodologies, approaches, and assumptions consistent with the American Institute of Certified Public Accountants (AICPA) Accounting and Valuation Guide: <i>Valuation of Privately-Held-Company Equity Securities Issued
as Compensation</i> and Company specific factors. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On October&nbsp;8, 2013, in connection with a debt financing arrangement, the Company issued a warrant
to purchase 364,742 shares of Series A redeemable convertible preferred stock. The warrant was fully vested and immediately exercisable upon issuance and has an expiration date of October&nbsp;8, 2023. The Company determined the fair value of the
warrant granted was less than $0.1&nbsp;million on the date of issuance. For the years ending September&nbsp;30, 2016 and 2017, the Company used a hybrid method and determined the change in fair value of the warrant which was recorded in other
income (expense), net. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On September&nbsp;2, 2014, in connection with a debt financing arrangement, the Company issued a warrant to purchase 160,606
shares of Series B redeemable convertible preferred stock. The warrant was fully vested and immediately exercisable upon issuance and has an expiration date of September&nbsp;2, 2024. The Company determined the fair value of the warrant granted was
less than $0.1&nbsp;million on the date of issuance. For the years ending September&nbsp;30, 2016 and 2017, the Company used a hybrid method and determined the change in fair value of the warrant which was recorded in other income (expense), net.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On December&nbsp;22, 2015, in connection with a debt financing arrangement, the Company issued a warrant to purchase 186,679 shares of Series C
redeemable convertible preferred stock. The warrant was fully vested and immediately exercisable upon issuance and has an expiration date of December&nbsp;22, 2025. The Company determined the fair value of the warrant granted was $0.1&nbsp;million
on the date of issuance. For the years ending September&nbsp;30, 2016 and 2017, the Company used a hybrid method and determined the change in fair value of the warrant which was recorded in other income (expense), net. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On March 28, 2016, in connection with a debt financing arrangement, the Company issued a warrant to purchase 74,567 shares of Series D redeemable convertible
preferred stock. The warrant was fully vested and immediately exercisable upon issuance and has an expiration date of March 28, 2026. The Company determined the fair value of the warrant granted was less than $0.1&nbsp;million on the date of
issuance. For the years ending September&nbsp;30, 2016 and 2017, the Company used a hybrid method and determined the change in fair value of the warrant which was recorded in other income (expense), net. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As these warrants to acquire redeemable convertible preferred stock are classified as liabilities, any potential beneficial conversion feature related to those
underlying shares of convertible preferred would not be recognized until such time as the warrant is exercised. At that point, any excess of the fair value of the Company’s common stock into which the shares of redeemable convertible preferred
are convertible over the effective conversion price, measured as the sum of the carrying amount of the warrant liability and the exercise price of the warrant, would be recognized as a beneficial conversion feature and would reduce earnings
available to common stockholders in the calculation of earnings per share. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On September&nbsp;6, 2017, in connection with the September 2017 debt
refinancing,&nbsp;the Company issued a warrant to purchase 634,921 shares of common stock. The warrants were fully vested and immediately exercisable upon issuance and has an expiration date of&nbsp;September&nbsp;6, 2027. The Company determined the
fair value of the warrant granted was $0.5&nbsp;million. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-28 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The fair values of the warrants to purchase common stock were determined using the Black-Scholes option pricing
model with the following valuation assumptions: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="92%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top" style="BORDER-TOP:2px solid #000000"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Expected term (years)</font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000" align="right"><font style="font-family:arial" size="2">6.25</font></td>
<td nowrap="" valign="bottom" style="BORDER-TOP:2px solid #000000"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Expected volatility</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">65.5%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Risk-free interest rate</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2.02%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Dividend yield</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="4" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>13. Redeemable convertible preferred stock </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Redeemable convertible preferred stock as of September&nbsp;30, 2016 and 2017 consists of the following: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="47%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>

<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in&nbsp;thousands,&nbsp;except&nbsp;share&nbsp;and&nbsp;per&nbsp;share&nbsp;data)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="18" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30, 2016</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Series</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares<br>authorized</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Outstanding</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Price&nbsp;per<br>share</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Liquidation<br>amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Proceeds,<br>net*</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="bottom"><font style="font-family:arial" size="2">A</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,263,133</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">27,898,391</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.329</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,111</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,141</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom"><font style="font-family:arial" size="2">B</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,988,887</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,828,281</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.792</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">25,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="bottom"><font style="font-family:arial" size="2">C</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,854,989</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,668,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1.500</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">37,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">36,726</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom"><font style="font-family:arial" size="2">D</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">30,442,280</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">29,096,365</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2.146</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">62,432</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">62,270</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">116,549,289</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">114,491,347</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">134,543</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">134,037</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="20" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="47%"></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" colspan="12" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b>(in thousands, except share and per share
data)</b></font></p> <p style="font-size:4px;margin-top:0px;margin-bottom:1px"><font size="1">&nbsp;</font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000;border-bottom:1px solid #000000" align="right"><font style="font-family:arial" size="2"><b>September&nbsp;30,&nbsp;2017</b></font>
<p style="font-size:4px;margin-top:0px;margin-bottom:1px" align="left"><font size="1">&nbsp;</font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Series</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares<br>authorized</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Outstanding</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Price&nbsp;per<br>share</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Liquidation<br>amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Proceeds,<br>net*</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="bottom"><font style="font-family:arial" size="2">A</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,263,133</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">27,898,391</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.329</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,111</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,141</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom"><font style="font-family:arial" size="2">B</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,988,887</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,828,281</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.792</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">25,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="bottom"><font style="font-family:arial" size="2">C</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,854,989</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,668,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1.500</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">37,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">36,726</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom"><font style="font-family:arial" size="2">D</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">64,124,559</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">59,743,942</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2.146</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">128,193</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">127,866</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">150,231,568</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">145,138,924</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">200,304</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">199,633</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="20" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">*</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Net of issuance costs. </font></td></tr></tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The holders of preferred stock have various
rights and preferences as follows: </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Voting rights </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The holders of redeemable convertible preferred stock shares are entitled to vote on all matters on which the common stockholders are entitled to vote. Holders of redeemable convertible preferred stock and common
stock vote together as a single class, not as separate classes. Each holder of Redeemable convertible preferred stock is entitled to the number of votes equal to the number of common stock shares into which the shares held by such holder are
convertible. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Dividends </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The holders of
shares of Series D redeemable convertible preferred stock are entitled to receive, if declared by the board of directors, noncumulative dividends at the rate of 8% per share of the Series D issue price per annum. After dividends on the Series D
redeemable convertible preferred stock have been paid, then the Company may declare and distribute in such year dividends among the holders of shares of Series A, Series B, and Series C redeemable convertible preferred stock on a pari passu basis.
No dividends have been declared for any period through September&nbsp;30, 2017. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-29 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Liquidation preference </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The holders of redeemable convertible preferred stock are entitled to have their shares redeemed upon the occurrence of certain redemption events. A liquidation or winding up of the Company, a greater than 50%
change in control, or a sale of substantially all of its assets, sales or exclusive licenses of all or substantially all of the Company’s intellectual property would constitute a redemption event. As the redemption event is outside the control
of the Company, all shares of preferred stock have been presented outside of permanent equity. Further, the Company has not adjusted the carrying values of the Series A, Series B, Series C and Series D redeemable convertible preferred stock to the
redemption value of such shares, since it is uncertain whether or when a redemption event will occur. Adjustments to increase the carrying value to the redemption values will be made when it becomes probable that such redemption will occur.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In a liquidation, dissolution, or <font style="white-space:nowrap">winding-up</font> of the Company, either voluntary or involuntary, each holder of
Series D redeemable convertible preferred stock is entitled to be paid in cash before any amount is paid or distributed to the holders of the Series A, Series B or Series C redeemable convertible preferred stock or common stock at an amount per
share equal to the greater of $2.146 plus an amount equal to all accrued and declared but unpaid dividends on such share of Series D redeemable convertible preferred stock (adjusted for stock splits, stock dividends, combinations, recapitalizations
and the like) and the amount payable on shares of Series D redeemable convertible preferred stock had such shares been converted to shares of common stock immediately prior to such liquidation. If the amounts available for distribution by the
Company to holders of Series D redeemable convertible preferred stock upon a liquidation are not sufficient to pay the Series D amount due, holders of Series D redeemable convertible preferred stock share ratably in any distribution. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Upon the completion of the initial Series D liquidation amount described above, the remaining assets and funds of the Company available for distribution to its
stockholders shall be distributed to each holder of outstanding shares of Series A, Series B and Series C redeemable convertible preferred stock, who shall be entitled to paid in cash, on a pari passu basis based on the relative initial liquidation
amount of each series, before any amount shall be paid or distributed to the holders of common stock, an amount per share equal to (i) $0.329, in the case of Series A redeemable convertible preferred stock, (ii) $0.792, in the case of Series B
redeemable convertible preferred stock, and (iii) $1.500, in the case of Series C redeemable convertible preferred stock plus an amount equal to all accrued and declared but unpaid dividends on such share of Preferred Stock. Should the
Company’s legally available assets be insufficient to satisfy the liquidation preferences, the funds will be distributed ratably among the holders of Series&nbsp;A, Series&nbsp;B and Series C redeemable convertible preferred stock in proportion
to the preferential amount each holder is otherwise entitled to receive. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Conversion </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Each share of Series&nbsp;A, Series B, Series C and Series D redeemable convertible preferred stock is convertible, at the option of the holder, into the number of
shares of common stock into which such shares are convertible at the then-effective conversion ratio. The initial conversion price per share for Series&nbsp;A, Series&nbsp;B, Series C and Series D redeemable convertible preferred stock is $0.329,
$0.792, $1.500 and $2.146 per share, respectively. The initial conversion price or ratio is subject to adjustment due to securities issued by the Company subject to certain limited exceptions, including securities issued in the acquisition of
another entity, lending or equipment leasing transactions, and stock purchases, stock splits, stock dividends, reorganizations and public offerings. The current conversion ratio for each series of redeemable convertible preferred stock is 1:1.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Each share of Series A, Series B, Series C and Series D redeemable convertible preferred stock is convertible into common stock immediately prior to the
completion of an initial public offering at a per share price of not less than $2.65&nbsp;(as adjusted for stock splits, stock dividends, reclassification and the like) in which the Company receives aggregate net proceeds not less than $40,000,000,
and the common stock is listed for trading on the </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-30 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
New York Stock Exchange or the Nasdaq Global or Global Select Markets. Each share of preferred stock is also convertible into common stock upon the written election of the holders of at least 60%
of the then outstanding (i)&nbsp;Series A, Series B, Series C and Series D redeemable convertible preferred stock, voting together as a class on an <font style="white-space:nowrap">as-converted</font> to common stock basis and (ii)&nbsp;Series C and
Series D redeemable convertible preferred stock voting together as a single class on <font style="white-space:nowrap">as-converted</font> to common stock basis. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>14. Common stock </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The fair value of the shares of common stock underlying the Company’s stock options has
historically been determined by management and approved by the&nbsp;board of directors. Because there has been no public market for the Company’s common stock,&nbsp;management and the board of directors have determined the fair value of the
common stock at the time of grant of any&nbsp;options by considering a number of objective and subjective factors, including valuations performed by an independent third-party specialists, valuations of comparable companies, operating and financial
performance, the lack of liquidity of the common stock, recent private stock sale transactions and general and industry-specific economic outlooks. Valuations performed by third-party valuation specialists were completed and used the methodologies,
approaches, and assumptions consistent with the&nbsp;AICPA,&nbsp;Accounting and&nbsp;Valuation Guide: <i>Valuation of Privately-Held-Company Equity Securities Issued as Compensation</i> and Company specific factors. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of September&nbsp;30, 2017, the Company reserved sufficient shares of common stock for issuance upon conversion of preferred stock and exercise of stock options
and warrants. Each share of common stock is entitled to one vote. The holders of shares of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the board of directors, subject to prior rights
of the holders of preferred stock. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In February 2013, the Company issued a total of 18,000,000 shares of restricted common stock to Emily Leproust,
William Banyai and Bill Peck, or the Founders. The shares were issued at par value of $0.00001 per share in exchange for intellectual property and other assets. Of the shares issued, 20% were vested upon issuance and the remaining 80% were subject
to repurchase at par value if the holder was no longer an employee of, or service provider to, the Company. The number of shares subject to repurchase decreases ratably over 48 months starting on February&nbsp;1, 2013. As of September&nbsp;30, 2017,
all 18,000,000 shares have vested and are no longer subject to a right of repurchase. </font></p> <p style="margin-top:8px;margin-bottom:0px;padding-bottom:0px; "><font style="font-family:arial" size="2">In September 2013, the Company issued an
additional 1,013,171 shares of restricted common stock to each Founder. The purchase price for the shares was $0.04 per share of common stock. The purchase agreements for the shares stipulate that no shares would vest until the first commercial sale
of synthetic biology products or synthetic oligos, or the Milestone. Following the achievement of the Milestone, 100% of the total shares would vests on the 3</font><font style="font-family:arial" size="1"><sup style="vertical-align:baseline; position:relative; bottom:.8ex">rd</sup></font><font style="font-family:arial" size="2"> anniversary from the date of the Milestone, subject to the founders’ continuous service status. During the year ended
September&nbsp;30, 2015, the Milestone was achieved and vesting commenced. All shares are expected to be fully vested on May&nbsp;8, 2018, which is the 3</font><font style="font-family:arial" size="1"><sup style="vertical-align:baseline; position:relative; bottom:.8ex">rd</sup></font><font style="font-family:arial" size="2"> anniversary of the Milestone. As of September&nbsp;30, 2017, the total unrecognized compensation cost related to this award that
is expected to be recognized over a weighted-average period 0.7 years was immaterial. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company issued 523,421 shares of restricted common stock to a
board member in March 2014 at a purchase price of $0.04 per share. The shares vest over a <font style="white-space:nowrap">72-month</font> period on a monthly <font style="white-space:nowrap">pro-rata</font> basis over the vesting period at the date
of grant. Further, upon appointment to the board of directors, the vesting would be over a <font style="white-space:nowrap">36-month</font> period on a monthly <font style="white-space:nowrap">pro-rata</font> basis over the vesting period beginning
at date of appointment to the board of directors which occurred in July 2014. The agreement includes a repurchase option for the Company whereby, in the event of a voluntary or involuntary termination of the purchaser’s continuous service, for
any reason, the Company has an irrevocable, exclusive option for a period of three months from such date </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-31 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
to repurchase all or any portion of the unvested shares at the termination date at a value of the lesser of the original purchase price per share and the fair market value of the shares. All
shares were initially subject to the repurchase option. As of September&nbsp;30, 2017, all 523,421 shares of common stock had vested under this agreement. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In May 2016, the Company issued 3,170,000 shares of restricted common stock to employees. The purchase price was $0.60 per share. The shares vest monthly over a
period of 48 months from the date of issuance and the Company recognized $0.5&nbsp;million of compensation expense related to the restricted stock during the year ended September&nbsp;30, 2017. As of September&nbsp;30, 2017, there was
$1.2&nbsp;million of total unrecognized compensation cost related to this issuance that is expected to be recognized over a weighted-average period of 2.7 years. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>15. Stock option plan </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In 2013, the Company established the 2013 Plan, which provides for the granting of stock
options to employees, consultants and directors of the Company. Options granted under the 2013 Plan may be either incentive stock options, or ISOs, or nonqualified stock options, or NSOs. ISOs may be granted only to Company employees (including
officers and directors who are also employees). NSOs may be granted to Company employees, consultants and directors. As of September&nbsp;30, 2017, the Company has reserved 34,306,102 shares of common stock for issuance under the 2013 Plan.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The exercise price of an ISO and NSO shall not be less than 100% of the estimated fair value of the shares on the date of grant, respectively, as
determined by the board of directors. The exercise price of an ISO granted to an employee who at the time of grant is a 10% shareholder shall not be less than 110% of the estimated fair value of the shares on the date of grant, respectively, as
determined by the board of directors. Options granted under the 2013 Plan have a term of ten years and generally vest over a four-year period with 25% of the shares vesting on the first anniversary of the option and the remaining vesting ratably on
a monthly basis over the remaining <font style="white-space:nowrap">thirty-six</font> months. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Activity under the 2013 Plan from during the years ended
September&nbsp;30, 2016 and September&nbsp;30, 2017 is summarized below: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="46%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares<br>available</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Options<br>outstanding</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Weighted<br>average<br>exercise<br>price<br>per&nbsp;share</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Weighted<br>average<br>remaining<br>contractual<br>term</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">
<p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="2"><b>Aggregate<br>intrinsic</b></font></p>
<p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="2"><b>value</b></font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Outstanding at September&nbsp;30, 2015</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,377,752</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,711,502</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.47</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8.88</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,138,150</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Additional shares authorized</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,299,510</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Stock options granted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2,441,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,441,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.60</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Stock options exercised</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(390,727</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.39</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Stock options forfeited</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">527,980</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(527,980</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.51</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Restricted shares granted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(3,170,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Early exercised options repurchased</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">65,417</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Outstanding at September&nbsp;30, 2016</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,659,659</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,233,795</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.50</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8.81</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,343,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Additional shares authorized</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,251,883</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Stock options granted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(8,486,040</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,486,040</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.87</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Stock options exercised</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(322,687</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.56</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Stock options forfeited</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">379,837</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(379,837</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.56</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"></td>
<td colspan="9" valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Outstanding at September&nbsp;30, 2017</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,805,339</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,017,311</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.67</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9.14</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,147,115</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Vested or expected to vest and exercisable at September&nbsp;30, 2017</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,017,311</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.67</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9.14</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,147,115</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td colspan="20" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-32 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table summarizes information about stock options outstanding at September&nbsp;30, 2017:
</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="56%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="center" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Options outstanding</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="center" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Options exercisable</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Exercise price</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total<br>outstanding</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="2"><b>Weighted<br>average</b></font></p>
<p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="2"><b>remaining</b></font></p>
<p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="2"><b>contractual&nbsp;life</b></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"> <p style="margin-top:0px;margin-bottom:0px" align="right"><font style="font-family:arial" size="2"><b>Total</b></font></p>
<p style="margin-top:0px;margin-bottom:1px" align="right"><font style="font-family:arial" size="2"><b>exercisable</b></font></p></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Weighted<br>average<br>exercise<br>price</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">0.04</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">902,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5.26</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">902,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.04</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">0.12</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,023,479</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6.20</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,023,479</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.12</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">0.60</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,681,792</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9.30</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,681,792 </font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.60</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">0.63</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">315,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7.18</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">315,000 </font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.63</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">0.74</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">264,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9.59</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">264,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.74</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">0.89</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,831,040</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9.89</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,831,040 </font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.89</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,017,311</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9.14</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,017,311</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.67</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i><font style="white-space:nowrap">Stock-based</font> compensation </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">During the year ended September&nbsp;30, 2016, the Company granted stock options to employees and <font style="white-space:nowrap">non-employees</font> to purchase
2,441,000 shares of common stock with a weighted-average grant date fair value of $0.35. During the year ending September&nbsp;30, 2017, the Company granted stock options to employees and <font style="white-space:nowrap">non-employees</font> to
purchase 8,486,040 of common stock with a weighted average grant date fair value of $0.67. The Company recognized stock-based compensation expense of $0.9&nbsp;million and $1.9&nbsp;million, for the years ended September&nbsp;30, 2016 and 2017,
respectively. As of September&nbsp;30, 2017, there was $6.7&nbsp;million of total unrecognized compensation cost related to <font style="white-space:nowrap">non-vested</font> stock options under the 2013 Plan that is expected to be recognized over a
weighted-average period of 3.9 years. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Total stock-based compensation expense recognized was as follows: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="86%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cost of revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">112</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">202</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">261</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">575</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Selling, general and administrative</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">484</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,114</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total stock-based compensation</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">857</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,891</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company uses the Black-Scholes option pricing model to calculate the grant date fair value of a stock option. The Black-Scholes
model requires various assumptions, including the fair value of the Company’s common stock, expected term, expected dividend yield and expected volatility. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The expected volatility of the Company’s stock options is estimated from the historical volatility of selected public companies with comparable characteristics to it, including similarity in size and lines of
business. The expected term of stock options represents the period that the Company’s stock-options are expected to be outstanding before being exercised. The risk-free interest rate is based on the implied yield currently available on U.S.
treasury notes with terms approximately equal to the expected life of the option. The expected dividend rate is zero as the Company currently has no history or expectation of declaring cash dividends on the Company’s common stock. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-33 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">The fair value of options granted during the years ended September&nbsp;30, 2016 and 2017, respectively, were
calculated using the weighted average assumptions set forth below: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="86%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Expected term (years)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6.25</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6.25</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Expected volatility</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">64.4%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">65.5%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Risk-free interest rate</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1.44%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2.02%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Dividend yield</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0%</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Shares subject to repurchase </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company has a right of repurchase with respect to unvested shares issued upon early exercise of options at an amount equal to the original&nbsp;exercise price of each unvested share being repurchased. The
Company’s right to repurchase these shares lapses pursuant to the vesting schedule of the original grant, which is generally 25% on the first anniversary of the original grant and ratably on a monthly basis over the remaining 36 months.&nbsp;As
of&nbsp;September 30, 2017,&nbsp;442,561&nbsp;shares remain subject to the Company’s right of repurchase. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>16. Net loss per share attributable
to common stockholders and unaudited pro forma net loss per share </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table sets forth the computation of the Company’s basic and
diluted net loss per share attributable to common stockholders: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="74%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except share and per share data)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Numerator:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(44,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Denominator:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Weighted-average shares used in computing net loss per share, basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,511,202</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,982,605</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss per share attributable to common stockholders, basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2.38</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2.47</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The potentially dilutive common shares that were excluded from the calculation of diluted net loss per share because their effect
would have been antidilutive for the periods presented are as follows:</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="74%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Shares subject to options to purchase common stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,233,795</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,017,311</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Unvested restricted shares of common stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,518,559</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,086,804</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Unvested shares of common stock issued upon early exercise of stock options</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">770,379</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">442,561</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Shares subject to warrants to purchase redeemable convertible preferred stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">786,594</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">786,594</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Shares of redeemable convertible preferred stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">114,491,347</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">145,138,924</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">133,800,674</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">169,472,194</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-34 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Unaudited pro forma loss per share </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The table presents the calculation of basic and diluted pro forma net loss per share for the year ended September&nbsp;30, 2017 (in thousands, except share and per share data): </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="85%"></td>
<td valign="bottom" width="8%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="font-size:1pt">
<td height="5" style="BORDER-TOP:2px solid #000000">&nbsp;</td>
<td height="5" colspan="4" style="BORDER-TOP:2px solid #000000">&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><u>Numerator:</u></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders, basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Add: Change in fair value of redeemable convertible preferred stock warrant liability</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">261</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss used in computing pro forma net loss per share, basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(59,049</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><u>Denominator:</u></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Weighted-average shares used in computing net loss per share, basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,982,605</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Add: Pro forma adjustments to reflect assumed conversion of redeemable convertible preferred stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">128,414,454</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Weighted-average shares used in computing pro forma net loss per share, basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">152,397,059</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Pro forma net loss per share, basic and diluted (unaudited)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(0.39</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="4" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>17. Geographic and product information </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The table below sets forth revenues by geographic region, based on <font style="white-space:nowrap">ship-to</font> destinations. North America consists of Canada and Mexico; EMEA consists of Europe, Middle East,
and Africa; and APAC consists of Japan, China, South Korea, Singapore, Malaysia and Australia. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="83%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended<br>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">United States</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,769</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,243</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">EMEA</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">459</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,023</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">APAC</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">41</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">274</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">North America</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">227</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,767</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The table below sets forth revenues by products. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="83%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Years ended</b></font><br><font style="font-family:arial" size="2"><b>September
30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2016</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Synthetic genes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,087</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,122</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Oligo pools</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">862</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,056</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">DNA libraries</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">320</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">517</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">NGS tools</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">72</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,269</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,767</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Long lived assets located in the United States are $14.5&nbsp;million and $14.4&nbsp;million as of September&nbsp;30, 2016 and 2017.
Long lived assets located outside of the United States were $0.1&nbsp;million and $0.4&nbsp;million as of September&nbsp;30, 2016 and 2017. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-35 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>18. Subsequent events </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On October&nbsp;20, 2017, the Company issued 1,398,145 shares of Series D redeemable convertible preferred stock for an aggregate purchase price of $3.0&nbsp;million. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On December&nbsp;22, 2017, the Tax Cuts and Jobs Act of 2017, or Tax Act, was signed into law. The effect of the Tax Act will be recorded discretely as a component
of the Company’s provision for income taxes related to continuing operations in the period of enactment. The Tax Act reduced the corporate tax rate from 35% to 21% for tax years beginning after December&nbsp;31, 2017. A blended rate will apply
for <font style="white-space:nowrap">non-calendar</font> year companies for the fiscal periods that include the effective date of rate change. Changes in the deferred tax asset valuation allowance assessment due to the Tax Act will also be recorded
as part of the Company’s provision for income taxes related to continuing operations. The Tax Act repeals the Alternative Minimum Tax for tax years beginning after December&nbsp;31, 2017. For net operating losses arising after December&nbsp;31,
2017, utilization is limited to 80% of taxable income with an unlimited carryforward period. The Tax Act allows companies to expense 100% of the cost of qualified property placed in service after September&nbsp;27, 2017 and before January&nbsp;1,
2023, with normal depreciation rules applying after that period. Deductions for net interest expense are limited to 30% of adjusted taxable income. The Tax Act also introduces new international tax provisions, including a mandatory deemed
repatriation tax and the implementation of a territorial system by providing a 100% dividends received deduction. The Tax Act also contains new provisions intended to prevent the erosion of the United States tax base. The Company is in the process
of evaluating the impact of the Tax Act on its consolidated financial statements and expects the most significant impact to be a reduction of its deferred tax assets for net operating loss carryforwards offset by a corresponding reduction of the
deferred tax asset valuation allowance. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On December&nbsp;28, 2017, the Company issued 2,884,602 shares of Series D redeemable convertible preferred
stock for an aggregate purchase price of $6.2&nbsp;million. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company has performed an evaluation of subsequent events through February&nbsp;8, 2018,
which is the date the audited annual consolidated financial statements were available for issuance. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>19. Events subsequent to February&nbsp;8, 2018
(unaudited) </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On March&nbsp;19, 2018 and May&nbsp;29, 2018, the Company issued 23,302,418 and 9,320,967 shares of Series D redeemable convertible
preferred stock for an aggregate purchase price of $50.0&nbsp;million and $20.0&nbsp;million, respectively. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On March&nbsp;21, 2018, the Company entered
into a new non-cancelable lease agreement to rent office space in South San Francisco, California for a period of 84 months. Total minimum lease payments under the lease agreement are $26.6&nbsp;million, with lease payments ranging from
$1.4&nbsp;million to $4.1&nbsp;million per year from 2019 to 2026. In connection with the lease agreement, the Company entered into a letter of credit with a financial institution for $0.6&nbsp;million, which is collateralized by the Company’s
cash and cash equivalents. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On July 2, 2018 and July 3, 2018, the Company issued 5,126,530 and 466,048 shares of Series D redeemable convertible
preferred stock for an aggregate purchase price of $11.0 million and $1.0 million, respectively. </font></p>
<p style="margin-top:24px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;* </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-36 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="4"><b><a name="fin460243_7"></a>Twist Bioscience Corporation </b></font></p>
<p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="4"><b>Condensed consolidated balance sheets (unaudited) </b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="77%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>(In thousands, except share and per share amounts)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>September&nbsp;30,<br>2017</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>June&nbsp;30,<br>2018</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>Pro&nbsp;forma<br>June&nbsp;30,<br>2018</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1"><b>Assets</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Current assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Cash and cash equivalents</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">31,227</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">90,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">90,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Short-term investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">30,977</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,599</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,599</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Accounts receivable, net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,346</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">4,289</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">4,289</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Inventory</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,827</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">4,253</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">4,253</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Prepaid expenses and other current assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,492</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,735</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,735</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total current assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">67,869</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">103,776</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">103,776</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Property and equipment, net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">14,834</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">12,760</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">12,760</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Goodwill</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,138</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,138</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,138</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Intangible assets, net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">920</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">763</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">763</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Restricted cash, <font style="white-space:nowrap">non-current</font></font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">202</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">202</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">202</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Other <font style="white-space:nowrap">non-current</font> assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">694</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">4,026</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">4,026</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">85,657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">122,665</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">122,665</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1"><b>Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit)</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Current liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Accounts payable</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,849</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">4,502</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">4,502</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Accrued expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,092</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,610</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2,610</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Accrued payroll</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">3,470</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">3,379</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">3,379</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Current portion of long-term debt</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,667</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,667</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Other current liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">1,066</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">5,930</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">5,930</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total current liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9,477</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">18,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">18,088</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Redeemable convertible preferred stock warrant liability</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">644</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">710</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Long-term debt, net of current portion</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9,154</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">7,868</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">7,868</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Other <font style="white-space:nowrap">non-current</font> liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">107</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">253</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">253</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">19,382</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">26,919</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">26,209</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Commitments and contingencies (Note 6)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Redeemable convertible preferred stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Series A redeemable convertible preferred stock, $0.00001 par value—28,263,133 shares authorized as of September&nbsp;30, 2017 and
June&nbsp;30, 2018; 27,898,391 shares issued and outstanding as of September&nbsp;30, 2017 and June&nbsp;30, 2018. No shares authorized, issued or outstanding, pro forma as of June&nbsp;30, 2018 (Liquidation preference of $9,111 as of
September&nbsp;30, 2017 and June&nbsp;30, 2018)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9,141</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">9,141</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Series B redeemable convertible preferred stock, $0.00001 par value—32,988,887 shares authorized as of September&nbsp;30, 2017 and
June&nbsp;30, 2018; 32,828,281 shares issued and outstanding as of September&nbsp;30, 2017 and June&nbsp;30, 2018. No shares authorized, issued or outstanding, pro forma as of June&nbsp;30, 2018 (Liquidation preference of $26,000 as of
September&nbsp;30, 2017 and June&nbsp;30, 2018)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">25,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">25,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Series C redeemable convertible preferred stock, $0.00001 par value—24,854,989 shares authorized as of September&nbsp;30, 2017 and
June&nbsp;30, 2018; 24,668,310 shares issued and outstanding as of September&nbsp;30, 2017 and June&nbsp;30, 2018. No shares authorized, issued or outstanding, pro forma as of June&nbsp;30, 2018 (Liquidation preference of $37,000 as of
September&nbsp;30, 2017 and June&nbsp;30, 2018)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">36,726</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">36,726</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Series D redeemable convertible preferred stock, $0.00001 par value—64,124,559 and 103,715,367 shares authorized as of
September&nbsp;30, 2017 and June&nbsp;30, 2018, respectively; 59,743,942 and 96,650,074 shares issued and outstanding as of September&nbsp;30, 2017 and June&nbsp;30, 2018, respectively. No shares authorized, issued or outstanding, pro forma as of
June&nbsp;30, 2018. (Liquidation preference of $128,193 and $207,411 as of September&nbsp;30, 2017 and June&nbsp;30, 2018, respectively)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">127,866</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">206,738</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total redeemable convertible preferred stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">199,633</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">278,505</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Stockholders’ equity (deficit)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Common stock, $0.00001 par value—210,000,000 and 275,000,000 shares authorized at September&nbsp;30, 2017 and June&nbsp;30, 2018,
respectively; 31,474,045 and 31,916,884 shares issued and outstanding at September&nbsp;30, 2017 and June&nbsp;30, 2018, respectively. 213,961,940&nbsp;shares issued and outstanding at June&nbsp;30, 2018 pro forma</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="1">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">2</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Additional <font style="white-space:nowrap">paid-in</font> capital</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">6,228</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">8,226</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">287,439</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Accumulated other comprehensive income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">33</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">68</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">68</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Accumulated deficit</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(139,619</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(191,053</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(191,053</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total stockholders’ equity (deficit)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(133,358</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">(182,759</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">96,456</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="9" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="1">Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">85,657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">122,665</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="1">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="1">122,665</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="1">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="12" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-37 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="fin460243_8"></a>Twist Bioscience Corporation </b></font></p>
<p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b>Condensed consolidated statements of operations and comprehensive loss (unaudited) </b></font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="72%"></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months ended June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(In thousands, except share and per share amounts)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Operating expenses:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cost of revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,191</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,096</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,318</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">14,282</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Selling, general and administrative</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,651</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">30,497</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total operating expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">49,160</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">67,875</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss from operations</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(41,859</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(50,855</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest income</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">225</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">590</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest expense</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(657</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(927</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other income (expense), net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">151</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(76</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss before income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,140</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,268</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Provision for income taxes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(161</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(166</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,434</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other comprehensive loss:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Change in unrealized loss on investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(25</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Foreign currency translation adjustment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">35</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Comprehensive loss</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,320</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,399</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss per share attributable to common stockholders—basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1.80</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1.91</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Weighted average shares used in computing net loss per share attributable to common stockholders—basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,556,612</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,921,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Pro forma net loss per share—basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(0.28</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">Pro forma weighted-average shares used in computing pro forma net loss per share—basic and diluted</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">185,949,305</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-38 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="fin460243_9"></a>Twist Bioscience Corporation </b></font></p>
<p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b>Condensed consolidated statements of cash flows (unaudited) </b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="82%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="1"><b>Nine months ended<br>June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="1"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Cash flows from operating activities</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,434</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Adjustments to reconcile net loss to net cash used in operating activities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Depreciation and amortization</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,774</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,398</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Loss (Gain) on disposal of property and equipment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(113</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">55</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Stock-based compensation</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,027</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,875</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><font style="white-space:nowrap">Non-cash</font> interest expense</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">235</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">150</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Change in fair value of redeemable convertible preferred stock warrant liability</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">178</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">66</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Amortization of debt discount</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">66</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">230</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Changes in assets and liabilities, net of impact of business combination:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accounts receivable</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1,349</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1,943</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Inventory</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(583</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2,426</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Prepaid expenses and other current assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">36</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(796</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other <font style="white-space:nowrap">non-current</font> assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(253</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1,452</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accounts payable</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">62</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,539</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accrued expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1,923</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">518</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accrued payroll</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">482</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(90</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Other liabilities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">819</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(158</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net cash used in operating activities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(39,843</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(49,468</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Cash flows from investing activities</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Purchases of property and equipment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(3,255</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2,641</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Proceeds from sale of property and equipment</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">521</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Purchases of investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(20,130</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(3,374</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Maturity of investments</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">27,325</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net cash provided by investing activities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,461</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,902</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Cash flows from financing activities</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Proceeds from issuance of common stock and exercise of stock options</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">291</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">65,152</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">83,873</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Payments of deferred offering costs</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1,925</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Repayment of long-term debt</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(2,430</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net cash provided by financing activities</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">62,740</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">82,239</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net increase in cash and cash equivalents</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">27,358</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">59,673</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash and cash equivalents at beginning of year</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,596</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">31,227</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash and cash equivalents at end of period</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">55,954</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">90,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td colspan="8" valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Supplemental disclosure of cash flow information</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Interest paid</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">366</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">587</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Income taxes paid</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">20</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b><font style="white-space:nowrap">Non-cash</font> investing and financing activities</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Property and equipment additions included in accrued liabilities and accounts payable</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">320</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Deferred offering costs included in accounts payable and accrued expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">516</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-39 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="fin460243_10"></a>Twist Bioscience Corporation </b></font></p>
<p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b>Notes to condensed consolidated financial statements (unaudited) </b></font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>1. The company </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Twist Bioscience Corporation (the Company) was incorporated in the state of Delaware on
February&nbsp;4, 2013. The Company is a synthetic biology company that has developed a disruptive DNA synthesis platform. The Company’s fiscal year ends September 30. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company has generated net losses in all periods since inception. As of June&nbsp;30, 2018, the Company had an accumulated deficit of $191.1&nbsp;million and has not generated positive cash flows from operations
since inception. Losses are expected to continue as the Company continues to invest in product development, manufacturing, and sales and marketing. Based on its recurring losses from operations incurred since inception, expectation of continuing
operating losses for the foreseeable future, and need to raise additional capital to finance its future operations, the Company has concluded that there is substantial doubt about its ability to continue as a going concern within one year after the
date that the unaudited condensed consolidated financial statements are issued. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company has raised multiple rounds of debt and equity financing,
including an aggregate of $78.9&nbsp;million from the sale of preferred stock between October of 2017&nbsp;and June&nbsp;of 2018. However, there can be no assurance that additional financing will be successful in raising additional capital or that
such capital, if available, will be on terms which are acceptable to us. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">If the Company is unable to obtain funding, the Company could be forced to
delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or commercialization efforts, which could adversely affect its business prospects, or the Company may be unable to continue operations.
Failure to raise additional capital or generate sufficient cash flows from operations could have a material adverse effect on the Company’s ability to achieve its intended business objectives. Although management continues to pursue these
plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations, if at all. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Accordingly, the unaudited condensed consolidated
financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.
</font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>2. Summary of significant accounting policies </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Basis of presentation </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The accompanying unaudited
condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information. Certain information and disclosures normally
included in the consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated
financial statements and the related notes for the fiscal year ended September&nbsp;30, 2017. The condensed consolidated financial statements are unaudited and have been prepared on a basis consistent with that used to prepare the audited annual
consolidated financial statements and include, in the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair statement of the condensed consolidated
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-40 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
financial statements. The condensed consolidated balance sheet as of September&nbsp;30, 2017 was derived from the audited consolidated financial statements, but does not include all disclosures
required by GAAP. The operating results for the nine months ended June&nbsp;30, 2018 are not necessarily indicative of the results expected for the fiscal year ending September&nbsp;30, 2018. The Company’s unaudited condensed consolidated
financial statements include its wholly-owned subsidiaries. All intercompany balances and accounts are eliminated in consolidation. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Use of
estimates </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The presentation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make
estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenue and expenses during
the reporting period. Actual results could differ from those estimates. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Significant accounting policies </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">There have been no material changes in the accounting policies from those disclosed in the audited consolidated financial statements and the related notes.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Unaudited pro forma condensed consolidated balance sheet information </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Immediately prior to the completion of the initial public offering (IPO) contemplated herein, all outstanding shares of convertible preferred stock will automatically convert into shares of common stock. The
unaudited pro forma condensed consolidated balance sheet information at June&nbsp;30, 2018 gives effect to the conversion of all outstanding shares of the Company’s convertible preferred stock into 182,045,056&nbsp;shares of common stock. It
also gives effect to an automatic conversion of warrants to purchase 786,594&nbsp;shares of redeemable convertible preferred stock into warrants to purchase the same number of shares of common stock, which results in the reclassification of the
redeemable convertible preferred stock warrant liability to additional <font style="white-space:nowrap">paid-in</font> capital. The unaudited pro forma condensed consolidated balance sheet information does not give effect to the potential proceeds
from the Company’s contemplated initial public offering. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Unaudited pro forma net loss per share </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Pro forma net loss per share, basic and diluted was computed to give effect to the conversion of the Series A, Series B, Series C and Series D convertible preferred
stock using the <font style="white-space:nowrap">as-if</font> converted method into common shares as though the conversion had occurred as of the beginning of the period or the original date of issuance, if later. Also, the numerator has been
adjusted to reverse the fair value adjustments related to the redeemable convertible preferred stock warrants as they will become common stock warrants and at such time will no longer require periodic revaluation. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Deferred offering costs </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Deferred offering costs,
which consist of direct incremental legal, consulting, banking and accounting fees relating to the Company’s contemplated IPO, are capitalized and will be offset against proceeds upon the consummation of the offering within stockholders’
equity. In the event an anticipated offering is terminated, deferred offering costs will be expensed. As of September&nbsp;30, 2017, there was no capitalized deferred offering costs on the consolidated balance sheets. As of June&nbsp;30, 2018, there
are $2.4&nbsp;million of deferred offering costs within other non-current assets on the unaudited condensed consolidated balance sheets. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Recent
accounting pronouncements </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In May&nbsp;2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) <font style="white-space:nowrap">2014-09,</font> <i>Revenue from Contracts with Customers (Topic</i><i></i><i>&nbsp;606)</i>, which provides accounting guidance for all </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-41 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
revenue arising from contracts with customers, and supersedes most current revenue recognition guidance. The core principle of the new standard is that a company should recognize revenue to
depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The two permitted transition methods under the new
standard are the full retrospective method, in which case the standard would be applied to each prior reporting period presented and the cumulative effect of applying the standard would be recognized at the earliest period shown, or the modified
retrospective method, in which case the cumulative effect of applying the standard would be recognized at the date of initial application. The Company adopted the new revenue standard, on October&nbsp;1, 2017, using the full retrospective method.
</font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In February&nbsp;2016, the FASB issued new lease accounting guidance in <font style="white-space:nowrap">ASU&nbsp;2016-02,</font> <i>Leases</i>. Under
the new guidance, lessees will be required to recognize for all leases (with the exception of short-term leases) at the commencement date: (1)&nbsp;a lease liability, which is a lessee’s obligation to make lease payments arising from a lease,
measured on a discounted basis; and (2)&nbsp;a <font style="white-space:nowrap"><font style="white-space:nowrap">right-of-use</font></font> asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified
asset for the lease term. The new lease guidance is effective for fiscal years beginning after December&nbsp;15, 2018, including interim periods within those fiscal years. Early application is permitted. The Company is currently evaluating the
impact that the adoption of this standard will have on its consolidated financial statements. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In August&nbsp;2016, the FASB issued <font style="white-space:nowrap">ASU&nbsp;2016-15,</font> <i>Statement of Cash Flows (Topic</i><i></i><i>&nbsp;230): Classification of Certain Cash Receipts and Cash Payments</i>, which was intended to reduce diversity in practice in how certain cash
receipts and payments are presented and classified in the statement of cash flows. The standard provides guidance in a number of situations including, among others, settlement of <font style="white-space:nowrap">zero-coupon</font> bonds, contingent
consideration payments made after a business combination, proceeds from the settlement of insurance claims, and distributions received from equity method investees. The ASU&nbsp;also provides guidance for classifying cash receipts and payments that
have aspects of more than one class of cash flows. The ASU is effective for fiscal years beginning after December&nbsp;15, 2017, and interim period within those fiscal years, with early adoption permitted. The amendments in this update should be
applied in retrospective transition for each period presented. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In November&nbsp;2016, the FASB has issued <font style="white-space:nowrap">ASU&nbsp;2016-18,</font> <i>Statement of Cash Flows (Topic</i><i></i><i>&nbsp;230):
Restricted Cash</i>. This ASU applies to all entities that have restricted cash or restricted cash equivalents and are required to present a statement of cash flows. The ASU requires that a statement of cash flows explain the change during the
period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. As a result, amounts generally described as restricted cash and restricted cash equivalents should be included with
cash and cash equivalents when reconciling the <font style="white-space:nowrap"><font style="white-space:nowrap">beginning-of-period</font></font> and <font style="white-space:nowrap"><font style="white-space:nowrap">end-of-period</font></font>
total amounts shown on the statement of cash flows. This ASU is effective for fiscal years beginning after December&nbsp;15, 2017, and interim periods within those fiscal years with early adoption is permitted. The Company is currently evaluating
the impact that the adoption of this standard will have on its consolidated financial statements. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In January&nbsp;2017, the FASB has issued <font style="white-space:nowrap">ASU&nbsp;2017-01,</font> <i>Business Combinations (Topic</i><i></i><i>&nbsp;805): Clarifying the Definition of a Business</i>, clarifying the definition of a business. The ASU affects all companies and other reporting
organizations that must determine whether they have acquired or sold a business. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The ASU is effective for annual periods
beginning after December&nbsp;15, 2017, including interim periods within those periods. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-42 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">In January&nbsp;2017, the FASB issued <font style="white-space:nowrap">ASU&nbsp;2017-04,</font> <i>Intangibles
— Goodwill and Other (Topic</i><i></i><i>&nbsp;350): Simplifying the Test for Goodwill Impairment</i>. This ASU simplifies the subsequent measurement of goodwill. The ASU eliminates step 2 from the goodwill impairment test, including for
reporting units with a zero or negative carrying amount that fail a qualitative test. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. This ASU
should be applied on a prospective basis. This ASU is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December&nbsp;15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests
performed on testing dates after January&nbsp;1, 2017. The Company has not yet determined whether it will early adopt this ASU. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In May&nbsp;2017, the
FASB issued <font style="white-space:nowrap">ASU&nbsp;2017-09,</font> <i>Compensation — Stock Compensation</i> (Topic&nbsp;718)<i>: Scope of Modification Accounting</i>, which clarifies when to account for a change to the terms or conditions of
a stock-based payment award as a modification. Under <font style="white-space:nowrap">ASU&nbsp;2017-09,</font> modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or
liability) changes as a result of the change in terms or conditions. This standard is effective for all entities for annual reporting periods beginning after December&nbsp;15, 2017, including interim periods within that reporting period. Early
adoption is permitted. The Company is evaluating the impact that this standard will have on its consolidated financial statements. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>3. Fair value
measurement </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following tables present information about the Company’s financial assets and liabilities that have been measured at fair value
on a recurring basis as of September&nbsp;30, 2017 and June&nbsp;30, 2018, and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="67%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Fair&nbsp;Value&nbsp;Measurement&nbsp;at&nbsp;September&nbsp;30,&nbsp;
2017</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Level&nbsp;1</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Level&nbsp;2</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Level&nbsp;3</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Assets</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash and cash equivalents</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,793</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,793</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Money market funds</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">21,494</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">21,494</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Corporate bonds</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,707</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,707</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Commercial paper</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">22,742</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">22,742</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">U.S. government treasury bonds</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,468</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,468</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">37,755</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,449</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">62,204</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Liabilities</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Redeemable convertible preferred</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">stock warrant liability</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">644</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">644</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="64%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Fair Value Measurement at June&nbsp;30, 2018</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Level&nbsp;1</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Level&nbsp;2</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Level&nbsp;3</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Assets</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cash and cash equivalents</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">58,711</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">58,711</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Money market funds</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,189</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,189</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Commercial paper</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,599</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,599</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">90,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,599</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">92,499</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><b>Liabilities</b></font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Redeemable convertible preferred</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">stock warrant liability</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">710</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">710</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-43 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">As of September&nbsp;30, 2017 and June&nbsp;30, 2018, gross unrealized gains and unrealized losses for cash
equivalents and short-term investments were not material, and the contractual maturity of all marketable securities were less than one year. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Redeemable convertible preferred stock warrants </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The
following table provides a reconciliation of beginning and ending balances of the Level&nbsp;3 instruments during the nine months ended June&nbsp;30, 2018: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="66%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Series&nbsp;A</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Series&nbsp;B</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Series&nbsp;C</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Series&nbsp;D</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Total</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Redeemable convertible preferred stock warrant liability:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Fair value as of September&nbsp;30, 2017</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">331</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">110</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">152</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">51</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">644</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Changes in fair value recorded in other income (expense), net</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">43</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">16</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">66</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="17" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Fair value as of June&nbsp;30, 2018</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">374</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">126</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">154</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">56</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">710</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>4. Inventory </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Inventory
consists of the following: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="78%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Raw Materials</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,243</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">3,105</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Work-in-process</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">385</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">893</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Finished Goods</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">199</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">255</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">$</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">1,827</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">$</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="2">4,253</font></td>
<td nowrap="" valign="top"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>5. Goodwill and intangible assets </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">There were no changes to the carrying value of goodwill during the nine months ended June&nbsp;30, 2018. Total amortization expense related to intangible assets was $0.2&nbsp;million for the nine months ended
June&nbsp;30, 2017 and 2018. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="63%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30, 2017</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except for years)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Useful&nbsp;lives<br>in years</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Gross<br>carrying<br>amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Accumulated<br>amortization</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Net&nbsp;book<br>value</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Developed Technology</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,220</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(305</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">915</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Tradenames&nbsp;&amp; Trademarks</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">20</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(15</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total indefinite-lived intangible assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,240</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(320</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">920</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="63%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="14" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>June&nbsp;30, 2018</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Useful&nbsp;lives<br>in years</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Gross<br>carrying<br>amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Accumulated<br>amortization</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Net&nbsp;book<br>value</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Developed Technology</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,220</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(457</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">763</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Tradenames&nbsp;&amp; Trademarks</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">20</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(20</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="13" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total indefinite-lived intangible assets</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,240</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(477</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">763</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="16" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-44 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>6. Commitments and contingencies </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Litigation </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In February&nbsp;2016, a complaint was filed in the Superior Court of the State of
California (County of Santa Clara), dated February&nbsp;3, 2016 on behalf of Agilent Technologies, Inc., against the Company and its CEO alleging (i)&nbsp;breach of contract against the CEO, (ii)&nbsp;breach of duty of loyalty against the CEO, and
(iii)&nbsp;misappropriation of trade secrets by the Company and the CEO. The Company believes that the complaint is without merit, and intends to vigorously defend itself. The Company is currently unable to predict the ultimate outcome of this
matter or estimate a reasonably possible loss or range of loss, and no amounts have been accrued in the condensed consolidated financial statements. </font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Indemnifications </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In the ordinary course of business,
the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend the indemnified parties for losses suffered or incurred by the indemnified party. Some
of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to
make under these provisions is not determinable. To date, the Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. The Company has also entered into indemnification agreements with
its directors and officers that may require it to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by corporate law. The Company
also has directors’ and officers’ insurance. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Leases </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In March 2018, the Company entered into a <font style="white-space:nowrap">non-cancelable</font> lease agreement to rent office space in South San Francisco for a period of 84&nbsp;months. Total minimum lease
payments under the lease agreement are $26.6&nbsp;million, with lease payments ranging from $1.4&nbsp;million to $4.1&nbsp;million per year from 2019 to 2026. In connection with the lease agreement, the Company entered into a letter of credit with a
financial institution for $0.6&nbsp;million, which is collateralized by the Company’s cash and cash equivalents. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>7. Related party transactions
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">During the nine months ended June&nbsp;30, 2017 and 2018, the Company purchased raw materials from a related party investor in the amount of $1.3
million and $1.8&nbsp;million, respectively. Payable balances and receipts and receivable balances with the related party were immaterial as of June&nbsp;30, 2018. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>8. Income taxes </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In determining its provisions for income taxes, the Company uses the annual estimated
effective tax rate applied to the actual <font style="white-space:nowrap"><font style="white-space:nowrap">year-to-date</font></font> profit or loss, adjusted for discrete items arising in that quarter. The Company’s annual estimated effective
tax rate differs from the U.S. federal statutory rate primarily as a result of state taxes, foreign taxes, and changes in the Company’s valuation allowance against its deferred tax assets. For both the nine months ended June&nbsp;30, 2017 and
2018, the Company recorded provisions for income taxes of $0.2&nbsp;million. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On December&nbsp;22, 2017, the Tax Cuts and Jobs Act of 2017 (Tax Act) was
signed into law. The Tax Act includes significant changes to the U.S. corporate income tax system, including a permanent reduction in the corporate income tax rate from 35% to 21% effective January&nbsp;1, 2018, as well as changes that could impact
the tax treatment of foreign earnings. Additionally, the utilization of net operating losses generated in tax years beginning after December&nbsp;31, 2017 will be limited to 80% of taxable income with an unlimited carryforward period. The Company <font style="white-space:nowrap">re-measured</font> certain deferred tax assets and liabilities based on the rates at which they </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-45 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">
are expected to reverse in the future. The <font style="white-space:nowrap">re-measurement</font> of the deferred tax balance was offset by a corresponding change in the related valuation
allowance. The Company calculated its best estimate of the impact of the Tax Act in the quarter ending December&nbsp;31, 2017 in accordance with its understanding of the Tax Act and the Securities and Exchange Commission’s guidance available in
Staff Accounting Bulletin No.&nbsp;118. Accordingly, the provisional amounts recorded by the Company may vary from the final amounts as the Company finalizes its analysis of the impact of the Tax Act. </font></p>
<p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>9. Warrants </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">In connection with its long-term debt
agreements, the Company issued warrants for its redeemable convertible preferred stock and common stock as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="34%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"> <p style="margin-top:0px;margin-bottom:1px"><font style="font-family:arial" size="2"><b>(in thousands, except share and<br>per share data)</b></font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Number of<br>shares<br>underlying<br>warrants</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Fair<br>value</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" rowspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Issuance date</b></font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" rowspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Expiration</b></font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" rowspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Exercise&nbsp;price<br>per share</b></font></td>
<td valign="bottom" rowspan="2" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Warrant date class/series:</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>June&nbsp;30, 2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Series A</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">364,742</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">374</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">October&nbsp;8,&nbsp;2013</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">October&nbsp;8,&nbsp;2023</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.329</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Series B</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">160,606</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">126</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">September&nbsp;2,&nbsp;2014</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">September&nbsp;2,&nbsp;2024</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.792</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Series C</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">186,679</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">154</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">December&nbsp;22,&nbsp;2015</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">December&nbsp;22,&nbsp;2025</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1.500</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Series D</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">74,567</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">56</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">March&nbsp;28,&nbsp;2016</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">March&nbsp;28,&nbsp;2026</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2.146</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total preferred stock warrants</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">786,594</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">710</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Common stock warrants</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">634,921</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">486</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">September&nbsp;6,&nbsp;2017</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">September&nbsp;6,&nbsp;2027</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.630</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="20" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The fair value of the Company’s warrants to purchase redeemable convertible preferred stock was derived from values as
determined by management and approved by the board of directors. Management has determined the fair value based primarily on analyses performed by the Company’s third-party valuation specialists under a hybrid valuation method which
incorporates the per share values calculated under the Option Pricing Method and the Probability-Weighted Expected Return Method weighted appropriately to arrive at a fair market value of the warrants. Valuations performed by third-party valuation
specialists were done contemporaneously and used the methodologies, approaches, and assumptions consistent with the American Institute of Certified Public Accountants Accounting and Valuation Guide: <i>Valuation of Privately-Held-Company Equity
Securities Issued as Compensation</i> and Company specific factors. There were no material changes in the assumptions used to determine the fair value of the Company’s warrants to purchase redeemable convertible preferred stock during the nine
months ended June 30, 2018. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>10. Redeemable convertible preferred stock </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Redeemable convertible preferred stock as of September&nbsp;30, 2017 and June&nbsp;30, 2018 consists of the following: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="52%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except share and per share data)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="18" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>September&nbsp;30, 2017</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Series</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares<br>authorized</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Outstanding</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Price&nbsp;per<br>share</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Liquidation<br>amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Proceeds,<br>net*</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">A</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,263,133</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">27,898,391</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.329</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,111</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,141</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">B</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,988,887</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,828,281</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.792</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">25,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">C</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,854,989</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,668,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1.500</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">37,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">36,726</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">D</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">64,124,559</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">59,743,942</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2.146</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">128,193</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">127,866</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">150,231,568</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">145,138,924</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">200,304</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">199,633</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="20" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-46 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="52%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in&nbsp;thousands, except share and per share data)</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="18" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>June&nbsp;30, 2018</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Series</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares<br>authorized</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Outstanding</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Price&nbsp;per<br>share</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Liquidation<br>amount</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Proceeds,<br>net*</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">A</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">28,263,133</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">27,898,391</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.329</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,111</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,141</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">B</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,988,887</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">32,828,281</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.792</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">25,900</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">C</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,854,989</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,668,310</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1.500</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">37,000</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">36,726</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">D</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">103,715,367</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">96,650,074</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2.146</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">207,411</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">206,738</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">189,822,376</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">182,045,056</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">279,522</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">278,505</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="20" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">*</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Net of issuance costs. </font></td></tr></tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>11. Stock option plan </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Activity under the 2013 Plan from during the nine months ended June&nbsp;30, 2018 is summarized below: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="47%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Shares<br>available</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Options<br>outstanding</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Weighted<br>average<br>exercise<br>price per<br>share</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Weighted<br>average<br>remaining<br>contractual<br>term</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Aggregate<br>intrinsic<br>value</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Outstanding at September&nbsp;30, 2017</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">6,805,339</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">18,017,311</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.67</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9.14</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,147,115</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Additional shares authorized</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,968,188</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Stock options granted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(8,126,217</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8,126,217</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1.10</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Stock options exercised</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(538,258</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.53</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Stock options forfeited</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,604,662</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1,604,662</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.77</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Early exercised options repurchased</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">95,419</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Outstanding at June&nbsp;30,2018</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,347,391</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,000,608</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.81</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8.61</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,360,237</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Vested or expected to vest and become exercisable at June&nbsp;30, 2018</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,000,608</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">0.81</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">8.61</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">9,360,237</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="20" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Stock-based compensation </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Total stock-based compensation expense recognized was as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="84%"></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months<br>ended June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Cost of revenues</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">95</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">275</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Research and development</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">272</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">521</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Selling, general and administrative</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">660</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,079</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total stock-based compensation</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,027</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,875</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">As of June&nbsp;30, 2018, there was $10.2&nbsp;million of total unrecognized compensation cost related to <font style="white-space:nowrap">non-vested</font> stock options under the 2013 Plan that is expected to be recognized over a weighted-average period of 3.3 years. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-47 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>12. Net loss per share attributable to common stockholders and unaudited pro forma net loss per share
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders:
</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="74%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months ended June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands, except share and per share data)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Numerator:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(42,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,434</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Denominator:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Weighted-average shares used in computing net loss per share, basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">23,556,612</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,921,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss per share attributable to common stockholders, basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1.80</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(1.91</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The potentially dilutive common shares that were excluded from the calculation of diluted net loss per share because their effect
would have been antidilutive for the periods presented are as follows: </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="74%"></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine months ended June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Shares subject to options to purchase common stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,397,981</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">24,000,608</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Unvested restricted shares of common stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,284,929</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,452,917</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Unvested shares of common stock issued upon early exercise of stock options</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">508,442</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">484,333</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Shares subject to warrants to purchase redeemable convertible preferred stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">786,594</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">786,594</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Shares subject to warrants to purchase common stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">634,921</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Shares of redeemable convertible preferred stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">144,929,204</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">182,045,056</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">161,907,150</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">209,404,429</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>Unaudited pro forma net loss per share </i></b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The table presents the calculation of basic and diluted pro forma net loss per share for the nine months ended June&nbsp;30, 2018 (in thousands, except share and per share data): </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="85%"></td>
<td valign="bottom" width="8%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="font-size:1pt">
<td height="5" style="BORDER-TOP:2px solid #000000">&nbsp;</td>
<td height="5" colspan="4" style="BORDER-TOP:2px solid #000000">&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Numerator:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss attributable to common stockholders, basic, and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,434</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Add: Change in fair value of redeemable convertible preferred stock warrant liability</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">66</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Net loss used in computing pro forma net loss per share, basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(51,368</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Denominator:</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"></td>
<td valign="top"></td>
<td valign="top"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Weighted-average shares used in computing net loss per share, basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">26,921,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Add: Pro forma adjustments to reflect assumed conversion of redeemable convertible preferred stock</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">159,028,004</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Weighted-average shares used in computing pro forma net loss per share, basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">185,949,305</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="font-size:1pt">
<td height="8"></td>
<td height="8" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Pro forma net loss per share, basic and diluted</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">(0.28</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">)&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="4" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-48 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>13. Geographic, product and industry information </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The table below sets forth revenues by geographic region, based on <font style="white-space:nowrap">ship-to</font> destinations. North America consists of Canada and Mexico; EMEA consists of Europe, Middle East,
and Africa; and APAC consists of Japan, China, South Korea, Singapore, Malaysia and Australia. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="77%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="4"></td>
<td height="5" colspan="4"></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">United States</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,723</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,011</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">EMEA</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,342</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,116</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">APAC</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">105</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">740</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">North America</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">131</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">153</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The table below sets forth revenues by products. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="77%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Synthetic genes</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,379</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">11,903</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Oligo pools</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,512</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,146</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">DNA libraries</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">410</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,208</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">NGS tools</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td nowrap="" valign="bottom" align="right"><font style="font-family:arial" size="2">—</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">1,763</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td colspan="5" valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="8" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The table below sets forth revenues by industry. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<p style="font-size:0px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="77%"></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td>
<td valign="bottom" width="6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="6" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Nine&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>(in thousands)</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018</b></font></td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Industrial chemicals</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">5,237</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">12,350</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Academic research</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">2,019</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4,223</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Healthcare</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">4</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">25</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Agricultural</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">41</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">422</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">7,301</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">17,020</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Long lived assets located in the United States were $12.3&nbsp;million as of June&nbsp;30, 2018. Long lived assets located outside
of the United States were $0.5&nbsp;million as of June&nbsp;30, 2018. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>14. Subsequent events </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">On July&nbsp;2, 2018 and July&nbsp;3, 2018, the Company issued 5,126,530 and 466,048 shares of Series D redeemable convertible preferred stock for an aggregate
purchase price of $11.0&nbsp;million and $1.0&nbsp;million, respectively. The Company received $5.0&nbsp;million in advance on June&nbsp;29, 2018 in connection with the issuance and had recorded it in other current liabilities as the receipt was
refundable. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The Company has performed an evaluation of subsequent events through September&nbsp;11, 2018, which is the date the unaudited interim
condensed consolidated financial statements were available for issuance. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">F-49 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:48px;margin-bottom:0px" align="center"><font style="font-family:arial" size="5"><b><i>shares </i></b></font></p>
<p style="font-size:24px;margin-top:0px;margin-bottom:0px">&nbsp;</p> <p style="font-size:96px;margin-top:0px;margin-bottom:0px">&nbsp;</p> <p style="font-size:36px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<p style="margin-top:0px;margin-bottom:0px" align="center">


<img src="./S-1_files/g460243g03i96.jpg" alt="LOGO">
 </p> <p style="margin-top:24px;margin-bottom:0px" align="center"><font style="font-family:arial" size="5"><b><i>Common stock </i></b></font></p> <p style="margin-top:24px;margin-bottom:0px" align="center"><font style="font-family:arial" size="6"><b>Prospectus </b></font></p> <p style="font-size:24px;margin-top:0px;margin-bottom:0px">&nbsp;</p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="49%"></td>
<td valign="bottom" width="2%"></td>
<td width="47%"></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top" colspan="3" align="center"><font style="font-family:arial" size="3"><i>Joint book running managers</i></font></td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="5"><b>J.P. Morgan</b></font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="5"><b>Cowen</b></font></td></tr>
<tr style="font-size:1pt">
<td height="24" colspan="3"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top" colspan="3" align="center"><font style="font-family:arial" size="3"><i><font style="white-space:nowrap">Co-managers</font></i></font></td></tr>
<tr style="font-size:1pt">
<td height="10"></td>
<td height="10" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="4"><b>Allen&nbsp;&amp; Company LLC</b></font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="right"><font style="font-family:arial" size="4"><b>Baird</b></font></td></tr>
</tbody></table> <p style="margin-top:48px;margin-bottom:0px"><font style="font-family:arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018
</font></p> <p style="margin-top:16px;margin-bottom:0px;padding-bottom:0px; "><font style="font-family:arial" size="2"><b>Through and including &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2018
(the 25<font style="font-family:arial" size="1"><sup style="vertical-align:baseline; position:relative; bottom:.8ex">th</sup></font> day after the date of this prospectus), all dealers that buy, sell or trade in our common shares, whether or not
participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers’ obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.
</b></font></p>
</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b>Part II </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="5"><b>Information not required in prospectus </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Item&nbsp;13.
Other expenses of issuance and distribution </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The following table sets forth the costs and expenses, other than underwriting discounts and
commissions, payable by us in connection with the sale of common stock being registered. All amounts are estimates except the Securities and Exchange Commission registration fee, the FINRA filing fee and the Nasdaq Global Market listing fee.
</font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td width="87%"></td>
<td valign="bottom" width="4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000">&nbsp;<font size="1">&nbsp;</font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" colspan="2" align="right" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"><font style="font-family:arial" size="2"><b>Amount<br>to&nbsp;be&nbsp;paid</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Securities and Exchange Commission registration fee</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">10,453.50</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">FINRA filing fee</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">$</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">13,437.50</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Initial Nasdaq Global Market listing fee</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Printing and engraving expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Legal fees and expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Accounting fees and expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Blue Sky qualification fees and expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Transfer Agent and Registrar fees</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Miscellaneous fees and expenses</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td valign="bottom"></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td valign="bottom"> <p style="border-top:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-left:2.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Total</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td>
<td valign="bottom" align="right"><font style="font-family:arial" size="2">*</font></td>
<td nowrap="" valign="bottom"><font style="font-family:arial" size="2">&nbsp;</font></td></tr>
<tr style="font-size:1px">
<td colspan="4" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td>
<td>&nbsp;</td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">*</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">to be provided by amendment </font></td></tr></tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Item&nbsp;14. Indemnification of
directors and officers </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Section&nbsp;145 of the Delaware General Corporation Law, or the Delaware Law authorizes a court to award, or a
corporation’s Board of Directors to grant, indemnity to directors and officers in terms sufficiently broad to permit such indemnification under certain circumstances for liabilities (including reimbursement for expenses incurred) arising under
the Securities Act of 1933, as amended, or the Securities Act. Article VII of our Amended and Restated Certificate of Incorporation (Exhibit 3.2 hereto) and Article VI of our Bylaws (Exhibit 3.3 hereto) provide for indemnification of our directors,
officers, employees and other agents to the maximum extent permitted by Delaware Law. In addition, we have entered into Indemnification Agreements (Exhibit 10.1 hereto) with our officers and directors. These indemnification agreements also generally
require us to advance any expenses incurred by the directors or officers as a result of any proceeding against them as to which they could be indemnified. In addition, we have purchased a policy of directors’ and officers’ liability
insurance that insures our directors and officers against the cost of defense, settlement or payment of a judgment in some circumstances. The Underwriting Agreement (Exhibit 1.1) also provides for cross-indemnification among us, and the Underwriters
with respect to certain matters, including matters arising under the Securities Act. </font></p> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Item&nbsp;15. Recent sales of unregistered securities
</b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Since January&nbsp;1, 2015, we have issued and sold the following unregistered securities: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">From February&nbsp;4, 2015 to September 30, 2018, we issued stock options to certain of our service providers, executive officers and directors to purchase an
aggregate of 34,418,994 shares of the Company’s common stock under the 2013 Plan, with exercise prices ranging from $0.00001 to $1.20 per share. No consideration </font></p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">II-1 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%"><font size="1">&nbsp;</font></td>
<td valign="top"> <p><font style="font-family:arial" size="2">
was received for such stock options. Such issuances were deemed to be exempt from registration under the Securities Act pursuant to benefit plans and contract relating to compensation as provided
under Rule 701 promulgated under Section&nbsp;3(b) of the Securities Act. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">On May&nbsp;23, 2016, we issued an aggregate of 3,176,000 shares of common stock and stock purchase rights to certain of our service providers, executive
officers and directors pursuant to exercises of then-outstanding stock purchase rights under the 2013 Plan, with a purchase price of $0.60 per share. Such issuances were deemed to be exempt from registration under the Securities Act pursuant to
benefit plans and contracts relating to compensation as provided under Rule 701 promulgated under Section&nbsp;3(b) of the Securities Act. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">In May and June 2015, we sold an aggregate of 24,668,310 shares of our Series C convertible preferred stock at a purchase price of $1.4999 per share for an
aggregate purchase price of approximately $37&nbsp;million to 28 investors, each of whom represented to us that it was an accredited investor. Such issuances were deemed to be exempt from registration under the Securities Act in reliance upon
Regulation D promulgated under the Securities Act. </font></p></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">From December&nbsp;22, 2015 through September&nbsp;6, 2017, we issued warrants to investors to purchase 634,921 shares of our common stock and 261,246 shares of
our Series C and D convertible preferred stock, with exercise prices ranging from approximately $0.63 per share to $2.1457 per share. An additional warrant to purchase 634,920 shares of common stock at an exercise price of $0.63 per share and would
be exercisable upon the drawing down of additional loans under our amended and restated loan and security agreement with Silicon Valley Bank dated September&nbsp;6, 2017. No consideration was received for such warrants. Such issuances were deemed to
be exempt from registration under the Securities Act in reliance on Section&nbsp;4(a)(2) of the Securities Act as by an issuer not involving a public offering. </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Between April and September 2016, we issued an aggregate of 3,990,593 shares of the Company’s common stock in connection with our acquisition of Genome
Compiler Corporation. This transaction was exempt from the registration requirements of the Securities Act in reliance upon Regulation D promulgated under the Securities Act. </font></p></td></tr></tbody></table>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="1%" valign="top" align="left"><font style="font-family:arial" size="2">•</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"> <p align="left"><font style="font-family:arial" size="2">Between January 2016 and July 3, 2018, we sold an aggregate of 102,242,652 shares of our Series D convertible preferred stock at a purchase price of $2.1457 per
share for an aggregate purchase price of approximately $219.38&nbsp;million to 78&nbsp;investors, each of whom represented to us that it was an accredited investor and it intended to acquire the securities for investment only and not with a view to
the distribution thereof. Such issuances were deemed to be exempt from registration under the Securities Act in reliance upon Regulation D promulgated under the Securities Act. </font></p></td></tr></tbody></table>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">None of the foregoing transactions involved any underwriters, underwriting discounts or commissions or any public offering, and we believes each transaction was
exempt from the registration requirements of the Securities Act as stated above. All recipients of the foregoing transactions either received adequate information about the Company or had access, through their relationships with the Company, to such
information. Furthermore, the Company affixed appropriate legends to the share certificates and instruments issued in each foregoing transaction setting forth that the securities had not been registered and the applicable restrictions on transfer.
</font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">II-2 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Item&nbsp;16. Exhibits and financial statement schedules </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>(a)</i></b><i> Exhibits. </i></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td></td>
<td valign="bottom" width="8%"></td>
<td width="90%"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Number</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Description</b></font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;1.1**</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Form of Underwriting Agreement.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;3.1**</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Amended and Restated Certificate of Incorporation of Twist Bioscience Corporation, as currently in effect.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;3.2**</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Form of Amended and Restated Certificate of Incorporation of Twist Bioscience Corporation, to be in effect upon the completion of this
offering.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;3.3*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex33.htm">Bylaws of Twist Bioscience Corporation, as currently in effect. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;3.4**</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Form of Amended and Restated Bylaws of Twist Bioscience Corporation, to be in effect upon the completion of this
offering.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;4.1**</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Specimen Common Stock Certificate.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;4.2**</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Amended and Restated Stockholders Agreement by and among Twist Bioscience Corporation and certain holders of its capital stock, dated
January&nbsp;8, 2016, as amended.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;4.3**</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Amended and Restated Registration Rights Agreement by and among Twist Bioscience Corporation and certain holders of its capital stock,
dated January&nbsp;8, 2016, as amended.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;4.4*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex44.htm">Warrant to Purchase Stock by and between Twist Bioscience Corporation and Silicon Valley Bank, dated October&nbsp;8,
 2013. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;4.5*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex45.htm">Warrant to Purchase Stock by and between Twist Bioscience Corporation and Silicon Valley Bank, dated September&nbsp;2,
 2014. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;4.6*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex46.htm">Warrant to Purchase Stock by and between Twist Bioscience Corporation and Silicon Valley Bank, dated December&nbsp;22,
 2015. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;4.7*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex47.htm">Warrant to Purchase Stock by and between Twist Bioscience Corporation and Silicon Valley Bank, dated March&nbsp;28,
 2016. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;4.8*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex48.htm">Warrant to Purchase Common Stock by and between Twist Bioscience Corporation and Life Science Loans II, LLC, dated
 September&nbsp;6, 2017. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;4.9*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex49.htm">Warrant to Purchase Common Stock by and between Twist Bioscience Corporation and Silicon Valley Bank, dated September&nbsp;6,
 2017. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">&nbsp;&nbsp;5.1**</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Opinion of Orrick, Herrington&nbsp;&amp; Sutcliffe LLP.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.1*+</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex101.htm">2013 Stock Plan and forms of agreement thereunder. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.2**+</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2018 Equity Incentive Plan and forms of agreement thereunder.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.3**+</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">2018 Employee Stock Purchase Plan.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.4*+</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex104.htm">Executive Incentive Bonus Plan. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.5**+</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Amended and Restated Employment Agreement by and between Twist Bioscience Corporation and Emily M. Leproust, dated
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.6**+</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Amended and Restated Employment Agreement by and between Twist Bioscience Corporation and James Thorburn, dated
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.7**+</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Amended and Restated Employment Agreement by and between Twist Bioscience Corporation and Mark Daniels, dated
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</font></p></td></tr>
<tr style="font-size:1px">
<td colspan="3" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">II-3 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">


<tbody><tr>
<td></td>
<td valign="bottom" width="5%"></td>
<td width="90%"></td></tr>

<tr style="page-break-inside:avoid">
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Number</b></font></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" style="BORDER-TOP:2px solid #000000; BORDER-BOTTOM:1px solid #000000"><font style="font-family:arial" size="2"><b>Description</b></font></td></tr>


<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.8**+</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Form of Indemnification Agreement between Twist Bioscience Corporation and each of its Officers and Directors.</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.9*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex109.htm">Fourth Amended and Restated Loan and Security Agreement by and between Twist Bioscience Corporation, Silicon Valley
Bank and certain other <font style="white-space:nowrap">co-borrowers,</font> dated September&nbsp;6, 2017. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.10*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex1010.htm">Lease Agreement by and between Twist Bioscience Corporation and ARE—San Francisco No.&nbsp;
19, LLC, dated July&nbsp;26, 2013. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.10.1*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex10101.htm">First Amendment to Lease by and between Twist Bioscience Corporation and ARE—San Francisco No.&nbsp;
19, LLC, dated August&nbsp;7, 2013. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.10.2*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex10102.htm">Second Amendment to Lease by and between Twist Bioscience Corporation and ARE—San Francisco No.&nbsp;
19, LLC, dated May&nbsp;19, 2015. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.10.3*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex10103.htm">Third Amendment to Lease by and between Twist Bioscience Corporation and ARE—San Francisco No.&nbsp;
19, LLC, dated September&nbsp;23, 2015. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.10.4*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex10104.htm">Fourth Amendment to Lease by and between Twist Bioscience Corporation and ARE—San Francisco No.&nbsp;
19, LLC, dated January&nbsp;6, 2016. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.10.5*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex10105.htm">Fifth Amendment to Lease by and between Twist Bioscience Corporation and ARE—San Francisco No.&nbsp;
19, LLC, dated April&nbsp;12, 2016. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.11*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex1011.htm">Lease Agreement by and between Twist Bioscience Corporation and ARE—San Francisco No.&nbsp;
32, LLC, dated March&nbsp;21, 2018. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.12*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex1012.htm">Sublease Agreement by and between Twist Bioscience Corporation and Blade Therapeutics, Inc., dated May&nbsp;
25, 2016. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.13*†</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex1013.htm">Supply Agreement by and between Twist Bioscience Corporation and Ginkgo Bioworks, Inc., dated March&nbsp;
2, 2018. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">10.14*†</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex1014.htm">End User Supply Agreement by and between Twist Bioscience Corporation and FUJIFILM Dimatix, Inc., dated November&nbsp;5,
 2015. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">21.1*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex211.htm">List of Subsidiaries. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">23.1*</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243dex231.htm">Consent of PricewaterhouseCoopers LLP. </a></font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">23.2**</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">Consent of Orrick, Herrington&nbsp;&amp; Sutcliffe LLP (included in Exhibit 5.1).</font></p></td></tr>
<tr style="font-size:1pt">
<td height="5"></td>
<td height="5" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"><font style="font-family:arial" size="2">24.1</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#ii460243_sig">Power of Attorney (included in signature page). </a></font></p></td></tr>
<tr style="font-size:1px">
<td colspan="3" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td></tr>
</tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">*</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Filed herewith. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">**</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">To be filed by amendment. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">+</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Indicates a management or compensatory plan. </font></td></tr></tbody></table> <p style="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="2%" valign="top" align="left"><font style="font-family:arial" size="1">†</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="1">Portions of this exhibit (indicated by asterisks) have been omitted pursuant to a request for confidential treatment that has been separately filed with the Securities and
Exchange Commission. </font></td></tr></tbody></table> <p style="margin-top:16px;margin-bottom:0px"><font style="font-family:arial" size="2"><b><i>(b)</i></b><i> Financial statements schedules</i><b><i>. </i></b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">No financial statement schedules are provided because the information required to be set forth therein is not applicable or is shown in the consolidated financial
statements or notes thereto. </font></p>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">II-4 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="3"><b>Item&nbsp;17. Undertakings </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreements certificates in such denominations and registered in such names as required by the
underwriters to permit prompt delivery to each purchaser. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is
against public policy as expressed in the Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer, or
controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the
final adjudication of such issue. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">The undersigned registrant hereby undertakes that: </font></p>
<p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">(1)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in
reliance upon Rule&nbsp;430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was
declared effective. </font></td></tr></tbody></table> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="page-break-inside:avoid">
<td width="3%" valign="top" align="left"><font style="font-family:arial" size="2">(2)</font></td>
<td width="1%" valign="top"><font size="1">&nbsp;</font></td>
<td align="left" valign="top"><font style="font-family:arial" size="2">For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">II-5 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="5"><b>Signatures </b></font></p>
<p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the city of San Francisco, State of California on October&nbsp;2, 2018. </font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p><div align="right">
<table cellspacing="0" cellpadding="0" width="40%" border="0" style="BORDER-COLLAPSE:COLLAPSE">


<tbody><tr>
<td width="7%"></td>
<td valign="bottom" width="1%"></td>
<td width="92%"></td></tr>


<tr style="page-break-inside:avoid">
<td valign="top" colspan="3"><font style="font-family:arial" size="2"><b>TWIST BIOSCIENCE CORPORATION</b></font></td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top" align="center"><font style="font-family:arial" size="2">By:</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top"> <p style="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em"><font style="font-family:arial" size="2">/s/ Emily M. Leproust</font></p></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2"><b>Emily M. Leproust</b></font></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="bottom"><font style="font-family:arial" size="2"><b>President and Chief Executive Officer</b></font></td></tr>
</tbody></table></div> <p style="margin-top:24px;margin-bottom:0px"><font style="font-family:arial" size="5"><b><a name="ii460243_sig"></a>Power of attorney </b></font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints, jointly and severally, Emily M. Leproust, James M. Thorburn and Mark Daniels, and each of them, as
his <font style="white-space:nowrap"><font style="white-space:nowrap">attorney-in-fact,</font></font> with full power of substitution, for him in any and all capacities, to sign any and all amendments to this Registration Statement (including <font style="white-space:nowrap">post-effective</font> amendments), and any and all Registration Statements filed pursuant to Rule&nbsp;462 under the Securities Act of 1933, as amended, in connection with or related to the offering contemplated by this
Registration Statement and its amendments, if any, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be
signed by our said attorney to any and all amendments to said Registration Statement. </font></p> <p style="margin-top:8px;margin-bottom:0px"><font style="font-family:arial" size="2"><b>Pursuant to the requirements of the Securities Act of 1933, as
amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated: </b></font></p> <p style="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE">


<tbody><tr>
<td width="40%"></td>
<td valign="bottom" width="1%"></td>
<td width="35%"></td>
<td valign="bottom" width="2%"></td>
<td width="21%"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="bottom" align="center" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2"><b>Signature</b></font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" align="center" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2"><b>Title</b></font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" align="center" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2"><b>Date</b></font></p></td></tr>


<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000" align="center"><font style="font-family:arial" size="2">/s/ Emily M. Leproust</font></p> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2">Emily M. Leproust</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:arial" size="2">President and Chief Executive</font></p> <p style="margin-top:0px;margin-bottom:1px"><font style="font-family:arial" size="2">Officer (principal
executive officer)</font></p></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">October&nbsp;2, 2018</font></td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000" align="center"><font style="font-family:arial" size="2">/s/ James M. Thorburn</font></p> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2">James M. Thorburn</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">Chief Financial Officer (principal financial officer and accounting officer)</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">October&nbsp;2, 2018</font></td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000" align="center"><font style="font-family:arial" size="2">/s/ William Banyai</font></p> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2">William Banyai</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">Director</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">October&nbsp;2, 2018</font></td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000" align="center"><font style="font-family:arial" size="2">/s/ Robert Chess</font></p> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2">Robert Chess</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">Director</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">October&nbsp;2, 2018</font></td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000" align="center"><font style="font-family:arial" size="2">/s/ Paul A. Conley</font></p> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2">Paul A. Conley</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">Director</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">October&nbsp;2, 2018</font></td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000" align="center"><font style="font-family:arial" size="2">/s/ Keith Crandell</font></p> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2">Keith Crandell</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">Director</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">October&nbsp;2, 2018</font></td></tr>
<tr style="font-size:1px">
<td colspan="5" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td></tr></tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">II-6 </font></p>

</div></center>


<p style="page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left"><a href="https://www.sec.gov/Archives/edgar/data/1581280/000119312518291186/d460243ds1.htm#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE">


<tbody><tr>
<td width="40%"></td>
<td valign="bottom" width="1%"></td>
<td width="35%"></td>
<td valign="bottom" width="2%"></td>
<td width="21%"></td></tr>

<tr style="page-break-inside:avoid">
<td valign="bottom" align="center" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2"><b>Signature</b></font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="bottom" align="center" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2"><b>Title</b></font></p></td>
<td valign="bottom" style=" BORDER-TOP:2px solid #000000"><font size="1">&nbsp;</font></td>
<td valign="bottom" align="center" style="BORDER-TOP:2px solid #000000;border-bottom:1px solid #000000"> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2"><b>Date</b></font></p></td></tr>


<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000" align="center"><font style="font-family:arial" size="2">/s/ Frederick Craves</font></p> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2">Frederick Craves</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">Director</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">October&nbsp;2, 2018</font></td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000" align="center"><font style="font-family:arial" size="2">/s/ Xiaoying Mai</font></p> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2">Xiaoying Mai</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">Director</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">October&nbsp;2, 2018</font></td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid">
<td valign="top"> <p style="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000" align="center"><font style="font-family:arial" size="2">/s/ Robert Ragusa</font></p> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:arial" size="2">Robert Ragusa</font></p></td>
<td valign="bottom"><font size="1">&nbsp;&nbsp;</font></td>
<td valign="top"><font style="font-family:arial" size="2">Director</font></td>
<td valign="bottom"><font size="1">&nbsp;</font></td>
<td valign="top" align="center"><font style="font-family:arial" size="2">October&nbsp;2, 2018</font></td></tr>
<tr style="font-size:1px">
<td colspan="5" valign="top"> <p style="border-bottom:1px solid #000000">&nbsp;</p></td></tr>
</tbody></table>
 <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:arial" size="2">II-7 </font></p>

</div></center>


</text>
</description></filename></sequence></type></document>
</body></html>